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PREFACE
Contemporary science (as scientists know only too well) is 
flooded with an ocean of unselected information. Despite inter­
national efforts to bring order among the immense number of 
scientific meetings held each year and to rank the wild forest 
of journals according to their immediacy, impact factor and 
many other indices characterizing their values, the jungle of 
information is becoming larger and more disorganized day by 
day. Creative scientific communities are trying to safeguard 
their integrity - of course without losing the unquestionable 
benefit of quick information exchange - by organizing small 
symposia, attended mostly by invited persons, where narrower 
scientific fields can be thoroughly treated and dicussed by the 
well-known celebrities of that field.
Everyone has to start his scientific career as a beginner 
with the possible exception of a genius.To avoid the exclusion 
of very promising young scientists from a mini-symposium and to 
take full advantage of the opportunity for these young people 
to meet an excellent selection of internationally known scien­
tists, a new organizational form was tested. At the Debrecen 
Medical University School of Hungary all the necessary facili­
ties are provided for the organization of successful small 
meetings on selected scientific topics. The experimental insti­
tutes of this university campus in Eastern Hungary have long 
traditions and the necessary organizational skill. This year, 
for the first time in the long line of earlier, really success­
ful symposia, such a mini-symposium was combined with an ad­
vanced course for young scientists. Thus, the original aim,
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i.e., the possibility of high level discussions among selected 
renowned scientists, was maintained without losing the oppor­
tunity to include promising members of the younger generation.
The Department of Biophysics was host to the experimental 
lessons, and the themes were coorganized with the Institute of 
Enzymology of the Hungarian Academy of Sciences.
The topics of the theoretical lessons could clearly be 
divided into five main parts:
1) Kinetics and mechanism of enzymes and metabolic 
networks
2) Dynamics of protein and nucleic acid structure
3) Dynamics of multienzyme complexes and metabolic 
pathways
4) Enzyme kinetics and regulation
5) Membrane dynamics
For those who are familiar with these fields it is im­
mediately obvious that the first four subjects represent a 
broader field and the last subject is strongly interdependent 
with the four others. The content of this book reflects the 
high scientific quality of the presentations, and the discus­
sions following the presentations give the reader an insight 
into the sometimes heated, but always relevant and objective, 
arguing of eminent scientists about their very up-to-date re­
sults and concepts. Although the experimental parts could not 
be included here, all participants of the summer school re­
ceived them before the actual experimental hours.
Thanks are due to those organizations who supported this 
fruitful meeting: among them the Federation of European Bio­
chemical Societies, the International Union of Biochemistry, 
the Hungarian Academy of Sciences, the Hungarian Societies of 
Biochemistry and Biophysics, the Regional Committee of the 
Hungarian Academy of Sciences and last, but not at all least, 
the two organizing institutes: the Institute of Enzymology of 
the Hungarian Academy of Sciences and the Department of Bio­
physics of the Debrecen Medical University School.
The skilled contribution of many coworkers is gratefully 
acknowledged. We hope that all guests and participants were
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satisfied with the pleasant atmosphere of the surroundings and 
enjoyed their stay with us.
The rapid publication of the proceedings with the generous 
help of the Publishing House of the Hungarian Academy of 
Sciences is part of our cherished traditions.
The Editors
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KINETIC POWER AND THEORY OF CONTROL
KELETI, T. and VÉRTESSY, B.
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Hungarian Academy of Sciences, Budapest, Hungary 
H-1502 Pf. 7
The evolution of living beings is based on the evolution 
of the 1./ individual macromolecules, 2./ metabolic pathways,
3./ regulation of the organism.
The evolution of the individual enzymes is considered to 
be linked to the free-energy change associated with the 
transient state barrier (Welch and Keleti 1981). The measure 
of the evolutionary "perfection" is the kinetic power, i.e. 
V m a x /KM = (Keleti and Welch 1984). The resultant of 
individual transition-state barriers (of the optimally evolved 
kinetic powers) influences the efficacy of the overall 
metabolic pathway in which the considered enzymes take place. 
Consequently the metabolic pathways which,at one hand,are the 
result of biological evolution, on the other hand,are also 
subject of the evolution. As a result of selection processes 
the metabolic pathways are characterized by more and more 
effective coherent functioning of the various elements and 
subsystems. Such a selection pressure leads to the formation 
of the cytosociological behaviour of the enzymes which 
renders them able to respond to the complete spectrum of
extrinsic factors (Welch and Keleti 1981). Therefore, the 
whole multienzyme sequence of a given biochemical pathway is 
the most likely focus in the evolutionary optimization of the 
metabolism. Since the regulation of an organism depends on the 
coherent functioning of the different metabolic pathways the 
cytosociological behaviour of the enzymes should be reflected 
in the cytosociological adaptation of biochemical pathways to
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each other.
The stabilization of the formed biochemical pathways and 
the evolving of their cytosociological adaptation lead to the 
formation of dynamically or statically interacting enzyme 
aggregates, i.e. organized multienzyme complexes. Their major 
benefit is the compartmentation of metabolites and the c on ­
comitant decrease in (or elimination of) the steady-state 
transient time (Friedrich 1974, 1984, 1985, Welch 1977,
Welch and Keleti 1981, Keleti 1984, Keleti et al. 1985).
In a consecutive reaction of two enzymes the transient 
time, X  , generally equals (Bartha and Keleti 1979):
t =  ( + KM )/k2 t E 21 0 (1)
If tE2 ^ o « KM 
T  = KM^k2 Í. E2^o
(cf. Hess and Wurster 1970) where E 2 J0 is the total c on ­
centration of the second enzyme in the consecutive reaction 
of two enzymes, K^ is the Michaelis constant of the substrate 
for the second enzyme and k 2 is the first order rate constant 
of the rate limiting step of the reaction catalyzed by the 
second enzyme. From (1)
X = l/k„ + KM/V = l/k9 + l/kn (3)l M max l p
or if [ E 2] o £<_ K m , f r om  (2)
X  = 1/kp (4)
(cf. Easterby 1973, Welch 1977a).
The "measure of perfection" is the magnitude of kp (Keleti 
and Welch 1984).
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If l/kr « l / k 2 , from (3)
L *  l / k 2 (5)
If k^ is very high and «m , from (4)
(6)
In the case of a consecutive reaction of n enzymes
T  - r  t ,  (i=l,2...n). Consequently in a best evolved 
2 1 n
multienzyme complex X'= V  1/k. (in the general case) or
2 1
r  = 0 (if [ E 1] o Km  i , for i = 2 , . . . n ).
Ihis means that the "extremal principle" of the evolution 
of multienzyme systems is the same as that of the individual 
enzymes (Welch and Keleti 1981, Keleti and Welch 1984).
For the description of regulatory properties of metabolic 
pathways a "theory of control" was developed (Kacser and Burns 
1973, 1979, Kacser 1983, Heinrich and Rapoport 1973, 1974, 1983, 
Heinrich et al. 1977) and improved (Westerhoff et al. 1984,
Fell and Sauro 1985).
Obviously, the more effective the control is, the more elastic 
the metabolic pathway will be, consequently it will be more 
able to respond to the changes in external conditions. Ihe 
best controllable, the most elastic metabolic pathway can be 
considered to be the most "perfectly" evolved.
Every enzyme reaction of a metabolic pathway is coupled 
to the neighbouring enzymes through its substrate(s) and 
product(s). The change in substrate concentration (since 
enzymes _in vivo work distant from saturation values) causes 
change in enzyme activity and the value of this change depends 
on the nature of the enzyme and the substrate participating 
in the reaction. The factor describing the response of the 
rate to an infinitesimal change in substrate concentration is
the "elasticity coefficient": ( fev/v) / ( S / S ) = The
magnitude of the elasticity coefficient depends on the c on ­
centration of all participants and on the associated kinetic 
constants. In the case of Michaelis-Menten kinetics (single 
enzyme-substrate complex and rate determining irreversible 
step of product formation):
( ^ v / v ) / ( <b S / S )  « (dv/dS)(S/v) = S(V - v )2/ v V K m =
ill a  X Hl a  X lvl
= V S/K..V - (S/Km ) (2- v /V ) =max M M max
= (Km + S ) / k m - (S/K m )[(2K m +S)/ (K m + S)]
= k m / (k m + s) (7)
Elasticity coefficient =
= = K../( K..+ S ) = V /(V + k _ S)^ S M M m a x  m a x  p
ri if (S < < K m ) s ( kp,S « " » a x ’
/T* CD 
< II
V S = S n a x V if ( s  > > k m ) = (k^S > > v»ax>
.» if s —
This means that at substrate saturation no elasticity, 
at high substrate concentration small elasticity can be 
observed. The elasticity is optimal at low substrate c o n ce n ­
tration and this is the normal circumstance in the living 
cells.
The factor describing the response of the overall rate to 
an infinitesimal change in enzyme concentration is the "control 
c o e f f i c i e n t " :
Cp = ( S v / V ) / ( S  P/P) = ( cO InV/ip I n P ), where V = flux = F and 
P = enzyme concentration = E, i.e. Cp = Cp.
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Since in a coupled reaction of two enzymes catalyzing 
reversible reactions (cf. Kacser and Burns 1983):
CF 1 f  pi + C F1 £■ p2 = 0 
tl b l z b2
(9)
C F1 /C F1 = - C'íl/L1 t2 b 2 b l
S1 /KM , S 1+ S 2 //KM , S 2 ^  1
V 1 = V l ^ W ^ q , ^ (10)
v 2 = k p ,2 /<'S2"S 3/Ke q , 2 ) (11)
where Kgq ^ is the equilibrium constant between the pools
of S t and S, Kj 1 im vj0 , i\ „ that between the pools of S 0 and S,. 1 2 ’ e q , 2 2 3
Applying further equations derived by Kacser and Burns
(1973) for more consecutive reactions :
F 1 F1: CF : Cp1 . ..= 1/k , : l /k p ,K
and
r.l ' i ' T , 2 ,'eq,l : 1/kp , 3 K eq, l Ke q , 2 : •
(12)
( l/ k p >1 )/(l/kp|1 + l/kr ) 2 K eqjl ♦ ...) (13)
( 1 / k r >2Ke q , l ) / ( 1 / k r , l  + 1 / kr , 2Ke q , l  + ) (14)
(1/kp,3Ke q , l Ke q , 2 )/(1/kr,l + 1/kr , 2 Keq,l + ' ' ' }
(15)
7
i. e. 1 (1 6)
Consequently kp Is the measure not only of the evolution 
of the individual enzymes (Keleti and Welch 1984) or of the 
coupled reactions (cf. equ.s (3), (4)) but also of the control 
parameters of the metabolic pathways, namely the elasticity 
coefficient and the control coefficient. The greater k0 is, 
the more "evolved", more "perfect" the enzyme is. The greater 
kn is, the smaller the transient time of the mipJtd reoc 
tion is. At low [ S] , which is the case under physiological 
conditions, the greater k„ is the more effective the elasticity is 
(cf. equ. (8)), and the velocity of the enzyme reactions in 
the metabolic pathway is greater (cf. equ.s (10), (11)).
In the course of evolution, first the enzymes developed 
individually - here the purpose is to increase the power 
(rate) and the specificity of enzyme catalysis. We can estimate 
how far in evolution the individual enzyme molecule can go, in 
optimizing (increasing) its kinetic power under the conditions 
of cell metabolism. According to an "evolutionary compromise" 
condition we get an approximate upper limit of k p  = k^^Ejy/2 
(cf. Keleti and Welch 1984), where k^ is the rate constant 
of diffusion. However, evolution can go much further in 
tailoring the regulatory character of cell metabolism, where 
the enzyme molecule is imbedded in its natural setting, and 
is connected with other enzymes through substrates and 
products. In this part of evolution the main purpose is to 
achieve the most perfect regulation, control mechanism, 
elasticity - even if it calls forth accidental decrease in 
some kp values of individual reactions ( - and perhaps 
increase in others).
Therefore, the fact that changes in more than one kp 
value (increases in some and decreases in others) can equally 
increase or decrease values (cf. equ.s (12)— (16)) does not
contradict our previous observations. For instance, we can 
easily see that " bC ^ l / S k p ^  is always negative, while
8
Cö C p l / S ? k p  ■ (j/i) is always positive which means that r j I ) J
increase in kp . decreases while increase in k p . (j/i) 
increases the respective Cpl, i.e. the measure of the control
limportance of the step per s e . Since the sum of all control
coefficients of a given metabolic pathway equals unity, only
one could approach full control importance, but it is equally
possible that none of the enzymes is a "pace-maker",
"bottleneck" or "key" enzyme. Consequently, changes in k-,Vvalues and the concomitant increase or decrease in Cp values 
may be equally useful for evolution, depending on whether a 
single-enzyme controlled or all enzymes controlled metabolic 
pathway is more powerful for the regulation in a given organism. 
Moreover, one should be aware that by changing the c i r cu m ­
stances a single-enzyme controlled pathway may change into an 
all enzymes controlled one, and vice v e r s a .
We have shown some considerations which say that the 
"extremal principle" of the evolution of enzymes, enzyme 
systems, metabolic pathways and their regulation is identical, 
namely the kinetic power, i.e. ^ m a x ^ M  = •
One should be aware of the fact that all these c on si de r ­
ations refer to a homogeneous "bulk" medium. The application 
of the theory to structural i z e d , organized states (which is 
the living cell) is under way (Welch et al. 1986).
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Dynamics of Biochemical Systems 
S. Damjanovich, T. Keleti, L. Trón (Eds)
HYSTERESIS AMD CRISES IN THE DYNAMICS OF GLYCOLYSIS
MARIO MARKUS and BENNO HESS
Max-Planck-Institut für Ernährungsphysiologie 
Rheinlanddamm 201, 4600 Dortmund 1, FRG
INTRODUCTION
Until a few decades ago, the analysis of metabolic pathways has 
relied on the classical assumption of self-regulation leading 
to steady states. The biochemical community then became aware 
of periodic reactions being a widespread feature of metabolic 
processes (for reviews, see [1,2]). Recently, more complicated 
dynamic states, namely aperiodic (chaotic) oscillations have been 
discovered in biochemistry: first in a single-enzyme system 
(the peroxidase-oxidase reaction [3]) and then in glycolyzing 
cell extracts. In the latter system, chaos was first predicted 
theoretically [4,5] and then found experimentally [6—0] under 
the conditions'df coupling of periodic glycolytic oscillations 
and periodic substrate flux. Coupled periodic processes play 
an important role at all levels of biological organization 
(see [9]). In particular, coupling between oscillatory meta­
bolic processes was demonstrated in yeast cells [10,11] and 
the slime mould [12].
Our investigations showed that glycolysis is able to convert 
a sinusoidal input flux into a variety of periodic, quasiperio- 
dic, intermittent and chaotic oscillations [4-9]. Thus, instead 
of just speaking of a frequency converter mechanism, as in 13], 
one may more generally speak of a time pattern converter. But 
this is not all: glycolysis may display more than one (two, 
three or four) types of oscillations under exactly the same 
conditions, depending on the previous history. The system then 
shows hysteretic behaviour ^5,9,11]. In such cases, different
11
attractors coexist in phase space (i.e. in a space of variables 
describing the dynamics of the system), each one having its own 
basin of attraction, and there are in general two ways of chang­
ing the system time pattern: 1. By perturbing the system so 
that it may jump in phase space from one attractor to another 
at constant external conditions ("switching" process). 2. By 
changing the external conditions. However, if this change is 
performed gradually one may not always expect a gradual change 
in the dynamic properties of the system, since abrupt transi­
tions (bifurcations) may occur. There are many types of bifur­
cations, such as the well-known saddle-node bifurcations, the 
period-doubling cascades [ 14,15] and the so-called crises, which 
have recently been found in simple mathematical mappings [16,17].
In what follows, we will discuss some new examples of glyco­
lytic processes illustrating hysteresis, switching and crises.
THE MODEL AND METHODS OF DISPLAY
In spite of the complexity of the glycolytic pathway, we have 
shown that the dynamics of glycolysis can be sufficiently well 
described by a simplified model containing three rates: that of 
the input flux and those of the key enzymes phosphofructokinase 
(PFK) and pyruvate kinase (PK). The model is described in detail 
in references [4,5]. It contains rate laws for PFK and PK that 
had accurately been determined from extensive kinetic measure­
ments. These rate laws depend on the concentrations of ADP, ATP, 
fructose-6-phosphate, fructose 1,6-bisphosphate, phosphoenolpy- 
ruvate (PEP), magnesium and potassium. The input flux rate V^n
is written as the sum of a constant flux V. and a sinusoidalin
flux A sin&lgt. Unless otherwise stated, the control condi­
tions are set as given in reference [5].
HYSTERESIS
In Fig. 1 we show a number of hysteresis loops obtained from 
the glycolytic model. The ordinates (resp. abscissas) show dif­
ferent dependent (resp. independent) variables of the dynamics 
of glycolysis.
As dependent variables in the examples shown in Fig. 1 we
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(a) ( d )[PEP]max
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Fig. 1. Hysteresis of the dynamics of glycolysis. A and Tg are 
the input flux amplitude and period, respectively. T is the 
response period.^max is the maximum Liapunov exponent per unit 
time. The conditions are: (a), (b) and (c) : 6t>e=14 min \  [Mg
=5 mM; (d) and (e): CO =14 min \  A=0.94 mM/min; (f): CO =6.4
min , [Mgtot]= 5 mM. [ Mgfc fc] is the total magnesium concentra­
tion (bound plus unbound). The arrows pointing to the abscissas 
of (a) to (e) correspond to Fig. 2. The arrow pointing to the 
abscissa in (f) corresponds to Figs. 3 and 4b
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have chosen: 1. The maximum value of [p e p] ( [pEp]max ) attained 
during the oscillations. 2. The period T of the response oscil­
lation relative to the external (input) period T . 3. The ma­
ximum Liapunov exponent per unit time •^max (see [ 18]), 
which is a measure of the average stability of the orbit. For
chaotic orbits, \  is larger than 0 and is equal to the re- max
ciprocal of the shortest average time in which a perturbation 
doubles its size. For periodic orbits, yVmax is smaller than 0 
and is equal to the reciprocal of the longest average time in 
which a perturbation decays to one half. Quasiperiodic oscilla­
tions (mixing of periodic oscillations having inconmensurate 
frequencies) are characterized by -^'max=0-
As independent variables in Fig. 1 we have chosen the input 
flux amplitude A and the total magnesium concentration [MgtQt], 
Note that only a fraction (about 25% in the present range of 
concentrations) is free as a divalent cation, the rest being 
bound to other solutes, as investigated in [19]. The abscissas 
in Fig. 1 were varied slowly enough so that the system remained 
in the neighbourhood of an attractor and leaving enough time 
for an accurate estimation of the ordinate ("slow time" method). 
We have described this procedure in detail in reference [5] for 
the special case of T/Tg versus A.
For each abscissa value of Fig. 1 one or two ordinate values 
are given. The latter case corresponds to two coexisting attrac­
tors ("birhythmicity"). For other control conditions, we have 
obtained loops of higher complexity involving three or four co­
existing attractors ("tri"- and "tetrarhythmicity",[5,9,11]).
Fig. 1 illustrates how manifold the differences between co­
existing attractors can be. Besides the differences in response 
period (given by Figs. 1b and 1e), there are differences in re­
sponse amplitude (Figs. 1a and Id) and differences in response 
stability (Figs. 1c and If). Fig. 1c (recorded under the same 
conditions as Figs. 1a and 1b) shows two coexisting periodic 
responses, one with very low stability (period 3Tg) and one 
with very high stability (period 10Tg). In fact, while *^max
for 3T is close to 0, yl for 10T shows a deep minimum. We e max e r
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have called systems displaying such a minimum "hyperstable"
[4]. The functional relevance of such systems relies in their
extreme insensitivity to perturbations. Figs. 1c and 1f show
chaotic regions (yt > 0). r max
We now pose the question: Which is the "watershed" in phase 
space separating the basins of attraction between two coexis­
ting attractors ? The answer would tell us which starting 
points in phase space lead to which attractors, and how we have 
to perturbate the system in ord$r to drive it from one attrac­
tor to the other (and thus from one time pattern to the other) 
and conversely. The method to obtain the "watershed" in phase 
space (see [l6,2o]) is illustrated for the glycolytic case in 
Fig. 2. In this figure, we show two phase variables ([a d p ] and
Fig. 2. Watershed ( S ) between different periodicities (peri­
ods 3Tg and 10Tg , Tg: input period), as obtained from the gly­
colytic model in a stroboscopic representation. H is a saddle 
point, U and S its unstable and stable manifolds, respectively. 
The double-arrow in the upper right side indicates switching 
from 3Tg (inside S) to 10Te (outside S), and vice-versa. The 
conditions are the same as those at the arrows pointing to 
the abscissas of Figs. 1a, b, c, d and e
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[PEP]) in a stroboscopic representation, in which the phase va­
riables are plotted at times nTg , n=1,2,3,.... A periodic so­
lution with period mTg leads to m points in this representa­
tion. The cross at the lower end of the double-arrow in Fig. 2 
is one of the stroboscopic points corresponding to period 3Te- 
The upper cross is one of the stroboscopic points corresponding 
to 10Tg . The other stroboscopic points are out of the scope of 
the figure. Point H is an unstable fixed point (saddle
type, period 3Tg), which was obtained using an extension of 
Newton's method (subroutine NS01AD from [21]).
The boundary between the basins of attraction of 3Tg and 10Te 
is given by the stable manifold S of H [ 16,20]. Thus, any 
initial condition lying inside the area delimited by S leads 
to 3Tg and any initial condition lying outside this area leads 
to 10Te- The double-arrow indicates a direct switching process 
from 3T to 10Tg by addition of PEP (arrow pointing upwards) 
and from 10Te to 3Tg by consumption of PEP (arrow pointing down­
wards) . At an appropriate phase, the reverse is possible, namely 
direct switching from 3Tg to 10Tg by consumption of PEP and from 
10Tg to 3Tg by addition of PEP. At an arbitrary phase, any 
transition from one basin to the other is of course possible, 
but transients have to be taken into account before the system 
settles on the final attractor (see [9]).
S in Fig. 2 was obtained by integrating the differential 
equations backwards in time starting from H . The unstable ma­
nifold U (obtained by integrating forwards starting from H) 
displays a long-winded transient spiral leading to period 3Tg.
CRISES
Recently, new types of bifurcations, namely so-called crises, 
have been described [l6,17]. In case of a "boundary-crisis", the 
disappearance of a chaotic attractor by colliding with its basin 
boundary is observed. In our model, such a collision takes place 
at the arrow pointing to the abscissa in Fig. 1f, causing the 
sudden disappearance of a chaotic time pattern in favour of a 
periodic time pattern (period 5Tg). The collision is illustrated 
in Figs. 3 and 4. Fig. 3 shows in a stroboscopic representation
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0.1 0.15 0.2 0.25 (mM)
Fig. 3. Stroboscopic plot illustrating a crisis. The chaotic 
attractor can collapse as it touches its basin boundary. This 
boundary is given by the stable manifold of the saddle of period 
5Tg (T : input period). The conditions correspond to the arrow 
pointing to the abscissa of Fig. 1f. The rectangle down below in the 
right indicates the region that is shown enlarged in Fig. 4
(a) (b)
Fig. 4. Enlarged section of the plane from Fig. 3. (a): Non­
vanishing chaos at A=0.423 mM/min (the chaotic attractor does 
not touch its basin boundary) (b): Crisis at A=0.424 mM/min 
(the chaotic attractor collides with its basin boundary)
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a chaotic attractor under the conditions where it collides with 
the stable manifold of a saddle with period 5Tg , which is the 
boundary that separates its basin from that of a stable orbit 
with period 5T . In the centre of the picture, we see 
stable manifold winds in an eight-shaped manner around an un­
stable orbit with period 2Tg.
Fig. 4b shows an enlarged section of Fig. 3. Fig. 4a shows 
the same section but at a slightly smaller value of A. Under 
the conditions of Fig. 4a (A=0.423 mM/min) the two attractors 
can coexist, but a small increase of A causes the crisis (A= 
0.424 mM/min).
We would now like to point to the phenomenon of "long-lived 
chaotic transients", which has been gaining some attention for 
the last two years in the analysis of simple theoretical map­
pings [16,17]. We explain this phenomenon with the help of the 
plots in Figs. 3 and 4b. A start on the chaotic points in these 
plots may imply that the system stays on it for hundreds of T . 
Only when a point in contact with the boundary is reached in 
the course of the oscillations, a transition to a periodic os­
cillation can actually take place. This is illustrated in 
Fig. 5, where we show the chaotic time pattern (period 5Tg) 
after about 4.5 hours. For somewhat larger values of A than in
[PEP)
( m M )
I------- 1------ H------- 1------- (------- 1------- 1------- 1------- 1------- 1-------»
0 2 4 6 8 TIME (hours)
Fig. 5. Autonomous transition from chaos to order due to a cri­
sis. The conditions are those of Figs. 3 and 4b.
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Fig. 5, the transients have a shorter life. Conversely, if A 
is decreased, the chaotic transients become longer and longer 
until they reach infinity, and then a new chaotic attractor is 
born. In other words, the reverse effect of a crisis is a route 
to chaos. In the presence of noise, long-lived transients tend 
to become shorter, since noise facilitates the crossing over the 
basin boundary.
DISCUSSION
We have investigated here some new forms of possible metabolic 
control. The quantitative knowledge of the enzymic rate laws has 
allowed us to determine actual metabolite concentrations, such 
as [a d p ] and [p e p], as functions of time, and to analyze the 
system's response as a function of control parameters such as the 
magnesium concentration.
It is important to note that the phenomena investigated here 
pose restrictions on the applicability of control coefficients
[22], even if these may be generalized from steady states to os­
cillatory systems by considering response quantities such as 
ytmax or tPEPlmax as functions of independent variables. In fact 
control coefficients are well defined derivatives, the determi­
nation of which relies on the assumption that the behaviour of the 
system is unique and continuous. These conditions are not al­
ways fulfilled in the cases treated here, where multivaluedness 
arises as a cause of the system' s dependence on its previous his­
tory, and discontinuities, such as crises, occur. General con­
siderations show that in principle any number of coexisting at­
tractors is possible in an enzymic system [23] , while the actu­
ally measured enzymic rate laws in our concrete case reveal up 
to four such coexisting attractors [5]. Although this multivalu­
edness may seem disadvantageous at first sight it could, however 
provide a memory capacity to the system. Furthermore, noise may 
become amplified since fluctuations cause jumps between the ba­
sins of attraction without ever allowing the system to settle on 
a well defined attractor [9]. Multivaluedness, just as determi­
nistic chaos, may thus provide a random generator to the system. 
When the biological meaning of a random generator is considered
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in the literature, one occasionally speaks about aperiodic os­
cillations as "dynamic diseases" (e.g. in neural disturbances; 
for a review see [24]). But,on the other hand,it has been shown 
that searching processes in all sorts of complex systems may be 
greatly improved by introducing randomness [25]. In biology, a 
search may be useful in chemotaxis and evolution, as well as in 
complex neural phenomena, such as searching memory and decision 
making. In predator-prey systems, randomness decreases the pre­
dictability of behaviour, and may thus serve as a disguising 
mechanism for prey behaviour [26]. Furthermore, cell cycle vari­
ability in cell populations can be simulated by a chaotic model 
[27],
We have shown here the existence of crises in a glycolytic 
model, as one of the sources of dynamic discontinuities. A re­
markable feature in the neighbourhood of a crisis is the appear­
ance of long-lived transients. The knowledge of such transients 
should be a warning to experimentalists: not everything that 
looks like a stable time pattern may stay forever, even if all 
conditions remain unchanged. Long-lived transients are part of 
the dynamic diversity of such a system, and they should be ex­
pected in biological experimentation, being possible phases in 
"time pattern morphogenesis".
The glycolytic system is indeed extraordinarily rich and one 
should consider this richness as being a reflexion of the func­
tional properties of a system composed of two allosteric enzy­
mes, widespread in living nature. Our considerations should be 
understood in terms of the most delicate regulatory properties 
of such systems. It should be kept in mind that similar proces­
ses may occur in any system including allosteric proteins or 
membrane transport.
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DISCUSSION
DYNNIK:
If I am not mistaken, quasiperiodic or even stochastic 
oscillations were obtained experimentally about 15 years 
ago by Hess and Boiteux in yeast extracts at a fixed 
velocity of substrate injection. Is it possible to rea­
lize such regimes in your model, say by including an ad­
ditional regulation of PFK by fructose 1,6-bisphosphate?
MARKUS:
The aperiodic measurements of A. Boiteux and B. Hess at 
constant input flux were too short in time to be iden­
tified as chaos or quasiperiodicity. They could have been 
transient oscillations. However, it is possible that 
chaos or quasiperiodicity may occur under such conditions, 
as has been predicted in a qualitative model (0. Decroly 
and A. Goldbeter, Proc. Natl. Acad. Sei. USA, 79, 6817— 
6921, 1982). We are at present working on a quantitative 
extension of our model, based on experimentally deter­
mined kinetic parameters, in order to investigate such 
effects.
DAMJANOVICH:
Of course, the quasiperiodic and chaotic states of the 
system are not to be considered as steady states. How­
ever, if you take the mean of the periods or a weighted 
average of the chaos you may make use of the catastrophe 
theory for the description of the sudden changes. On the 
other hand, the individual components of the quasiperi­
odic or periodic states can also be described as Markovian 
chains, since the component n determines the whereabouts 
of component n+1. Of course, this is the opposite for the 
chaos. Could you please comment on these remarks?
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MARKUS:
Sudden changes, such as crises, may certainly be con­
sidered as "catastrophes" in a general sense. However, 
the mathematical theory as formulated by René Thom is 
too special to be applicable here: it describes these 
phenomena as combinations of seven elementary catastro­
phes, relying on the assumption that a potential can be 
defined and that the system comes to a rest at a poten­
tial minimum. I do not know of any mathematical general­
ization of this special approach that makes it possible 
to include multiple oscillatory states as described here. 
As to Markovian chains, it has been shown in calculations 
of the Kolmogorov-Sinai-entropy that in some special 
cases (not in general) chaotic processes can be described 
by Markovian chains. For details on this topic you may 
consult the paper by G. Györgyi and P. Szépfalusy (from 
Eötvös University) in Phys. Rev. A, 3J_/ 3477-3479 (1985).
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INTRODUCTION
It is now generally recognized that there exist multiple pathways for the transport of divalent cations across the mitochondrial inner mem­brane (1). The longest-known of these is an electrogenic uniporter, pre­sent in most animal tissues, that can accumulate Ca2+ and other divalent cations (Mn2+, Ba2+ and Sr2+ but not Mg2+) at the expense of an electro­
chemical proton gradient generated by electron transport or ATP hydro­lysis (2-5). It is inhibited by ruthenium red (6), and probably involves the Ca2+ -binding protein known as calvectin (1, 7). This pathway is re­versible, in the sense that in the absence of an electrochemical proton gradient it can serve as a pathway for the release of accumulated Ca2+ from the mitochondria.
There are at present two pathways known which seem to be involved specifically in the release of Ca2+ from mitochondria. A Na+ -dependent pathway (8, 9), which occurs in excitable tissues such as heart (8), brain (9) and brown fat (10), consists of an electroneutral exchange of intramitochondrial Ca2+ against extramitochondrial Na+ . A second release 
pathway (11, 12),occurring in heart and liver, as well as in certain tu­
mors, is activated by the oxidation of intramitochondrial nicotinamide nucleotides and involves an exchange of intramitochondrial Ca2+ against extramitochondrial H+ . These two pathways are insensitive to ruthenium red (8, 11) and their specificity for divalent cations has not yet been investigated in detail.
This paper summarizes some recent results from our laboratory rela­
ting to the above pathways of divalent-cation transport by mitochondria. Our studies of the electrogenic uniporter and the Na+ -dependent efflux systems have primarily concerned the cation specificity of these proces-
Abbreviation: CCCP, carbonyl-cyanide m-chlorophenylhydrazone *Fellow of International Seminar of ühemistry, University of Uppsala. 
Permanent address: Department of Biochemistry, University of Nairobi, Nairobi, Kenya**Permanent address: Dipartimento di Biochimica, Biofisica e Chimica 
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ses, especially regarding the cooperativity of Ca2+ and Mn2+ uptake and its modulation by extramitochondrial Mg2+. The nicotinamide nucleotide- induced release of Ca2+ was investigated mainly from the point of view 
of nicotinamide nucleotide specificity and the possible regulatory roles 
of adenine nucleotides in this process.
ENERGY-LINKED UPTAKE AND Na+ -DEPENDENT RELEASE OF Ca2+ AND Mn2+ BY MITO­CHONDRIA FROM RAT LIVER, HEART AND BRAIN
Our interest in the effects of Ca2+ and Mn2+ on mitochondria origi­
nates from observations reported over 30 years ago. In 1953 Slater and Cleland (13) demonstrated that Ca2+ causes a swelling of mitochondria and an uncoupling of oxidative phosphorylation. The following year Lindberg and Ernster (14) reported that Mn2+ prevents the uncoupling effect of Ca2+ and can even reverse it in the presence of ATP. Mn2+ and ATP were also shown to induce a contraction of swollen mitochondria (15). Mg2+ had an effect similar to that of Mn2+ although at higher concentrations (16).
Following the demonstration in the early 1960s that mitochondria 
can accumulate Ca^+ (17, 18) and Mn2+ (19) in an energy-dependent manner, 
we investigated the uptake of the two cations when added simultaneously to rat liver mitochondria. We found that Ca2+ accelerates the uptake of Mn2+ and Mn2+ retards the uptake of Ca2+ (20, 21). Similar findings were 
independently reported by Chance and Mela (22, 23). We further found that 
extramitochondrial Mg2+ , which was not taken up by the mitochondria, was 
capable of maintaining the enhancement of Mn2+ uptake by Ca2+ even after terminated Ca2+ uptake (24).
The cooperative uptake of Ca2+ and Mn2+ and its modulation by Mg2+ were subseqeuntly investigated in some detail by several laboratories (25-28), with essentially similar results. Our studies were performed 
with rat liver mitochondria respiring in the presence of succinate and glutamate as substrates and in the absence and presence of P-j , under limited and massive loading conditions. The following parameters were in­vestigated: uptake of the radioactive cations (45ca2+ or 54Mn2+) using a rapid filtration technique; H+ ejection accompanying cations uptake, using a glass electrode; stimulation of state 4 respiration, using an 
O2 electrode; intramitochondrial nicotinamide nucleotide oxidoreduction, monitored fluorometrically. Illustrative data are shown in Figs. 1 and 2. Fig. 1 shows the time course of the respiration-dependent uptake of Ca2+ and Mn2+ in the absence and presence of P-j using radioisotopes. Ca2+ up­take is more rapid in the presence than in the absence of Pi, and its rate in both cases is diminished by Mn2+ . Conversely, Mn2+ uptake is re­latively slow in both cases and its rate is markedly enhanced by Ca2+, especially in the presence of Pi. The stimulation of Mn2+ uptake by Ca2+ in the presence of Pi is further illustrated by measurements of O2 uptake, nicotinamide nucleotide oxidoreduction and H+ ejection, shown in Fig. 2.
Using the above parameters and a variety of experimental condi­
tions, the following results were obtained (24):
1. The cooperative uptake of Ca2+ and Mn2+ required the simultane­ous presence of the two cations; when Mn2+ was added after terminated 
Ca2+ uptake, its rate of uptake was no longer enhanced. However, the two
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Fig. 1. Uptake of Ca2+ and Mn2+ by rat liver mitochondria in the absence 
and presence of Pi. From ref. 24. Rat liver mitochondria (1.9 mg protein/ ml) were incubated in a medium containing 20 mM Tris-Cl, pH 7.2, 100 mM KC1, 5 mM succinate, 5 mM glutamate. 3.3 mM Pi and 133 pM Ca2+ and/or 133 yM Mn2+ were added when indicated. At the time intervals indicated an 
aliquot was rapidly filtered and the radioactivity determined, o-o 45Ca2+; «-• 45ga2+ + Mn2+; a -a  54Mn2+; a -a  54Mn2+ + Ca2+.
1 3 3 ^  133pM 133(X  C aC lj
C»CI2 M rra2 *t33>jM MnCtJ
Fig. 2. Respiratory stimulation, nicotinamide nucleotide (PN) redox cycle, and H+ ejection accompanying the uptake of Ca2+ and/or Mn2+ by rat 
liver mitochondria in the presence of P-j. From ref. 24. The incubation 
mixture contained 20 mM Tris-Cl, pH 7.2, 100 mM KC1, 2.5 mM succinate,2.5 mM glutamate, 1.7 mM Pj and 1.4 mg prot/ml.
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cations were not taken up at the same rate, and, once initiated, Mn?+ uptake was maintained at an accelerated rate even after virtually all Ca2+ had been incorporated.
2. The cooperativity between the Ca2+ and Mn^+ uptakes was indepen­dent of the presence of Pi, indicating that the same carrier was involved in the massive and limited uptake processes.
3. The cooperativity and kinetics of Ca2+ and Mn2+ uptake were not noticeably influenced by univalent cations (K+ , Na+ , NH4+ ).
4. Mn2+ inhibited and Ca2+ stimulated the uptake of Sr2+ and Ba2+ .
5. Mg2+ was not taken up by the mitochondria, but its presence in 
the incubation medium resulted in a maintenance of the accelerating effect of Ca2+ on Mn2+ uptake even when Mn2+ was added after completed Ca2+ up­
take; this effect also occurred both in the presence and absence of Pi-
6. Ca2+ and Mn2+ mutually eliminated the oscillatory kinetics of up­
take found with either cation when present alone. Again, Mg2+ had an ef­fect similar to that of Mn2+ . The relative concentrations of the three cations exhibiting these effects were similar to those needed for the pre­vention of Ca2+ -induced mitochondrial swelling and uncoupling of oxidati­ve phosphorylation by means of Mn2+ and Mg2+.
These data were interpreted to indicate that the energy-linked 
electrogenic divalent-cation carrier of liver mitochondria is controlled with regard to its cation specificity by a regulatory site that is situ­ated on the outer surface of the inner membrane. Mg2+ (and possibly Mn2+) in the intermembrane space act as effectors of the carrier. In their ab­sence, the carrier is highly active with Ca2+ and has a relatively low activity with Mn2+ . In the presence of Mg2+ (or Mn2+) at the regulatory 
site, the activity of the carrier with Ca2+ decreases, and that with Mn2+ increases; Sr2+ and Ba2+ behave similarly to Mn2+. Binding of Mg2+ (or Mn2+ ) to the regulatory site occurs only in the presence of Ca2+, which thus acts as a "feedback" regulator of the carrier. Although the rela­tionship of this mechanism to the regulation of the structural and func­tional state of liver mitochondria remains unclear, it was pointed out that the striking antagonistic effects of Ca2+ on one hand, and of Mn2+ and Mg2+ on the other, on mitochondrial energy coupling and membrane 
structure may be reflections of this mechanism.
More recently these studies were extended to include mitochondria from rat heart and brain. The results, a detailed account which is being published elsewhere (29), were essentially similar to those earlier ob­tained with liver mitochondria regarding both the cooperativity between Ca2+ and Mn2+ uptake and its modulation by Mg2+. The enhancement of 
Mn^+ uptake by Ca2+ is most pronounced in liver, and the inhibition of 
Ca2+ uptake by Mn2+ or Mg2+ is strongest in heart. Brain mitochondria take up Mn2+ relatively rapidly even in the absence of Ca2+.
In these recent studies we have also investigated the efflux of Ca2+ and Mn2+ from rat liver, heart and brain mitochondria as induced either by the uncoupler CCCP or by Na+ according to the mechanism first
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LIVER HEART BRAIN
Fig. 3. Effect of CCCP and Na+ on the efflux of Ca2+ from mitochondria from rat liver, heart and brain. From ref. 29. The incubation mixture 
contained 20 mM Tris-Cl, pH 7.5, 100 mM KC1, 5 mM glutamate, 5 mM malate, 3 mM Pi, 100 pM Arsenazo III, 0.5 mg mitochondrial protein/ml, 30 pM Ca2+ and Mn2+ as indicated. After Ca2+ was taken up, 1 pM ruthenium red was added followed by either 3 pM CCCP or 10 mM Na+ .
described by Crompton et _a]_. (8, 9) for mitochondria from excitable tis­sues.
Ca2+ efflux was monitored spectrophotometrically using the non­
penetrant metallochromic dye Arsenazo III after loading the mitochondria with Ca2+ in the presence of substrate and P-j and the addition of ruthe­nium red to inhibit the reuptake of Ca2+. As shown in Fig. 3, CCCP caused a release of Ca2+ from all three sources of mitochondria and the rate of the release was diminished by Mn2+. Na+ induced as expected a release of Ca2+ from heart and brain but not from liver mitochondria and the rate 
of the Na+ -induced Ca2+ release was likewise diminished by Mn2+.
Mn2+ efflux was measured by determining the 54Mn2+ released from the mitochondria using a rapid filtration technique. Mn2+ loading was carried out in the presence of substrate but in the absence of Pi since it was found that Pi prevents Mn2+ release by either CCCP or Na+ , pro­bably because of the precipitation of insoluble manganese phosphate. Ruthenium red was again added to prevent reuptake. As shown in Fig. 4, Mn2+ efflux was induced by CCCP in all three sources of mitochondria and its rate was accelerated by Ca2+. Na+ enhanced Mn2+ efflux in the case of brain and heart but not in the case of liver mitochondria. The Na+-indu-
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LIVER HEART BRAIN
Fig. 4. Effect of CCCP and Na+ on the efflux of Mn2+ from mitochondria from rat liver, heart and brain. From ref. 29. The incubation mixture contained 20 mM Tris-Cl, pH 7.5, 100 mM KC1. 5 mM glutamate, 5 mM malate 0.5 mg mitochondrial protein/ml and 30 pM 54[v|n2+ + 30 pM unlabelled Ca2+. After Mn2+ was taken up, 1 pM ruthenium red was added followed by either 3 pM CCCP or 10 mM Na+ . At the time intervals indicated an aliquot was rapidly filtered and the radioactivity determined.
ced release in contrast to that induced by CCCP was not significantly af­fected by Ca2+.
From these results it appears that the uncoupler-induced release of 
Ca2+ and Mn2+ display a cooperativity similar to the energy-linked upta­ke, consistent with the notion that it proceeds by way of the electroge- nic uniporter operating in the reverse direction. That this efflux is in­sensitive to ruthenium red can be explained as proposed by Bernardi et al. (30) on kinetic grounds, by assuming that it is the uncoupler-induced H+ -uptake rather than the cation release itself which is rate-limiting. The Na+-Ca2+ exchange carrier present in heart and brain mitochondria can evidently also catalyze Na+-Mn2+ exchange. However there is no evidence for a cooperativity between Ca2+ and Mn2+ transport through this carrier similar to that found with the electrogenic uniporter.
Ca2+ EFFLUX FROM MITOCHONDRIA AS INDUCED BY OXIDATION OF INTRAMIT0CH0ND- RIAL NICOTINAMIDE NUCLEOTIDES
Much interest has recently been directed to the oxidation-reduction state of intramitochondrial nicotinamide nucleotides as a potential regu­lator of Ca2+ release. It has been shown that a net Ca+ release from liver and heart mitochondria can be induced by shifting the redox state of mitochondrial nicotinamide nucleotides to the oxidized state using either oxaloacetate or acetoacetate (11), J>butylhydroperoxide (t-Bu00H) 
(31), or menadione (32). Acetoacetate and oxaloacetate oxidize NADH se­
lectively, through ß-hydroxybutyrate dehydrogenase and malate dehydroge­nase respectively. Menadione and t-Bu00H cause an oxidation of both NADH and NADPH, the former via DT diaphorase and the latter via glutathione peroxidase, glutathione reductase and the energy-linked nicotinamide nucleotide transhydrogenase. From these findings alone it would seem that
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it is the oxidation of NADH rather than NADPH which is responsible for the Ca?+ release. Indeed Panfili et a K  (33) arrived at this conclusion from experiments demonstrating a specific binding of NAD+ to the Ca2+- binding protein calvectin. Moreover Lötscher et al_. (31, 34) found that the oxidized forms of both NAD+ and NADP+ are split by mitochondrial gly- cohydrolase and that ADP-ribose derived from NAD+ binds to a protein which may thereby be activated to promote Ca+2 release. This glycohydro- lase is inhibited by ATP (35) which has been shown to inhibit Ca2+ rele­ase (36). Other laboratories on the other hand have arrived at the con­clusion that oxidation of NADPH may be primarily responsible for the Ca2+ release (37-41).
In an attempt to clarify the nicotinamide nucleotide specificity of the Ca2+ release we carried out a series of experiments in which we com­
pared the effects of oxaloacetate, t-BuOOH, menadione and a-ketoglutarate + NH4+ on this process. Under the conditions employed a-ketoglutarate + 
NH4+ cause an oxidation of NADPH but not of NADH (42). This is shown in 
Fig. 5 which compares the redox states of NAD(H) and NADP(H) as a func­tion of time after treatment with oxaloacetate, menadione, t-BuOOH and a-ketoglutarate + NH4+ . It may be seen that, as expected, oxaloacetate induced a selective oxidation of NADH, menadione and t-BuOOH oxidized both NADH and NADPH, and a-ketoglutarate + NH4+ caused a selective oxida­tion of NADPH. It may also be seen that in all cases there was a disappea­rance of oxidized nicotinamide nucleotides, provided that Ca2+ was pre­sent in the incubation medium, and that this effect was inhibited by ATP.
In Fig. 6 it is shown that oxaloacetate, menadione and t-BuOOH induced a release of Ca2+ from the mitochondria, which was virtually complete after 5 minutes following the addition of these agents. This effect was correlated in time with the disappearance of NAD* and was completely abolished by 0.1 mM ATP (not shown). No release of Ca2+ oc­curred within 10 minutes after the addition of a-ketoglutarate and NH4+ . These data strongly support the conclusion that the Ca^+ efflux occurring upon the oxidation of intramitochondrial nicotinamide nucleotides is:1) dependent specifically on NADH oxidation; 2) reguires a cleavage of NAD+ ; 3) is inhibited by ATP which also inhibits NAD+ cleavage; and 
4) reguires the presence of intramitochondrial Ca2+ , without which NAD+ is not cleaved. These conclusions are in accordance with those reached by Richter and associates (31, 34-36, 43, 44).
Fig. 7 shows in a schematic form our tentative interpretation of the present findings. In accordance with earlier proposals by Lötscher et al. (31, 34), our data support the conclusion that Ca2+ efflux requi­res activation by ADP-ribose which is formed from NAD+ through an ATP- 
sensitive NAD-glycohydrolase. Moser et al. (35), have indeed isolated such an enzyme from mitochondria and have also demonstrated the occurrence in mitochondria of a cleavage of NAD+ into ADP-ribose and nicotinamide as well as the ADP-ribosylation of a protein (42). We further propose that intramitochondrial Ca2+ , which is not required for the activity of the NAD+ glycohydrolase per se (35) may inhibit the resynthesis of NAD+ from ADP-ribose and nicotinamide; the latter reaction has been demonstrat­ed by Frei et al_. (44) using radioactive nicotinamide. By this inhibition intramitochondrial Ca^+ may enhance the steady-state level of ADP-ribose and thereby the activation of the ADP-ribose dependent Ca2+ -release pro­tein.
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Fig. 5. Changes of reduced and oxidized nicotinamide nucleotides induced by oxa- loacetate (OAA), menadione, t-BuOOH or a-ketoglutarate (a-kg) and NH4+. Mitochon­dria (2 mg protein/ml) were incubated in a medium containing 210 mM mannitol,10 mM sucrose, 10 mM Tris-Cl, pH 7.4, 0.5 mg/ml bovine serum albumin, 15 mM succinate, 9 pM rotenone 30 pM Ca2+ and 0.1 mM ATP were present when indicated. After 2 minutes incubation, the oxidizing agents were added; 2 mM OAA, 0.3 mM menadione, 2 mM t-Bu00H or 2 mM a-kg and 2 mM NH4+. At times indicated the reac­tion was stopped by the addition of acid or alkali. NAD(P)+ and NAD(P)H were determined enzymically in the acid and alkali extracts respectively (see ref. 45).o-- o NAD(P)H; •- - • NAD(P)H + Ca2+; d-- □ NAD(P)H + Ca2+ + ATP; o— o NAD(P) + ;#---# NAD(P)+ + Ca2+; □ NAD(P)+ + Ca2+ + ATP. (From ref. 46)
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Ca2*
Fig. 6. Ca2+ release induced by oxaloacetate (OAA), menadione, t-BuOOH or 
a-ketoglutarate (ct-kg) + NH4+ . Mitochondria (2 mg protein/ml) were incu­bated in a medium containing 210 mM mannitol, 70 mM sucrose, 10 mM Tris- Cl, pH 7.4, BSA (0.5 mg/ml), 5 mM succinate, 3 y M  rotenone, 100 y M  Arse- nazo III. At time zero, 50 yM Ca2+ was added. When indicated 2 mM OAA,0.3 mM menadione, 2 mM t-BuOOH or 2 mM a-kg + 2 mM NH4+ was added. Ca2+ uptake and release were followed spectrophotometrically at 665-685 nm.
ATP
nicotinamide
Fig. 7. Hypothetic scheme of the regulation of Ca2+ efflux by NAD+ clea­vage and ATP. In accordance with Richter and associates (31, 34-36, 43,44) it is proposed that Ca2+ uptake through the electrogenic uniporter results in a lowering of the intramiatochondrial ATP concentration and thereby a relief of the inhibition of NAD+ -glycohydrolase. At the same time, intramitochondrial Ca2+ inhibits the resynthesis of NAD+. As a 
result, the level of ADP-ribose increases and this activates Ca2+ release. For further explanation, see text.
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The proposed mechanism explains a) how a decrease in mitochondrial 
ATP level, due to active Ca2+-uptake, may promote NAD+ -cleavage; and b) why intramitochondrial Ca2+ is needed for this cleavage. The resulting 
increase in ADP-ribose activates Ca2+ efflux. Thus, the cycle as a whole regulates Ca2+ efflux in relation to Ca?+ uptake. A detailed account of these results and conclusions will be published elsewhere (46).
CONCLUDING REMARKS
The possible role of the three mitochondrial Ca2+-transport systems in the regulation of cellular Ca2+ homeostasis is widely recognized (see 
e.g. refs. 1 and 47-49 for review). The electrogenic uniporter is gene­rally regarded as an efficient mechanism for sequestering Ca2+ , especial­ly in emergency situations where there is an increased influx of Ca?+ from the extracellular space due to a decreased cellular energy level, in ischemia (50). The protective effect of Mn2+ against mitochond­rial injury caused by high Ca2+ concentrations may constitute an impor­tant defence mechanism (29, 51). In addition there is growing evidence that the mitochondrial transport of Mn2+ may have a function in regulat­
ing intra- and extramitochondrial Mn2+ -dependent enzymes (52).
The Na+ -dependent Ca2+ -efflux system in mitochondria of excitable tissues may play an important role in the regulation of cytosolic Ca2+ concentration, and thereby of Ca2+ -dependent enzymes in tiic c^tusul, 
in relation to the prevailing action potential.
The Ca2+-efflux mechanism induced by mitochondrial nicotinamide 
nucleotide oxidation and cleavage is another conceivable regulator of cy­tosolic Ca2+ concentration. The physiological role of this system is not yet fully understood. However, this mechanism has been implicated in cell injury caused by oxidative stress, such as exposure of cells to organic hydroperoxides or to agents that give rise to the formation of the super­oxide radical and hydrogen peroxide, e.g. quinones (32, 53, 54). These treatments lead to an extensive oxidation of mitochondrial NAD(P)H via glutathione peroxidase, glutathione reductase and the energy-linked trans- hydrogenase. The ensuing increase in cytosolic Ca^+ concentration causes a collapse of the cytoskeleton, with a damage of the cell membrane as a consequence.
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DISCUSSION
RICARD:
I wonder whether you have any working hypothesis about 
the molecular nature of this memory effect? Is this 
memory effect related to a "slow" conformation change 
of the protein?
ERNSTER:
That sounds like a reasonable explanation. But we need 
more data in order to answer this question.
KACSER:
Is not the time constant involved in the hysteresis 
rather large? It seems to be of the order of minutes.
ERNSTER:
A hysteresis may indeed involve a slow conformational 
change of protein.
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1. INTRODUCTION
It is well known that many intracellular enzymes are present in high 
concentrations (Srere, 1967; Sols and Marco, 1970). Then, protein-protein 
interactions, both homologous (Hulme and Tipton, 1971) and heterologous 
(Hess and Boiteux, 1972), could induce intracellular changes in some pro­
perties of the enzymes important for metabolic regulation. This may be 
significant for phosphofructokinase, a highly modulated enzyme whose acti­
vity was reported to show a concentration dependent behavior (Hulme and 
Tipton, 1971; Hofer, 1971). Several procedures suitable for kinetic 
studies have been reported as approximations to intracellular conditions 
concerning protein concentration, one of the factors in which assays in 
vitro used to be markedly different from in vivo, mainly due to technical 
reasons. The measurement of enzyme activity in permeabilized cells, de­
signated as the in situ approach, has been used to study a number of en­
zymes (Sols, 1975; Aragon et al. 1980). In the case of phosphofructokinase 
we have also used the purified enzyme at a concentration in the physiolo­
gical level in an attempt to reproduce in vitro the behavior observed in 
situ, as well as the addition of polyethylene glycol (PEG) to increase the 
local protein concentration (Boscá, et a l , 1985; Aragón and Sanchez, 
1985). The later approach has additionally been employed to study the ac­
tivity of other enzymes (Medina et a l , 1985).
This article presents the kinetic studies that we have carried out to 
simulate in vivo conditions related to enzyme concentration. Most of these 
studies are focused on the regulation of several eukaryotic phosphofructo- 
kinases.
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2. THE IN SITU APPROACH
Reeves and Sols (1973) developed the in situ approach for the study 
of the activity of intracellular enzymes in permeabi1 ized E. coli by tolu­
ene treatment to disintegrate the cell membrane. By now, several dozens of 
enzymes have been studied in situ in microorganisms (Sols et a l . 1976; Ba­
nuelos and Gancedo, 1978); with most of them the parameters measured were 
similar in situ and in vitro although some differences were pointed out in 
a significant proportion of cases.
A general method for the kinetic study of enzymes in animal cells was 
developed by Aragon et al (1980) by treatment with bifunctional reagents 
to crosslink proteins and subsequent permeabilization by delipidation with 
digitonin without scape of intracellular proteins. The procedure, origi­
nally described for erythrocytes, could be applied to ascites tumor cells 
(Lazo and Sols, 1980) and other types of cells, but not to hepatocytes. 
With this approach a systematic exploration of the kinetic behavior of the 
glycolytic enzymes in erythrocytes was carried out. As shown in Table 1 
the Km and Vmax values for the majority of the enzymes were essentially 
the same in situ as in vitro (a diluted hemolysate). The most significant 
difference was exhibited by phosphofructokinase, which will be described 
in the next section.
In addition to the study of individual enzymes, the in situ approach 
provides the possibility of evaluating the flux of a metabolic pathway 
starting from any of its intermediates under near physiological condi­
tions. Fig. 1 shows the production of lactate in situ in erythrocytes from 
several glycolytic intermediates. As indicated, the generation of lactate 
was higher from glucose-6-P than from glucose supporting the idea that 
hexokinase may 1 imitate the glycolytic flux in vivo in these cells. The 
rate of the pathway from g.lucose-6-P and glyceraldehyde-3-P was in the 
order of the activity of the limiting enzymes below these intermediates, 
presumably aldolase and phosphoglyceromutase.
Several other methods for partial permeabilization of animal cells 
have been published by other investigators (for a review see Aragon et a l , 
1980). Some of them imply insufficient permeabilization to metabolites 
while incomplete retention of proteins is brought about by others. Faced 
with this dilemma, the approach described above may be the most practical 
one for kinetic studies of enzymes, even at the expense of potential arti-
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Table 1.
Glycolytic enzymes of rat erythrocytes in situ and in vitro. 
(From Aragon et a l , 1980)
Vmax_ _ _ _ _ _ _  Sq g mM
En- In vitro In situ - - - - - - - - - - - - - - - - - -zymea units/g % Substrate in situ in vitro
HK 0.08 33 (TDI) Glc 0.2 0.2
ATP 0.15;1.5 0.3
PGI o15 47 (TDI) Fru-6-P 0.1 0.1
PFK 8 48 (DMS) Fru-6-P d0.2 (0.04) 2 (0.025)
ITP 0.3 0.3
ALD 0.5 40 (TDI) Fru-1,6-P2 0.02 0.02
TIM 200 40 (TDI) Gra-3-Pe 0.4 0.4
GAPDH 9 57 (DMS) Gra-3-P 0.3 0.3
NAD+ 0.18 0.05
Pi 10 10
PGK 16 44 (DMS) 3-P-Grie 0.7 0.7
PGM 0.7 62 (DMS) 3-P-Gri 0.1 0.1
ENO 8 57 (TDI) 2-P-Gri 0.02 0.02
PK 6 58 (DMS) P-enol- pyruvate 1.5 0.8
LDH 44 51 (DMS) Pyruvate
NADH
0.2
0.03
0.2
0.03
d
a )  The abbreviations correspond to the 11 enzymes of the pathway ordered
as they operate in the glycolytic direction.
b ) Shown as % of value in vitro. The reagent used for crosslinking is
shown in parentheses: TDI, toluene diisocyanate; DMS, dimethyl 
suberimidate.
a)  In the reverse reaction with respect to glycolysis.
d ) Numbers in parentheses are the values in the presence of positive
effectors.
e) Gra, glyceraldehyde; Gri, glycerate.
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LACTATE PRODUCTION
p mol/min/g
IN SITU 
IN VIVO
Glucose 0.04
Glyceraldehyde-3-P(GA3P) 0.12
Glucose - 6  -P(G6P) 0 .07
Glucose 0 .08
Dihydroxiacetone (DHA) 0. 1
Fig. 1 Glycolysis in situ ■) and in vivo ( 0 >  □ )  in raterythrocytes. The reaction mixture contained 6 mM MgITP, 5 mljl MgADP, 0.5 mM NAD , 20 mM Pi, 0.1 mM AMP, 1 mM NH. , 0.1 mM p ,p -di(adenosine-5'-)pentaphosphate,1 mM DTE.
facts mediated by the crosslinking of some intracellular proteins.
3. REGULATION OF EUKARYOTIC PH0SPH0FRUCT0KINASES AT PHYSIOLOGICAL CONCEN­
TRATION OF ENZYME.
Phosphofructokinase is a key regulatory enzyme of the glycolytic 
pathway whose activity responds to a variety of metabolic signals (Sols 
et a l , 1981). Several eukaryotic phosphofructokinases have been studied to 
examine the influence of enzyme concentration on their allosteric regula­
tion as described below.
Animal phosphofructokinases
Among the enzymes studied in situ in erythrocytes, phosphofructo­
kinase exhibited the most striking difference with respect to the in vivo 
assay. As indicated in Fig. 2, the enzyme in situ showed an affinity for 
fructose-6-P in the absence of positive effectors, such as Pi, AMP and 
NH4+ , markedly higher than in vitro . A concomitant reduction in the 
ATP inhibition was also observed (Sols et a l , 1981).
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Fig. 2. Phosphofructokinase activity of rat erythrocytes in situ and in vitro. Mg^TP was 1 mM. Effectors were 5 mM Pi, 0.1 mM AMP and 1 mM NH. . # ,  ■, In situ; O . □, in vitro. The pH was 7.4 (From Aragon et a l , 1980).
Although these results suggested that the intracellular concentration 
of enzyme may contribute to the change observed in its kinetic behavior, 
they could also be related to some chemical modification of the enzyme 
produced by the permeabilization procedure. To test this possibility we 
studied the allosteric regulation of phosphofructokinase in vitro but 
employing concentrations of enzyme in the physiological range. Fig. 3A 
shows that the affinity for fructose-6-P was decreased when the purified 
muscle enzyme was assayed at a concentration of 0.6 mg/ml, which is in the 
order of its physiological level in muscle (Ling et a l , 1965; Tornheim and 
Lowenstein, 1976) as compared to 100-fold more diluted concentration of
enzyme. To measure the activity of the concentrated enzyme we used a very 
2+low Mg /ATP ratio to decrease the reaction velocity. The increase on the 
apparent affinity for fructose-6-P reflected a drastic reduction in 
the ATP inhibition, as indicated in Fig. 3B.
As another way to simulate a high concentration of enzyme we included 
PEG (Mr = 6000) in the kinetic assay as a "crowding" agent to increase the 
local protein concentration, and thus favoring the aggregation of the 
diluted enzyme (Reinhart, 1980). Fig. 3 shows that phosphofructokinase ex­
hibited a roughly similar behavior in the presence of PEG as when the en­
zyme was used at physiological concentration, and also similar to what we 
previously observed with the in situ approach. Then, essentially the same
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Fig. 3. Effect of physiological concentration of enzyme and poly­ethylene glycol on muscle phosphofructokinase. Purified rabbit muscle phosphofructokinase was used at 0.6 gg/ml (open symbols) and 0.6 mg/ml (solid symbols). Addition of 105» PEG as indicated. MgClp was in excess over ATP with the diluted enzyme and was only 1% of that of ATP and with 4 mM EDTA in the case of the concentrated enzyme. Effectors were 5 mM Pi, 0.1 mM AMP, and 1 mM NH. ; A > A ,  without effect- o r s ; 0 , 0 ,  with effectors. A, ATP was 5 mM and the pH was 7.0. B, fructose-6-P was 0.5 mM and the pH was 6.8 (From Boscá et a l , 1985).
result has been obtained by employing three different procedures, which 
have in common the use of concentrations of enzyme in the physiological 
range. The reduction in the ATP inhibition was also observed in the pres­
ence of a mixture of relevant phosphofructokinase effectors used at con­
centrations that prevail in working muscle (Boscá et a l , 1985). A similar 
influence of the enzyme concentration on phosphofructokinases from other 
animal sources as liver and ascites tumor cells has been shown (Boscá et 
a l , 1985; Lazo and Sols, 1980). Accordingly, these results suggest that 
the regulation of phosphofructokinase is among other factors dependent on 
its high concentration in vivo, leading to a sensitivity to inhibition by 
ATP compatible with high levels of activity, as it is the case in working 
muscle, without the need for a lowering of the endogenous concentration of 
ATP. Our results agree with prior observations by several investigators 
which were suggestive of a possible concentration dependent activity for 
animal phosphofructokinase, although the extrapolation to physiological
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1concentration was uncertain (Hulme and Tipton, 1971; Hofer, 1971; Wenzel 
et a l , 1976; Reinhart, 1980).
The utilization of phosphofructokinase at physiological concentra­
tions affords the possibility of measuring the ATPase and fructose-1,6- 
-bisphosphatase-minor activities of the enzyme. Fructose-2,6-P2 and citra­
te affected the ATPase activity but not the fructose-1,6-bisphosphatase 
activity, in which assay ATP is not present. These results suggest that 
both citrate and fructose-2,6-P2 are mechanistically "secondary" alloste­
ric effectors that require the presence of ATP to modify the activity of 
phosphofructokinase (Boscá et a l , 1985).
Yeast phosphofructokinase
Yeast phosphofructokinase, in contrast to those in animal tissues, 
has been claimed not to exhibit a concentration dependent kinetic behavior 
on the basis of both in situ studies (Bafiuelos and Gancedo, 1978) and in 
vitro assays at a wide range of enzyme concentration (Laurent et a l , 
1979). The use of the three approaches described above to examine the in­
fluence of enzyme concentration gave us the opportunity to reinvestigate 
this possibility. As illustrated in Fig. 4, the enzyme studied in situ was 
markedly less sensitive to ATP in comparison to the assay in a cell free 
extract or in situ. Repetition of the same kinetic study by using purified 
yeast enzyme at physiological concentration led to a similar result (Fig. 
5). PEG was able to reproduce the behavior observed in both cases, al­
though it had to be added to the assay mixture at concentrations higher 
than the 10% concentration used with several mammalian phosphofructo- 
kinases and other enzymes.
These results strongly suggest that the ATP allosteric regulation of 
yeast phosphofructokinase can be affected by its intracellular concentra­
tion, as in the case of animal phosphofructokinase. Nevertheless, these 
observations do not contradict those previously described by Banuelos and 
Gancedo (1978) and by Laurent et al (1979) because the lack of difference 
related to enzyme concentration was reported solely on the basis of fruc- 
tose-6-P kinetics. We have confirmed this observation, not finding a sig­
nificant change in the fructose-6-P saturation curve either with concen­
trated enzyme or in the presence of PEG (Aragón and Sanchez, 1985).
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[Mg A T P ] ,  mM [ Mg ATP], mM
Fig. 4 Fig. 5
Fig. 4. ATP inhibition nf yeast phosphofructokinase in situ andin vitro. Fructose-6-P was 0.3 mM an the pH was 6.4. Activity at 0.1 mM MgATP was taken as 100%. Inset: effect of various concentrations of PEG on ATP inhibition in vitro. (From Aragön and Sanchez, 1985)
Fig. 5. ATP inhibition of purified yeast phosphofructokinase at high and low concentration of enzyme. Conditions as in Fig. 4. (From Aragón and Sanchez, 1985)
Dictyostelium discoideum phosphofructokinase.
In contrast to most phosphofructokinases, the enzyme from the slime 
mold D. discoideum has simple kinetic properties, it exhibits no sigmoid- 
icity for fructose-6-P and no sensitivity to any of the typical allosteric 
effectors (Baumann and Wright, 1968), including fructose-2,6-Pg as we 
have recently observed (unpublished results). This enzyme was chosen to 
test the effect of enzyme concentration on an apparently non-al1osteric 
phosphofructokinase. H g .  6 shows that this enzyme was very little sensi­
tive to ATP inhibition, as compared to other phosphofructokinases and not 
affected by PEG. Concentrations of PEG higher than 10% had also no effect. 
This result suggest that some properties of the allosteric regulation of 
phosphofructokinase may be required to exhibit a concentration dependent 
activity, presumably the enzyme capability to aggregate.
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Fig. 6. Effect of polyethylene glycol on D. discoideum phospho- fructokinase. Fructose-6-P was 15 uM and the pH 6.8.(Ospina, Sanchez and Aragon, unpublished results.)
4. OTHER ENZYMES AT PHYSIOLOGICAL CONCENTRATION.
Liver cells could not have been well permeabi1 ized for kinetic 
studies. Then, we have used the PEG approach to study the influence of en­
zyme concentration on the kinetic parameters of other potentially regula­
tory liver enzymes. Among the enzymes examined, pyruvate kinase L was the 
most significantly affected, which affinity for P-enolpyruvate was marked­
ly increased in the presence of PEG. In contrast with the liver enzyme, 
the behavior of muscle pyruvate kinase M, a non-regulatory isozyme, was 
not affected by PEG (Fig. 7). A similar decrease in the cooperativity for 
P-enolpyruvaste was observed when pyruvate kinase L was studied in situ in 
permeabi1 ized erythrocytes (Aragon et a l , 1980).
Out of the other enzymes tested only two were significantly affected 
by PEG: L-serine dehydratase, which showed an increase in the affinity for 
L-serine and a sigmoidal saturation curve in the presence of PEG, and gly­
cogen phosphorylase a from muscle that exhibited a higher Sq for Pi 
(Medina et a l , 1985). The later result agrees with that reported by Eagle 
and Scopes (1981) for the enzyme assayed at high concentration.
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Fig. 7. Effect of polyethylene glycol on liver and muscle pyruvate kinase. ADP was 1 mM. 0 > A >  Control; 9 , A ,  plus 10% PEG. (From Medina et a l , 1985)
5. CONCLUDING REMARKS
Three different approaches have been used for enzymatic kinetic stud­
ies at concentrations of enzyme in the physiological range. Phosphofructo- 
kinase was the enzyme most significantly affected by its concentration. 
The three procedures used in this study gave essentially similar results 
on the regulatory behavior of this enzyme. Each of these approaches in­
volves a potentially damaging artifact. Nevertheless, the fact that the 
artifacts are different in each case cancel them as responsible of the 
marked differences in quantitative behavior relative to the usual in vitro 
assay. The common denominator is to favor the enzyme aggregation to its 
normal in vivo state. Hence, in relation with studies of physiological re­
gulation of phosphofructokinase, the mere dilution of the enzyme typical 
of in vitro assays can markedly alter its allosteric behavior. This study 
also shows that the behavior of phosphofructokinase observed in si tu can 
be explained on the basis of homologous protein-protein interactions, 
although other possibilities are not excluded.
Most other enzymes studied either in permeabilized cells or in the 
presence of PEG, did not show a significant change in their kinetic behav­
ior, indicating that the majority of enzymes may not be affected by their 
concentrations in vivo. The exception seems to be the case of some regüla-
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tory enzymes such as phosphofructokinase and pyruvate kinase L. D. discoi- 
deum phosphofructokinase, as well as muscle pyruvate kinase, both appar­
ently non-allosteric isozymes, were not affected by PEG, suggesting that 
the effect of enzyme concentration, when it occurs, may work mainly by ad­
justing some of the properties of regulatory enzymes.
Acknowledgements: I am indebted to Prof. A. Sols for valuable suggestions 
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DISCUSSION
KELETI:
About 10 years ago Jancsik et al. published (J. Mol. Catal. 
_1_, 137, 1975) that polyvinylalcohol and polyvinylpyrro­
lidone depending on the molecular weight and concentra­
tion may activate or inhibit aldolase V . Aldolase is -1 max
a pure Michaelis-Menten type enzyme in buffer but shows 
inhibition by excess substrate in the presence of the 
above mentioned polymers.
ARAGON:
In our hands, aldolase did not exhibit a concentration 
dependent behavior when it was studied either in per- 
meabilized erythrocytes or by using the liver enzyme in 
the presence of polyethylene glycol. Nevertheless, this 
does not exclude that the enzyme from other sources, as 
muscle for instance, may show such a behavior. In any 
case, more than one approach should be used to extrapo­
late this type of results to physiological conditions to 
rule out possible artifacts.
WELCH:
Im am very interested in the results you have shown for 
phosphofructokinase (PFK), especially the polyethylene­
glycol (PEG) effects. Indeed, PEG has been shown to 
affect the properties of many enzymes, in some cases by 
mimicking the heterogeneous environment in vivo. PFK from 
erythrocytes has been found to bind reversibly to cell 
"ghosts", the degree of association being influenced by 
regulatory effectors. (For example, see the review 
article by C. Masters in CRC Cricital Reviews of Bio­
chemistry , 1981.) The bound form of PFK displays kinetic 
properties resembling those which you see with PEG. It 
seems, therefore, that some of your results with PEG 
might be due to the circumstance, that PEG is mimicking 
the in situ milieu of the membrane surface. (Incidentally,
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one should note that toluenization of cells would disrupt 
this state of organization.)
ARAGON:
Yes, it can certainly be the case. Although concerning the 
binding of phosphofructokinase to the cell membrane we 
need to consider how significant the proportion of the 
bound enzyme is, and also the ionic strength used to study 
those interactions.
RICARD:
In order to compare kinetic properties of enzymes at very 
different enzyme concentrations, one has to be certain 
that the substrate concentration is in large excess with 
respect to the enzyme concentration. Is that the case 
even for very high substrate concentrations?
ARAGON:
Yes it is. The concentration of the enzyme we used in 
those studies was estimated to be around 1 yM considering 
the enzyme as a tetramer and that the subunit molecular 
weight of the muscle isozyme is about 90 000 daltons.
EASTERBY:
Muscle phosphofructokinase has been shown to be phosphor- 
ylatable in vivo and phosphorylation is proposed to 
stabilize the tetramer. Have you looked at the extent if 
any, of phosphorylation of your enzyme?
ARAGON:
This is a very interesting question. I did not mention the 
phosphorylation mechanism as another possibility for the 
regulation of phosphofructokinase because although this 
enzyme has been reported to undergo such a covalent modi­
fication, the physiological meaning of this phenomenon is 
unknown so far. Nevertheless, we though that perhaps the 
possible kinetic changes induced by the phosphorylation-
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-dephosphorylation mechanism could be visualized by 
assaying the enzyme at a higli'concentration. Then we 
extracted the enzyme from resting and exercising skeletal 
muscle, when phosphofructokinase is subjected to a very 
high change in its activity. But unfortunately we did not 
observe any change in the kinetic behavior of the enzyme, 
even in the presence of polyethylene glycol (Miranda, M.E 
and Aragon, J.J., unpublished results).
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A number of models for allosteric enzymes proposed in the 
early 60's do not consider many multi-stage enzymic mechanisms 
with their complex conformational dynamics often induced 
through cascade systems.
New discoveries stimulate new approaches to the modelling 
of conformationally regulated enzyme systems. Using methods 
of the theory of graphs and taking the hierarchy of enzymic 
systems into account, we can study these systems in more de­
tails. At first the theory of graphs was used for some simpler 
enzyme reactions (Volkenstein and Goldstein, 1966). Ever since 
we have formulated the kinetic models in terms of schematic 
language commonly employed by biochemists. Our schemes (graphs) 
however not only illustrate the process but can also be quan­
titatively analyzed. Very complex graphs may be simplified in 
such a way as to obtain rate equations for multi-subunit en­
zymes. In the present paper we consider not only the interac­
tions of enzymes with various ligands, but also their various 
equilibrium or non-equilibrium distributions among conforma­
tional states. We also investigate both linear (one-enzymic) 
and non-linear (multi-enzymic) processes, formulating in the 
last instance the conditions of their instability or self-os­
cillations .
Linear graphs for rapid equilibrium, steady-states and
pre-steady states
Various states of an enzyme are pictured as graph "nodes"
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and their interconversions - as directed "branches", if we use 
so-called "linear" graphs:
%
Complex graphs can be simplified according to our rules 
summarized elsewhere (Cornish-Bowden, 1976). Graph for pre­
steady-state kinetics (1b) contains additional branches with 
t-values and directed from all nodes to initial nodes (Gold­
stein, 1983). ~-value is a time variable transformed according 
to Laplace-Carson. In accordance with the laws of thermodynam­
ics there are no cycles in the equilibrium graph (1c), this 
graph thus being a directed tree (Volkenstein and Goldstein, 
1966,b). This equilibrium simplification of ours has been used 
by Cha (1968) for analysis of graphs with a number of equilib­
rium sub-graphs connected by slow stages.
For each of the graphs (1) the rate equation is obtained 
according to the rule:
v
ZD.kl ^
I . D . 1 1
ID .k
(2 )
where is a sum of tree values for trees directed to i-th 
node. For steady-states (graph 1a) without simplifications the 
rule (2) coincides with the rule of King-Altman (1 956) . Using 
graph (1b) we obtain reaction rate v(t) transformed according 
to Laplace-Carson. v(t) is informative by itself but may be 
re-transformed into time-dependent function v(t) which is a 
sum of exponential terms, their number being equal to the num­
ber of graph nodes minus one. On the experimental curves and 
for a time scale chosen only a few exponential terms (as a 
rule not more than two) are reliable. It means that a complete 
graph should be simplified by abolishing very slow as well as 
very rapid stages to obtain a graph with three nodes only. If
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exponential terms are all of equal signs, their reliable sepa­
ration may be difficult to obtain. For this reason it is desir­
able to choose such conditions which would give opposite signs 
for two exponential terms. In our laboratory such conditions 
were experimentally realized for lactate dehydrogenase pre­
equilibrated with some ligands (Yagodina et al., in press).
Two experimental curves shown in Fig. 1 exactly fitted the same 
rate equation with the only difference in parameter values:
-A.t -A„t
P(t) = vt + ß1 (1-e ) + ß2 (1-e ) (3)
Fig. 1
Time-dependent rate of lactate 
dehydrogenase-catalyzed reac­
tion (pH 8): 1 - without pre­
equilibration, 2 - pre-equi- 
librated with 0.25 mM NAD+ 
and 0.5 mM pyruvate (Yagodina 
et al., in press).
If we use graph (1b), we must change the number of t-branches 
to obtain different initial conditions and, as a consequence, 
different parameters of Eq. (3) (Goldstein, 1983). In this way
the unusual inflection point (8^>0, ß2<0, A >A2> in curve 2 has 
been obtained. We interprete the two slow stages clearly re­
vealed in curve 2 under conditions of pre-equilibration as slow 
pH-dependent enzyme conformational transitions.
Modifications of Monod-Wyman-Chanqeux model
The model proposed by Monod et al. (1965) is apt to under­
go various modifications. According to this model, we can di­
vide the whole complicated graph into a number of conformation­
al blocks, each for identical independent enzyme subunits. For
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two conformational states R and T we have two conformational 
sub-graphs connected by transition stages (see Fig. 2). In­
dices i, j refer here to different enzyme complexes with li­
gands, L+i are constants of conformational transitions 
(i=0, . .., n, . .., N), n is the number of subunits, N is the
total number of enzymic complexes with ligands.
Fig. 2
Block-graph for two enzymic 
conformations and arbitrarily 
complicated reaction mechanisms
For all of different enzymic mechanisms consistent with block- 
graph of Fig. 2 we obtain the following rate equation:
v nvr
1 + Qvt/vr 
1 + Q (4)
where Q = vr and are reaction rates for a single
active site in R and T conformations, respectively. The separa­
tion of conformational transitions (function Q) from reaction 
rates (vfc, vr) is reflected in Eq. (4). Functions vfc and vr in
this context are supposed to be known. Function Q is easily 
obtained in two cases: 1.) rapid equilibration of different 
conformations, 2.) slow (as compared to other stages) conforma­
tional transitions.
The graph in the first case is the tree, thus, only single 
(R >^- -Tp) transition between two sub-graphs R and T is to be 
considered. The function Q in this case is the following
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(Popova et al., 1983):
(5)
where rg, t are concentrations of a single enzymic subunit in
complexes with various ligands s = 1, 2, ... . Function Q from
Eg. (5) is easily applied to various mechanisms.
For example, for a two-substrate mechanism rQ^ i r S 1
rS.S_ -*■ r we have:1 2  o
Q = L
1 +c^ (1+C2S2)
1+S1(1+S2) (6 )
where , S2 are dimensionless substrate concentrations and 
c^  and c2 are parameters. In the case of slow conformational 
transitions instead of Eg. (5) we have:
Q Lo
s1 +s
+ Er
/1 t +lt 1 o s -
t + It o s
./1 n
(7)
where 1, are constants for single-subunit conformational tran- ±s
sitions. It is Eg. (8) that may be deduced from Eg. (7) for 
the two-substrate mechanism:
Q = L,
1+c^S^ (1+C2S2)+c2^2 
1 + S ^  ( 1  + S 2  )  + 0 ^ 2
1+c^S2 + S^ (c^ +CgS2 ) 
1 + c 3 S 2 + S 1 ( c ^  + c_,S2 ) (8)
The concentrational maximum exponent 2n in Eg. (8) is twice 
as greater as it is in Eg. (6). It means that in the case of 
non-eguilibrated conformations an enzyme has "memory" of both 
its conformational states.
This effect results in complicated curves v(S^,S2> with 
intermediate plateau or intermediate minimum (Popova et al.,
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1983) similar to those shown in Fig. 3.
V
0
Reaction rate versus substrate 
concentration for a slowly and 
reversibly dissociated oligo­
meric enzyme S (n=8; c-|=20;
Fig. 3
C 2 = 0 . 2 ;  c 3 = 0 . 8 ;  Vt/Vr=0.005).
Models of slow dissociating multi-subunit systems 
The steady-state rate equation for slowly reversibly dis­
sociating enzyme systems is similar to the one shown in Eq. (4)
with the exception of another Q function. For dissociation into 
two halves and, in particular, for a single-substrate reaction 
we obtain:
Here Eq denotes the variable total enzyme concentration. Let's 
use now Eq. (4) with Q from Eq. (9) to interprete kinetic
curves obtained for a-ketoglutarate dehydrogenase (Severin et 
al., 1976). Kinetic curves v(S) presented in Fig. 3 are fitted 
to experimental data according to Eqs. (4), (9). We see that
the enzyme activity decreases and the intermediate minimum 
vanishes with the increase of enzyme concentration. Curves 
with an intermediate minimum may prove important, if such an 
enzymic system becomes an open one. The substrate inflow into 
such a system may cause unstabilities and, as a consequence, 
discrete regulation of enzyme activity.
(9)
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Many oligomeric enzymes are known to change their symmetry 
as a result of ligand binding. The half-asymmetry of oligomeric 
enzymes is well known and is used in so called "flip-flop" 
models (Lazdunski, 1974). Multi-enzyme complexes consisting of 
a large number of subunits are in their turn also organized 
into symmetrical structures. Dynamics of their quaternary 
structures may lead to lower symmetries, namely, to the sub­
groups of their point group of symmetry. We suppose, that in 
this way the identical subunits will fall into two or three or 
more conformational classes. During conformational transitions 
concerving a lower sub-symmetry subunits ma pass from one con­
formational class to another one like subunits in the "flip- 
flop" models do. Each of the conformational classes may corres­
pond to a definite stage of a cyclic multi-stage enzymic pro­
cess. As an example, three conformational states for each of 
24 identical subunits, forming a cubic structure, may be q u e u ­
ed. The multi-enzymic complexes for dehydrogenases of a-keto 
acids do form such structures (Goldstein, Kornilov and Smeta- 
nitz, in press).
Now we would like to discuss a model for aspartate trans- 
carbamylase using numerous data consistent with its symmetry­
changing dynamics.
We consider three conformational states (Saifullin and 
Goldstein, in press):
1. ) a fully symmetrical state in which two ligands (suc­
cinate S1 and carbamoylphosphate S2) are bound;
2. ) a half-asymmetrical state arranged to bind succinate 
only at half of catalytic subunits;
3. ) fully inactive state.
Using graph-theoretical approach we obtain for this model:
Models for symmetry-changing conformational transitions
n+s2) [i+s1 n +s2)]n 1+ -y-Lcd+cS.,) 2
(1 0 )
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The Hill's coefficient nu is computed from Eq. (10) in accor-ri
dance with Eq. (11):
S1 . _6Y_
nH Y (1 —Y) 6S1 (1 1 )
The value (n„-1) is plotted then in Fig. 4 for various S_ 
values. It is clearly seen from Fig. 4 that "cooperativity" - 
that is the value (n -1) - changes from initial positive 
values to negative ones and then to positive again with the 
increase of . This kind of dependence, obtained in the model, 
agrees with the available experimental data.
Fig. 4
Substrate-dependent "cooperativ 
ity" estimated for aspartate 
transcarbamoylase in accordance 
with the proposed model (see 
Eq. 10).
Self-oscillations in bifunctional enzyme kinetics regulat­
ed by phosphorylation/dephosphorylation
Recently a lot of data concerning the evolutional combina­
tion of different enzymes into one multi-functional enzyme by 
the gene fusion have been obtained. Activities of all the en­
zymes combined become concerted and controlled by conformation­
al dynamics. This concerted behaviour becomes especially ef­
fective, in case it is induced by means of specific modifica­
tory enzymes. A very interesting example of such systems has 
recently been discovered. We mean a bifunctional enzyme 6-phos- 
phofructo-2-kinase/fructose-2,6-bisphospatase (6PF2K-ase/F26P2-
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ase), regulated by phosphorylation/dephosphorylation (Hers,
1984). Two reciprocal enzyme activities usually linked to two 
different enzymes in a substrate ("futile") cycle are here 
arranged into a single protein, the result being their confor­
mational interrelation. Our analysis shows that the feedback 
interactions are organized here in such a manner as to produce 
self-oscillatory regime resulting in time separation of recip­
rocal flows without futile energy loss. It is interesting that 
substrates F6P (fructose-6-phosphate) and F26P2 (fructose-2,6- 
bisphosphate),if arranged in 6PF2K-ase/F26P2-ase, influence 
the protein kinase modificatory activity. Such feedback control 
through the modificatory enzyme (so-called "cascade regulation") 
is really very effective. The system considered is an important 
regulatory block of metabolic networks. F26P2 has recently 
been shown to have a strong regulatory effect on glycolysis. 
Thus, oscillations of this metabolite, predicted in this 
paper, may supply one more explanation for well known glyco­
lytic oscillations.
The non-linear graph (Goldstein and Shevelev, 1985) for 
this multi-enzymic system shown in Fig. 5 is pictured accord­
ing to the mass action law. All of reaction participants 
(substrates and enzymes) are considered here as time depend­
ent variables. In Fig. 5 they are shown as circles and reac­
tions - as squares.
We designate here F6P as , F26P2 as S2. E^  is a dephos- 
phorylated bifunctional enzyme catalyzing the forward reac­
tion -*■ S2, while E2 is a phosphorylated bifunctional en­
zyme catalyzing the reaction S2 -*■ . Protein kinase cat­
alyzing the reaction S2 ■* . Protein kinase E^ catalyzes the
phosphorylation E^  -*■ E2. Phosphatase (not shown) catalyzes 
the dephosphorylation E2 E^  . Substrates S^  and S2 are re­
versibly bound to protein kinase E^ to form inactive complexes. 
This fact seems to be very plausible and does not contradict 
experimental data. Graph of Fig. 5 has been analysed with the 
help of the graph-theoretic computer programme detailed in 
(Ivanova and Tarnopolsky, 1979). The applied algorithm is 
similar to rules of Clarke (1974) and of Goldstein and Shevelev
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Fig. 5
Graph for bifunctional system 6PF2K-ase/F26P2-ase controlled by phos- 
phorylation/dephosphorylation with substrate feedback regulation.
(1985). On this basis the conditions for self-oscillations 
have been obtained and corresponding parameter values have 
been computed. The oscillatory behaviour for the system dis­
cussed is shown in Fig. 6. The computed unstable state is the 
following: E.. = 10-1, S.^2, E2 = 10-1, S2 = 1 , E3=10-2, S.jE.^0.2, 
S2E3=0.1. Oscillations arise around this unstable state.
Fig. 6
Self-oscillatory kinetics computed for graph of Fig. 5 (6PF2K-ase/F26P2-ase 
system)
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DISCUSSION
BARDSLEY:
Is it possible to incorporate the laws of microscopic 
reversibility into graph theoretic methods so that the 
rate equations are properly dimensioned with respect to 
the correct number of independent rate constants?
GOLDSTEIN:
The laws of microscopic reversibility as well as other 
physical principles (for example, time-hierarchy and 
space-symmetry of complicated enzymic systems) should be 
incorporated, of course, into graph theoretic methods. 
The application of these principles allows the number of 
independent kinetic parameters to be reduced. As a con­
sequence we obtain sufficiently simpler rate equations 
when using graph theoretic methods.
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I - INTRODUCTION
Kinetic equations that describe the behaviour of allosteric enzymes, 
appear to be extremely complex, much more complex than the corresponding 
substrate-binding isotherms. The substrate-binding isotherm of a four-site 
enzyme for instance, is a 4:4 equation, that is the ratio of two polynomials 
of the fourth degree in substrate. For the same type of enzyme, the simplest 
kinetic scheme would be expressed by a 10:10 rate equation!
By the very nature of their steady state equations one would expect the 
allosteric enzymes to display a very complex kinetic behaviour [1-3]. Most 
allosteric enzymes however exhibit a smooth kinetic response when the subs­
trate concentration is varied. In most cases, one observes positive or nega­
tive co-operativity as well as substrate inhibition. Although complex rate 
equations may generate smooth curves [4] , there is little doubt that a 
large potential of kinetic complexity of allosteric enzymes does not seem to 
be often encountered in nature. One may therefore wonder whether some con­
straints between rate constants may not have arisen in the course of Evolu­
tion, thus resulting in a partial degenerescence of rate equations and there­
fore in their simplification. The existence of constraints between rate 
constants means the existence of some definite structural properties of 
polymeric enzymes.
Enzyme kineticis ts have derived the steady state equations of various 
models of allosteric enzymes.As expected, these equations are exceedingly 
complex and tell us nothing about the way subunit interactions and confor­
mational constraints modulate the rate of product appearance . On the other 
hand, the classical models of subunit interactions, namely the Monod et al
[5] and the Koshland et al [6] models, have been derived for equilibrium 
conditions occurring between the protein and a ligand. As it will be seen
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later, these models are not applicable to rate data.
The aim of this communication is to precisely study how the dynamics 
of subunit interactions modulates, under non-equilibrium conditions, the 
rate of an enzyme reaction and to understand how this process may have been 
subjected to evolutionary pressure.
II - THE THERMODYNAMIC FORCES THAT CONTROL ENZYME REACTIONS AND THEIR 
EVOLUTION
The simplest enzyme reaction may be described by the model
k1[S]
ES EP
k2 [P]-l- -c
If one assumes, as done by Albery and Knowles [7], that the improvement of 
catalytic efficiency is the driving force of evolution, evolutionary pres­
sure must tend to maximize the reaction flux, J. from S to P through the 
various internal states of the reaction. Improving the catalytic efficiency 
of the reaction implies that the reciprocal of the flux decreases. The upper 
limit of functional efficiency, called "catalytic perfection" [8] will be 
reached when :
- the binding of the substrate and the product are both diffusion-controlled;
- the ratio 1/[S] is small enough to make one of the terms of the flux 
equation dominant;
- the free energy changes involved when passing through the central transi­
tion states are small.
The reaction flux is then solely defined by the diffusion-controlled 
rate constant and by the overall equilibrium constant.
Another important question is to figure out which kind of molecular 
device allows this improvement of catalytic efficiency. If AG^ and AG^ ' 
are the free energies of activation associated with an enzyme reaction 
process and the corresponding uncatalyzed reaction , one may write for the 
internal states of the free energy profile
(1)
AG^ , = AG^ i + A GB - X --1 ss s ss
AG^ = AG^ l + agb - X .c sx S sx
AG^ = AG^ I + agb - X _-c px p px
AG t. = AG *1 + agb - X .2 PP p PP
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In these expressions AG^l , AG^i , AG^L , AG^ l are the non-enzymatic freess sx px pp
energies of activation required to go from a ground to a transition state,
namely from S to to , from S to X^ , from P to X^ and from P to P^ ,
B Brespectively. -AGg and -AG^ are the binding free energies of the substrate 
and of the product. Similarly X _ X _, X _ and X _ are the driving forces 
that allcw to pass the free energy barriers, namely which allow to go from S to 
S* , from S to X ,^ from P to X^ and from P to P^ . These driving, or thermo­
dynamic, forces exerted in either the forward or the backward direction 
consist of two contributions : the binding energy of the transition states 
to the enzyme and the free energy associated with the conformation changes 
of the enzymes which pass from a strained to a less strained state. These 
driving forces may be expressed as
TX . = AG - ss ss + AG?s
TX _ = AG - sx sx + AG?X
TX _ = AG . px px + AG?X
TX _ = AG . PP PP + agbp
B R BIn these expressions AG_ AG_ AG_ represent the binding free energies
S  ^ P T T Tof the various transition states. AG AG ., AG _ are the free energiesss sx pp
released upon the conformation changes of the enzyme in going from a ground
to a transition state, namely from ES to ES^ , from ES to EX^ , from EP to
EX^ and from EP to EP^ , respectively.
The evolutionary pressure, which tends to decrease the AG^ values of
B Bthe central transition states (equations 1), tends to make AG and AG ass P
close to zero as possible and to maximize the driving forces X. When
the driving forces are close to their maximum values, the binding and confor- 
B Tmational energies AG and AG which appear in equations (2) are independently 
reaching their own maximum values. A ligand-induced conformation change 
requires some energy to occur, therefore the binding energies have reached 
their maximum possible values when all the transition states, , X^ and 
P^ are tightly bound to the free enzyme form without any additional confor­
mation change of this enzyme. Therefore this improvement of catalytic effi­
ciency implies that the enzyme should have the same conformation in all the 
transition states.
Upon passing a free energy barrier, the enzyme relapses from a strained
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to an unstrained conformation. The functional efficiency of the enzyme is 
maximum when the energy released during this conformation change in maximum, 
and therefore the same for all the reaction steps. This implies that
(3) T T TAG . = AG . = AG . ss sx px
T T= AG . = AG PP
and therefore that
(4) px
Moreover, it follows from the above reasoning that substrate and product 
stabilize the same, or energetically indistinguishable, conformation (s ).
Then, the activation free energies associated with the internal 
states reduce to (equation 1)
AG^-v AG^l - X .-1 SS ss
AG^ -v. AG^l -• X .c SX sx
AG^ -v AG*'. ■- X .-c px sx
AG* -v. AG^_ •- X .2 PP PP
Therefore if an enzyme has reached its maximum functional efficiency this 
implies that the two following requirements have been met, namely:
- the enzyme should have the same conformation, along the reaction co­
ordinate, in all the transition states;
- the substrate and the product stabilize in the ground states energetically
indistinguishable conformations, or even the same conformation [8, 9].
Ill - THE PRINCIPLES OF STRUCTURAL KINETICS
As outlined previously [9-13] , the aim of the structural kinetic 
formalism is to express the rate of a chemical process, carried out by a 
polymeric enzyme, in terms of both the corresponding process carried out 
by an ideally isolated subunit and the role played in this process by 
subunit packing and distorsion within the polymer. As a matter of fact, 
subunit interactions may affect a chemical process in two different ways. 
Owing to protomer arrangement and association, they can modify the rate of 
a conformational transition associated with that reaction step . Moreover 
they may strain the active site and therefore modify the rate of the process. 
These two types of energy contributions tend to stabilize the polymeric 
enzyme with respect to the ideally isolated subunit.
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Since the conformation of an enzyme has to be relieved at the 
top of the energy barrier, one may expect the quaternary constraints between 
subunits to be relieved in the transition states. Obviously there cannot 
be any experimental proof that quaternary constraints are relieved in the 
transition states, but this assumption is necessary to explain the occurrence 
of catalysis.
In its simplest version, the structural kinetic formalism relies on 
three postulates :
- the postulate that an unstrained subunit occurs under only two conforma­
tions, A (unliganded) and B (liganded);
- the postulate of uniqueness of subunit conformation in all the transition 
states;
- the postulates that quaternary constraints are relieved in the transition 
states.
These statements are formulated in terms of postulates, but the discus­
sion presented in the above section shows that evolutionary pressure should 
favour the emergence of these molecular properties.
Let there be any kind of chemical process, involved in a reaction 
carried out by a polymeric enzyme, the corresponding activation energy may 
be ideally split up into three energy contributions :
1) The intrinsic energy contribution AG^* which corresponds to what the 
activation energy would be in absence of any subunit interaction. This 
is the free energy of activation of an ideally isolated protomer.
2) The second energy contribution is termed the protomer arrangement contri­
bution, S(aAGlnt) . It expresses quantitatively how subunit arrangement 
and association, apart from any strain of the active sites, may modulate 
the rate of the conformational transition associated with the chemical 
process. This energy component corresponds to the free energy of subunit 
polymerization, on assuming that no conformation change occurs during this 
process. If there exist 1 subunits in conformation A and m subunits in 
conformation B, in a ground or a transition state, this protomer arrangement 
energy contribution assumes the form
(6) S(aAGlnt) = (1) (“aG^) + (™)(“aGbb) + l m C V ^ )
3) The third energy contribution is called the quaternary constraint 
contribution, S(°AGlnt), and expresses how the strain between subunits 
through quaternary constraints may modify the reaction rate. It may be
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expressed by an equation similar to equation (6) above. Since quaternary 
constraints however must be relieved in the transition states, this contribu­
tion applies to ground states only.
Therefore the expression of the free energy of activation for the 
process carried out by the polymeric enzyme assumes the form
(7) A = AG^* + S(aAGint) + S(°AGlnt) 
and the corresponding rate constant is
(8) k = k* Ila Ila 
where
k T
k* = — —  exp {-AG^/RT} 
h
(9)
a = exp{-(aAG)/RT} 
a = exp{-(aAG)/RT}
k , h and T are the Boltzmann constant, the Planck constant and the absoluteJD
temperature, respectively, a and o are dimensionless coefficients analogous 
to equilibrium constants. They are termed interaction and strain coeffi­
cients, respectively, k* is the so-called intrinsic rate constant [9, 12].
An illustration of the principles of structural kinetics is to be found 
in references 9 and 12.
IV - STRUCTURAL KINETIC EXPRESSION OF RATE EQUATIONS
The structural formalism allows one to express how subunit interactions 
and conformational constraints modulate the steady state rate of product 
appearance. For a dimeric enzyme, if subunits are loosely coupled, the model 
that describes the rate of product appearance is shown in Figure 1.
In this model, the subunits are assumed to exist in only two unstrained con­
formations A and B in the ground states, and the corresponding equation is 
2:2 in substrate concentration, namely [12]
(10)
- - - AA - 2 22k* K* [S] + 2 k* —  K*[S]
aAB
1+2 —  K* [S] + —  K*2 [S]2
aAB aBB
In this expression k* and K* are apparent catalytic and affinity constants 
defined as
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Figure 1 :
Kinetic model for loose coupling 
in a dimeric enzyme.
(a) The intrinsic process for an 
ideally isolated subunit.
(b) Kinetic model for a dimeric 
enzyme.
(c) Kinetic model for a dimeric 
enzyme after graph reduction.
k*(k*  + k* )
K* = —  ------------ 2—
k* (k* + k* )-p -s
Clearly when no subunit interaction occurs, a^= cigg = a.gg = 1 and equation (10)
reduces to
(12)
2 k* K* [S]v _ _______2__
[E]0 1 + K*[S]
and the enzyme does not display any co-operativity. Kinetic co-operativity 
in equation (10) obviously appears as a consequence of subunit interactions 
which hinder , or facilitate, the rate of the conformational transitions.
If subunits are tightly coupled (Figure 2) , the structural rate 
equation becomes more complex and one has to take account of the strain of 
the active sites generated by the inter-subunit conformational constraints. 
When, as shown in Figure 2 (b), conformational constraints are relieved in
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the unliganded and fully liganded states
(13)
and
514)
°AA °BB
BB
AB “AB °A
In this case, the corresponding structural rate equation assumes the form
[12]
(15) —
- - - AA - 2 22 k* K* [S] + 2 k* —  K* [S]
“ab
[e ]q 1 + 2 —  a* K* [S]+ —  K*2 [S]2
“BB A aBB
Figure 2:
Kinetic model for tight coupling 
between subunits in a dimeric en­
zyme.
(a) Quaternary constraints are not 
relieved in the non-liganded and 
fully-liganded states.
(b) Quaternary constraints are 
relieved in the non-liganded and 
fully-liganded states. The intrin­
sic process is shown between (a) 
and (b).
The same structural formalism allows to derive the expression of the 
corresponding substrate-binding isotherms under equilibrium conditions.
For the model of Figure 1, the corresponding substrate-binding isotherm is
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(16) v = 2 Y
aAA aAA 2 22 —  K* [S] + 2 —  K*Z [S]
aAB aBB
1 + 2 —  K* [S] + —  K*2 [S]2
“ab “bb
and for the model of Figure 2 (b) one has
(17) v = 2 Y =
aAA “aA 2 22 —  o* K* [S] + 2 —  K*Z [ST
“bb A____________^BB__________
1+2 —  o* K* [S] + —  K*2 [S]2“BB a “bb
Clearly, equations (10) and (15) do not reduce to equations (16) and (17). 
Therefore the important conclusion which may be derived from the use of the 
structural formalism is that subunit interactions and conformational con­
straints affect substrate binding and the rate of conversion of substrate - 
into product in a different way. This matter will be discussed later on 
in this paper.
V - SUBUNIT COUPLING AND KINETIC CO-OPERATIVITY OF POLYMERIC ENZYMES
The maximum or minimum Hill coefficient is a classical measure of 
co-operativity. For 2:2 substrate binding equations, the extreme (maxi­
mum or minimum) Hill coefficient is obtained at half-saturation of the 
enzyme by the ligand. Under non-equilibrium conditions the extreme Hill 
coefficient of a 2:2 rate equation
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[S] + <!> [S]2
(18) -^------ 2-----cs]o *j[s]+ +^ [s]z
may be shown to be [13]
(19) h = ------- 2--------
ext ------------
' f 2?
where the parameter r is defined as
f,n) _ lim d2(E0/v) _ - *1(*2*1 " W
} =  1 / S ^  °  d ( l / S ) 2  =  2  ? 2
In expressions (18)-(20) the i^ s and tp's are groupings of rate constants.
For loosely coupled subunits (model of Figure 1), the expression of 
substrate-binding Hill coefficient at half-saturation of the substrate is
(21) 1/2 2 /p1 +
whereas the extreme kinetic Hill coefficient assumes the form [13]
2(22) ext 1 + /2-c
In either equation (21) or (22) the p parameter is defined from subunit 
interaction coefficients as, namely
(23)
From the comparison of equations (21) and (22) several interesting conclusions 
may be drawn [13] .
- For loose coupling between subunits, the concept of kinetic co-operativity 
is meaningful only if p < 2.
- A positive substrate-binding co-operativity is "amplified" when expressed 
under steady state conditions by measuring the conversion of substrate into 
product.
- A negative substrate-binding co-operativity is "attenuated", under non­
equilibrium conditions, by measuring the rate of product appearance.
Therefore loose coupling between subunits does not allow strong negative 
co-operativity to occur. Moreover for dimeric enzymes, although loose 
coupling between subunits may generate positive kinetic co-operativity, this 
co-operativity is not accompanied by any sigmoidicity of the rate curve.
When tight coupling of subunits occurs, as shown in Figure 2 (a), the 
extreme substrate-binding co-operativity, as expressed by the Hill coefficient 
is
(24) 1/2
2 /p'
1 + J V
but p' is now defined as
(25) P' =
2 2 
aAB °AB
aAA °AA aBB °BB
82
and depends on both the interaction (a) and strain (o) coefficients. The 
corresponding kinetic Hill coefficient, under non-equilibrium conditions, 
assumes the form [13]
(26) ext
1+ AA AA
<2 '~AB
Here again, comparison of equations (24) and (26) allows some important 
conclusions [13] :
- The kinetic co-operativity may occur only if p ' a o ^<2.
- The substrate-binding co-operativity is solely defined by the p' coef­
ficient, whereas the kinetic co-operativity is expressed by p' and the 
ratio Moreover p' and may take independent values, in such
a way that the sign of substrate-binding and kinetic co-operativities may 
be opposite.
- If the substrate-binding co-operativity is positive (p'>1), the kinetic 
co-operativity must be positive as well.
- If the substrate-binding co-operativity is negative (0<p'<l), the kinetic 
co-operativity may be negative or positive.
- If p' = 1, that is if there is no substrate-binding co-operativity, there
may exist a positive kinetic co-operativity if ^ 1* Then strain of
the active sites, exerted through quaternary constraints, may generate a 
kinetic co-operativity which is not associated with any real substrate­
binding co-operativity. Moreover for a dimeric enzyme, tight coupling 
between subunits may generate a sigmoidal rate curve.
If now subunits are tightly coupled, but if the strain is relieved in 
the non-liganded and fully-liganded states (Figure 2b), the substrate­
binding Hill coefficient is
(27) hl/ 2
but now 
(28) BB
“AA °A2
Thermodynamics imposes that [9,13]
(29) BB aAA°*2A
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which implies that p"> 1. Therefore substrate-binding co-operativity can 
only be positive or nil. The corresponding kinetic Hill coefficient is
As previously , whereas substrate-binding co-operativity is solely defined 
by the value of p", kinetic co-operativity is defined by both p" and 
a o*/a . Comparison of equations (27) and (30) shows that kinetic co- 
operativity cannot be negative and that a positivie kinetic co-operativity 
may be generated by a strain of the active sites, even in the absence of 
substrate-binding co-operativity.
VI - CATALYTIC EFFICIENCY AND FUNCTIONAL SIMPLICITY OF ALLOSTERIC ENZYMES
It has now become possible to answer the basic question raised in the 
introduction of this paper, namely : is there any mechanistic reason which 
explains that the potential kinetic complexity offered by allosteric enzymes 
is only rarely encountered in Nature ? In other words, is there any mechanis­
tic reason for the frequent occurrence of functional simplicity ?
Probably the driving force of neo-darwinian evolution of allosteric en­
zymes is the improvement of their catalytic efficiency, exactly as for the 
monomeric enzymes [7, 14, 15]. If one wants to figure out how a polymeric 
protein may have a catalytic function, one has to postulate that the inter­
subunit constraints are, at least in part, relieved in the transition 
states. Geometric and electrostatic destabilization could not occur 
otherwise [16-18]. Simple kinetic and thermodynamic considerations have 
allowed to show that the improvement of catalytic efficiency during evolu­
tion involves :
- the complete relief of inter-subunit constraints in the transition states;
- the uniqueness of conformation of the subunits that have bound any of the 
transition states;
- the uniqueness of conformation of the liganded subunits in the ground 
states, whatever the nature of the ligand , substrate or product is.
These requirements are precisely those which lead to degenerescence, 
and therefore to a simplification of the rate equations. For a dimeric 
enzyme for instance, the simplest kinetic scheme should lead to a 3:3 
rate equation. However when the three above conditions apply the rate equa­
tion degenerates to a 2:2 one. The mechanistic conditions which lead to
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catalytic efficiency, lead to functional simplicity as well. This allows to 
understand that evolutionary pressure tends to reduce the potential kinetic 
complexity offered by allosteric enzymes. The existence of this complexity, 
as expressed by "bumps" and turning points on the rate curves [3] may be 
viewed as an ancestral character of enzyme function.
VII - CONCLUSIONS
Several interesting conclusions may be drawn from the above theoretical 
considerations. The classical models of Monod et al [5] or Koshland et al 
[6 ] cannot be applied to non-equilibrium conditions which are precisely 
those of enzyme reactions. A so-called structural formalism, more general 
than the Koshland formalism, allows to express and to compare how 
subunit interactions and conformational constraints modulate either sub­
stratebinding to the enzymes or the rate of product appearance, under steady 
state conditions.
Loose coupling between subunits results in an amplification of positive 
kinetic co-operativity with respect to the corresponding substrate-binding 
co-operativity. Alternatively, this mode of subunit coupling leads to an 
attenuation of negative kinetic co-operativity with respect to the corres­
ponding substrate-binding co-operativity.
Tight coupling of subunits may lead to inversion effects. That is 
negative substrate-binding co-operativity may be associated with positive 
kinetic co-operativity. Moreover a complete lack of substrate-binding 
co-operativity may occur together with positive kinetic co-operativity.
This surprising effect is due to the strain of the active sites generated by 
inter-subunit constraints.
The mechanistic conditions which increase the catalytic efficiency of 
enzymes, increase their functional simplicity as well. Evolution should have 
favoured the emergence of enzymes that display both catalytic efficiency 
and functional simplicity.
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DISCUSSION
ATKINSON:
As you said, there is no thermodynamic or kinetic reason 
why substrate binding curves and velocity response curves 
must be identical. Whether they are or not depends simply 
on whether the rapid binding (Michaelis) assumption is 
valid and whether the intrinsic rate constants are changed 
by modifiers. But isn't it perhaps significant that in the 
few cases in which binding curves, and the effects of mod­
ifiers on them, have been determined they are nearly iden­
tical with the velocity response curves? Do you know of 
established counter-examples? Evolution may have selected 
this type of response in many or most cases because of 
regulatory advantages of such behavior.
RICARD:
The catalytic constants originating from the various en­
zyme-substrate complexes may, by chance, have similar 
values but I can hardly believe these values to be identi­
cal . The catalytic rate constant values depend on the 
energy levels of both the corresponding ground and transi­
tion states. If my assumption that the intrasubunit strain 
is relieved in the transition states, were correct, the 
energy levels of the ground and transition states, along 
the reaction coordinate, should be different. This indeed, 
should lead to different catalytic rate constant values. 
There is little doubt that very different models, for 
instance the Monod's model and the "simple" Koshland's 
model may fit pretty closely the same binding data. It is 
only through best fit estimation procedures that "validity" 
of the models may be appreciated. The same type of anal­
ysis has certainly to be performed when comparing kinetic 
models, or, when comparing kinetic overbinding models.
I do not believe one may safely speak about the "validity" 
of a given model until the quality of the fit has not been 
compared with that of possible rival models.
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As far as the intrinsic properties of a regulatory en­
zyme are concerned I can't see any advantage in having 
kinetic patterns similar to, or different from substrate­
binding curves. Our structural formalism may predict the 
existence of sigmoidal kinetic curves with a degree of 
co-operativity similar to or higher than that obtained 
from the substrate binding isotherms.
ATKINSON:
You suggested that subunit interaction might facilitate 
catalytic action. That is obviously possible, but the 
opposite effect (a decrease in catalytic activity as a 
consequence of oligomerization) is also possible and has 
been observed. The catalytic subunits of aspartate trans- 
carbamylase (which are trimers, but without subunit in­
teractions) catalyse the reaction rapidly with normal 
("hyperbolic") kinetics. The intact enzyme catalyzes the 
reaction considerably more slowly but with sigmoid kinet­
ics, so that sensitivity to substrate concentration is 
much greater than in the case of the subunits. Similar 
behaviour is seen in oxygen binding by hemoglobin and by 
its a-ß subunits. It seems that formation of oligomers 
may involve a sort of negative spring loading that can 
be overcome by binding interactions, thus producing the 
steep response that is necessary for regulatory sensitiv­
ity. Evolution is selection from among a wide range of 
thermodynamic and kinetic possibilities. Regulatory sen­
sitivity may well be more biologically important than 
maximal catalytic effectiveness.
RICARD:
On the whole I agree with these comments. What I simply 
wanted to outline is that the classical models of co-oper­
ativity of necessity implied the binding of a ligand to 
be decreased if subunit interaction occurred.
The structural formalism we proposed shows that subunit 
interactions may enhance both catalytic efficiency and
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substrate co-operativity, which do not appear as antago­
nistic anymore.
BARDSLEY:
It is clear that rate equations calculated by graph theo­
retic or structural techniques must be identical. Do the 
3:3 rate equations for your scheme reduce in degree to 
2:2?
What interpretation do you propose when the parameter p>2? 
Do you just abandon interpretation in the presence of 
substrate in solution?
RICARD:
The presented rate equations have been derived by conven­
tional techniques (King-Altman method for instance). The 
structural formalism is not a new way of deriving steady- 
state rate equations but its aim is to show how enzyme 
structure modulates reaction rate. The 3:3 rate equations 
reduce to 2:2 equations because some postulates have been 
made on the nature of the transition states.
When p>2, the reaction is inhibited by an excess substrate 
in the range of investigated substrate concentration. In 
this range the very concept of the Hill coefficient becomes 
meaningless.
CORNISH-BOWDEN:
I should like to comment on Dr. Atkinson's first point.
He said that in the small number of cases for which ex­
perimental evidence existed there was a good correspon­
dence between equilibrium binding behaviour and velocity 
behaviour. I want to emphasize that the number of such 
experimental cases is indeed small and to point out that 
15-20 years ago similar arguments were advanced to dis­
miss the possibility of kinetic co-operativity in mono­
meric enzymes. Although kinetic models were proposed by 
Ferdinand (Biochem. J. 9J3, 278-283, 1966), Keleti (Acta 
Biochim. Biophys. Acad. Sei. Huna. 3, 247-258, 1968) and
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others at about the same time as the well known quasi­
equilibrium models of Monod et al. and Koshland et al. 
(Monod, J., Wymann, J. and Changeux, J.-P., J. Molec. Biol. 
12, 88-1 18, 1 965; Koshland, D.E.Jr., Némethy, G. and Fil­
mer, D. , Biochemistry 5^, 365-385, 1966), they were not 
given serious attention for a long time because all of 
the known examples of co-operative enzymes were believed 
to be oligomeric enzymes. We now know from the work of a 
number of groups, including Dr. Ricard's in particular, 
that kinetic co-operativity in monomeric enzymes is a real 
phenomenon in the real world, and we are reminded that we 
should be cautious about making broad generalizations on 
the basis of a very small number of experimental examples.
RICARD:
I can only agree with these comments.
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It is an established fact today that, under normal condi­
tions, the structure of DNA is for the most part close to the 
Watson-Crick right-handed double helix or, as people usually 
say, the B form. This has been most clearly demonstrated in 
recent studies of very short DNA rings (comprising a couple of 
hundreds of bp). Shore and Baldwin (1983a) observed clear os­
cillations of the ring closure probability as a function of the 
number of base pairs in DNA with a period of about 10 bp. Horo­
witz and Wang (1984) concluded that the pitch of DNA in solu­
tion is equal to 10.54 bp.
DNA samples used in these studies have only recently be­
come available with the advent of genetic engineering. In gen­
eral, genetic engineering techniques have revolutionized the 
whole field of DNA structure and dynamics. It is primarily 
these techniques that made the recent discoveries possible 
which have considerably widened our knowledge of the structural 
range of DNA. The classical B form was shown to be the main but 
by no means the only possible DNA structure.
What are the alternative (other than the B form) struc­
tures and when are they formed? Below, I am going to answer 
this question.
First of all it should be emphasized that no alternative 
structures are formed in linear, non-superhelical DNA. A linear 
DNA molecule is in the B form practically throughout its length, 
though of course it exhibits small bending and torsional fluc­
tuations (Hagerman, 1981; Shore and Baldwin, 1983a,b; Horowitz
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and Wang, 1984; Frank-Kamenetskii, 1985; Frank-Kamenetskii et 
al. 1985). It is very rarely (after each hundred thousand bp, 
on the average) interrupted by solitary open, disrupted base 
pairs. The available data indicate that the lifetime of this
open state is as short as 10  ^s. A given base pair opens every -210 s. I restrict myself to these short comments about the 
dynamics of linear DNA (for a comprehensive discussion of the 
subject and literature, see my recent paper (Frank-Kamenetskii,
1985)) and will now turn to alternative structures in super­
helical DNA.
Negative superhelicity is known to be the universal prop­
erty of DNA in both prokaryotic and eukaryotic cells. Special 
enzymes, topoisomerases, maintain the degree of superhelicity 
in vivo. In the superhelical state the DNA dobule helix is 
under the stress. As a result, negative superhelicity favours 
any alternative structure that releases the superhelical stress. 
In early studies (before 1980) only two candidates, namely the 
open region and the cruciform structure, were considered. Vo- 
logodskii et al. (1979) studied theoretically the competition 
between these two possibilities and predicted that long palin­
dromic sequences, comprising about 20 bp or more, would from 
cruciform structures under sufficient superhelical stress. This 
theoretical prediction has been quantitatively conformed by 
numerous studies of cruciform formation in palindromic regions 
of different prokaryotic DNA (Lilley, 1980; Panayotatos and 
Wells, 1981; Vologodskii and Frank-Kamenetskii, 1982; Singleton 
and Wells, 1982; Lyamichev et al., 1983; Singleton, 1983).
Probably the most striking feature of cruciformation is 
its very slow kinetics, especially at a low temperature. This 
is due to the necessary formation of a large open region as an 
intermediate state in the course of the cruciformation. This 
phenomenon has extensively been studied theoretically (Vologod­
skii and Frank-Kamenetskii, 1983) and experimentally (Mizuuchi 
et al., 1982; Courey and Wang, 1983; Sinden and Petijohn,
1984; Panyutin et al., 1984). It was also used by Lyamichev et 
al. (1984) to study the problem of the presence of cruciforms
in vivo.
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After the left-handed Z form was discovered (Wang et al., 
1979) it became clear that this structure should be listed as 
an additional (and a rather powerful) candidate capable of re­
ducing the superhelical stress. However, as in the case of the 
cruciforms, the Z form formation requires a specific nucleotide 
sequence, namely alternating purines and pyrimidines in both 
DNA strands. There are no such sequences in natural prokaryotic 
genomes (though they are quite often found in eukaryotic DNA).
As a result one could study the B-Z transition in plasmids 
carrying artificial purine-pyrimidine inserts.
Two-dimensional gel electrophoresis proved to be the most 
powerful technique for studying the conformational transitions 
(B-Z, B-cruciform, etc.) under superhelical stress (Wang et 
al., 1983; Lyamichev et al., 1983; Haniford and Pulleyblank,
1983; Peck and Wang, 1983; Panyutin et al., 1984). This method 
is based on the fact that when a transition occurs in super­
helical DNA which releases the superhelical stress the overall 
dimensions of the molecule increase and it slows down in the 
gel. This results in a characteristic discontinuity of the 
two-dimensional pattern (see Fig. 1).
Such patterns as shown in Fig. 1 made it possible to ob­
tain quantitative information about the energetics and kinetics 
of cruciformation (Courey and Wang, 1983; Lyamichev et al.,
1983; Panyutin et al., 1984) and the energetics of the B-Z
transition in (GC) •(GC) and (GT) •(AC) sequences (Peck and n n n n
Wang, 1983; Haniford and Pulleyblank, 1983; Frank-Kamenetskii 
and Vologodskii, 1984; Vologodskii and Frank-Kamenetskii, 1984). 
Recently Panyutin et al. (1985) have shown by this method in
conjunction with the S1 endonuclease mapping that the (AT)n*(AT)n 
sequences form cruciforms rather than the Z form under super­
helical stress.
Treatment with the S1 endonuclease is widely used by bio­
chemists to detect and locate alternative structures in DNA.
This method is very efficient in detecting cruciformation as 
well as the B-Z transition. In the former case the scission is 
located at the centre of the palindromic region whereas in the 
latter case it is located at the ends of the purine-pyrimidine 
tract (Lilley, 1980; Panayotatos and Wells, 1981; Rich et al., 
1984).
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Figure 1
A typical two-dimensional gel electrophoresis pattern for DNA 
undergoing a superhelical stress-induced conformational tran­
sition (the pattern on the right). In the first direction (top 
to bottom) DNA moved under the tested conditions. In the second 
direction (left to right) the intercalating dye chloroquine 
was added. The dye relaxed the negative superhelicity and all 
alternative structures disappeared. As a result it was possible 
to calculate the number of each topoisomer. The pattern on the 
left shows a control experiment for DNA that cannot undergo any 
structural transition during electrophoresis.
Numerous studies indicate that homopurine-homopyrimidine 
sequences (such as (GA)n*(TC)n are very good substrates for the 
S1 endonuclease (Hentschel, 1982; Larsen and Weintraub, 1982; 
Weintraub, 1983; Cantor and Efstradiadis, 1984; Htun et al., 
1984). Do these sequences form the cruciform or the Z form or 
some novel alternative structure? This is the most intriguing 
question in the field since long homopurine-homopyrimidine 
tracts are often met in eukaryotic DNA.
Very recently we have studied the problem with the aid of 
two-dimensional gel electrophoresis (Lyamichev et al., 1985). 
First of all we constructed a plasmid carrying a 509-bp-long 
fragment of sea urchin DNA. This fragment included the 
(GA)^g•(TC)^g stretch. With the aid of two-dimensional gel
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electrophoresis and the S1 endonuclease mapping we have shown 
:hat the (GA) ^•(TC)^^ stretch undergoes a sharp structural 
transition with increasing superhelicity. As in the cases of 
cruciform and Z form formation, the observed transition partly 
relaxed the superhelical stress. In contrast with the other 
two well-documented transitions, the observed transition strong­
ly depended on pH (see Fig. 2).
5PH
Figure 2
The pH dependence of the -0tr value, the negative superhelical 
density of DNA corresponding to the transition midpoint.
The data in Fig. 2 clearly indicate that neither cruciform 
nor the Z form formation can be associated with the observed 
transition since the equilibrium between these structures and 
the B form is known to be pH-independent. We arrive at the 
conclusion that at high negative superhelicity and/or low pH a 
novel DNA structure is formed in homopurine-homopyrimidine 
regions. Lyamichev et al. (1985) called this structure the H 
form. A comprehensive quantitative analysis of the observed 
transition led Lyamichev et al. (1985) to the conclusion that 
the H form has the structure shown in Fig. 3.
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Figure 3
Model of the H form proposed by 
Lyamichev et al. (1985). The 
homopyrimidine strand forms 
stacked singly protonated C-C 
pairs with thymines looped out 
of the structure.
Proposing the structure in Fig. 3 Lyamichev et al. (1985) 
proceeded from the very important works by Gray, Ratliff and 
their coworkers who studied poly(TC) by CD and other methods. 
Having studied the yield of photodimers of different types 
Brown et al. (1985) presented conclusive evidence of the for­
mation at low pH of stacked protonated C-C pairs with thymines 
looped out of the structure. On the other hand, Gray et al. 
(1984) demonstrated the formation of C-C+ pairs between anti­
parallel strands.
The proposed model of the H form makes it possible to ex­
plain the asymmetric cleavage by the S1 endonuclease of two DNA 
strands in the (GA)n‘(TC)n tracts described by Htun et al. 
(1984). These authors reported that the homopyrimidine strand 
was cleaved only in the centre of the tract, whereas the homo­
purine strand was cleaved virtually throughout the tract. This 
is exactly what one could expect for the structure in Fig. 3.
Thus, the family of alternative structures which are form­
ed in superhelical DNA has been enlarged by one more member.
Now we know three such structures: the curciform formed in 
palindromic regions, the Z form formed primarily in alternating
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purine-pyrimidine tracts and the H form formed in homopurine- 
homopyrimidine tracts.
Do alternative structures play any role in the functioning 
of DNA in the cell? At the moment we cannot answer this ques­
tion. There are a lot of indications that the superhelical 
stress in vivo is, on the average, lower than in vitro. It is 
most probably due to this fact that attempts to observe alter­
native structures in vivo have failed. The available data in­
dicate that alternative structures in vivo have failed. The 
available data indicate that alternative structures are not 
stable in vivo without complexing with special proteins. Such 
proteins shifting the equilibrium towards the formation of al­
ternative structures have been extracted from eukaryotic cells 
in the case of the Z form (Rich et al., 1984). Among them the 
Red protein from Ustilago is of the greatest interest since 
its ability to induce the B-Z transition explains the first 
stage of homological recognition during genetic recombination. 
Proteins specifically stabilising the cruciform and/or the H 
form still await discovery.
One can speculate that negative superhelicity, which 
dramatically increases the probability of spontaneous formation 
of alternative structures in DNA, greatly facilitates their 
recognition by specific proteins.
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We are at present aware of three experimentally described types of 
dynamic behavior characteristic for protein molecules: 1) Reversible ther­
mal unfolding being the best known and most studied of the three. The equi­
librium is between the native, globular structure and a far more disroga- 
nized state that more or less resembles the time averaged structure of the 
random coil of a synthetic long chain polypeptide. Efforts have been made 
to separate the total net energy of stabilization into component parts of 
which hydrogen bond formation, sidechain solvation and electrostatic inter­
actions are the best understood. 2) Fluctuations of structure. A small sys­
tem represented by the assembly of atoms constituting a macromolecule is 
expected to show energy, and density fluctuations which are not negligible 
(Cooper, 1984). The corresponding time dependent structural changes are 
less well understood. They can be described within several frames of refer­
ence. The deviations from Average three dimensional coordinates allow de­
scription in terms of amplitudes, "flexibility of chain" (Huber and Bennett, 
1983). In dimensionless energy terms the form of the distribution function 
for energy terms describes the contributions from inter- and intrastate 
fluctuations. In kinetic terms the same movements are characterized by 
relaxation times and relaxation time spectra. 3) Most of the properties of 
a protein molecule are profoundly influenced by its state of hydration. The 
dehydrated molecule has no biological activity (Rupley et al., 1983). The 
hydration equilibria are often described in terms of hydrophobic and hydro­
philic hydration and expressed as protein/water weight ratio. These equi­
libria are presumably coupled to most of protein reactions. At the same 
time the bound water is characterized by abnormal vapor pressure. The object 
of this paper is to show that methods are available allowing the investiga­
tion of the relationships among these three phenomena.
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The cooperative thermal unfolding equilibrium per se has not been im­
plicated in the biological function, although it is true that during protein 
synthesis the nascent chain has to undergo a folding reaction. The over­
whelming majority of evidence at hand suggests that the native structure re­
presents a free energy minimum and the chain spontaneously refolds itself 
from the unfolded state. As a consequence the thermodynamic parameters ob­
tained from the study of unfolding define the forces responsible for main­
taining the unique, native three dimensional structures. Careful thermal 
studies of unfolding have shown (Lumry et al., 1966) that in many cases the 
transition can be described by a two-state model. This does not mean that 
unfolding or refolding take place in one step but that the concentration of 
possible intermediate forms is negligible, compared to the concentration of 
the end states. This observation, of course, does not hold for all proteins, 
especially in case of multisubunit, multidomain proteins for which the un­
folding sequence can show many separate steps (Privalov, 1982). The free 
energy associated with stability is the net sum of large and compensatory 
changes in enthalpy and entropy. The magnitude of the free energy change 
associated with unfolding, 1 - 1 0  kcal, reports that the native structure is 
marginally stable under biologically significant conditions. Marginal in the 
sense that we are near enough to the transition region so that the probabil­
ity of a molecule to be found in the unfolded state, although very small, 
is not negligible. Although voluminous literature exists describing the 
probable sources of free energy stabilization in terms of hydrogen bonds, 
sidechain solvation and electrostatic interactions, our interest here is 
to develop an argument for linking experimentally the unfolding reaction to 
the thermodynamic fluctuations around the native state.
Studies of the kinetics and relaxation time spectra of the unfolding 
reaction have led to the proposal (Tsong, 1982) that every step of the 
overall reaction representing the unfolding of either the whole molecule or 
a domain or subunit takes place via two linked consecutive reactions: a 
rapid initial change representing a more subtle conformational rearrangement 
followed by the unfolding of the chain on much slower time scale.
The nature of the first step is not so well understood, it represents 
the adjustment of the native, average state to a new state corresponding to 
the conditions imposed. It also represents a shift of the free energy mini­
mum towards the transition state. It stands to reason that if the first 
step is on the path towards the transition state for unfolding it could be 
compared to the nucleation step in many phase changes. The average of the
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native state is shifted and the molecule is sampling more of the states 
where the number of broken bonds increases until the critical nucleation 
size, the transition state is reached. The endstates of these thermodynami­
cally predictable fluctuations represent structures of more disordered and 
solvent accessible nature. It has to be stressed here that this is not a 
state we usually associate with partial unfolding which is generally con­
sidered to involve unfolding of a part of the protein to a state past the 
transition state and more similar to the unfolded state. We suggest that it 
is the fluctuations between the transition state analogues that the relaxa­
tion measurements of Tsong observe in the fast time range (Tsong, 1982). 
Regardless of the problems associated with these detailed studies the ex­
perimental evidence allows us to describe a tentative model of stability and 
structural movements. At low temperatures the fluctuations sampled around 
the native state are predominantly of a non-cooperative nature and of small 
amplitudes. At higher temperatures larger amplitude and more cooperative 
fluctuations become more probable. In the transition state region the intra­
state fluctuations are complemented by the interstate fluctuation giving 
rise to large heat capacity changes. Thus the intrastate fluctuations, ex­
perimentally observed, are linked to the stability and interstate equilibria.
The model proposed has a quantitative basis in the statistical mechan­
ical treatment of protein unfolding developed mainly by Ikegami (Ikegami, 
1981). In this and other similar treatments (Cerf, 1978) the approach is to 
assume that a homogeneous field of interaction energy exists making all 
bonds identical, each representing the average interaction energy. Such a 
mean field simplification of Weiss type allows qualitative predictions 
about the thermal phase equilibrium but it gives little additional informa­
tion. The important point emerging from this statistical-mechanical model 
of denaturation is its possible extension to the case of time dependence.
The model predicts that as the temperature increases the native state, a 
metastable one in our case, relaxes to the stable state at the new tempera­
ture (the unfolded one) exhibiting two relaxation times. The first one 
characterises a very fast process associated with a nucleation type of 
phenomena followed by a slower process corresponding to the well known 
unfolding step. The first step, the fast one, is an intrastate rearrange­
ment shifting towards the transition state, the words used to describe it 
are pretransition, nucleation. We have thus theoretical grounds to believe 
that the native structure stabilized by the cooperative network of bonds 
undergoes fluctuations along the reaction coordinate (arrow B in Fig. 1).
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These fluctuations are similar to the shift in the energy minimum of the 
native state at increased temperature, arrow A in Figure 1. A clear relation­
ship is thus established between the thermal unfolding reaction character­
izing the thermal stability of the protein and the intrastate fluctuations 
of the native state at lower temperatures. The role of hydration in these 
arguments and observations is great. The thermal stability and unfolding 
enthalpy increase and decrease rapidly when the protein is dehydrated 
(Fujita and Noda, 1981). The biological activity and conformational fluctua­
tions are as a rule (Rupley et al.( 1983) restored at lower levels of hyd­
ration than the thermal stability is . This points to preferential interaction 
of water with the unfolded form. In principle it can be stated that without 
hydration conformational transitions, both intrastate and interstate are 
not possible. Solvation reactions are thus linked to the structural transi­
tion.
Figure 1 .
Schematics of the energy balance 
for transition state kinetics.
Figure 2.
Average enthalpy (•) and entropy (o) 
of activation for lysozyme as a 
function of H(t), hydrogens remain­
ing unchanged at 298 K. From Gre­
gory et al. , 1982.
We ask now what evidence do we have to support our model. One of the 
methods first used to detect fluctuations within the native macrostate was
104
hydrogen exchange kinetics and most of our investigations have used this 
method. The exchange reaction CONH + HOH* t CONH + HOH* catalyzed by both 
hydrogen and hydroxyl ions has an apparent first order rate constant ex­
pressed as follows
k = k + k (H) + k„OH (OH) (1)
where k^ stands for water catalysis. The different peptide and sidechain 
groups on a polypeptide chain exchange in the unfolded state with rates 
differing somewhat due to the different electrostatic interactions with the 
nearest neighbors. For most purposes it is sufficient to use an average 
rate constant <kgx>. If we investigate an exchanging site found in the glob­
ular, native state of the protein we find that the rate is greatly attenu­
ated. We can express the new rate as
app ß<k > ex (2)
The constant ß is the structural attenuation factor which contains informa­
tion about fluctuations and stability. The temperature dependence of the
apparent rate constant k contains both the enthalpy of activation forapp
<k > a known quantity and temperature dependence of the conformational 
process. Figure 2 shows the activation energies and entropies for exchange 
from lysozyme plotted as a function of H^ a quantity representing the 
point in the complex curve for which the activation energy is calculated. 
The extraction of average activation energies from a sum of first order 
reactions is possible because of the extreme spread of the rate constants 
(8-9 magnitudes). Figure 2 shows as expected an increase in enthalpy be­
cause the variable Hr is inversely proportional to the average rate con­
stant at each point. What, however, is more important is that there are 
indications that the function as depicted is a composite of two functions, 
one w1' *"b a moderate slope in the region of low activation energies and a 
steep function dominating the region of high activation enthalpies, the 
latter presumably being responsible for the larger more cooperative motion 
reaching high on the right hand side of the potential well in Figure 1.
The most interesting thing, however, is that the unfolded state of the in­
terstate transition, the classical unfolding reaction seems to contribute 
little to the exchange. For any residue with such a dominating exchange 
pathway it can easily be shown (Barksdale and Rosenberg, 1982) that;
A H i p p (3)
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The average contribution by AHgx is quite well known (Gregory and 
Rosenberg, 1983) and precise values for AHq are available in literature. 
Values for the apparent activation energy in Figure 2 never reach values 
indicative for major contributions by the pathway represented by Eq. (3).
The earlier models for hydrogen exchange (Barksdale and Rosenberg, 
1982) associating the high enthalpy exchange with thermal unfolding were 
based on data not yet of sufficient quality to detect the consistently low­
er enthalpies. We would like to stress that of course the thermal unfolding 
does contribute to exchange in the transition region but the competition 
from intrastate fluctuations of considerable cooperativity and amplitude 
dominates the exchange. This is in good qualitative agreement with Ikegami’s 
model and our hydrogen exchange data. Tsong argues further that the rapid 
relaxation should be a structural one in the native state possibly associ­
ated with solvent penetration into the protein matrix. Enthalpy and entropy
pairs are plotted for a series of H values in Figure 3. 
v v rem & ,J. 4;The linear portions of the plot, described by AH+ = a + bAS are often 
referred to as the compensation plot. Such an extrathermodynamic relation­
ship is not part of the thermodynamic system of axioms and laws and repre­
sents a purely observational phenomenon. The presence of such a plot, how­
ever, is an indicator for the existence of certain common properties for the 
series of reactions differing in the discontinuous variable (Lumry and Ra- 
jander, 1970; Eftink et al., 1983; Lumry and Gregory, 1985). The AH or AS 
plot, however, might result in a linear relationship with a slope close to 
the experimental temperature even without the existence of compensation.
This is due to the statistical nature of the errors in the two variables 
and can be avoided by using the Krug plot which is the plot of AH agains AG. 
It can be shown that the Krug plot then also results in a straight line 
with a slope of b/(b+T), where T is the experimental temperature. In our 
specific case we have to interpret not one linear function but two, each 
representing about half of the indexed points.
In order to use the parameters a and b provided by the above relation­
ship, we have to establish models for the reaction and show that the reac­
tion schemes representing these models can lead to linear relationships. 
Hopefully, we should also be able to predict the behavior of our functions 
when new variables are introduced.
In search for a simple first model we observe that similar values for 
the slope b (often called T ) equal to 360° are observed for a series of 
conformational transitions in proteins (Gregory et al., 1982). The simplest
106
model for our reaction is the mandatory coupling model of Eftink et al. 
(1983) used for the study of ligand binding to proteins. We assume thus that 
the exchange reaction is coupled to a conformational equilibrium according 
to
k 3
N t A +  E x c h a n g e  ( 4 )
k2
N represents the nonaccessible and A the accessible state. The scheme
is formally identical with the Carlsberg mechanism. For k2 >>k^;k^ it can
be shown that the measured rate constant is k =K k„. Proceeding now in aapp eq 3
similar fashion as Eftink and Ghiron did using the absolute rate theory for 
any observed, apparent rate constant we write
kapp =(kT/h)kf Keq (5)
R l n k a p p  =  R l n ( k T / h )  +  R ln k i j j  +  R l n K e q  ( 6 )
K e q
Taking the derivative of Rink we arrive at:app
AH*p p  =  RT +  AH$ +  AHe q  ( 7 )
We will return to Eq. (6 ), multiplying both sides with -T and taking a 
derivative in respect to T
As|pp = R(1 + RlnT + In F/h) + Asf + ASeq (8)
If we multiply Eq. (8 ) with -T and combine it with 7 we can rearrange it for 
constant temperature as
AHa p p  =  C o n s t a n t  +  p A G Q +  T A S * p p  ( 9 )
Equation 9 is the same form as equations shown by Eftink and Biltonen to 
yield compensation plots when p is the extrathermodynamic variable. In 
other words the rates for the points in the range of the linear plot with 
a slope of 360° are determined by the size of the conformational contribu­
tion expressed for the sake of convenience by a multiplier p and an imagi­
nary minimal free energy increment AGo. We have thus two relationships
AHapp = A + AG! + PAGo + TAStpp (10)
AHapp = a + bAsapp (11}
The subscript app as before refers to the experimentally obtained values.
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For the above equations to be valid certain restrictions have to exist. By 
comparing the corresponding terms we see that if we assume
a = A + Ag| + pAGD (12)
the right hand side of the Eq. (12) must remain constant for a limited range. 
This is true if the AA term (the AA term to be used below refers to change 
of quantities over the linear range of index points) of pAGQ is small com­
pared to A + AG3 . A small value for pAGQ is characteristic for a process 
where the large changes in enthalpy and entropy in Eqs. (7, 8 ) compensate 
each other. The AG3 for poly-DL-alanine at pH 7 is around 19 kcal (Gregory 
et al., 1982). The magnitude of AApAG^ can from our experimental data be 
estimated as 1.5 kcal at most. The simulations by Eftink and Biltonen show 
that a 6 % change in the conformational free energy contribution still 
results in a straight line when data are plotted according to Eq. (11). The 
precision of our measurements would not allow us to easily see deviations 
from straight line behavior until AApAG^ moves into the range of 3 kcal. 
Having included the varying free energy term into the constant a the con­
stant b will represent the experimental temperature.
We conclude that the apparent compensation plot with a slope corre­
sponding to a compensation temperature of 360° can be explained by the 
coupling of the exchange process to a conformational equilibrium. As a test 
for such an assignment we will predict the effect of glycerol addition on 
the behavior of the compensation plot. Glycerol as a rule stabilizes the 
native compact conformations of proteins by way of preferential interaction 
(Gekko and Timasheff, 1984). Such a shift of stability will appear in the 
pAGQ term, however the AApAGQ term should show little change. We would thus 
expect a shift due to the change in absolute value but very little change 
in slope. As seen in Figure 3 the effect of 5 M glycerol on exchange from 
lysozyme follows the predicted pattern.
To find a reasonable model for the line representing the fastest hyd­
rogens is somewhat more difficult, the values for the slope, b,=Tc are very 
high. It is at once evident that mandatory or non-mandatory couplings to 
some equilibrium involving conformational process are unlikely. The ob­
served values for AS^ and AH^ do not correspond to conformational equilibria. 
Let us assume that a fast equilibrium, compared to exchange, still exists 
for the distribution of reactants between the solution and the protein 
phase, thus Eq. (5) and the transition state approximation still hold only
if K is now a much smaller number related to the equilibrium of broken eq
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and non broken hydrogen bonds and to the first approximation similar to all 
the sites in the region represented by the large b. The difference in ob­
served rate lies in which for our model is dependent both on visosity 
and orientation factors. For the slower sites the dominating factor was the 
probability of a structural transition and differences in k^ we discuss now, 
although present, did not dominate the observed enthalpy values.
k 3 / i  =  A i / n d - AG3 / RT =  A j / t l o i  e “ AGV RT  e - AGW  ( 1 3 )
The term is associated with the surmounting of the barriers for 
reactant transport within the domain (Beece et al. , 1980). A and T)  ^repre­
sent the steric factors and frequency as well as damping. This expression
inserted into k = K k_ and derivatives taken in respect to 1/T and T as app eq 3
before lead to the following expressions for the activation enthalpy and 
entropy observed.
As|pp,i = ASeq + Asf -  R l n ^  ■* AS*0 = A Se q  + AS^ + A s f c  (14)
AHtpp,i = AHeq + AH! + AHn (15)
We adopt now the simplest model where packing density provides a change in
the n indexed components for enthalpy and entropy according to the follow- 
± ± ± ±ing: AH^ = AHrlo + aph and AS^ = AS,^ + ßpS. We insert these expressions 
into Eqs. (14, 15), combine and rearrange as previously for Eqs. (7, 8 and
9).
AHapp,i A + TßjS + TASípP,i (16)
The middle term in Eq. (16) represents the extra quantity varying with
index. We know from the data in Figure 3 that in this case the variation
term is large enough not to be neglibible compared to A in Eq. (16).
Linearity in such conditions can be observed over limited range. Comparing
± ±Eq. (16) with the standard compensation plot Air = a + bASr for the corre­
sponding terms we can write
a = A
a - j h  +  T 3 ± S
b  =  — ------ j — —  +  T
AsapP,i (17)
At larger values of the two AA terms, cuh in the range we consider is 
negative and so is AS^pp ^. Consequently the first term in expression for 
b is positive and b>T. The effect of glycerol is much more difficult to 
predict. We see from Figure 3 that both the constant term A and the slope 
change. We know that the presence of glycerol will influence the bond
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breaking equilibrium K . We cannot predict the direction of all the terms 
in the presence of glycerol. Data for bond breaking thermodynamics in such 
solutions are not available. Thus all we can say is that the effect of 
glycerol does not contradict our second model that accounts for the higher 
value for b. Also a high value for b has been found for hydration equilibria 
of proteins, a process directly related to motility of sidechains (Liischer- 
Matli and Ruegg, 1982; Schinkel et al., 1985).
Figure 3.
Enthalpy-Free energy compensation 
plot <AH:f:> as a function of <AG*> 
without glycerol (•) and with 5 M 
glycerol (o), at 298 K. From 
Gregory et al., 1985, submitted.
Figure 4.
Out-Exchange kinetics of tritiated 
trypsin at pH 2 in presence and 
absence of ethanol. From Woodward 
et al., 1975.
We have thus reasonable evidence to suggest that the rate of the 
observed exchange of slower hydrogens is determined by a conformational 
equilibrium between nonaccessible and more accessible state. The evidence 
from the enthalpy values here and previously published (Gregory et al.,
1982) would indicate that the equilibrium is not identical with the thermal 
unfolding processes. Whether the difference between accessible and non-ac- 
cessible state lies in unfolding of a chain segment into solvent or melting 
and hydration of section in situ represents rather a semantic than physical 
difference. The important point is that a structural equilibrium is present, 
an equilibrium where breaking of the hydrogen bond structure represents the
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rate determining function in the exchange process.
The rate process for the fastest hydrogens is not dominated by break­
ing of structures but by a tortuous path type of a transportation process 
linked to internal and external viscosity.
Experiments on hydrogen exchange in the presence of 10-20 % ethanol 
(Woodward et al., 1975) give further support for two rate limiting steps.
We know that at low temperature ethanol in this concentration range acts 
similarily to glycerol (Velicelebi and Sturtevant, 1979) but has little 
viscosity. Our models would predict that the fastest hydrogen would show 
little effect of ethanol addition whereas the slower ones should be in­
fluenced profoundly. This is the actual case as seen in Figure 4.
The data and the models proposed show that hydrogen exchange 
kinetics combined with study of stability and the effects of viscosity 
allow some insight into the nature of fluctuations and their relationship 
to solvent.
(Supported by NSF-PCM 8303027)
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The dynamic properties of protein molecules, like intramolecular fluc­
tuations of thermodynamic functions, etc., seem to play an important role 
in the function of proteins (Gurd & Rothgeb, 1979; McCammon & Karplus, 
1980; Somogyi et al., 1984a). In the wide spectrum of the different phy­
sical methods, fluorescence spectroscopy proved to be a successful one
in studying protein dynamics (Lakowicz & Weber, 1973;Eftink & Ghiron,
1975, 1977; Barboy & Feitelson, 1978; Hevessy et al., 1981; Somogyi et 
al., 1984b; Matko et al., 1984; Jameson et al., 1984).
The subject of the present paper is to show how the quenching of pro­
tein fluorescence can be related to and used to obtain information about 
protein dynamics.
In general case, the excited state of a fluorophore can decay by a few 
competing and independent pathways:
kfa) A* -*■ A + hv
kob) A* -► A + heat ( 1)
k+ [Q]c) A* + A:Q
Here A* and A are the excited and ground state of the fluorophore, kf is 
the rate constant of the decay by photon emission, hv, k is the sum of rate 
constants of processes like local quenching (caused by the neighboring 
solvent molecules or residues in the case of a protein), and k+[Q] is the 
rate constant of decay caused by the collision of the fluorophore in the 
excited state and a quencher molecule being present in concentration [Q]. 
(The presence of static quenching, which is due to the complex formation 
between A and Q, is disregarded here).
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On the basis of scheme (a), the average lifetime of the excited state
T can be obtained as:
T = (kf + kQ + k+ [Q])_1. (2)
Since the fluorescence intensity measured in steady state circumstances 
(continuous, relatively low level excitation) is proportional to this 
lifetime, it is easy to show that the ratio of the fluorescence inten­
sities obtained without and with the presence of quencher Q is described 
by:
^  =  1 + k + T0 [ Q ] ,  ( 3 )
the Stern-Volmer equation, where FQ and F are the fluorescence intensities 
in the absence and the presence of quenching, T0  is the average lifetime 
when Q=0 and:
k+To = Ksv <4
is the Stern-Volmer constant. When only ot(< 1) fraction of the fluoro- 
phores are accessible to the quencher, the modified Stern-Volmer or Lehrer 
equation is useful to analyze the quenching data (Lehrer, 1971):
o
AF
2  ___1_  _ J _
a + aKsv [Q]* (5)
During the derivation of the above equations, it is assumed that every 
collision of the quencher is effective, i.e. we are dealing with "strong" 
quencher, otherwise KgV contains one additional factor, 0<Y<1, charac­
teristic of how effective the given quencher is. Equation (5) is the 
usual form applied for the study of protein fluorescence, when part of the 
emitted light originates from fluorophores (like tryptophan, tyrosine, 
etc. residues)buried inside the macromolecule. While studying quenching 
of protein fluorescence, two main problems arise:
1) The proteins usually contain both external (located on or close to 
the surface) and internal (not exposed to the solvent) 
fluorophores. In the case of applying ionic quencher, this 
problem diminishes since these quenchers, just by being strongly 
charged, can quench only the external fluorophores. In the case 
of a neutral quencher (like oxygen, acrylamide, etc.) however, the 
simultaneous quenching of both types of fluorophores occurs
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resulting in serious difficulties of how to interpret the 
"average" quenching constants obtainable. To overcome this 
problem, it is required to have the separate quenching parameters 
for the two classes. Such a method will be described here as 
"double quenching."
2) In contrast to the interpretation of Ksv (or k+ characteristics of 
the quenching of model compounds like tryptophan, etc., in simple 
solvent, the detailed molecular description of 1^., and therefore 
the interpretation of Ksv, is not straightforward for proteins. 
For external fluorophores, there are two possibilities: they are 
either permanently exposed to the solvent and therefore to the 
quencher as well, or their transient exposure is controlled by 
some kind of gating provided by the surface dynamics of the pro­
tein, i.e. by the motion of the neighboring groups (McCammon & 
Northrup, 1981; Szabó et al., 1982). Regarding the internal 
fluorophores, again there are two different possible mechanisms to 
account for the quenching. First, like the hydrogen exchange, here 
the reactants (the excited fluorophore and the quencher) can come 
into contact (resulting in quenching) either by the transient 
exposure of the fluorophore to the solvent (partial unfolding) 
(Englander & Kallenbach, 1984) or by a mechanism in which the 
quencher penetrates the protein body as it is shown for the case 
of oxygen (Calhoun et al., 1983; Hagaman & Eftink, 1984). 
Obviously, depending on which mechanism is involved in the actual 
quenching, the information contained by Ksv will be different.
According to the above, to learn more about protein dynamics, it is 
necessary to develop appropriate models like the one describing oxygen 
penetration (Gratton et al., 1984; Jameson et al., 1984). The alternative 
model, compared to the penetration, has been developed (Somogyi et al., 
1985) and will also be described here.
The method of "double quenching"
With one independent variable, the quencher concentration, a linear 
relationship seen in Eq. (5), yields two parameters a and Ksv. If we 
desire to resolve the mechanism in further detail by characterizing the 
quenching constants and accessibility for the two main classes of
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fluorophores, the external and internal, we have to increase the number of 
variables. One way to do this is to simultaneously apply two quenchers 
showing the selectivity in their ability to quench (Somogyi et al., 1985). 
One of the quenchers should be specific (like I“, Cs+, etc.), being able 
to quench only the external fluorescence, while the other one should be 
nonspecific (like oxygen or acrylamide). According to the above, let us 
consider a protein having three classes of fluorophores: a) external, b) 
internal and quenchable by the nonspecific quencher only, and c) non- 
quenchable. The fluorescence intensities Foe (=aFQ), FQ  ^ (=3Fq) and FQn 
(=yF0) then add up to FQ, the total intensity. Therefore:
(X + 3 + Y-1. (6)
By then using the exact proportionality between the lifetime and 
fluorescence intensity, and the additivity of fluorescence, one can arrive 
at:
f 1,2 _ _ _ _ _ _ a_ _ _ _ _ _  B
F0 1+K1e[Q1]+K2[Q2] 1+K1i[Q1] Y' (7)
where F-j 2 is the total fluorescence intensity in the presence of the two 
quenchers with concentration of [Q-j ] for the nonspecific quencher and [Q2] 
for the specific one. The K-|e, and K2 are the appropriate
Stern-Volmer constants being assigned according to the indexes. It is 
then obvious, that for the total fluorescence intensities, F-j, measured in 
the presence of Q-j and the absence of Q2, one obtains (by inserting [Q2] = 
0 into Eq. (7)):
—  =  --------------------  +  ----------^---------  +  y.  ( 8 )F0 1+K1e[Ql] 1+KU [Q1]
Combining Eqs• (7) and (8):
£ o  = Fo  _  ^ i e [Qi1 + { i + K i e [ Q i l } 2 1 (g)
AF F^F, 2 a aK2 [Q2] *
Equation (9) shows that by keeping [Q1] constant and varying [Q2], the 
plot of Fq/AF as 1/[Q2] results in a straight line with intercept and 
slope depending on [Q1] (see Fig. 1). It should be noted that when [Q^ ]= 0, 
Eq. (9) reduces to the modified Stern-Volmer plot for quencher No. 2. 
Therefore, two parameters out of the six (a and K2) can be obtained from a 
titration in the absence of Q-|.
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Figure 1. The quenching of lysozyme by iodide (02^  in ^he presence of 
acrylamide (Q-j) plotted according to Eq. (5). The acrylamide concentra­
tions were: no acrylamide x-x-x, 0.1 M 0-0-0, 0.2 M A-A-A, 0.3 M +-+-+, 
0.4 M • The concentration of iodide was varied from 0 to 0.18 M.
The buffer was on all occasions 50 mM phosphate, pH 7.0, containing 0.1 mM 
Na2 S2 C> 3 (to prevent I3  formation) . The excitation wavelength was 297 nm 
and the emission was monitored at 337 nm. The bandwidth of 5 nm was used 
in all measurements. The temperature was kept constant at 303 ± 0.1 K.
The accessibility and quenching constant characteristic of I- was calcu­
lated from the lowest curve as a = 0.33 and K = 8.13 M \
To proceed further, a secondary plot should be used by plotting the 
square roots of slopes, 5^^, against [Q3 ] (see Figure 2):
( 1 0 )
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Figure 2 .  The square root, £1//2, of the straight lines from Fig. 1 
plotted against acrylamide concentration. The value of K1e was calculated 
as the ratio of the slope and intercept of the straight line shown (K1e = 
1 . 6 2  M ~ 1 ) .
The value of K-je can be determined either by using the slope and intercept 
of Eq. (10) or using the already known value of C1K2  and the slope.
The parameters remained then to evaluate are 8, y and Kpp. For this, 
one can define X and calculate its value from the already known parameters 
as:
|_ F0 1+K1e[Ql]
Denoting the value of X at [ß-j] = 0 by XQ, we write:
__1_ = 2 __!_ __1_
X0-X 8 + 8K1:L [Qt] '
Plotting 1/(X0-X) vs. 1/[Q^] should result in a straight line and the
S
1+KppIß! + Y- ( 1 1 )
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values of ß and can accordingly be calculated from the slope and
intercept (see Figure 3). The value of y then comes from Y=1-a-ß.
Figure 3. The plot of (X0-X)-1 vs. [Q-j]— ^ - The values of ß and 
were calculated according to Eq. (12) as ß = 0.63 and = 3.57 M“ .
Gated quenching of protein fluorescence/phosphorescence
With the exception of permanently exposed fluorophore groups of pro­
teins , there are two main pathways to quench the protein fluorescence/ 
phosphorescence: a) the penetration model assumes the quencher to
penetrate the protein matrix; b) the partial unfolding model prescribes 
that the internal groups of the protein occasionally and transiently 
become exposed to the solvent.
The latter mechanism is usually discussed in terms of a reaction 
scheme borrowed from the hydrogen exchange literature (Barksdale S 
Rosenberg, 1982; Calhoun et al., 1983a,b):
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( 13)■'cl OP t A. c^l op
+ Q Aop=Q-
Here, A and A stand for the ground and excited states of the fluorophore, 
subscripts cl and op stand for the nonaccessible (closed) and accessible 
(open) states, Q is the quencher molecule while k+ is the bimolecular 
quenching constant characteristic of the rate of encounter complex formed 
between the exposed fluorophore and the quencher molecule.
Due to the finite lifetime of the excited state, however, the scheme 
(13) gives only an approximate description of gated quenching. For 
example, for the quenching constant Kgv, Eq. (13), results in:
rlQ] == fcppk+yglkcl+k+[Q] (14)
with t0 being the lifetime of the excited state in the absence of 
quencher, i.e., it predicts the quenching reaction to be fist order in 
quencher concentration only in a limited range when k+ [Q]<<kcj_.
To have a more precise description, one has to deal with the extended 
scheme of:
Acl Aop+ +
+ 4-
Acl A*Aop
MQ] (15)
Aop:Q
In a general case the scheme (15) represents a given fraction, a, of the 
protein fluorescence. If fraction 1-a cannot be quenched by the given 
quencher, one can apply probabilistic considerations to calculate the 
probability, W, that the a fraction of the fluorescence will not be 
quenched by the applied quencher, i.e. the probability that the excited 
state assigned to a will decay in any other way but quenching:
*+[Q]t01 + p,cl
1 + ucl
w = (16)
To  + v c l  M Ö l To 1 + --1--------- TZ----Tycl 1 + -2- + —
vcl uo
Here vQ and vc  ^are the average time of the fluorophore being in the open
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(17)
a n d  t h e  c l o s e d  s t a t e ,  t q  i s  t h e  l i f e t i m e  o f  t h e  e x c i t e d  s t a t e  i n  t h e  
a b s e n c e  o f  t h e  q u e n c h e r  a n d :
P c l (1 - p0> v c l
u c l  +  v o  '
B y  t h e  u s e  o f  E q .  ( 1 6 ) ,  o n e  c a n  o b t a i n  t h e  f o r m  o f  t h e  m o d i f i e d  
S t e r n - V o l m e r  e q u a t i o n :
F 0  _  F 0  _  1  ^ 1 1
V f  "  Ä F  ~  +  “ o b s Ks v  W  '
( 1 8 )
w i t h  t h e  p a r a m e t e r s :
a n d :
“ o b s  =  a a g
P o k + To
a g
w h e r e :
« g  =  P o < 1 +  p
c l
1 c l
( 1 9 )
(20)
(2 1 )
A s  i t  i s  s e e n  b y  t h e  i n s p e c t i o n  o f  E q s .  ( 1 8 ) —( 2 1 ) ,  o u r  m o d e l  d e s c r i b e s  
t h e  q u e n c h i n g  t o  b e  f i r s t  o r d e r  i n  t h e  q u e n c h e r  c o n c e n t r a t i o n .  F u r t h e r ,  
t h e  g a t i n g  a f f e c t s  t h e  a p p a r e n t  a c c e s s i b i l i t y ,  ct0 ^ s ,  a n d  t h e  S t e r n - V o l m e r  
c o n s t a n t ,  K g v ,  d e p e n d i n g  o n  t h e  r a t i o  o f  v c 1 / t q  ( s e e  T a b l e  1 ) .
T a b l e  1 .  T h e  q u e n c h i n g  p a r a m e t e r s  o f  g a t e d  q u e n c h i n g  i n  t h e  l i m i t i n g  
c a s e s .
v c l « To v c l » To
a o b s a p o “
Ks v p o k + To k + To
T h e  p r o d u c t  <x0 b s Ks v '  h o w e v e r ,  r e m a i n s  a P Qk + T0  i n d e p e n d e n t l y  o f  t h e  r a t i o  
o f  v c x / T o *  T h i s  i s  c h a r a c t e r i s t i c  o f  t h e  m o d e l  t h a t  h a s  d i a g n o s t i c  p o w e r  
f o r  e x a m p l e ,  b y  c h a n g i n g  t h e  v i s c o s i t y ,  w h i c h  c e r t a i n l y  a l t e r s  t h e  r a t i o  
o f  v c p / T Q b u t  l e a v e s  t h e  v a l u e  o f  P Q u n c h a n g e d  ( a l t e r i n g  b o t h  v c p  a n d  v Q 
i n  t h e  s a m e  w a y ) ,  t h e  a b o v e  p r o d u c t  ( a 0 b s - K s v *  w o u l d  d e c r e a s e  l i n e a r l y
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with the viscosity, while the change of KgV itself would show a different 
profile depending on the change of vc^/t0 (see Eqs. (20) and (21)). 
(Supported by NSF-PCM 8303027)
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DISCUSSION
CHERRY:
Could you comment on how your rate constant for acrylamide 
quenching of internal tryptophans in lysozyme compares 
with the rate constants for oxygen quenching and acryl­
amide quenching reported for other proteins.
SOMOGYI:
This "double quenching" method gives us the Stern-Volmer 
constants for the two tryptophan subclasses. Their con­
version into bimolecular rate constants is based on the 
observations by Imoto et al. (Proc. Natl. Acad. Sei. USA, 
69, 1 151 , 1 971 ) saying, that about 90 % of the total 
fluorescence of lysozyme can be attributed to TRP-108 
and Trp-62 residues. According to the Lee-Richards 
criterion the Trp-62 is a solvent exposed residue while 
Trp-108 is a deeply buried one. The rate constant for 
acrylamide quenching of the latter "internal" residue has 
been estimated using the singlet lifetime measured and 
assigned to this residue by Formoso and Forster (cf. J. 
Biol. Chem. 250, 3738, 1975). Regarding the acrylamide 
quenching data, our value (kgnt: 1.7x109M 1s 1) is signif­
icantly smaller than those assigned to small indole com­
pounds and fully exposed residues in small peptides and 
9-1 -1proteins (4-9x10 M s ). It lies between the values ob­
served for human serum albumin and monellin, which in 
turn, lie by a factor of s5 below obtained for RNAse-T^, 
the most often used model for completely buried trypto­
phanes. Furthermore, our value is smaller than the rate 
contants for oxygen quenching usually assigned to buried 
residues, except Trp-314 in LADH, where the rate constant 
of oxygen quenching is comparable to our value, while the 
acrylamide quenching constant is extremely small. These 
relations are not so surprising, since oxygen is expected 
to diffuse into a protein matrix much more readily than 
acrylamide (cf. Eftink and Jameson, Biochemistry, 21,
4443, 1982).
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DYNAMIC INTERACTIONS BETWEEN METABOLIC SEQUENCES
DANIEL E. ATKINSON
Department of Chemistry and Biochemistry, 
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Los Angeles, California 90024, USA
A living system is strikingly dynamic. At any moment in a 
living cell a large number of reactions are occurring, most of 
them at rates very much greater than they could attain at sim­
ilar concentrations in the absence of biological catalysts. 
Living systems differ very strongly from the non-living world 
in the variety of chemical reactions of which they are composed 
and in the velocities of those reactions.
But an even more specific difference between living and 
non-living systems is the intricate pattern of functional cor­
relations and interrelationships that characterize life. Each 
reaction is a functional part of a metabolic sequence, and 
each sequence is interrelated functionally with many other se­
quences. These functional relationships are so obvious that we 
may sometimes tend to take them for granted and fail to recog­
nize their significance. However, they are so fundamentally 
important that it may not be an exaggeration to say that, in 
effect, they constitute life. Thus in discussing dynamic in­
terrelationships between sequences we deal with life at its 
most fundamental and irreducible level.
The pattern of interrelations is shown at a simplified 
level in Figure 1, which applies to heterotrophic aerobic 
cells. The three basic needs of all cells are energy (a suit­
able ATP/ADP ratio), electrons or reducing power (a suitable 
NADPH/NADP+ ratio), and starting materials for the biosynthesis 
of the cell's components. In aerobic heterotrophic metabolism, 
all three are supplied by oxidation of carbohydrates, fats, 
and proteins. As the diagram shows, only a few compounds, all
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intermediates of glycolysis, the citrate cycle, or the pentose 
phosphate pathway, serve as starting materials for synthesis 
of nearly all of the compounds in the cell. Since those com­
pounds are consumed in synthetic sequences, there is a constant 
flow of carbon atoms through them. In contrast, the flow of 
energy and electrons from catabolic sequences to biosynthetic 
and other processes where they are needed is mediated by turn­
over of essentially constant ATP/ADP and NADPH/NADP+ pools, 
with little flow of carbon atoms.
Figure 1.
A functional block diagram of the metabolic organization 
of a typical heterotrophic aerobic organism.
Chemical energy is potentially available from any system 
that contains two or more compounds that are related by a fea­
sible chemical reaction, if that reaction is not at equilibrium. 
Two of the major functions of catabolism are to hold the ratios 
of ATP to ADP, and of NADPH to NADP+, at essentially constant 
values that are far from equilibrium for the reactions in 
which they will serve to transfer energy to other processes in 
the cell. These two transducing systems, ATP/ADP and 
NADPH/NADP+, link catabolic and anabolic sequences with defi­
nite stoichiometric ratios. It is clear that they must also
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be involved in the functional kinetic controls that primarily 
distinguish living from non-living chemistry.
I suggest that the factors that are involved in dynamic 
correlations between metabolic sequences can be grouped under 
four headings:
a) A pattern of relative affinities of enzymes for cou­
pling agents that causes kinase and dehydrogenase reactions to 
respond to the ATP/ADP or the NADPH/NADP+ ratio rather than to 
the absolute concentrations of the individual compounds.
b) Organization of metabolism so that nearly every con­
version is paired with an oppositely-directed conversion that 
involves different reactions and a different overall stoichiom­
etry, especially with regard to the coupling agents, ATP/ADP 
and NADPH/NADP+.
c) High kinetic orders of the reactions that are cata­
lyzed by most regulatory enzymes.
d) Modulation of the activity of regulatory enzymes by 
modifier or effector metabolites.
a) Response to ratios
In any chemical energy-transducing system, such as an 
electrical storage cell or the coupling systems of living or­
ganisms , the most important operating parameter is the ratio 
of the components. In order that the ATP/ADP ratio., for ex­
ample, can be held essentially constant it is necessary that 
both the regeneration of ATP by phosphorylation of ADP and the 
conversion of ATP to ADP as metabolic energy is used (for ex­
ample, in biosynthesis, pumping materials across membranes, or 
muscular movement) must respond to the ratio of concentrations 
rather than to absolute concentrations. This type of response 
has been observed for a number of kinases and dehydrogenases.
It is the basis for the pattern of regulatory interactions by 
which the ATP/ADP ratio, or the adenylate energy charge, is 
very strongly stabilized in the cell. This is probably the 
most fundamental manifestation of biological homeostasis, and 
it depends in a conceptually simple way on the properties of 
enzymes that catalyze reactions in which ATP and ADP are inter- 
converted. Similar interactions tend to stabilize the reduced-
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oxidized ratio of the NADP system. Because the NADH/NAD^ system 
functions within the block of catabolic sequences rather than 
between blocks, it does not appear in the metabolic functional 
block diagram of Fig. 1. It is, however, an important coupling 
system between substrate oxidation and electron transport phos­
phorylation, and its ratio is stabilized by the same kinds of 
interactions that operate in the cases of the ATP/ADP and 
NADPH/NADP+ couples.
An enzyme will respond to a substrate/product ratio if 
the Sq g values (the concentrations at which the site is half 
saturated with the ligand in the absence of competing ligands; 
sometimes termed the effective Michaelis constant) for both 
substrate and product are small in comparison with their phys­
iological concentrations. Then the site will always be virtual­
ly saturated, and the fraction of the sites at which substrate 
and product are bound will depend on the ratios of their con­
centrations to their respective SQ values. Thus for the nuc­
leotide binding site of a kinase, the ratio of sites binding 
ATP to those binding ADP will be given bv
(ATP/S0.5(ATP))/(ADP/S0.5(ADP))- If the S0.5 values were lar9e 
in comparison with physiological concentrations, most of the
sites would be empty, ATP and ADP would compete only weakly, 
and the amount of each that was bound would depend mainly on 
its absolute concentration rather than on the concentration 
ratio. Energy homeostasis would not then be achievable.
In addition to causing the velocity of the reaction to 
respond to the ratio of substrate to product, high affinity of 
an enzyme for S and P also allows the nature of that response 
to be precisely adjusted to increase its sensitivity and tc 
meet physiological needs. Figure 2 shows how the fraction of 
sites that bind A as a function of the mole fraction of A in 
an A-B pool depends on the relative affinities of the site for 
A and B. If the Sq values were equal, the fraction of sites 
bearing A would merely equal the mole fraction of A, as shown 
by the central diagonal straight line. If the affinity for A 
were greater than that for B, one of the upper curves would 
describe the binding, and if the affinity for product were 
greater one of the lower curves would apply.
132
Figure 2.
Fraction of binding sites bearing 
compound A as a function of the mole 
fraction of A in an Á-B mixture; ef­
fects of relative affinities for A 
and B. The numbers indetifying the 
curves are the ratios of the dis­
sociation constants K /K .
A D
Many kinases bind ADP more firmly than ATP, often by a 
ratio of about 5, giving a response curve that would lie be­
tween the 1/4 and 1/10 curves in the figure. This property may 
at first thought seem undesirable, since it means that ADP will 
be an effective product inhibitor. The extent of inhibition is 
shown by the difference between that curve and the uppermost 
curve, where ADP binds so weakly that competition is negligible. 
The loss in catalytic activity is much more than compensated 
for, however, by an increase in regulatory sensitivity. Most of 
the range of reaction velocity is condensed into a rather nar­
row range at the high end of the mole fraction scale. The rel­
atively large slope of the curves in that region obviously al­
lows for much greater sensitivity in regulation than would be 
possible in the absence of ADP inhibition. Similar but recip­
rocal interactions at catalytic sites of enzymes that contribute 
to regeneration of ATP lead to curves with complementary slope, 
as seen in Figure 3. Here R signifies the regeneration, and U 
the utilization or use of ATP.
The abscissa of Figure 3 is the energy charge, (ATP + 0.5 
ADP)/(ATP + ADP + AMP), the effective mole fraction of ATP. It 
is evident that this pattern of responses will lead to powerful 
stabilization, since a tendency for energy charge to decrease 
will be resisted by an increase in the rate at which ATP is 
regenerated and a decrease in the rate at which it is used. A 
tendency for the value of energy charge to rise will similarly 
be resisted by appropriately-directed responses.
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Figure 3.
Generalized responses of regulatory enzymes in ATP-regenerating 
sequences (R) and in ATP-utilizing sequences (U) to variation 
in the value of the adenylate energy charge.
b) Oppositely-directed sequences
Enzymes are catalysts, and like all catalysts they affect 
the rates of reactions but cannot directly determine the direc­
tion of reaction. The direction, of course, is determined by 
thermodynamic considerations: all reactions go in the direction 
of decreasing AG; that is, toward equilibrium. But no matter 
how finely adjusted were the enzymic responses, a chemical sys­
tem that hovered sluggishly near equilibrium could not have 
many of the characteristics that we observe in actual living 
systems. It is necessary for an organism to be able, for ex­
ample, to store energy at times and to retrieve the stored 
energy at others. An organism that operated around equilibrium 
could store fats only when the concentration of acetyl coen­
zyme A was high (above the concentration at which it is in 
equilibrium with palmitoyl coenzyme A), and could retrieve 
energy from stored fat only if the concentration of acetyl co­
enzyme A fell below that equilibrium concentration. Thus under
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conditions of energy need it would be handicapped by low con­
centrations of the very intermediates that are required for re­
generation of ATP. Such an organism could not respond dynami­
cally and appropriately to changing conditions and metabolic 
needs, and could not be expected to survive.
We may then seem to have a paradoxical situation or at 
least a difficult problem of design. If we are to have the 
dynamic metabolic interactions that are necessary for life, 
both the direction of conversions and their rates must respond 
to metabolic signals. Rates depend on the activities of enzymes, 
and can be modulated (point d below) , but the direction of a 
reaction or reaction sequence, being under thermodynamic con­
trol, responds only to the concentrations of the reactants and 
products. It cannot be reversed by an external signal.
Properly speaking, a problem can exist in advance of its 
solution only as a consequence of conscious thought or fore­
sight. In the blind world of evolution, where differential re­
production selects from among random mutations, there can be 
no planning, no foresight, and thus no problems to be solved. 
Only in retrospect, when we consider evolved mechanisms or 
structures, can we feel that a problem was solved or a dif­
ficulty surmounted. In that retrospective sense, we may say 
that the arrangement that evolved appears to be the only pos­
sible solution to the problem of how to make the directions 
of metabolic conversions dynamically responsive to metabolic 
need.
For nearly every metabolic conversion, two separate and 
distinct pathways exist. The pahtways are composed of different 
reactions and the overall sequences differ in stoichiometry, 
especially with respect to the coupling agents ATP/ADP and 
NADPH/NAD+. Because the ATP/ADP system is maintained very far 
from equilibrium, a difference in the number of ATP-to-ADP con­
versions that are stoichiometrically coupled to a metabolic 
sequence will cause a large difference in the overall equilib­
rium constant of the conversion. The difference is of the order
7 8of 10 to 10 for each ATP that is converted to ADP. Thus the 
equilibrium constant for the hydrolytic reaction
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fructose-1,6-bis-P + fructose-6-P + Pi
4is about 10 , but for the phosphofructokinase reaction
fructose-6-P +ADP fructose-1,6-bis-P + ATP
-4the equilibrium constant is about 10 . Thus under any conceiv­
able physiological conditions the phosphofructokinase reaction 
must go in the direction opposite to that written. In that 
direction the equilibrium constant is of course about 10^.
This simple example illustrates the general plan around 
which metabolism is organized: paired oppositely-directed con­
versions, containing different reactions or sequences of reac­
tions, with different ATP/ADP stoichiometries. This organiza­
tion is shown in Fig. 4 for the general case.
y  A T P eq y A D P eq
Figure 4 .
Two oppositely-directed reaction sequences with different 
ATP/ADP stoichiometries. The value of x is large enough so 
that conversion of B to C by the upper pathway is thermo­
dynamically favorable under physiological conditions, and 
the value of y is small enough (it may be zero or negative) 
so that conversion of C to B is favorable under the same 
conditions.
Because of the difference in the equilibrium constants (or 
in free energy change) of the two conversions, the members of 
a pair of such sequences are thermodynamically favorable in 
opposite directions under physiological conditions. Thus the
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kinetic controls that determine the fluxes through the two se­
quences can determine the direction of net conversion. Thermo­
dynamic limitations on regulatory flexibility are thus circum­
vented, and metabolic signals can control both the directions 
and the rates of metabolic conversions. Such signals directly 
affect only rates, but because of the oppositely-directed se­
quences, coordinated control of rates controls the direction of 
net conversion. Other examples are glycolysis and gluconeogene- 
sis, storage and mobilization of fats, and, in photoautotrophs, 
photosynthesis and respiration. These major energy-related 
conversions illustrate a general feature of metabolic design; 
such paired sequences, effecting oppositely-directed conver­
sions, are found throughout metabolism. Amino acids, for example, 
are typically synthesized by one sequence of reactions and 
oxidized by another with different ATP stoichiometries.
This pairing of sequences may be considered the basic fea­
ture of evolved metabolic design. It is the feature that allows 
metabolic conversions to operate far from equilibrium, where 
rates can be high and responses rapid, but to be able to re­
verse direction rapidly in response to metabolic signals. Other 
aspects of enzymic behavior, including the other features in 
our list, are part of the mechanism by which the regulatory pos­
sibilities of oppositely-directed sequences are effected.
c) High-order reactions
Most enzymes that catalyze first reactions in sequences, 
or branch-point reactions, bind one or more substrates cooper­
atively, and the reactions that they catalyze are of kinetic 
order higher than one with respect to those substrates. The 
rates of such reactions obviously respond more sensitively to 
changes in substrate concentrations than do ordinary first- 
order reactions. This is illustrated in Figure 5, where the 
cross-sectional area from the bottom of the openings up to the 
concentration of substrate is proportional to the rate of re­
action .
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Figure 3.
Schematic representation of the variation of reaction velocity 
as a function of substrate concentration for a first-order or 
standard Michaelis enzyme (A) and for a cooperative enzyme that 
catalyzes a reaction that is fourth order with respect to sub­
strate. Water flow is taken as an analog of reaction velocity. 
The shaded blocks represent dams or barriers, with openings cut 
in them to allow flow of water. The level of water behind the 
dam is analogous to substrate concentration, and for any level 
the area of the opening through which the water flows is pro­
portional to reaction velocity. For both figures the value of 
Sq 5, the concentration at which velocity is half of the maximal 
velocity, is 1.0. Note that the incremental increase in velocity 
that results from a small increase in substrate concentration 
is much greater for the fourth-order enzyme, over a range of 
concentrations below Sq 5, than for the first-order enzyme at 
any substrate concentration.
d) Response to modifiers
The kinetic properties of regulatory enzymes change when 
specific modifiers, or metabolic signals, bind to modifier 
sites. The most common effect caused by modifiers is change in 
the affinity of the enzyme for one or more substrates. The 
amount of substrate bound to an enzymic site is a function of 
the ratio (S/Sq ,_)n, where n is the effective kinetic order. 
Thus a change in Sq has as large an effect on reaction 
velocity as does a change in substrate concentration. It is 
also evident that high kinetic order will render an enzyme more
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d v / d ( S )
Figure 6 .
Schematic representation of variation of reaction velocity as 
a function of substrate concentration for a fourth-order enzyme; 
effect of change in So.5 . The analogy is the same as in Fig. 5. 
This figure shows the effect of a modifier that causes the value 
of Sq 5 to change. In this analogy, the modifier causes deforma­
tion of the shape of the opening, while not affecting its total 
cross-attentional area (that is, the modifier affects So. 5 but 
not the maximal velocity of the reaction). The ticks on the 
sides of the openings indicate the value of Sq 5 , and ticks on 
abscissa are at 0.5-unit intervals.
sensitive to changes in the value of SQ ^, and hence to changes 
to changes in the concentration of modifiers that change Sq , 
than would be possible for a first-order enzyme. The effect of 
change in Sq  ^ is illustrated in Figs. 6 and 7, where relative 
values of 1.0, 0.7, and 0.5 are compared. The rate of reaction 
is changed strongly by a two-fold change in Sq . Much larger 
changes than this in the value of Sq  ^ are frequently observed 
in studies on regulatory enzymes.
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Figure 7.
Schematic representation of variation of reaction velocity as a 
function of substrate concentration for a fourth-order enzyme; 
effect of change in Sq 5 .  The lower portions of the openings shown 
in Fig. 6 are superposed for more direct comparison of the effects, 
at constant substrate concentration, of a change in the value of 
Sq The velocity corresponding to the area of dark shading is 
increased to correspond to the area of the light shading by a two­
fold change in Sq 5 .
To summarize, dynamic interactions between sequences are 
an essential aspect of metabolism, and might be considered to 
be the basic characteristic of life. The features that are res­
ponsible for such interactions may be grouped into four catego­
ries. One is a consequence of the organized interactions of 
many enzymes: metabolic conversions exist typically as paired 
oppositely-directed sequences, with sufficiently different cou­
pling-agent stoichiometries between members of a pair so that 
the forward direction is always thermodynamically favorable for 
one sequence and the reverse direction for the other. This is 
the fundamental basis of metabolic organization. Without this 
feature, flexible and dynamic functional responses would not 
be possible. The other three types of features are behavioral 
patterns of individual enzymes. The affinities of regulatory 
enzymes for the coupling agents that link sequences stoichio-
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metrically (ATP/ADP and NDPH/NADP+) are typically so great that 
the binding sites are virtually saturated at all times. This 
makes the rates of reactions sensitive to ratios such as ATP/ADP 
and so allows the ratios or mole fractions of such coupling 
agents to be strongly stabilized. Greater affinity for the 
product (e.g., ADP in the case of kinases) increases the sen­
sitivity of enzyme response by condensing much of the range of 
reaction velocity into a narrow range of coupling agent ratio 
or mole fraction. The affinities of many regulatory enzymes for 
their substrates are modulated by binding of modifier metabo­
lites. This leads to responses that are appropriate to the 
metabolic conditions that are signalled by the modifier. Final­
ly, most regulatory enzymes bind their substrates cooperatively, 
which greatly increases the sensitivity of responses to sub­
strate concentrations and to the effects of modifiers that cause 
changes in the affinities of enzymes for their substrates. Sen­
sitivity is often further enhanced by cooperative binding of 
modifiers as well.
All four types of regulatory features appear to be neces­
sary for sensitive functional dynamic interactions between 
sequences, and it would be difficult or impossible to imagine 
a metabolic system functioning effectively in the absence of 
any one of them. By the same token, any mathematical or con­
ceptual model of metabolism must explicitly take all of these 
four features of metabolic interactions into account if it is 
to have possible relevance to the chemical activities of 
actual living cells.
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DISCUSSION
ARAGON:
As you have shown phosphofructokinase exhibits a sigmoidal 
saturation curve for fructose-6-P, and the extent of this 
sigmoidicity is dependent on its inhibition by ATP, among 
other factors. In relation to this matter, when the be­
havior of this enzyme is studied by using ITP as a phos­
phate donor instead of ATP, it also exhibits sigmoidicity 
for fructose-6-P despite of the fact that ITP is not an 
inhibitor of this enzyme. Could you please make some 
comment on this subject?
ATKINSON:
Phosphofructokinase is unusual in that ITP, GTP, CTP and 
UTP can all serve as phosphoryl donors. Only ATP decreases 
the affinity for F6P, which seems to be related to the 
special regulatory role of the adenylate nucleotides. I 
cannot say anything useful about the factors that are 
responsible for a sigmoid response to F6P concentration.
KRETSCHMER:
Is reversible enzyme phosphorylation a process related to 
metabolic regulation or rather to signals from outside of 
the cell?
ATKINSON:
Phosphorylation caused by signals from outside the cell, 
such as epinephrine or glucagon, often seem to serve to 
override local regulatory systems. Thus, to take the 
first case discovered, phosphorylation of liver glycogen 
phosphorylase converts the adenylate-sensitive form 'b' 
to the effectively adenylate-independent form 'a'. How­
ever, there are also phosphorylations that probably are 
not responses to external signals.
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RICARD:
IVhat is your personal opinion about the "functional 
advantages" of negative cooperativity which is frequently 
encountered in nature?
ATKINSON:
I am not convinced that negative cooperativity occurs 
frequently in nature, although it may do so. Positive 
cooperativity is useful when, as is generally the case 
in metabolism, substrate concentrations are to be stabi­
lized by modulation of fluxes. Negative cooperativity 
would of course facilitate the opposite type of inter­
action: stabilization of fluxes by modulation of con­
centrations. It is possible that such a response might 
sharpen the concentration pulses of regulatory compounds. 
Thus if phosphodiesterase exhibited negative cooperativ­
ity, the cell's response to epinephrine might be enhanced.
OVÁDI:
Can PFK be regulated by changing of the ratio of ATP/ADP 
which occurs under physiological condition?
ATKINSON:
If the thrust of your question relates to the fact that 
changes in the ATP/ADP ratio are small, my answer is yes,
I think these small changes are regulatory. Indeed the 
fact that the ATP/ADP ratio (or the ATP mole fraction or 
the energy charge) remains nearly constant when fluxes 
vary by several hundred fold seems to me to be conclusive 
evidence that the metabolic sequences that regenerate ATP 
and those that use ATP are very effectively and rapidly 
controlled by the adenine nucleotide system.
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The regulation of flux through pathways and other 
sequences of consecutive reactions has received considerable 
attention. The theoretical basis for the related temporal 
response of such sequences and their ability to adapt to 
changing needs within the cell has been less well studied. 
In any sequence of consecutive enzyme reactions there is a 
lag in the appearance of end-product following initiation. 
The lag is due to the accumulation of intermediates within 
the sequence and is characterised by the transient time. The 
transient time may be defined as the intercept of the 
steady-state asymptote to the progress curve in the 
formation of product with the time axis, taking as the zero 
time point the time at which the sequence was initiated. The 
transient time indicates the time scale on which the pathway 
operates and is a measure of its adaptive capacity or 
responsiveness to changing flux requirements. Analysis of 
the transient time falls broadly into three categories:
(a) The analysis and optimisation of coupled enzyme assays.
(b) The analysis of the response and time-scale of metabolic 
processes.
(c) The analysis of the channelling of intermediates within 
multifunctional proteins and multienzyme complexes.
The theoretical analysis of transience has largely 
dealt with freely diffusing systems of enzymes and
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substrates. Comparison of theoretically derived transients 
with experimentally observed values may therefore reveal 
limitations on diffusion, or compartmentation of components. 
If “^ t is defined as the theoretically evaluated transient 
and that measured, either within the cell or in
v itro, three situations may arise:
(i) "^ t = "^m enzymes and substrates are freely
diffusing.
(ii) '*'t > T m substrates are channelled between enzymes
and diffusion into the bulk medium is restricted.
(iii) T t < Tm there is restriction of diffusion and
enzymes or substrates may be compartmentalised.
COUPLED ENZYME ASSAYS
The earliest interest in the temporal response of 
consecutive enzyme systems was directed towards coupled 
enzyme assay procedures [1,2,3], To facilitate the analysis 
and in order to generate linear, homogeneous, differential 
equations amenable to solution a number of simplifying 
assumptions were made. The principle assumption was that the 
sequence would eventually enter a steady-state in which the 
concentrations of intermediates do not change with time. In 
order to achieve this it was assumed that the initial enzyme 
of the sequence would be rate-limiting and additionally, if 
it were severely rate-limiting, the steady-state
concentrations of Intermediates would be less than the Km 
values of the enzymes Involved. Under these circumstances 
first-order rather than Michaells-Menten kinetics would be 
observed and the differential equations would be soluble. 
Also the steady-state rate of product formation would 
represent the activity of the initial enzyme.
The single auxiliary enzyme system
The analysis of such system in which a primary.
146
rate-controlling enzyme is coupled to a single auxiliary 
enzyme through irreversible reaction gives rise to the 
following scheme [1,2,3]:
Vo Vm/Km
S O ------------------ > S I ------------------- > P
and:
d[Sl]/dt + Vm/Km. [SI] = Vo .................................. (1)
d[P]/dt = Vm/Km. [SI] ........................(2)
[SI] = Vo. Y  (1 - e x p ( - t / r  ))  (3)
[P] = Vo (t "f exp (-t/TT ) - Y )   (4)
T  = Km/Vm .......................... (5)
with boundary condition [SI] = [P] = 0 at t = 0, where Vo is
the required velocity and Vm/Km the pseudo-first-order rate 
coefficient. In the steady-state (t —  > °° ) one may also 
w r i t e :
[Sl]ss = Vo Y ............................... (6)
a n d :
[P] = Vo (t - Y  ) ...................(7)
t--> oO
Equation 7 represents the steady-state asymptote to the 
progress curve and intersects the time axis at t= Y . Thus 
the transient time is given by Eq.(5) and is equivalent to 
the Km/Vm ratio of the auxiliary enzyme and is independent 
of the primary enzyme whose activity is sought. The 
intercept on the ordinate axis is -[Sl]ss and represents the 
steady-state concentration of intermediate. In physical 
terms this means that the concentration of product in the 
steady-state has been depressed, below that expected if the 
pathway had entered the steady-state at zero time, by an 
amount equal to the concentration of intermediate.
The virtue of this simple analysis is that it closely 
represents the situation in many coupled assay systems and 
allows prediction of the accuracy of rate measurements. 
Equation 3 may be written in the alternative form [3 ]:
[Sl]/[Sl]ss » 1 - e x p ( - t / T  ) = v/Vo ........... (8)
where v represents the rate of product formation at time t.
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It is therefore possible to predict the fractional 
attainment of the required steady-state rate and 
this can be measured with greater than 1?6 accuracy (v/Vo > 
0.99) provided t > ft. 6 "f .
Generalisation to an unlimited number of coupling enzymes
In the example above involving a single auxiliary 
enzyme, it would have been possible to dispense with the 
first order approximation and apply Michaelis-Menten 
kinetics [ft]. However, in cases where more than one 
auxiliary enzyme is involved, Michaelis-Menten behaviour 
results in simultaneous differential equations with no 
analytical solution. The problem may still be approached as 
before and the model extended to include an unlimited number 
of enzymes resulting in the following scheme [3]:
Vo Vl/Kl V2/K2 Vn/Kn
S O -------> S I ------- > S 2 ------- > S 3 ..... S i ......S n ------- > P
with associated equations:
d [ Si ]/dt + [ S i l / ^ i  = [Si-1]/ ^i-l i — 2 , 3 .....n ---- (9)
d[P]/dt = [Sn]/T'n ......................... (10)
and boundary condition [Si]=[P]=0 at t=0, where:
1 = Kl/Vi .............................. ( 11 )
resulting in: i
[Si] = V o r i ( l - ^ A 3 exp(-t/ Tj) ---- (12)
d=l
where: i-1 1
Ad = ^ d  j [ l/( T d - "^k) ..... (13)
k = l ,k^d
n n
and: [P] = Vo(t Ci e x p l - t / ^ i )  - ^  *^1) ..(1ft)
1=1 i=l
where: n n
Ci = T ± j ~ l / (  T i - ^d ) ........(15)
d=i.d^i
Once more in the steady-state (t-->o°):
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[P] = Vo(t -J> ‘•i) .................... (16)
t __>CX3 1 =  1
Thus the transient time for the sequence is simply the sum 
of the individual enzyme transients ^ = ^ K i / V i .  Similarly the 
ordinate intercept is given by -Vo ^i which is the sum of 
the steady-state concentrations of the n intermediates . The 
model is in most respects equivalent to that of the single 
auxiliary enzyme. However, it differs in one important
respect, no generalisation may be made concerning the time 
required to reach a particular fraction of the steady-state 
flux. This is dependent on the specific values of the 
transient times of the enzymes concerned. However, Eqs.
(12),(1Ü) & (16) are symmetrical with respect to transient 
times and the order of auxiliary enzymes within the sequence 
does not affect the temporal response.
This model, though simple, led to useful
generalisations about the behaviour of sequences and 
pathways. In general the initial enzyme, though rate 
determining, does not contribute to the transient time. The 
transient time for the sequence is the simple sum of the
individual enzyme transients and the enzymes which dominate
the transient response (ie. those having greatest "V values) 
are not necessarily those of lowest activity. They may have 
high Km values and possibly low affinity for their
substrates. This led to the proposal that 'time-limiting' 
enzymes might exist which, though of high capacity, would 
also have high Km's. These enzymes if positioned after a 
branch point would control the flow of material along the 
branch and would only respond if the substrate accumulated 
and was sufficiently long-lived [3]. Such an enzyme was 
subsequently identified in the arom multifunctional 
protein complex of Neurospora crassa [53. Shiklmate
kinase controlled the anabolic or catabolic fate of aromatic 
intermediates within the complex. The time-limiting enzyme 
concept has subsequently gained wider acceptance [6].
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The consequences of extending the sequence
When there is more than one auxiliary enzyme it is 
difficult to generalise about the rate of attainment of a 
steady-state owing to the presence of multiple transient 
times. However, it is still of interest to know the effect 
of extending the sequence. This difficulty can be partially 
resolved by making the auxiliary enzymes kinetically 
identical, which in the present context means giving them 
identical transient times. This can be achieved by adding 
enzymes in proportion to their Km's, thus keeping the Km/Vm 
ratio constant. The following scheme describes the 
situation:
Vo 1 /'V l/'t 1/T
S O -------> S i ------- > S 2 ------- > S3 .............. S n ------- > P
Each step has the same first-order rate coefficient 
given by 1 / T  (ie.Vm/Km). The analysis of this sequence 
separates the effects of enzyme kinetic properties from 
those of pathway length and results in the following 
solutions [7] :
i-1V- d
[Si] = Vo( T  - (Tr/d!) (t/'X) exp (-t/ ' X  ) ) ----(17)
d =o
and:
n-1
d d .
v/Vo = 1 - n /d ! ( t / T o )  e x p ( - n t / T o )  ....... (18)
d =0 
n-1
[P]/[S] = (t/To) n . (n-d )/d ! . (t/T0 ) .exp(-nt/Tó) - 1.
d =0 ... (19)
w here:
To = n T  ........................(20)
v is the velocity of product formation and [S] represents 
the sum of the steady-state intermediate concentrations.
Thus it is possible to describe the fractional 
attainment of the steady-state rate in terms of an overall
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transient time for the sequence and the number of auxiliary
enzymes. The 
shown in Table
Attainment of
consequences of extending the sequence are 
: 1 .
TABLE 1
the steady-state velocity in a coupled enzyme
The half-time.
sequence
the time to reach 99% of the steady-state
flux and the velocity at the transient time are shown.
No.auxiliary 
enzymes (n) v/Vo = 0.5
t/Tb
v/Vo = 0.99
v/Vo
at t = ^  0
1 0.693 4.605 0.632
2 0. 839 3- 319 0. 594
3 0.891 2.802 0.577
4 0. 918 2.511 0 . 567
5 0.934 2.321 0.560
6 0.945 2.185 0 . 554
7 0.952 2.082 0 . 550
8 0. 959 2.000 0 . 547
9 0.963 1.934 0 . 544
10 0.967 1.879 0.542
15 0. 978 1.696 0.534
20 0 . 983 1.592 0. 532
This solution has two important consequences. Firstly 
it is possible to completely describe the generalised time 
course of a coupled enzyme system providing all enzymes are 
given the same transient time. Secondly, extending the 
sequence Increases the time required to reach 50% of the 
steady-state rate but decreases the time required to reach 
99% of this rate. Therefore, given two sequences with the 
same overall transient time, the longer will approach the 
steady-state first. As the number of enzymes becomes very 
large the pathway response approaches a step function and no 
product is seen until the transient time is reached. At
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this point product appears and is produced at the 
steady-state rare 17J. Tne implication for the design of 
coupled enzyme assays is clear. The system is best defined 
if all enzymes have the same transient time and no loss of 
accuracy of steady-state measurements is incurred by
extending the sequence, as the steady-state is approached 
more rapidly.
GENERALISATION OF THE THEORY OF PATHWAY TRANSIENCE
The previous models rely on detailed kinetic 
description of the enzyme sequence but have one common 
property. The transient or lag time in product formation is 
the result of accumulation of intermediates within the 
pathway. This suggests a more general approach to the 
analysis of transience based solely on mass conservation and 
requiring no detailed kinetic knowledge of the pathway 
[8,9]. All material input must appear as intermediate, 
either free or enzyme-bound, or as product [9 ).
Vo
SO <---> SI <---> S2 ............ Si..
t
jvo.dt = [Si] + ]> [ESi] + [P]
0
where Vo is 
intermediates
[P] = Vo(t
the rate 
is implied 
Vo
1 / V o .-I”
of input and 
. This yields:
dVo - [Si]/Vo
0
S n ------> P
(2 1 )
summation over all
- ^  [ESi]/Vo> ..(22)
in the steady-state one may write:
Vss
[P] = Vss (t - 1/Vss. jt.dVo -^[SiJ/Vss ~^[ES1]/Vss) . (23)
0
this is of the form:
[P] = Vss ( t - T  ) ..................... (2Ü)
where TT is given by:
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Vss
T  « l/Vss. Jt.dVo + 2  [Si]/Vsß + ^ [ E S i ] / V s s  .........(25)
0
The transient time consists of three components, one 
due to the variation in the rate of input and two due to 
accumulation of intermediates. If we consider first the case 
when the rate of input is constant then:
T = 2 [ S i ] / V s s  + [ESi]/Vss = ^  ...................(26)
Here a dynamic property of the system is described by 
static parameters, namely the steady-state concentrations 
and flux. The transient times are generally associated with 
intermediates and not with individual enzymes and the 
overall transient is again the sum of the individual 
transients. The steady-state parameters may be arrived at 
either by measurement or theoretically from a knowledge of 
pathway kinetics without need for solution of differential 
equations. Comparison of theoretical and measured values is 
therefore possible.
Enzymes obeying Mlchaells-Menten kinetics
For a sequence of irreversible reactions obeying 
Michaelis-Menten kinetics with constant rate of input Vo, 
the individual transients take the form:
't = ^ f r e e  + ^bou n d  = Km/(Vm - Vo) + [ E ] / V m ...... (27)
The second term represents the reciprocal of the turnover 
number of the enzyme involved and is only significant if the 
enzyme concentration ([E]) is comparable to Km. This is 
generally not the case and enzyme-bound intermediate does 
not contribute significantly to the transient. The transient
'Ytime is then given by 1 free and reduces to the
pseudo-first-order value when the enzyme capacity is large 
compared to the rate of input. The ratio of first-order to 
Michaelis-Menten transients is given by:
T'fo / ^ m m  = (1 - Vo/Vm) .............................(28)
This ratio rapidly converges to unity for Vm/Vo ratios
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greater* than 2 and the pathway becomes essentially 
first-order. Similarly, if the time required by a single 
auxiliary enzyme obeying Michaelis-Menten kinetics to reach 
99% of its steady-state rate is compared with that of a 
first-order enzyme, it is found that the first-order 
approximation is valid for Vm/Vo ratios greater than 6 [9].
Rate modification by effectors which are 
intermediates within pathways of the type considered can be 
accounted for by their effects on Km and Vm values.
Reversible first-order reactions
In this case the individual transients are given by:
n x— 1
T  i = 1/ki + ^  1/kx. I [ 1/Ky .......... (29)
x=i+l y=i
where k's represent rate coefficients for forward reactions 
and K's represent equilibrium constants. Thus each 
individual transient is modified by all subsequent steps up 
to the next irreversible step (1/Ky=0).
Variation in the rate of input
The term:
Vs s
1/Vss . t . dVo 
0
in the description of the transient given in E q . (25) is due 
to the variation in the rate of input to the pathway. This 
may result from substrate depletion, the establishment of a 
steady-state in the ES complexes of the initiating enzyme or 
from feedback on the Initial boundary or enzyme of the 
system. In the present context, depletion of substrate or 
source material for the pathway may be Ignored as this would 
preclude the establishment of a steady-state. Similarly in 
the absence of feedback it may be shown that this term is
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identical to the transient or characteristic time of the 
initiating enzyme. This is likely to be in the micro- to 
millisecond range and will generally be negligible compared 
to the intermediate-associated transient which will be in 
the millisecond to second range. One may therefore conclude 
that this term will normally represent the effect of 
feedback on the initial enzyme of the pathway.
Where feedback is negative the term will also be 
negative and has the effect of reducing the transient time. 
This is because material will initially be input at a rate 
greater than that observed in the steady-state and the 
intermediate-associated transients will consequently be 
overestimated. Thus systems involving negative feedback can 
help to establish the pathway in the steady-state more 
rapidly. Moreover the effects of feedback may be quantified.
This is amply demonstrated by a study of glycolysis 
in the perfused rat heart. The temporal response of 
glycolysis is dominated by the section of the pathway 
between glucose and fructose 1,6-bisphosphate.
Phosphofructokinase is the primary control point but control 
is also exerted on hexokinase through feedback inhibition by 
glucose 6-phosphate. This serves to vary the rate of input 
of glucose to the patnway as the glucose 6-phosphate level 
changes. The result is a 30-50% reduction of the transient 
time under most conditions.
Transition between steady-states
The previous equations have referred to pathways 
entering a steady-state from rest but they may be modified 
to allow for the more likely occurrence of a transition 
between steady-states. If a transition occurs from
steady-state (a) to (b), Eq.(24) still applies but the
transient time is now given by:
T  = 't'b - Va/Vb. ^ a  ..................... (30)
Here Va and Vb are the appropriate fluxes and ^ a  and ^ b  are
155
still given by Eq.(25). Therefore the transition between any 
two steady-states may be analysed on the basis of the 
establishment of each state from rest and the transient 
times are functions of state.
REFERENCES
[1] McClure,W.R. (1969) "A kinetic analysis of coupled
enzyme assays" Biochemistry 8^ 2702-2786
[2] Hess.B. & Wurster,B. (1970) "Transient time of the 
pyruvate kinase-lactate dehydrogenase system of rabbit 
muscle in vitro" FEBS Lett. 9, 73-77
[3] Easterby,J .S. (1973) "Coupled enzyme assays: A general 
expression for the transient" Biochim.Blophys.Acta 
2 9 3 . 552-558
(4 ] Storer.A.C. & Cornish-Bowden,A. (1974) "The kinetics of 
coupled enzyme reactions" Biochem.J. 1 4 1 . 205-209
[5] Welch,Q.R. & Gaertner,F. (1976) "Coordinate activation
of a multienzyme complex by the first substrate" 
Arch.Biochem.Blophys. 172. 476-489.
[6] Heinrich,R. & Rapoport,T.A. (1975) "Mathematical
analysis of multienzyme systems: II.Steady state and 
transient control" BloSystems 7 ,130-136
[7] Easterby,J.S. (1984) "The kinetics of consecutive enzyme
reactions. The design of coupled assays and the temporal 
response of pathways" Biochem.J. 219. 843-847
[8] Bartha,F. & Keleti,T. (1979) "Kinetic analysis of
interaction between two enzymes catalyzing consecutive 
reactions" Oxld.Commun. 1^, 75-84.
Í9] Easterby,J.S. (1981) "A generalized theory of the 
transition time for sequential enzyme reactions" 
Biochem.J. 1 9 9 . 155-161
156
DISCUSSION
OVÁDI:
How do you determine the kinetic parameters for the cal­
culation of the theoretical value of t ?
EASTERBY:
In vitro, in homogenates at as near physiological condi­
tions as possible. Intracellular pH and nucleotide con­
centrations were measured by NMR, together with some of 
the phosphorylated intermediates of glycolysis. Those not 
measurable by NMR were measured by conventional enzymic 
techniques.
CORNISH-BOWDEN:
You made the point that the time required to reach 99 % 
of the steady-state rate decreases as the number of en­
zymes in the pathway increases. While this is true, it is 
a little misleading because it depends on the fact that 
you are measuring time in units of the transient time.
But the transient time itself increases with the number 
of enzymes, and the time measured in seconds required to 
reach any fraction of the steady-state rate also increases 
with the number of enzymes.
EASTERBY:
Yes, what I intended to imply was that of two sequences 
having the same transient time, the longer will approach 
tne steady-state first.
RICARD:
Do you know whether a linear sequence of enzyme reactions, 
that independently follow Michaelis-Menten kinetics, may 
exhibit damped oscillations during the approach of the 
overall steady-state?
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EASTERBY:
It has been claimed to have been observed but I do not 
believe it is possible.
BARDSLEY:
The characteristic polynomial for topologically linear 
systems can only have real negative roots. Non real zérus 
and hence damped oscillators require closed loops in the 
topological scheme.
DYNNIK:
What kind of tissue was used in your experiments? How is 
it possible to split glycolytic intermediates in a whole 
heart, to compare that system with the homogenate?
EASTERBY:
We did not try to reconstitute glycolysis in vitro, we 
merely determined the kinetic parameters. In the case of 
the early reactions of the pathway these values were also 
used for computer simulations.
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Introduction
The isolation of the separate components of sequential biochemical 
pathways has been extremely useful; historically, this approach has been 
necessary to the development of our knowledge of metabolism. However, it 
has always been implicit in the isolation and characterization of biologi­
cal systems j_n vitro that these substances had been removed from the 
natural milieu, and therefore some of the interactions that might occur in 
vivo were lost. In the case of the enzymes of the Krebs tricarboxylic acid 
cycle, when mitochondria are disrupted six of the enzymes are released in a 
soluble form. We present in this work evidence that such solubility need 
not exist in vivo. These ideas are not novel; indeed they have been pre­
sented elsewhere many times (1-4). In order to simplify discussion, we 
suggest the use of the term "metabolon" to mean a functional complex of 
enzymes sequential in a metabolic pathway which is bound to a cellular 
structural element.
Methods
Liver mitochondria from three Sprague-Dawley rats were prepared as 
described earlier (5). The mitochondrial pellet was resuspended in the
isolation medium (220 mM mannitol, 70 mM sucrose, 2 mM HEPES'KOH, pH 7.0) 
at a protein concentration of 100 to 200 mg/ml. The mitochondrial suspen­
sion (5 ul) was assayed for citrate synthase (EC 4.1.3.7) activity with 
DTNB in 100 mM Tris-Cl, pH 8.1 at 25°C (6) in the absence of any disruptive 
agent. This value of enzyme activity was always less than 5% of total
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activity present. The total activity was measured by assaying citrate 
synthase activity in the presence of 1% Triton X-100. No effect on enzyme 
activity was seen over a range of 0.2 to 2% Triton X-100. One ml of the 
mitochondrial suspension was then placed in a 1.5 ml microfuge tube and 
subjected to sonic oscillation for 15 s at a power setting of 3 on a Heat 
Systems 225W sonicator equipped with a tapered microtip. This represents 
the minimum power setting sufficient to produce cavitation in this system, 
and heating of sample was negligible at these low power settings. These 
parameters may vary from preparation to preparation, but each preparation 
was subjected to sonic oscillation until at least 60% of total citrate 
synthase was exposed. The sample was then assayed for exposed citrate 
synthase activity, which refers to that enzyme activity after sonic 
oscillation measured in the absence of detergent.
Portions of the mitochondrial suspension containing 6 mg protein were 
pipetted into a volume of 150 mM KC1, 2 mM HEPES-KOH, pH 7.0 sufficient to 
give a final volume of 0.6 ml. The final pH of the mixture was 6.5. These 
samples were incubated 20 min on ice to allow whatever structural changes 
due to changes in ionic strength to occur. Exposed enzyme content was 
determined (no Triton X-100 added), and then the samples were centrifuged 
at 32,000 xg for 30 min at 4°. The supernatant solution was then withdrawn 
and the pellet resuspended in 0.6 ml of 0.1 M HEPES*K0H, pH 7 by gentle 
scraping with a glass rod followed by expression through a 25 gauge syringe 
needle three times, and enzyme activities determined. The entrapped water 
volume of the pellet, determined with [ l4C ] - i n u l i n  as described earlier 
(9), was found to be 2% of the total volume. Multiple determinations of 
sedimented exposed citrate synthase activity (and total citrate synthase 
activity determined in the presence of detergent) showed a variation of no 
more than 10% of the values presented. All data presented in the present 
work are the average of at least duplicate determinations. A unit of 
enzyme is that amount catalyzing the formation of 1 pmole/min of product. 
In all cases, exposed enzyme refers to that enzyme assayed in the absence 
of detergent. Values of enzyme activity given for the pellet are those 
found in the sediment produced by 32,000xg for 30 min in the absence of 
detergents.
Aconitase (EC 4.2.1.3) (8), (NAD+ )isocitrate dehydrogenase (EC 
1.1.1.41) (9), fumarase (EC 4.2.1.2) (10), malate dehydrogenase (EC 
1.1.1.37) (11), and S-hydroxybutyrate dehydrogenase (EC 1.1.1) (12) were 
assayed by the methods previously described. Protein concentration was
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determined by the method of Bradford (13). Antiserum to rat heart citrate 
synthase was prepared as described previously (14), followed by sodium 
sulfate precipitation and Sephadex G-100 chromatography to obtain purified 
immunogl obul i n s .
Results and Discussion
When mitochondria are subjected to gentle sonic oscillation by the 
method described we find that about 60% of the original total activity 
measured in the presence of Triton X-100 becomes measurable without added 
detergent. One half of this exposed citrate synthase can be sedimented at 
32,000xg and one half remains in the supernatant solution (Table I). It 
should be noted that the conditions of isolation were those generally
Table I Citrate synthase activity present in various fractions
of gently sonicated mitochondria+
Sampie Citrate Synthase Units
mitochondrial suspension, enzyme assayed
with 1% Triton X-100 present (total units 0.36 + 0.13
present/6 mg protein)
mitochondrial suspension after sonic oscillation 0.22 +_ 0.06
(units exposed, no detergent present)
32.000 xg pellet (1% Triton X-100) 0.27 + 0 . 0 7
32.000 xg pellet (no detergent) 0.12 + 0.02
32.000 xg supernatant 0.12 +_ 0.03
+The values presented are mean +_ standard deviation for eight different 
preparations of mitochondria, from duplicate determinations of bound enzyme 
per preparation. The amount of enzyme exposed varied from preparation to 
preparation, leading to higher deviations in the data presented above than 
is seen on values obtained in single preparations, but no normalization was 
done.
accepted as representing physiological pH and ionic strength, and that the 
consistency and reproducibility of this effect was within acceptable limits.
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Mitochondria untreated by sonic oscillation show at most 5% of the total 
citrate synthase activity (and in most preparations no enzyme is measurable 
without detergent). This demonstrates that the conditions of the standard 
enzyme assay do not disrupt mitochondrial structure. Sonic oscillation for 
time periods three to four times longer than described in Methods causes 
the release of all the citrate synthase as a soluble enzyme into the super­
natant solution without diminishing the total amount of enzyme observed 
(data not shown). Similarly, freezing the mitochondrial sample once, with 
isopropyl alcohol-dry ice, and thawing caused release of enzyme with all 
the enzyme activity in the supernatant solution (data not shown).
These results (Table I) could be interpreted as enzyme entrapment in a 
substrate-permeable but enzyme-impermeable vesicle. This possibility was 
tested by measuring inhibition of the exposed enzyme by rat heart citrate 
synthase antibodies. Antibodies (Mr=160,000) would not be expected to pen­
etrate a vesicle that retained citrate synthase (Mr = 100,000). Inhibition 
of exposed enzyme by antibody was observed (Table II). The presence of 
citrate synthase in the detergent-disrupted mitochondria in experiment 1
Table 2 Reactivity of citrate synthase exposed by gentle
sonication of rat liver mitochondria+ with 
anti-rat heart citrate synthase IgG
Experiment 1
Samp!e Citrate Synthase Units
+ Triton X-100 - Triton X-100
sonicated mitochondria 0.38 + 0 . 0 0.16 + 0.02
sonicated mitochondria 0.36 + 0.01 0.19 + 0.01
+ Control IgG
sonicated mitochondria 0.15 + 0.0 0.0 + 0.0
+ anti-RHCS IgG
Experiment 2
Sample + Triton X-100 - Triton X-100
pel 1et 0.31 + 0.04 0.18 + 0 . 0 3
pellet + anti RHCS IgG 0.18 + 0.01 0.025 + 0.003
pellet + \% added TX-100 0.0 + 0 . 0 0.0 + 0 . 0
added before anti- RHCS
+ In experiment 1, 35 vg IgG were added to samples of sonicated
mitochondria (6 mg) in 0.6 ml 150 mM KC1 , 2 mM HEPES, pH 7.0, and all 
samples were incubated on ice for 1 h; and exposed enzyme (-Triton X-100)
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and total enzyme (+Triton X-100) were determined. The sonicated 
mitochondrial sample was then centrifuged and 35% of the exposed citrate 
synthase was found to be sedimented. In experiment 2, gently sonicated 
mitochondria were prepared and centrifuged at 32,000 x g for 30 min before 
addition of antibody, followed by a 1 h incubation on ice before enzyme 
assay. The two experiments were done on different preparations of
mitochondria. Data presented are average +_ ranges for duplicate assays.
after treatment with the antibodies to citrate synthase demonstrated that 
the antibody cannot penetrate to and inhibit latent enzyme (enzyme within 
intact mitochondrial structure). The reaction of antibody with citrate 
synthase requires at least five minutes before the enzyme activity begins 
to show measurable inhibition. Therefore, those enzyme assays in the pre­
sence of Triton X-100 (total reaction time 2 minutes) accurately reflect 
the amount of latent (unexposed by sonication) enzyme present in these 
samples even in the presence of antibody. Experiment 2, done on 
resuspended pellets of sedimented gently disrupted mitochondria shows the 
same result caused by antibody addition. Therefore, enzyme measured as 
sedimentable is not latent enzyme exposed by the resuspension procedure 
before centrifugation. In experiment 1, the enzyme activity measured in 
Triton X-100 (line 3 column 1 of Table II) represents that citrate synthase 
within intact mitochondrial structure which cannot be reached by the added 
antibody. In experiment 2, Triton X-100 is added to make all the enzyme 
available, and it can be seen in this instance that all the enzyme is 
inhibited by antibody.
Another possible source of error in estimation of the stability of the 
complex arises from the purely technical consideration that, in resuspen­
sion of pelleted samples of mitochondria even gently treated with disrup­
tive techniques, the application of force necessary to obtain a homogenous 
suspension might conceivably disrupt intact structures, thus leading to 
further expression of previously latent enzyme. To a small extent this 
does happen, as can be seen by examination of Table I. The average reco­
very of citrate synthase is 110% +_ 22 in the binding assays. To study this 
effect, we did an experiment where a resuspended pellet was recentrifuged, 
and resuspended again. The resuspended pellet showed no significant 
increase in exposed sedimentable citrate synthase, although a small amount
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was found in the supernatant of the second centrifugation. This implies 
that the exposed sedimentable enzyme is not an artifact of the physical 
stress of resuspensions of pelleted mitochondria.
ß-Hydroxybutyrate dehydrogenase is a well known marker enzyme for the 
inner membrane of liver mitochondria. The pellet obtained by centrifuging 
gently-disrupted mitochondria has 93% of the total ß-hydroxybutyrate 
dehydrogenase activity present in these mitochondria (35% initially exposed 
by gentle disruption). The total amount of ß-hydroxybutyrate dehydrogenase 
is measured by sonic oscillation of mitochondria in 15 sec bursts followed 
by an enzyme assay until a constant amount of enzyme is observed in 
successive treatments. The remaining 7% is observed in the supernatant 
solution of the gently disrupted mitochondria.
The effect of pH and ionic strength on the yield of sedimentable 
exposed citrate synthase was determined (Figure 1). These data were dif­
ficult to interpret simply, since mitochondrial structure and stability are 
influenced by these parameters. Nonetheless, sedimentable exposed enzyme 
was apparent throughout the range of conditions tested despite any struc­
tural changes that may have occurred.
pH [Kc|mM
Fig. 1 Effect of pH and ionic strength on formation of a sedimentable 
exposed citrate synthase in gently disrupted mitochondria. The bars asso-
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d a t e d  with each point show the range of duplicates. (A) The effect of pH. 
Samples were prepared with 20 mM HEPES-KOH at the indicated pH values, also 
containing 150 mM KC1 and 6 mg sonicated mitochondria. The pH values were 
measured on the supernatant solutions after assay. (B) The effect of ionic 
strength. Samples were prepared in 2 mM HEPES (pH 7) with KC1 concentra­
tions as indicated, and 6 mg gently disrupted mitochondria, and bound 
exposed citrate synthase measured.
The sedimentable exposed enzyme activity was measured after sonic 
oscillation followed by incubation at various temperatures. The data (not 
shown) indicate that the complex is stable at 4°, 25°, and 37° for 30 min.
The effect of including certain metabolites and other compounds in the 
assays on the amount of exposed sedimentable citrate synthase was also 
studied. The amount of exposed sedimentable citrate synthase was not 
affected by 50 uM oxalacetate, 1 mM citrate, 0.1 mM disodium ethylenedi- 
aminetetracetic acid 0.1 mM MgCl2 or 0.1 mM CaCl2 - However, 0.1 mM or 1 
mM potassium phosphate causes the release of all exposed citrate synthase 
into the supernatant. This is not an effect of ionic strength (See Figure
1) so it must be considered to be a specific effect of phosphate. This 
observation raises the possibility that the Krebs tricarboxylic acid cycle 
metabolon may exist on at least two levels of regulation. Additionally, we 
can prepare sedimentable citrate synthase by hypoosmotic shock (mitochon­
dria diluted to 1 mg/ml to 10 mg/ml in water) treatment with low concentra­
tion of detergent (0.005% triton X-100 at 6 mg/ml mitochondria, or hyper­
osmotic shock at 30% sucrose).
If the enzymes of the Krebs tricarboxylic acid cycle are indeed 
arranged in a metabolon, it would be predicted that the other enzymes con­
sidered to be soluble, i.e., fumarase, malate dehydrogenase, aconitase, and 
(NAD+ )isocitrate dehydrogenase, would also be present in a sedimentable 
form. This was tested and found to be the case (Table VI). Succinyl CoA 
synthase (succinate thiokinase) was not studied here, since the enzyme has 
previously been shown to be bound to the a-ketoglutarate dehydrogenase 
complex (15), and its assay in crude systems is difficult. Nonetheless, 
this previous work and the present results definitely show all the 
"soluble" matrix enzymes of the Krebs tricarboxylic acid cycle can be 
present in a bound and potentially organized form.
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Table 3 Sedimentation of Krebs Tricarboxylic cycle enzymes 
from gently disrupted mitochondria-1-
Enzyme Units
Enzyme
Experiment 1 
Citrate Synthase 
Fumarase
(NAD+ ) Isocitrate 
Dehydrogenase 
Experiment 2 
Citrate Synthase 
Malate Dehydrogenase 
Aconitase
Exposed Pel 1et Supernatant
0.21 + 0.005 0.12 + 0.0025 0.14 + 0 . 0 1  
0.07 + 0.0 
0.018 + 0.001
0.23 + 0.0 
0.05 + 0.0
0.14 + 0 . 0 5  
0.019 + 0.0015
0.31 + 0.015 
6.3 + 0 . 2  
0.09 + 0.01
0.16 + 0.0
2.6 + 0.1
0.045 + 0.003
0.21 + 0.0
5.1 + 0 . 1 5
0.023 + 0.0
+Numbers represent the average enzyme activities of duplicate assays +_ 
ranges, with all enzymes determined in the same samples. Experiments 1 and 
2 were different preparations of mitochondria. In experiment 1 the samples 
were prepared as described in Methods, whereas in experiment 2, 5 mM 
2-mercaptoethanol was included in the KC1/HEPES buffer.
The microstructural changes induced by sonic oscillation are shown in 
Figures 2 and 3.
Fig. 2 Transmission Electron Microscopy of thin section of intact and 
gently disrupted mitochondria. Samples were processed by routine technique 
and examined on a Phillips 301 electron microscope with an operating 
voltage of 60 kV. Inset bars present 1 micron. Part A, intact 
mitochondria. Part B, gently disrupted mitochondria.
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Fig. 3 Scanning Electron Microscopy of intact and gently disrupted 
mitochondria. Portions of each mitochondrial sample were fixed in glu- 
taraldehyde, transferred to ovalbumin-coated cover slips, osmicated and 
critical-point dried. The samples were then gold-sputtered and examined in 
an ISI 40 scanning electron microscope. Insert bars represent 1.5 micron 
on parts A and C, and 0.5 micron on parts B and D. Parts A and B, intact 
mitochondria. Parts C and D, gently disrupted mitochondria.
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These data demonstrate that there is minimal although significant 
change in structures by these techniques. It must be considered that the 
thin-section photographs represent only a portion of each mitochondrion's 
structure, and with study of the scanning electron micrographs and negati­
vely stained samples (not shown) the most likely conclusion is that the 
population of mitochondria obtained by gentle sonic oscillation is a homo­
genous one, with virtually no "intact" structures remaining.
In conclusion, we have investigated an experimental system wherein the 
enzymes of the Krebs tricarboxylic acid cycle behave in such a manner that 
a sequential reaction mechanism involving purely soluble activities in the 
mitochondrial matrix is highly unlikely. The enzymes are available for 
assay, yet exist in a form sedimentable at moderate centrifugal force. We 
have preferentially studied the activity of citrate synthase since there is 
no cytoplasmic isozyme in mammalian systems. This enzyme is easily and 
accurately assayable in crude systems such as this; it is stable; and spe­
cific antibodies were available for it. Citrate synthase shows the proper­
ties of accessibility to antibodies, sedimentabi1ity under varying 
conditions of pH, ionic strength, temperature, and presence of substrates 
which would be expected if in vivo it was present in a metabolon.
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DISCUSSION
SLUSE-COFFART:
Is it possible that, after gentle sonication and centrif­
ugation at 50 000 g, the measurable enzymic activity in 
the pellet in the absence of detergent is linked to in­
verted submitochondrial particles?
SRERE:
The electron micrographs show very few submitochondrial 
particles. Vie have in addition tried differential centrif­
ugation of the sonicated mitochondria and found no evi­
dence for smaller particles containing exposed enzyme 
activity.
KACSER: '
The close association of enzymes on some matrix could 
affect the control properties of the pathway of which 
they form part. For example, if two consecutive enzymes 
are closely associated, this may result in "channelling" 
of the substrate/product. The outcome of this is that, 
from a control point of view, there is only one func­
tional entity and only one control coefficient. This 
will affect the distribution of control in the system.
Has this aspect been considered?
SRERE:
No experiments on the control aspects of the isolated 
complex has been performed.
AMLER:
Do you think, that the folding of the inner mitochondrial 
membrane controls matrix enzyme complexes associated with 
this membrane?
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SRERE:
The shape of cristae of mitochondria varies from tissue 
to tissue, and there are no theories to explain the charge 
in morphology. We do know that under various metabolic 
conditions the cristae can change their conformation but 
there is no evidence that the folding controls the en­
zymes attached to it.
CHERRY:
Perhaps I could comment on the effect of matrix proteins 
on mobility of inner mitochondrial membrane proteins.
X think it is important to distinguish here between rota­
tional and lateral mobility. We have measured the rota­
tional mobility of cytochrome oxidase and got similar 
results in intact mitochondria, submitochondrial-particles 
and in reconstituted vesicles, indicating that there is 
no significant restriction by matrix proteins. On the 
other hand, lateral diffusion coefficients for inner mem­
brane proteins determined by other groups are much less 
than expected for free diffusion in a lipid bilayer so 
there may well be an effect of the matrix on lateral 
mobility.
SRERE:
I should have mentioned that Dr. Cherry has shown that 
some of the electron transport proteins in the inner mem­
brane occur as aggregates.
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CHARACTERIZATION OF METABOLITE POOLS BY "ENZYME PROBES"
PETER FRIEDRICH
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Hungarian Academy of Sciences, Budapest, P.O.B.7,
Hungary H-1502
The living cell is a highly organized hierarchy of c o m ­
partments. According to Kempner /1980/ , a metabolic c o m pa rt ­
ment is a subcellular region of biochemical reactions kinet- 
ically isolated from the rest of cellular processes. This g e n ­
eral definition allows for various physical means in creating 
a compartment. In the most obvious case a compartment is s u r ­
rounded by a membrane which determines the traffic of matter in 
and out of the compartment. Such compartments, e.g. the cytoplasm 
or the mitochondrial matrix, are usually large relative to an 
enzyme, let alone substrate, molecule and therefore we refer to 
them as macrocompartments. Kinetic isolation of a reaction can, 
however, be achieved by more subtle means. In a multienzyme 
complex some intermediates may be "channelled" from one enzyme 
to the other without mixing with the rest of cellular material. 
Alternatively, both enzymes and metabolites may be attached to 
binding sites within a macrocompartment, which introduces h e t e ­
rogeneity inasmuch as the enzyme or metabolite pool becomes 
subdivided into free and bound fractions. Enzyme-enzyme channels 
and intracellular binding sites are as a rule in the order of 
the size of a molecule, hence we refer to them as m i c r o c o m p a r t ­
ments /cf . Friedrich , 1984/.
Our attention will be focussed here on microcompartment- 
ation established by binding sites. If an enzyme is attached to 
some cellular structure, as for example glyceraldehyde-3- 
-phosphate dehydrogenase /GAPD/ is anchored at the erythrocyte 
membrane /e. g. Kliman and Steck, 1980; Solti et al., 1981/ or
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h e x o k i n a s e  at the m i t o c h o n d r i a l  m e m b r a n e  / e . g . W i l s o n ,  1 98 0/, 
the g i v e n  r e a c t i o n  w i l l  o c c u r  at a c e r t a i n  c e l l u l a r  n i c h e , t h u s  
the p r o d u c t  m e t a b o l i t e  w i l l  be a b u n d a n t  in t h a t  l o c a t i o n .  Su c h  
a n c h o r i n g  of e n z y m e s  m a y  be a p h y s i c a l  p r e r e q u i s i t e  for c h a n ­
n e l l i n g  of m e t a b o l i t e / s /  f r o m  one e n z y m e  to the o t h e r ,  i . e . f o r  
a n o t h e r  ty p e of m i c r o c o m p a r t m e n t a t i o n . H o w e v e r ,  the l o c a l  c o n ­
f i n e m e n t  of c a t a l y t i c  a c t i v i t y  may a l s o  s e r v e  o t h e r  ends. For 
e x a m p l e ,  the s p e c i f i c i t y  of p r o t e i n  k i n a s e s ,  w h i c h  p h o s p h o -  
r y l a t e  a n u m b e r  of s u b s t r a t e  p r o t e i n s  in v it ro, is t h o u g h t  to 
be l a r g e l y  d e t e r m i n e d  by the s u b c e l l u l a r  l o c a t i o n ,  i.e. by the 
j u x t a p o s i t i o n  of the t a r g e t  p r o t e i n .  Dat a h a v e  b e e n  p r e s e n t e d  
s u g g e s t i n g  tha t the b i n d i n g  of p r o t e i n  k i n a s e ,  and the c h a n g e  
of its b i n d i n g  s i t e  / t r a n s l o c a t i o n / ,  m ay be i n s t r u m e n t a l  in the 
p l a s t i c  c h a n g e s  of n e u r o n s ,  i.e. in m e m o r y  m e c h a n i s m s  / K a n d e l  
and  S c h w a r t z ,  1982; S a i t o h  and S c h w a r t z ,  1985/. C y t o s k e l e t a l  
p r o t e i n s ,  p a r t i c u l a r l y  MAP -2, are t h o u g h t  to h a r b o u r  p r o t e i n  
k i n a s e s  / V a l l e e  et al., 198 4/, w h i c h  t h e r e b y  m a y  i n f l u e n c e  a 
n u m b e r  of c e l l u l a r  p r o c e s s e s ,  lik e m o t i l i t y ,  s h a p e  c h a n g e s ,  
i n t r a c e l l u l a r  t r a n s p o r t ,  cel l d i v i s i o n ,  etc.
On the o t h e r  hand, if a m e t a b o l i t e  is b o u n d  to s o m e  m a c r o -  
m o l e c u l e  in a m a c r o c o m p a r t m e n t ,  the c o n s e q u e n c e s  are q u i t e  
d i f f e r e n t .  The i m m e d i a t e  r e s u l t  of s u c h  a b i n d i n g  is the 
l o w e r i n g  of the c o n c e n t r a t i o n  / a c t i v i t y /  of the fr e e  m e t a b o ­
lite, h e n c e  the d e c r e a s e  of m e t a b o l i c  f l u x  u s i n g  tha t m e t a b o ­
lite. S i n c e  b i n d i n g  is r e v e r s i b l e ,  an a b u n d a n t  b i n d i n g  s p e c i e s  
m a y  s e r v e  as a b u f f e r  a t t e n u a t i n g  s h a r p  c h a n g e s  in the p r o d u c ­
t i o n  of the m e t a b o l i t e .  It m u s t  be e m p h a s i z e d ,  h o w e v e r ,  tha t 
in s t e a d y - s t a t e  a b i n d i n g  s p e c i e s  h as no e f f e c t  on fl u x  u n l e s s  
its c o n c e n t r a t i o n  in the c e l l  can be a l t e r e d .
It has bee n r e c o g n i z e d  for l o n g  / e . g . S o l s  and M a r c o , 1 9 7 0 /  
t ha t  m u c h  of the i n t r a c e l l u l a r  m e t a b o l i t e  p o o l s  is b o u n d  to 
f u n c t i o n a l l y  r e l a t e d  m a c r o m o l e c u l e s ,  m a i n l y  e n z y m e s .  One can 
e v e n  e s t i m a t e  the d i s t r i b u t i o n  of a c o m p o u n d  b e t w e e n  f r e e  and 
b o u n d  f r a c t i o n s  in the k n o w l e d g e  of th e  i n t r a c e l l u l a r  c o n c e n ­
t r a t i o n  of the c o m p o u n d ,  of the b i n d i n g  s p e c i e s  and the c o r r e -  
s p o d i n g  d i s s o c i a t i o n  c o n s t a n t / s / .  H o w e v e r ,  s u c h  e s t i m a t e s  
n e c e s s a r i l y  i m p ly an u n s t r u c t u r e d  r e s e r v o i r  a nd the v a l i d i t y  
of the  law s  of d i l u t e  s o l u t i o n s ,  two a s s u m p t i o n  h a r d l y  a p p l i c ­
a b l e  to the l i v i n g  cell.
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We h a v e  e a r l i e r  d e v i s e d  a s i m p l e  a p p r o a c h  to c h a r a c t e r i z e  
m e t a b o l i t e  p o o l s  in r e s p e c t  of fre e and b o u n d  f r a c t i o n s  / S o l t i  
a nd F r i e d r i c h ,  19 7 9/. The r a t i o n a l e  of the a p p r o a c h  is as 
f o l l o w s .  T he c e l l s  /or the t i s s u e s /  are d i s r u p t e d  a nd s i m u l ­
t a n e o u s l y  an e n z y m e  is i n t r o d u c e d  w h i c h  a t t a c k s  the m e t a b o l i t e  
in q u e s t i o n .  The t i m e  c o u r s e  of d e c a y  of the m e t a b o l i t e  is th e n  
f o l l o w e d .  In the s i m p l e s t  case, w h e n  the t o t a l  a m o u n t  of the 
m e t a b o l i t e  is free, one g e t s  a s i n g l e  f i r s t  o r d e r  d e c a y  c u r v e  
/ p r o v i d e d  t ha t  the i n i t i a l  m e t a b o l i t e  c o n c e n t r a t i o n  is w e l l  
b e l o w  its K / and the rat e c o n s t a n t  is p r o p o r t i o n a l  to th e  c o n ­
c e n t r a t i o n  of the d e g r a d i n g  e n z yme. If in a d d i t i o n  to the f r e e  
f r a c t i o n  t h e r e  is a l s o  a b o u n d  f r a c t i o n  of the m e t a b o l i t e ,  the 
d e c a y  c u r v e  w i l l  be b i p h a s i c , a s  lon g as the d i s s o c i a t i o n  r a t e 
c o n s t a n t  of the m e t a b o l i t e  is c o m p a r a b l e  or s m a l l e r  t h a n  the 
r a t e  c o n s t a n t  of e n z y m a t i c  d e g r a d a t i o n .  M o r e  t h a n  o ne b o u n d  
f r a c t i o n ,  w i t h  d i s s i m i l a r  d i s s o c i a t i o n  r a t e  c o n s t a n t s ,  w i l l 
r e s u l t  in th e c o r r e s p o n d i n g  n u m b e r  of s l o w  p h a s e s .
S i n c e  in s u c h  an e x p e r i m e n t  the d e g r a d i n g  e n z y m e  is u t i l ­
i z e d  to p r o b e  the m e t a b o l i t e  pool, we h a v e  r e f e r r e d  to it as an 
" e n z y m e  p r o b e "  / S o l t i  and F r i e d r i c h ,  197 9/ .  The s c o p e  of the 
m e t h o d  can be s u m m a r i z e d  b r i e f l y  as f o l l o w s .  It is a p p l i c a b l e  
to any c o m p o u n d  for w h i c h  an a p p r o p r i a t e  d e g r a d i n g  e n z y m e  
e x i s t s ,  w h e t h e r  e n d o g e n o u s  or e x o g e n o u s .  C o m p l e x e s  w h o s e  
d i s s o c i a t i o n  is c o n s i d e r a b l y  f a s t e r  t h a n  the e n z y m a t i c  d e c a y  
e s c a p e  d e t e c t i o n .  S i m i l a r l y ,  d i f f e r e n t  b i n d i n g  s p e c i e s  
/ c o m p l e x e s /  w i t h  c l o s e l y  s i m i l a r  d i s s o c i a t i o n  r a t e  c o n s t a n t s  
c a n n o t  be d i s t i n g u i s h e d  f r o m  e a c h  oth er. The a c t i v i t y  of the 
d e g r a d i n g  e n z y m e  m u s t  not c h a n g e  o v e r  the t i m e  p e r i o d  of 
a n a l y s i s .  W i t h  the n u m b e r  of b o u n d  f r a c t i o n s  r e s o l u t i o n  rapidly 
d e t e r i o r a t e s :  m o r e  t h a n  two b o u n d  f r a c t i o n s  c an be d i s t i n  
g u i s h e d  o n l y  u n d e r  v e r y  f a v o u r a b l e  i n s t a n c e s .  O b v i o u s l y ,  the 
m e t a b o l i t e  m u s t  not be g e n e r a t e d  in the s y s t e m  d u r i n g  analysis.
In the f o l l o w i n g  the a p p l i c a t i o n  of t h i s  " e n z y m e  p r o b e "  
m e t h o d  for the c h a r a c t e r i z a t i o n  of m e t a b o l i t e  p o o l  h e t e r o ­
g e n e i t i e s  w i l l  be i l l u s t r a t e d  t h r o u g h  two  e x a m p l e s :  NAD 
m i c r o c o m p a r t m e n t a t i o n  in h u m a n  e r y t h r o c y t e s  and c A M P  m i c r o -
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c o m p a r t m e n t a t i o n  in w i l d  t y p e  and m e m o r y - m u t a n t  D r o s o p h i l a  
m e l a n o g a s t e r .
In f r e s h  h u m a n  e r y t h r o c y t e s  the NAD + N A D H  c o n c e n t r a t i o n  
is a b o u t  50 juM and the o x i d i z e d  f o r m  of the c o e n z y m e  is greatly 
f a v o u r e d .  We m o n i t o r e d  the d e c a y  of NAD in p a c k e d  red c e l l s  
/ h a e m a t o c r i t : 1 0 0 % /  a f t e r  cel l d i s r u p t i o n  by s o n i c a t i o n  / S o l t i  
and F r i e d r i c h ,  197 9/. N a m e l y ,  the e n z y m e  NAD-glycohydrolase /EC 
3 . 2 . 2 . 5 / ,  w h i c h  s p l i t s  NAD at the n i c o t i n a m i d e - r i b o s e  lin kage, 
is l o c a t e d  on the o u t e r  s u r f a c e  of red cel l m e m b r a n e  and g a i n s  
a c c e s s  to i n t r a c e l l u l a r  NAD onl y  a f t e r  c e l l  d i s r u p t i o n .F i g . 1 
s h o w s  the t i m e  c o u r s e  of NAD d e c o m p o s i t i o n  in the h e m o l y s a t e  
and t he g r a p h i c  r e s o l u t i o n  of o v e r a l l  r e a c t i o n  int o t h r e e  
k i n e t i c a l l y  d i s t i n g u i s h a b l e  p h a s e s .  P h a s e  III / t - ^ ^ l  m i n /  
c o r r e s p o n d s  to the r e a c t i o n  of f r e e  N AD as e v i d e n c e d  by the 
c l o s e l y  s i m i l a r  ^ y / 2  m e a s u r e c * for a d d e d  N AD in a d i l u t e  h o ­
mogenate. P h a s e  II m i n /  p r o v e d  to be i d e n t i c a l  w i t h  the
r e a c t i o n  of NAD b o u n d  to GAPD, w h e r e a s  in p h a s e  I ^
h o u r s /  som e u n i d e n t i f i e d  N A D - c o m p l e x  d e c o m p o s e s  w h i c h ,  however, 
b e c o m e s  r a p i d l y  d e s t r o y e d  in the p r e s e n c e  of 0.0 1 % T r i t o n  
X - 1 00 . The a s s i g n m e n t  of p o o l  II as G A P D . N A D  c o m p l e x  c o u l d  be 
m a d e  by m e a s u r i n g  NAD d e c a y  f i r s t  at 0°C w h e n  f r e e  N AD is main­
ly d e c o m p o s e d ,  and t h e n  c o n t i n u i n g  the r e a c t i o n  at 37°C, w h e n  
p o o l  II b e c o m e s  d e p l e t e d  / F i g . 2/. The l a t t e r  p r o c e s s  ran 
p a r a l l e l  w i t h  the " s t r i p p i n g "  of NAD f r o m  its G A P D - c o m p l e x , 
m o n i t o r e d  by the d e c r e a s e  of r e a c t i v i t y  of the e n z y m e ’s e s s e n ­
tia l S H - g r o u p  a g a i n s t  i o d o a c e t a t e .  N a m e l y ,  b o u n d  NA0 had b e e n 
s h o w n  to m a r k e d l y  f a c i l i t a t e  t h i s  a l k y l a t i o n  of the e n z y m e  
/ C s e k e  and B o r o s s ,  1970/. I n t e r e s t i n g l y ,  the d e p l e t i o n  of poo l 
II led to the a r r e s t  of l a c t a t e  p r o d u c t i o n  in the h a e m o l y s a t e  
/ F i g . 3/. The r e s u l t s  s u g g e s t  tha t  in the red c e l l  the p o o l  II 
of NAD is n e c e s s a r y  and s u f f i c i e n t  to m a i n t a i n  the n o r m a l  flu x 
of g l y c o l y s i s .
R e c e n t l y  we h a v e  b e e n  e n g a g e d  in the s t u d y  of c A M P  m e t a b ­
o l i s m  in m e m o r y - m u t a n t  D r o s o p h i l a  m e l a n o g a s t e r .  The d u n c e  m u ­
t a n t  s t r a i n s  are d e f e c t i v e  in a c A M P - s p e c i f i c  phosphodiesterase 
/ P D E - I I / ,  h a v e  e l e v a t e d  cAM P l e v e l s  and p e r f o r m  p o o r l y  in an 
e l e c t r i c  s h o c k - o d o u r  l e a r n i n g  p a r a d i g m  / D u d á i  et al., 1976; 
B y e r s  et al., 1981; Dud ái, 1985/. We a d d r e s s e d  the q u e s t i o n
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Fig.l. Tim e  c o u r s e  and k i n e t i c  r e s o l u t i o n  of NAD d e c a y  in human 
e r y t h r o c y t e  s o n i c a t e  at 37°C. 0 time: s t a r t  of 30 s son - 
i c a t i o n .  At t i m e s  s a m p l e s  w e r e  w i t h d r a w n  for N AD + N A D H 
d e t e r m i n a t i o n ,  (a): O v e r a l l  d e c a y  (•) (b): C u r v e  (o) w as 
d e r i v e d  by s u b t r a c t i n g  the e x t r a p o l a t e d  s l o w  p h a s e  I 
/ b r o k e n  l i n e /  f r o m  the c u r v e  in (a). C u r v e  III (A)  was 
o b t a i n e d  f ro m  c u r v e  (o) in a s i m i l a r  m a n n e r .  F r o m  S o l ti 
and F r i e d r i c h  /1979/.
w h e t h e r  the e x t r a  c A M P  in the m u t a n t  /in w i l d  t y p e  C a n t o n - S :  1.6 
p mo l per mg fly; in d u n c e M ~ ^ : 6 to 10 pmo l  per mg f l y /  is fre e 
or is s e q u e s t e r e d  by b i n d i n g  to p r o t e i n .  We a p p l i e d  t he "enzyme 
p r o b e "  m e t h o d ,  a n a l o g o u s l y  to h u m a n  e r y t h r o c y t e s :  we f o l l o w e d  
the tim e c o u r s e  of cAM P d e c a y  in f r e s h  h o m o g e n a t e  of f l i e s  u n ­
d er the e f f e c t  of e n d o g e n o u s  c y c l i c  n u c l e o t i d e  phosphodiesterases 
/ F r i e d r i c h  et al., 1984/. The d e c a y  c u r v e  w a s  s t r o n g l y  biphasic
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Fig.2. Resolution of NAD pools. The NAD decay was monitored as in Fig.l 
but at 0°C (#), then at 37°C (o), finally after addition of 0.01 % 
(final concentration) Triton X-100 (•). From Solti and Friedrich (1979).
Fig. 3. Lactate production from 5 mM glucose /A/ and development of
iodoacetate-resistance /B/ in a 90 % red cell sonicate, a: Lactate 
production of intact cells /*/, of sonicate /#/, and of sonicate 
after addition of 100 uM NAD as indicated by the arrow / A / .  
b: Development of iodoacetate resistance of glyceraldehyde-3- 
phosphate dehydrogenase. Note that the resistance /i.e.stripping 
of GAPD/ reaches maximum at about the same time /about 15 min/ 
as lactate production ceases. From Solti and Friedrich /1979/.
178
w i t h  b o t h  w i l d  t y p e  and m u t a n t  f l i e s  ( F i g . 4). A v e r y  r a p i d  
p h a s e  w a s  f o l l o w e d  by a s l o w  p ha se. The a p p a r e n t  f i r s t  o r d e r  
r a t e  c o n s t a n t  of the l a t t e r  w a s  s i m i l a r  for C a n t o n - S  and 
d u n c e ^ 1 1 / 4. 5  / + 0 . 5 / x  I D -2 m i n -1 and 4. 2  / + 0 . 6 / x  1 0 _2 m i n ' 1 ,
r e s p e c t i v e l y / .  The e x t r a p o l a t e d  i n t e r c e p t s  on the o r d i n a t e  of 
the s l o w  p h a s e s  gave, h o w e v e r ,  d i f f e r e n t  v a l u e s  f or the t o t a l  
a m o u n t  of s l o w l y - d e g r a d i n g  cAMP: in the m u t a n t  the s l o w  c o m p o ­
n e n t  was a b o u t  t h r e e  t i m e s  as hig h as in the n o r m a l  /1. 5 vs.
0 . 5 5  p m o l  c AM P  p er mg fly/.
F i g . 4. Ti m e c o u r s e  of c A M P  d e c a y  in D r o s o p h i l a  h o m o g e n a t e s  
/ 1 0 0  mg f l y / m l /  at 0°C. c A M P  was d e t e r m i n e d  by r a d i o ­
i m m u n o a s s a y .  o, C a n t o n - S  flies; □  , d u n c e M11 fli es.
F r o m  F r i e d r i c h  et al. /19 84/.
C o n t r o l  e x p e r i m e n t s  i n d i c a t e d  tha t the o c c u r r e n c e  of s l o w  
p h a s e  w a s  not due to i n a c t i v a t i o n  of POE s  in the h o m o g e n a t e .  
A d e n y l a t e  c y c l a s e  a c t i v i t y  w a s  p r a c t i c a l l y  nil d u r i n g  the
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e x p e r i m e n t ;  w i t h  d i l u t e  h o m o g e n a t e  e x o g e n o u s  c A M P  g a v e  a f i r s t 
o r d e r  d e c a y  / c f . F r i e d r i c h  et a l . , 1 9 8 4 / .  The o b s e r v e d  u p w a r d  
s h i f t  of the o r d i n a t e  i n t e r c e p t  c o u l d  a l s o  be m o d e l l e d :  if 
e x o g e n o u s  cAM P w a s  a d d e d  at the t i m e  of h o m o g e n i z a t i o n  of C a n -  
t o n - S  flies, the s l o w  p h a s e  m o v e d  u p w a r d  w i t h o u t  c h a n g e  of the 
s l o p e  / F i g . 5/.
Fig. 5. E f f e c t  of e x o g e n o u s  cAM P on the s l o w  p h a s e  of c A M P
d e c a y  in C a n t o n - S  h o m o g e n a t e ,  o, no a d d i t i o n ;  •, 30 p m o l e  
of c A M P / m g  fly i n c l u d e d  in the h o m o g e n i z i n g  b u f f e r .  Fr o m  
F r i e d r i c h  et a l . / 1 9 8 4 / .
Thu s the i n t e r p r e t a t i o n  of Fig. 4 is t h a t  in the m u t a n t  
p a r t  of the e x t r a  c A M P  is b o u n d  to p r o t e i n ,  in all p r o b a b i l i t y  
to the regiiLatory / R / s u b u n i t  of c A M P - d e p e n d e n t  p r o t e i n  kin a s e :  
in d u n c e ^ ^  the c o n c e n t r a t i o n  of R . c A M P  c o m p l e x  is a b o u t  
t h r e e f o l d  the n o r m a l .  We do not k n o w  the e x a c t  m e a n i n g  of thi s 
o b s e r v a t i o n .  It may i n d i c a t e  tha t  the h i g h  c A M P  in the m u t a n t  
k e e p s  the p r o t e i n  k i n a s e  h o l o e n z y m e  in a h i g h e r  d e g r e e  of 
d i s s o c i a t i o n  r e s u l t i n g  in s o m e  e x t r a  p r o t e i n  p h o s p h o r y l a t i o n .  
Ind e ed , s u c h  p h e n o m e n a  h a v e  b e e n  d e m o n s t r a t e d  / D é v a y  et al.,
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1 984/. On the o t h e r  hand, s i n c e  the c a t a l y t i c  and r e g u l a t o r y  
s u b u n i t s  of c A M P - d e p e n d e n t  p r o t e i n  k i n a s e  m ay be e x p r e s s e d  
s e p a r a t e l y ,  the h i g h e r  l e v e l  of R . c A M P  m a y  be p a r t  of a c o m ­
p e n s a t o r y  m e c h a n i s m  d e v e l o p e d  by the m u t a n t  in o r d e r  to n e u ­
t r a l i z e  the e x c e s s  of cAMP, w h i c h  o t h e r w i s e  m i g h t  be detrimental 
to p h y s i o l o g i c a l  p r o c e s s e s  m o r e  v i t a l  tha n  a s s o c i a t i v e  learning.
In c o n c l u s i o n ,  the e n z y m e  p r o b e  m e t h o d  can be conveniently 
u s e d  to c h a r a c t e r i z e  m e t a b o l i t e  p o o l s  in r e s p e c t  of t h e i r  r e ­
a c t i v i t y  h e t e r o g e n e i t y ,  w h i c h  g e n e r a l l y  s t e m s  f r o m  sequestration 
by b i n d i n g .  It s h o u l d  be n o t e d  t h a t  the m e t h o d  is s i m p l e  and 
c a n  be w i d e l y  a p p l i e d ,  as e n d o g e n o u s  or e x o g e n o u s  d e g r a d i n g  
e n z y m e s  can be f o u n d  for m o s t  n a t u r a l l y  o c c u r r i n g  c o m p o u n d s .
The c i r c u m s t a n c e  tha t the d e c a y  c u r v e  is s t a r t e d  at the t i m e 
of h o m o g e n i z a t i o n  r e d u c e s  the p o s s i b i l i t y  of p o s t - d i s r u p t i o n a l  
r e a r r a n g e m e n t s  in b i n d i n g .  The e x a m p l e  of c A M P  a n a l y s i s  i l l u s ­
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DISCUSSION
SLUSE-GOFFART:
My question deals with the first example of kinetically 
distinguishable compartments. Is it excluded that the 
three-NAD compartments are due to three different levels 
of disruption of erythrocytes, namely no disruption, par­
tial disruption and total disruption?
FRIEDRICH:
We have carefully excluded this obvious possibility. We 
made sure that haemolysis by sonication be complete, 
which we monitored by the release of haemoglobin. In our 
standard protocol we applied the minimum time of sonica­
tion that produced practically 100 % haemolysis. Further 
sonication did not change the time course of coenzyme 
decay shown in Fig. 1 .
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The dynamical properties of energy metabolism (EM) such as 
stabilization of ATP (or energy charge) (1-3) , trigger phenom­
ena (2, 4, 5), self-oscillations (6-8) are due to the presence 
of a great number of feedback and feedforward loops (both pos­
itive and negative) in EM. The regulatory loops of allosteric 
nature can easily be identified. At the same time, regulatory 
loops can arise at the stoichiometric level (2, 4, 5, 9-11).
The mechanisms of their formation and their functions have 
hardly been studied. It is not clear, either, why the number 
of the regulatory loops in EM is as large as it is. Does not 
this lead to excessive metabolic control?
The aim of the present paper is to attract attention to 
the peculiarities of the stoichiometric organization of EM and 
of the system of regulatory loops. The results come from anal­
ysis of the available data by mathematical models and from our 
own experiments.
RESULTS
Structure and regulation of the aerobic EM of animal 
tissues
The core of aerobic EM is the tricarboxylic acid cycle 
(TCA-cycle). It is in this system that fragments of the initial 
substrates in the form of AcCoA are being oxidized to CC^
185
Figure 1
A scheme of the metabolic pathways of the aerobic energy metab­
olism (top) and various types of regulation of the tricarboxylic 
acid cycle and pyruvate dehydrogenase (bottom). Activation (+) 
and inhibition (-) of different reactions are shown by dashed- 
and-dotted and dotted lines, respectively.
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(Fig. 1, top). The cycle cannot be treated as an isolated cir­
cular system. The various satellite reactions feeding in and 
out of the cycle (shown by thin and double lines on the top of 
Fig. 1) cannot be disregarded. The net fluxes in the reactions 
do not exceed 10 % of maximal cycle flux in the heart. Owing 
to these reactions, however, the sum of the cycle intermediates 
can vary under physiological conditions by one order of magni­
tude and more (12)
The carbohydrates, even (e) and odd (o) fatty acids (FFA), 
branched chain ketoacids (BCKA) and propionate enter the cycle 
as AcCoA and (or) SuccCoA. The bulk of the flux is through 
AcCoA. The entry through SuccCoA is minor (except for ruminant 
liver) and its hyperactivation causes severe metabolic disor­
ders (13).
The dashed arrows (Fig. 1, bottom) indicate different 
types of regulation of the TCA-cycle and of pyruvate dehydro­
genase (PDH) reaction. Except for the inhibition of citrate 
synthase (CS) by malate, all the regulatory mechanisms involve 
negative feedback loops (NFLs), which may be grouped into local 
and global ones. All the entries to the cycle undergo a multi­
ple control.
There are also stoichiometric feedback and feedforward 
loops, which are not as readily evident. Let us consider a few 
examples of such NFLs. For instance, the CoA - AcCoA pair cou­
ples the CS and PDH reactions, owing to a constancy of the sum 
of CoA-thioesters in the mitochondria. Analogously, all the 
NADH-producing dehydrogenases are coupled to the reactions of 
the respiratory chain. The reactions of ATP synthesis are cou­
pled to cellular ATPases. Lipman was the first to notice this 
property of coenzymes (14).
Coenzyme cycles of EM
Disregarding the complicated structure of EM and focussing 
attention on the net reactions of coenzyme conversions, we 
arrive at a scheme (for EM of muscles) containing three coen­
zyme cycles (Fig. 2).
187
A-cyc le N-cycLE C-cyCLE
Figure 2
Coenzyme cycles and global negative feedback loops (dashed 
and dashed-and-dotted lines) in muscle energetics
The C-cycle is formed by the reactions of conversion of 
the initial substrates (s) to AcCoA and by the CS-reaction of 
TCA-cycle. The NAD-reducing dehydrogenases and the reactions 
of respiratory chain constitute the N-cycle, and the reactions 
of ATP synthesis and hydrolysis - the A-cycle. The coupling 
between the cycles is due to the systems of the oxidative phos­
phorylation and TCA-cycle.
Each type of coenzyme has its own buffer. For ATP, NADH 
and AcCoA, these are CrP, reduced substrates and acetylcarni- 
t ine.
This representation of the aerobic EM reveals a hierarchy 
of global NDLs, which form a family of nested loops (dotted 
lines in Fig. 2). The NFLs formed by the adenylates and inor­
ganic phosphate, Pi, control fluxes in all cycles. The effect 
of the pyridine nucleotides is limited by the dehydrogenases 
of N- and C-cycles. The influence of CoA-thioesters extends 
to the reactions of C-cycle. Fluxes in the cycles are preset 
by the ATPase load, i.e. by the net rate of ATP hydrolysis by 
the ATPases of actomyosin and sarcoplasmic reticulum and by 
Na+-K+ ATPase. Ca2+ participates in the control of all coenzyme
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cycles. However, it cannot be considered as an external regul­
ator, because its level is regulated by adenylates and P^.
The system of the coenzyme cycles for liver EM is slightly 
different due to the synthesis of ketone bodies with the AcCoA 
to CoA conversion running independently of TCA-cycle. In the 
liver, the net rate of ATP hydrolysis is determined by Na+-K+ 
ATPase and by "ATPases" of biosynthetic pathways. The CrP-buf- 
fer is absent and Ca^+ is not involved in the immediate control 
of EM.
Dynamics of the cycles
It would be now interesting to compare the maximum fluxes 
and the total content of the coenzymes in the A, N and C-cycles. 
Their magnitudes for rat heart mitochondria are as follows: 
20-23, 7-8, 1.5 pmol/sec/g dry wt and 4-5, 1-1.5, 0.5-1 ymol/g 
dry wt, respectively. It follows from this comparison that the 
turnover time in each cycle is less than a second. With these 
values the jumps in the rates of consumption of ATP, NADH or 
AcCoA might cause a depletion of the appropriate coenzymes, 
because of the delays in the metabolic pathways of ATP, NADH 
and AcCoA synthesis.
However, the depletion never occurs owing to the buffers 
and to a great number of NFLs, whose immediate effect is the 
levelling off of the fluxes. The effect is primarily due to 
adenylates and P^ which activate various pathways of EM and 
reduce the rates of ATP hydrolysis by ATPases (Fig. 2).
The importance of such a control of ATPases during the 
transient periods of overload, when the rate of ATP hydrolysis 
(Va d p ) exceeds by far that of its synthesis, is seen from 
Fig. 3. The system without feedback control of ATPases is 
critically dependent on workload (right). The increase in its 
magnitude or duration (periods of workload are marked by black 
rectangles) will cause ATP depletion and the development of 
the rigor state. The system with feedback control (left) can 
stand twice as great a load without ATP depletion (shown by 
broken lines). In this system the inhibition of ATPases by the
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Figure 3
Effect of overload on cytosolic ATP level and the net rate of 
ATP hydrolysis (V^ jjp) in a model of muscle energy metabolism. 
Periods of increased load are marked by black rectangles. Left, 
a system incorporating the regulation of ATPases by their 
products; right, a system lacking this feedback regulation.
accumulated ADP will lead to a rapid fall of VAQp and, hence, 
of the force developed by muscle. It is this spike constituent 
of the force developed (VADp) that is important for many volun­
tary efforts. The above mechanisms of the regulation of ATPases 
and of Ca + level in cytosol by adenylates and P must be taken 
into consideration in explaining the autonomous control of EM 
and in studying the phenomena of muscle fatigue and myocardial 
failure.
Coupling of fluxes in the coenzyme cycles
In the system considered (Fig. 2) the feedback structure 
looks ike a family of embedded loops, some of them embracing 
2 or 3 cycles. The theory of automatic regulation states that 
the inclusion of NFLs into various technical systems greatly 
reduces output signal sensitivity to changes in the internal 
elements. Systems with common NFLs, embracing all unreliable 
elements, show better suppression of noise than systems with
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local loops embracing single elements (15).
In the EM, fluxes are set up by the ATPase load. Hence a 
low sensitivity of fluxes in the cycles to variations in dif­
ferent parameters can be anticipated.
At the same time, fluxes in the coenzyme cycles are cou­
pled through the reactions of oxidative phosphorylation and 
TCA-cycle (Fig. 2). Because of the proton conductivity of mito­
chondrial membrane and the satellite reactions feeding in and 
draining the TCA-cycle out, the stoichiometry of the production 
of 12 ATP molecules per 1 AcCoA molecule is not fixed. Due to 
such slippage in the coupling systems the relationship between 
fluxes in the C- and A-cycles can be different under different 
conditions. Consider the EM of the heart as an example. Fig. 4 
presents the calculated steady-state characteristics of EM.
The upper left figure shows the dependence of flux in the C- 
cycle (which has the same rate as that of CS-reaction) on the 
ATPase load, i.e. on the flux in the A-cycle. The dotted, dash­
ed and solid lines correspond to substrate (pyruvate) concen­
trations of 200 yM, 1 mM and 5 mM. It is easily seen that the 
flux in the CS-reaction as a function of the ATPase load re­
mains invariant within 1 % with respect to the 25-fold change 
in pyruvate level. The growing pyruvate concentration will 
only cause an increase in the operating range of fluxes. This 
holds to within 2-3 % also for the other reactions of TCA- 
cycle, except malate dehydrogenase (MDH).
The ATP/ADP ratios, both cytosolic (cyt) and mitochondrial 
(mit), and the NADH/NAD ratio also show a weak sensitivity to 
variation of pyruvate in this concentration range (lower left 
and middle plots of Fig. 4). By contrast, the concentrations 
of oxaloacetate (OAA) and citrate change by more than one or­
der of magnitude with the same values of ATPase load (upper 
right and middle plots).
It is important that the rate of the CS-reaction remains 
constant with the strongly varying level of OAA. The effect of 
the increased level of the substrate OAA is compensated by the 
appropriate increase in the level of the inhibitor of CS cit­
rate .
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A-CYCLE FLUX (ATPase Lood,|*mo(J)dry wt/min)
Figure 4
Steady-state characteristics of myocardial energetics, calcu­
lated by the model. The dotted, dashed and solid lines corres­
pond to pyruvate concentrations of 200 yM, 1 mM and 5 mM.
A-cycle flux (ATPase Load, nmxly <*y wt>nrO
Figure 5
Steady-state characteristics for liver metabolism, calculated 
by the model for the case of gluconeogenesis from lactate and 
pyruvate whose concentrations vary in the ranges 100 yM ■+■ 4 mM 
and 10 yM ■* 0.4 mM, respectively. The dotted, dashed and solid 
lines correspond to pyruvate carboxylase activities of 5, 10 
and 15 ymol/min/g dry wt.
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Satellite reactions and regulation of TCA-cycle
The 25-fold increase in pyruvate concentration produces a 
marked change in the rate of OAA influx to the cycle through 
the pyruvate carboxylase (PC) reaction (Fig. 1, top) . However, 
the rate of CS-reaction remains unaltered (Fig. 4, left and 
top) and the excess OAA is utilized by malic-enzyme and phos- 
phoenolpyruvate carboxykinase (see Fig. 1).
The same properties are seen in the ctKG-node. The increase 
in the aKG-influx through glutamate-pyruvate transaminase at 
excess pyruvate is largely compensated by its outflux through 
the glutamate dehydrogenase (Fig. 1, top). The effect of in­
creasing aKG concentration in the aKGDH-reaction is compen­
sated by an increase in the level of the inhibitor of aKGDH, 
SuccCoA.
Thus, in spite of the noticeable variation in the rates 
of the satellite reactions, the segment of TCA-cycle from CS 
to sugcinate dehydrogenase (SDH) behaves as a whole unit. This 
is achieved due to the great number of global NFLs in the TCA- 
cycle .
Similar properties of the TCA-cycle have been revealed 
also in the liver in the case of gluconeogenesis from lactate 
or alanine. Here the fluxes in the satellite reactions can 
amount to as much as 30 % of the maximum flux in the TCA-cycle.
The relationships between steady-state fluxes in the C- 
and A-cycles of liver EH are shown in Fig. 5. The rate of glu­
coneogenesis is predetermined by lactate, whose concentration 
changes from 100 yM to 4 mM for each curve in the model. The 
dotted, dashed and solid lines correspond to PC activity of 5, 
10 and 15 ymol/g dry wt/min. Gluconeogenesis is an additional 
ATPase load for the liver EM. Because of this, the variation 
of PC activity causes a change in both the maximum rate of 
gluconeogenesis and the operational range of ATPase loads. 
However, despite such a strong change in the activity of PC, 
providing OAA to the cycle, the rate of the CS-reaction as a 
function of the ATPase load remains unaltered (Fig. 5, left). 
All the reactions of TCA-cycle, except MDH, also behave as a
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single unit (with accuracy of 2-3 %). By contrast, the rate of 
ketogenesis, not subjected to the global feedback control, 
changes appreciably (Fig. 5, right). As a result, the net flux 
in the C-cycle is not stabilized either.
The results obtained show that the satellite reactions 
affect the concentrations of the intermediates, but not the 
fluxes and stoichiometry of TCA-cycle. This type of regulation 
of TCA-cycle and other branches of EM, involving the system of 
embedded NFLs, makes fluxes in the coenzyme cycles invariant 
with respect to the changing cellular parameters.
Flexibility of the control and homeostasis
The great number of NFLs in EM is not excessive and it 
makes the biochemical control flexible. With varying cellular 
parameters, it permits either synergetic or antagonistic opera­
tion and the replacement of one regulatory mechanism by another 
(16) .
In the myocardium, with glucose as a substrate, the main reg­
ulators in the TCA-cycle are adenylates, , Ca and the con­
centrations of intermediates in the whole range of workloads 
(16). The presence of fatty acids causes a large increase in 
the levels of AcCoA, SuccCoA and NADH in the mitochondria (17) 
and the regulation of TCA-cycle by these coenzymes becomes pro­
nounced. Owing to the satellite reactions, there is a rise in 
the concentrations of the intermediates. In these conditions 
the effect of Ca^+ and ADP on the key dehydrogenases is re­
duced (since they are K-type activators) and is partially re­
placed by that of NADH (16).
The above examples show that the combinations of the reg­
ulatory NFLs are determined by the operational conditions in 
the EM. Owing to the flexible multiloop control, fluxes in the 
coenzyme cycles become insensitive to changes in different 
parameters within a certain range. This means that the funda­
mental function of the system-balance between energy yields 
and demands - is well stabilized with ever changing and float­
ing environmental parameters. This is what may be called the 
biochemical homeostasis.
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Destruction of homeostasis and various types of the 
feedforward inhibition
The reasons for destruction of homeostasis are many. We 
restrict ourselves to consideration of the mechanisms of the 
inhibition of fluxes in the coenzyme cycles at the expense of 
depletion of only one or two coenzyme forms (Fig. 2).
The depletion of NAD and blocking of the flux in the N- 
cycle occur in the absence of 02 during anoxia or ischemia. A 
similar depletion of the coenzymes of C- and Y-cycles can also 
be observed in certain conditions. For this to occur, it is 
sufficient to add in excess a substrate which is oxidized as 
CoA-thioester. With substrates entering the TCA-cycle as AcCoA 
and SuccCoA, different mehcanisms of flux inhibition in EM are 
possible (10, 11). We will confine to the case of substrates 
as AcCoA.
If the TCA-cycle operates as a closed circular system 
(Fig. 6, left top), then the addition of excess substrate S 
causes an accumulation of AcCoA coupled with the reduction in 
the level of free CoA. This reduction is first compensated by 
the accumulation of aKG so that the flux in the cycle remains 
unaltered. After the intermediates have largely been converted 
to aKG, further reduction of CoA level will cause a drop in 
the rate of the aKGDH-reaction and therefore, in the rate of 
OAA regeneration in the cycle, which, in turn will result in 
a reduced rate of the CS-reaction producing free CoA. This 
leads to a still greater reduction of the level of CoA and to 
the inhibition of aKGDH. The process, which is an autocatalyt- 
ic one, stops when aKG becomes a trap for the intermediates 
and AcCoA for CoA and SuccCoA. In the actual system the inhi­
bition is not complete because of the satellite reactions, 
which supply OAA, and also because of the deacetylation of 
AcCoA to CoA. The steady-state rate of the substrate S oxida­
tion slowly decreases with the increasing level of S (Fig. 6, 
left and bottom). This mechanism is feasible for pyruvate (11)
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Figure 6
Top, a simplified scheme of the oxidation of different sub­
strates (S, left) and acetoacetate (right) in the tricarbox­
ylic acid cycle of heart tissue. Bottom, steady-state rate 
of the oxidation of S as a function of its concentration 
(left) and the reactions of purine metabolism in the mito­
chondria (right).
Adenylate kinase is known to be absent from the mito­
chondria of various tissues. Its function is taken by di- and 
mononucleotide kinases (DK and MNK, Fig. 6, right and bottom). 
The AMP level in the mitochondria is determined, to a large 
extent, by the GTP/GDP ratio and by the rate of ATP hydrolysis 
to AMP.
During the inhibition of flux in the cycle the rate of 
the GDP-dependent succinate thiokinase (STK) reaction also 
drops. As a result, the GTP/GDP ratio reduces and AMP is ac­
cumulated. This accumulation is particularly prominent with 
the autocatalytic substrates converted to appropriate acyls 
at the expense of ATP and GTP hydrolysis. In the inhibited 
state, the proportion of AMP in the adenylate sum greatly in­
creases, i.e. it becomes a trap for ATP and ADP. This mechanism 
dominates in the case of TCA-cycle inhibition by excess of
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caproic acid (Dynnik, Kosenko, Kaminsky, unpublished).
Both types of trap, the CoA-trap and the ATP, ADP-trap, 
are realized in different conditions with other substrates, in 
particular with ketone bodies (KB). In this case (Fig. 6, right 
top) STK is shunted by 3-oxoacid CoA transferase (OCT), which 
is equivalent to GTP hydrolysis. That is why the perfusion of 
isolated heart with excess of KB causes a rapid cessation of 
contractile activity (18).
Particular attention should be given to the stoichiometry 
of KB oxidation. In the absence of different sources of AcCoA, 
this system is a degenerate trigger in which both stable sta­
tionary states are inactive.
As seen from the scheme (Fig. 6, top and right), the 
steady-state regime in the system is possible with equal rates 
of the STK and OCT reactions (V^^^). The rates of the produc­
tion of AcCoA (V^  = 2V2) and OAA (V^V^V^) will be the same 
only in this case. However, this state is unstable because it 
can be realized for any given flux in a system only at a def­
inite concentration of acetoacetate (AcAc). Beyond this con­
centration, the rate of OAT (V^ ) exceeds that of STK (Vj) and 
AcCoA is formed at a rate higher than that of OAA. As a result 
of AcCoA accumulation, the above mechanisms become efficient. 
Below this critical level of AcAc, STK is dominating and the 
rate of OAA production is higher than that of AcCoA. In this 
case AcCoA is being depleted in the CS-reaction and OAA be­
comes a trap for the intermediates of the TCA-cycle.
The oxidation of most substrates and their conversion to 
AcCoA are regulated by a great number of NFLs. The addition 
of excess substrates destroys this control in such a way that 
the excessive production of AcCoA becomes possible. The excess 
of AcCoA, on the strength of the peculiar stoichiometry of 
TCA-cycle, leads to the formation of coenzyme traps, which 
inhibit fluxes in the coenzyme cycles, thus destroying the 
homeostasis of the whole system.
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CONCLUSIONS
1. The aerobic EM includes three conjugated coenzyme cy­
cles regulated by the system of embedded NFLs.
2. The loops formed by adenylates and also by phosphate 
and Ca2+ (muscle, brain and heart tissues) are ranking high 
in the hierarchy of regulation.
3. The control exerted by the system of NFLs is flexible, 
depending on the conditions prevailing in the cell.
4. A system so organized appears as a homeostat. It can 
stabilize its main function (fluxes) under conditions of float­
ing cellular parameters. The effects of Pasteur and Crabtree, 
the Sparing effect of fatty acids, the phenomena of muscle 
fatigue and myocardial failure clearly demonstrate this ability.
5. The various stoichiometric negative feedforward loops 
may lead to destruction of homeostasis.
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DISCUSSION
ATKINSON:
Your simulated system showed a wide range of values of 
the ratio ATP/ADP, up to 10C0 or so. Yet analytical values 
cluster closely around about 5. (Of course these are 
determinations of total concentration, and do not take 
binding into account.) What do you think about this 
discrepancy?
DYNNIK:
In our models, the ATP to ADP ratio changes 100 times or 
even more in the whole range of ATPase loads. This may 
reflect the changes of free nucleotides or their activity 
ratio.
Up to 90 % of ADP in muscle and about 30-40 % in liver is 
bound. Biochemists concerned with muscle energetics prefer 
to estimate it from the CrP/Cr ratio.
There is also a problem with the reliable determination of 
mitochondrial ATP/ADP ratio. Most of the extraction ex­
periments give a value for it of about 1 or even lower.
How is mitochondrial metabolism regulated, if the in vivo 
ratio is about 0.2? I think all these discrepancies are 
bound to the applied routine analytical methods.
ATKINSON:
It seems to me that there is a bothersome paradox here, 
which continues to be puzzling. Most of the ADP in muscle 
is bound to proteins: much less is bound in yeast or 
bacteria. We would expect that the constant ratio would 
be (free ATP)/(free ADP). Yet extraction experiments 
yield the same ratio of total ATP and ADP concentrations 
for cells of most if not all types. I do not understand 
this.
DYNNIK:
If we have equal ratios for total nucleotides in various
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tissues, this means that the actual ratios are very dif­
ferent. In any case it would be risky to compare data of 
excitable tissues of mammals with those of yeast and bac­
teria. In the mammalian tissues, the free ATP/ADP ratio 
may change by orders of magnitude; in yeast and bacteria 
it does not. Which state of muscle metabolism may we com­
pare with that of yeast and bacteria?
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INTRODUCTION
Triosephosphates are situated at the branching point of several 
metabolic pathways» Their physiological concentrations are 
rather low in the micromolar range /l/. At the same time the 
concentrations of enzymes catalyzing their conversion in the 
glycolytic pathway are 10 - 100 pM, which probably means that 
the enzymes are densely packed /l, 2/. This situation favours 
the formation of protein-protein complexes and by the same 
token the functional compartmentation of these metabolites. 
Therefore, it was important to study whether the rate and 
direction of triosephosphate conversion could be regulated by 
enzyme-enzyme interactions.
We have investigated the complex formation between aldolase and 
three functionally related enzymes, glyceraldehyde-3-phosphate 
dehydrogenase /GAPD/, triosephosphate isomerase /TPI/ and 
glycerolphosphate dehydrogenase /GDH/. All of these enzymes are 
oligomers. The two dehydrogenases dissociate on dilution 
/Table 1/, moreover, the substrates induce their dissociation. 
As a result of dissociation in the case of GAPD a more active, 
in the case of GDH a less active enzyme species is formed /3,
4/. Aldolase and isomerase can be considered as stable 
oligomers over a wide range of protein concentration.
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Table 1. Interactions between enzymes related to triose- 
phosphates
Homologous Heterologous 
interactions
Dissociation 
constant, pM Ref.
GAPD T -T---------2D 1,0 /5 /
D ^ ---------*2M O CO /5 /
aldolase- D 0.3 /6/
TPI aldolase- D 1.2 111
GDH D ^ --------^2M 4.0 /4/
aldolase- D 0.2 /8,9/
aldolase- M 1.0 /8,9/
T, D and M represent the tetrameric, dimeric and monomeric 
enzyme species, respectively.
Thus the subunit-subunit interactions of dehydrogenases have 
to be taken into account in the study of heterologous inter­
actions, since preferential binding of enzyme forms of dif­
ferent specific ativities to the other enzymes may ensure in 
itself a kind of regulation in metabolic flux.
Two approaches have been used: physico-chemical methods, 
mostly fluorescence polarization measurements, to. characterize 
quantitatively the enzyme complexes, and a kinetic approach 
based on the analysis of consecutive reactions catalysed by 
functionally related enzymes.
QUANTITATIVE CHARACTERIZATION OF ENZYME COMPLEXES 
A typical experiment of the study of interaction between 
aldolase and GAPD is shown in Fig.l. The dehydrogenase was 
covalently labelled with fluorescent dye and the fluorescence 
polarization was measured in the presence of increasing con­
centration of unlabelled aldolase. The curve illustrates the 
change in polarization at the equilibrium state. Inactivation 
of neither enzymes occured during the experiments. Since 
there was no free dye in solution to interact with aldolase
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and the quantum yield of the dye bound to the dehydrogenase 
was not affected by addition of aldolase, the increase in 
anisotropy is suggested to be directly related to the binding 
of unlabelled aldolase to the labelled dehydrogenase.
Fig.l. Change in fluorescence polarization of labelled 
dehydrogenase /0.5 pM/ as a function of aldolase 
concentration in 50 mM Tris-HCl, 1 mM EDTA, 2 mM 
NAD, pH 7.5 after k h incubation at 20°C. Inset: 
determination of the dissociation constant and 
stoichiometry of the labelled aldolase-dehydrogenase 
complex by Wu-Hammes plot.
From Wu-Hammes plot /Fig.l inset/ the apparent dissociation 
constant and apparent stoichiometry were estimated to be
0.3 pM and 2 tetrameric aldolase /tetrameric GAPD, respective­
ly. The latter means that a tetrameric aldolase molecule 
probably binds a dimeric dehydrogenase /6, 13/.
Similar types of experiments have been carried out with other 
enzyme complexes /Table l/. Aldolase interacts with both GAPD 
and GDH preferentially with their dimeric forms which are 
catalytically more active species. The dimeric isomerase is 
also bound to the tetrameric aldolase. The values of 
dissociation constants of heterologous complexes indicate 
that the interactions occur at enzyme concentrations consid­
erably lower than those known to exist in cytosol /l/.
205
Furthermore, since the strengths of interactions are comparable 
there is a possibility for the interactions to endow the com­
plexes with dynamics that result in dissociation-association 
phenomena. Therefore, the question arises: have heterologous 
interactions functional consequences or not?
KINETIC ANALYSIS OF TWO-ENZYME SYSTEM
The complex formation between aldolase and GAPD has been 
studied in considerable detail in several laboratories /10-12/. 
We have presented also kinetic evidence for the binding of 
these enzymes to each other /13/. It was found that the KM 
value of GAP for dehydrogenase determined in the coupled 
reaction was significantly lower than the one determined in 
the individual reaction /Fig.2/.
Fig.21. Fitting of the consecutive reaction catalysed by
aldolase and &APD. The concentration of enzymes was 
3 pM. The assay contains 3 mM fructose-1,6-P, 2 mM 
NAD, 6 mM P. in 50 mM Tris-HCl buffer, pH 7.5, 1 mM 
EDTA. The solid lines are the theoretical curves 
calculated according to the Michaelis-Menten equation 
with the following parameters: V of GAPD reaction:-, 
9.5xl0-%  min” ; v,of aldolase reaction: 3x10 ^M min 
Kjyj of GAPjcl.5x10 4M/ measured in separate reaction/ 
or 1.5xlO-::3M /measured in coupled reaction/.
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Although in aqueous solution glyceraldehyde-3-phosphate /GAP/ 
exists in equilibrium mixture of the inactive diol and active 
aldehyde forms, however, the aldehyde-diol conversion is 
expected to be rapid compared to the transit of the aldehyde 
form from aldolase to dehydrogenase in a non-interacting 
enzyme system. Thus the decrease in the value measured in 
the coupled reaction may indicate that a part of the aldehyde 
form of intermediate liberated at the active site of aldolase 
is trapped by dehydrogenase without diffusing into the bulk 
solution.
In order to get direct evidence for the channelling of the 
intermediate, GAP, the "isotope dilution" technique has been 
used.
The scheme of two consecutive reactions catalysed by enzymes 
E-^  and Eg in the presence of an external intermediate is the 
following:
( I b+J +[b])
where the asterisk indicates radioactive metabolites.
If [A+J K-jyj for E-^  and (LB+]+[B3 for Eg then the
progress curve of product formation can be described as the 
sum of the two equations:
fcf . vt - I (1 - e-kt)
[Cl - [ B j a -  e-M )
where v is the steady state velocity of the reaction catalysed 
by a given concentration of E^ in the absence of added inter­
mediate and k is the pseudo first order rate constant of the 
conversion of intermediate measured in an independent experi­
ment with the same concentration of Eg used in the consecutive 
reaction. ^BQ^ is the initial concentration of unlabelled B.
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To calculate the relative specific radioactivities (r=
= [c+]/(fb+J + [cj)) of the end product which would indicate 
different interacting mechanisms, kinetic parameters v,T and 
k have to he determined from the time courses of coupled and 
uncoupled reactions at given concentrations of enzymes E-^  and 
E2« (v is the seady-state slope of the progress curve of the 
coupled reaction,T is the intercept on time axis, k is cal­
culated from the time course of conversion of B in the absence 
of A+.) All of the kinetic parameters determined are their 
weighted sums for reactions catalysed by complexed and 
uncomplexed enzyme species since the solutions always contain 
free E-^  and E? /14/.
Fig. 3 illustrates the models of different interacting 
mechanisms and the relevant equations for calculation of rela­
tive specific radioactivities. It is to be emphasized that by 
comparing rmeasure(j with r (i=l,2,3) values one can identify 
the mechanism of interaction of functionally related enzymes 
without knowing the concentration of the heterologous complex 
In a given enzyme system.
We used this approach to identify the mechanism of interaction 
in the aldolase-GAPD enzyme system. TPI was added to the system
i./ to eliminate the undesirable aldehyde ---=► diol conversion
of GAP; ii./ to have a reconstituted part of glycolytic 
pathway, hence the consequence of interaction might be 
examined from the physiological view points. It has to be 
pointed out that the validity of the equations are not 
influenced by the presence of TPI if the kinetic parameters 
are determined in the presence of TPI.
208
no interaction
r’ '  v t- -£ (1 -e - ‘ ,) . [B l. ( 1 - r ‘ t>
interaction with conformational 
changes
v't-vT
! * y't-v'T(l-e4)4Bl„(1-e-f)
, perfect channel”
|B]0 (1-e )
where . kIE,U,
Fig.3. Models of different interacting mechanisms and the 
relevant equations for calculation of relative 
specific radioactivities /r/ ^
indicates: vt - v^(l - e- ^ )
The conversion of triosephosphates catalysed by GAPD and TPI 
can be described by a single pseudo first order reaction 
/Fig.<4, curve 1./ indicating that i./ TPI was in excess to 
ensure the rapid equilibrium of triosephosphates; ii./
[GAP]<  Kjyj for dehydrogenase as determined in the presence of 
TPI. Hence the rate constant reflects the activity of GAPD 
in the given system. In addition, we have found that the time 
course of GAP conversion is not influenced by the presence of 
aldolase. The v value was determined from the steady-state part 
of the curve and the intercept on time axis of the linear part 
of curve 2 equals X in the three-enzyme system.
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Fig.4. Time courses of enzymatic reactions catalysed by- 
two- or three-enzyme systems GAP oxidation 
catalysed by GAPd in the presence of aldolase and 
TPI and in the absence of aldolase; Dashed area 
represents the deviation from average, /curve 1/ 
Fructose-1,6-P conversion into phosphoglycerate in 
the coupled reaction of aldolase, TPI and GAPD 
/curve 2/; the same as curve 2 with added GAP 
/curve 3/. Enzyme concentrations are 0.13, 0.53 
and 0.60 pM for aldolase, isomerase and dehydro­
genase, respectively.Initial concentration of GAP 
and fructose-1,6-P, if present, 6.4x10 and 2 mM, 
respectively.
For isotope incorporation from [14i  Fructose-1,6-P into 
phosphoglycerate, the reaction was stopped at time t and the 
concentrations of label],ed and total product were determined 
by high performance liquid chromatographic analysis followed 
by scintillation counting /l4/ and by NADH production, 
respectively.
Table 2 illustrates the results of four sets of experiments. 
The increase in reciprocal X value as compared to k value 
does in itself indicate some kind of enzyme-enzyme inter­
action in the system without revealing the type of inter­
action.
Table 2. Kinetic parameters measured in the three-enzyme 
system and the relative specific radioactivities
Exp. v 
juMs-1
if^ 1—1 
1—1 1 1—1
^ 1w
Relative specific radioactivity 
rl r2 r3 rmeas
1 6.3 0.20 0.043 0.58 0.65 0.75 0.75
2 8.0 0.22 0.054 0.63 0.70 0.76 0.75
3 5.6 0.22 0.054 0.59 0.66 0.72 0.71
4 5.6 0.22 0.054 0.61 0.68 0.74 0.72
The reaction mixtures contained 0.13-0.20 juM aldolase,
0.50-0.60 pM GAPD, 0.50-0.60 pM TPI, 2 mM Fructose-1,6-P,
6 mM NAD, 4 mM arsenate in 40 mM TEA buffer, pH 8.5.GAP: 59-64 pM, t: 23-32 s.
However, by comparing the values of calculated and measured
relative specific radioactivities /r ,= r*£a'1-cu -^a :^e<:i/^ measured oa '
the mechanism of interaction can be identified with the 
"leaky channel" model. This means that GAP formed endogenously 
in the coupled reaction reaches GAPD before equilibration with 
the external GAP and both complexed and uncomplexed de­
hydrogenase molecules have the same ability to bind and con­
vert exogenous GAP.
KINETIC ANALYSIS OF THREE-ENZYME SYSTEM
In order to get information how TPI takes part in or 
influences the interaction between aldolase and GAPD the 
kinetics of three-enzyme system has been analysed and compared 
with that of the two-enzyme system. The scheme of the 
consecutive reactions catalysed by aldolase and GAPD in the 
presence of excess TPI is the following:
k ’ [GAP]
■ GAP ------------- > NADH
1 K’ eq
DHAP
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If (Fructose-l,6-P| for aldolase and ^GAP] KM for GAPD,
and TPI ensures rapid equilibrium between triosephosphates 
Ck = QdhAP]/CgAP"] ), NADH concentration can be calculated:
FnADíŰ = 2vt - —  Cl - e_k,t)k ’
In a non-interacting three-enzyme system the steady-state 
velocity of NADH formation should be double of the rate meas­
ured in the absence of TPI, since the 2:1 stoichiometry of 
hexosephosphate per GAP conversion does hold. V value will be 
comprised in the equilibrium constant /K / of triosephospha­
tes (X= l/k’ = ÍK + l)k), where k and k* are the pseudo first 6C[order rate constants measured in the absence and presence of 
TPI. The effect of TPI on the activity of aldolase has been 
analysed by comparing the steady-state velocities in the two- 
and three-enzyme systems. For the calculation of the C value, 
which is directly related to the activity of dehydrogenase in 
the three-enzyme system, the pseudo first order rate constant 
/k’/ of the conversion of GAP catalysed by GAPD was determined 
in the presence of TPI. It is to be noted that no kinetically 
significant TPI-GAPD interaction can be detected.
Table 3 summarizes the results of á typical series of 
experiments measured in the two- and three-enzyme systems. In 
a system containing aldolase and dehydrogenase the v value 
represents the steady-state velocity of the consecutive reac­
tions since a two-fold increase in aldolase concentration- 
results in a practically two-fold increase in the v value.
This also indicates that the activity of aldolase is not 
influenced by GAPD. However, the presence of TPI does not 
produce a two-fold elevation in the value of v as expected for 
a non-interacting enzyme system. Moreover, by increasing the 
concentration of TPI, the steady-state rate of the consecutive 
reactions changes oppositely. However, by increasing the con­
centration of dehydrogenase a two-fold v value can be measured. 
Simultaneously, the increase of TPI concentration results in a 
decrease in the reciprocal ^ value indicating an apparent
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decrease in the activity of dehydrogenase. The finding that 
the elevation of TPI concentration causes significant decrease 
both in the steady-state velocity and in the reciprocal ^  
values which can be reverted by the increase of GAPD concen­
tration, may indicate the alternative binding of TPI and GAPD 
to aldolase. This suggestion seems to be supported by our 
recent fluorescence polarization measurements.
Table 3. Kinetic parameters of the consecutive reactions 
catalysed by three-enzyme system
aldolase
pM
GAPD
juM
TPI
uM
V ss
}M/s
i/r
s
k
-1s
0.45 0.06diol---^ aid
0.12 0.45 - 3.5 >1
0.24 0.45 - 6.9 >1
- 0.45 0.15 0.043
0.12 0.45 0.15 5.8 0.13 0.043
0.12 0.45 0.49 5.0 0.10 0.043
0.12 0.91 0.15 0.063
0.12 0.91 0.15 6.9 0.14
0.12 0.91 0.50 5.4 0.11
The assay contained 6 mM NAD, 4 mM arsenate and 2 mM FDP 
or 0.05 mM GAP in 50 mM TEA buffer, pH 8.5.
CONCLUSION
The results presented here suggest that in the muscle where 
the physiological concentrations of proteins are significantly 
higher than in these experiments, aldolase and GAPD can form 
heterologous association. Due to the physical interaction 
between-them the apparent activity of dehydrogenase increases 
since i./ the catalytically more active oligomeric form, GAPD 
dimer is involved in the complex formation; ii./ the inter­
mediate, GAP, of the coupled reaction is directly trans­
ferred from from aldolase to dehydrogenase due to the
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juxtaposition of active sites of the enzymes. The active site 
of dehydrogenase seems not to be buried, at least not com­
pletely, by aldolase. Nevertheless, GAP might be functionally 
compartmentalized at near-physiological conditions by the pro­
tein complex even if TPI perturbs the interaction by competing 
with dehydrogenase for the binding to aldolase. As a con­
sequence of aldolase-TPI interaction the rapid equilibrium 
between triosephosphates may not be ensured or triosephosphates 
produced by aldolase-TPI complex probably are not available 
freely for enzymatic conversion catalysed by aldolase-GAPD 
complex.
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DISCUSSION
EASTERBY:
Extrapolation of your data on the "leaky-channel" model 
to zero concentration of exogenously added intermediate 
should allow you to calculate the efficiency of transfer 
of the intermediate between active sites (i.e.: the frac­
tion of intermediate transferred directly). Have you 
carried out this calculation?
OVÁDI:
The efficiency of transfer of the intermediate between 
active sites can be calculated if the dissociation con­
stant of the heterologous enzyme complex is known, or 
Ej is completely complexed by E^.
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I. INTRODUCTION
Viscosity is an important physical property of a medium, being defined 
"macroscopically" from the realm of continuum mechanics and "microscopical­
ly" from statistical mechanics. Basically, it relates to transfer of 
momentum (and therefore to particle mobility) in a given medium. The role 
of viscosity in biochemical processes has been largely ignored, owing 
primarily to the penchant for extrapolating from dilute aqueous solution 
in vitro to the (supposedly similar) condition in vivo.
In principle, viscosity plays an intimate role in all aspects of 
enzyme action, in ligand association/dissociation processes as well as in 
energization of the protein for catalytic turnover. The basic issue is, 
whether or not medium viscosity is actually rate-determining in any of 
these processes. Under in vitro conditions its influence is usually quite 
insignificant, compared to the chemical events of ligand binding/release 
and catalysis. A discordant note to this status rerum comes with the 
increasing realization, that many enzymes of intermediary metabolism oper­
ate in vivo in heterogeneous states far different from that of isolated 
enzymes ini vitro.
Here, we shall relate the potential roles of viscosity in enzymatic 
processes in light of recent information on 1 ) enzyme organization in the 
cell, 2) the nature of cellular microenvironments, and 3) the dynamical 
properties of protein molecules.
II. CELLULAR INFRASTRUCTURE AND THE ORGANIZATION OF METABOLISM
In recent decades electron microscopy has revealed a complex and 
richly diverse particulate infrastructure in living cells— especially 
larger eucaryotic cells. This structure encompasses the extensive
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membraneous reticulation (e.g., plasmalemma, endoplasmic reticulum, meso- 
somes [bacteria]), as well as the hyaloplasmic space. The latter region, 
containing the so-called "ground substance", is laced with a dense array of 
various cytoskeletal elements (e.g., microtubules, microfilaments, inter­
mediate filaments) and an interlocking microtrabecular lattice (1). With 
so much surface area, it is not surprising that a significant amount of 
cellular water is "structured" (i.e., has physical properties unlike that 
of normal bulk water) (2-5). Estimates vary, as to the exact percentage of 
the cell water that is so "structured".
What with the ambience of abundant particulate elements and "struc­
tured" water, as well as rather high protein concentration, one would 
intuit that the cytoplasmic viscosity must be large. Thus far, however, 
measurements indicate values 3-5X that of normal water (for small diffusing 
molecules the size of most intermediary metabolites) (2-5). Most of the 
experimental probes, used to determine cytoplasmic viscosity, sample widely 
different regions of the cellular space during the course of the measure­
ment. Thus, the actual viscosity value so obtained is a statistical 
averaged quantity. In localized microenvironments, such as those close to 
the surface elements, the viscosity is surely greater.
Accumulating empirical and theoretical considerations indicate that 
the majority (if not all) of the enzymes of intermediary metabolism operate 
in vivo in association with particulate structures. A perusal of the liter­
ature reveals evidence for enzyme organization in virtually all major 
metabolic pathways (for recent reviews see refs. 5-10). The organizational 
mode, of the multienzyme systems of specific metabolic processes, may en­
tail formation of protein-protein complexes and/or individual adsorption 
to cytological substructures. Strong evidence has come also from centrifu­
gation studies on whole cells(ll-12) and cell fragments (13). Experimen­
tal and theoretical calculations (14,15) of protein "concentrations", in 
association with cytomembranes and organelles, indicate high, crystal-like 
densities of protein molecules in (on) particulate structures of the cell. 
There is a remarkable homology, in the surface area-to-volume ratio for 
all membraneous cytological substructures. Such considerations led Sitte 
(14) to propose, that all cytomembraneous elements have evolved in a 
common fashion to function as effective "protein collectors" in the opera­
tion of cell metabolism. And, work from Porter's group (16) shows the 
microtrabecular lattice itself to be "dressed" with a multitude of (as yet 
unidentified) proteins.
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Thus, cell biology presents us with a rather simple, biphasic view of 
cellular infrastructure: _a solid phase, encompassing extensive membraneous 
surfaces and the fibrous lattice-work; and a_ soluble phase, containing a 
considerable amount of "structured" water. We must focus on the solid 
phase as the primary site of intermediary metabolic processes, with the 
soluble phase functioning largely in such subservient roles as thermal buf­
fering, distribution of common substrates, regulatory substances, and salt 
ions, etc. In the remainder of our discussion here, we will consider the 
specific influence of solvent viscosity on enzymatic processes and its pos­
sible relationship to the organizational state of multienzyme systems in 
vivo.
III. INFLUENCE OF VISCOSITY ON THE BINDING/RELEASE OF SUBSTRATe/pRODUCT 
ON THE ENZYME
Here (and in subsequent sections), we consider a simple Michaelian 
enzyme reaction of the form
E + S ■ — * ES — E + P 
k-s
The fundamental role of viscosity in the formulation of the rate con­
stants (k+s,k_g) for binding/release of substrate (or product) is well- 
known in enzymology (17,18). Under diffusion-controlled steady-state con­
ditions, the unitary rate constants reduce in the limit to the Smoluchowski 
rate coefficient, k^ , given by
kjj = fl-fe- D-rc (1 )
where C is a factor relating to geometric restrictions on the mode of ap­
proach of ligand to the enzyme active site (0 < A S Air), f a factor relat­
ing to electrostatic effects, D the diffusion coefficient for the ligand, 
and r^  a critical reaction radius. Using the Stokes-Einstein inverse rela­
tion between diffusion coefficient (D) and viscosity (n), we see that 
kp « (1/n).
The Smoluchowski theory (19) shows how viscosity, in principle, influ­
ences the basic binding/release of ligand molecules to the protein. But, 
realistically, what does it tell us about viscosity and enzyme action?
First, its potential is brought to bear only under conditions when the chem­
ical events of ligand binding/release are faster than diffusive processes. 
Even in this case, it may be difficult to dissect the relative influence 
of diffusivity from the other parameters in Eq. (1). Obviously, a clear
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understanding of the importance of viscosity in the approach of ligands to 
(and escape from) the enzyme depends on our grasp of the complete mechanis­
tic picture of the given enzyme, as well as a knowledge of the actual trans­
port properties of the ambient medium.
The Smoluchowski rate coefficient has come to play a more general role 
in enzyme kinetics, serving to delimit the overall dynamics of enzyme activ­
ity. Consider the reaction of free substrate with free enzyme to yield pro­
duct. The apparent second-order rate constant for this reaction is k /Kcat/ m
(20). Rigorous reasoning shows that the upper (evolutionary) limit on
kcat/Km is 3 ust kp (20). That is to say, no matter how effective is the
enzyme as a catalyst, from the standpoint of the speed and efficiency of the
chemistry of substrate-binding and catalytic-turnover, the overall rate of
catalysis can proceed no faster than the rate of diffusion of substrate to
the enzyme active site. Recently, Keleti and Welch (21) extended these
arguments, to suggest that a more complete evolutionary picture is obtained
by conjugating to t^le respective enzyme concentration (density) in
situ. Accordingly, the "kinetic power", k„ = V /k , emerges as the real1 m a x * ro
measure of the kinetic potential of an enzyme reaction iri vivo.
Welch et^ al. (22) examined an additional role of viscosity in enzyme 
kinetics, viz., the "cage effect" of the solvent environment on enzyme- 
ligand recombination. As a nascent ligand (e.g., product) molecule emerges 
from the enzyme binding site (with a certain impulsive energy), it will 
feel a translational barrier —  whose height is a function of the local sol­
vent viscosity. Theoretical simulation showed that, for the case of an en­
zyme whose chemistry of recombination is very effective, a marked viscosity 
("cage") effect is seen at a viscosity value as low as 3-4X that of water. 
Coincidentally, that is the range of measured cytoplasmic viscosity (see 
Section II).
IV. INFLUENCE OF VISCOSITY ON THE TRANSIENT TIME OF METABOLIC PROCESSES
Since enzyme action involves a composite of unitary rate processes, it 
may be difficult to perceive of the general effect of solvent viscosity on 
a given enzyme by dissecting it into effects on the individual rate con­
stants. A holistic quantity which is directly related to viscosity is the 
transient time, T. As seen for example in the chapter by Dr. Easterby 
(this volume), T is an important parameter in the overall dynamics of a 
multienzyme system. Physically, it is defined by the time required for 
diffusion and accumulation of intermediate substrate/product species to
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levels sufficient to sustain a steady state. Since it depends on mass trans 
fer from one enzyme to another in the sequence, one intuits that T must be 
a function of medium viscosity.
Consider the following two-enzyme (irreversible) sequence:
v
catalyzed by enzymes and E^ . Let us suppose for simplicity that the over 
all flux is limited by the first reaction (whose velocity is vq), such that 
the second enzyme is subsaturated. Then, the transient time for this system 
is found to be
t = K2 /v2 (2)
where K0 and V_ are the Michaelis constant (K ) and the maximal velocity Z Z m
(V ), respectively, for the second enzyme. Using explicit expressions max
for K and V , it was shown (23) that m max
T = (TTTj-Dj- [E2 ] ) _ 1  exp (Ep/kBT) (3)
where [E2] is the total number-density of enzyme E2 molecules, r^. and 
the molecular radius and diffusion coefficient, respectively, for species 
I, E an activation energy for the conversion E.I—>E„ + P, k the Boltz-P / Z D
mann constant, and T the absolute temperature.
Equation (3) gives a way of calculating the transient time of an enzyme 
system as a function of solvent properties —  assuming the system to be 
homogeneously dissolved in a bulk phase. Employing typical values of r ,
[E], and Ep, and taking the solvent viscosity to be 3-5X that of water, we 
find IS3-5 min (23). (For a multienzyme sequence the individual transient 
times are additive.) Such numerical values do not correspond to observed 
metabolic transients. This situation has been used as a general theoreti­
cal argument in favor of enzyme organization in vivo (23).
V. VISCOSITY AND THE PROTEIN-DYNAMICAL BASIS OF CATALYTIC TURNOVER
The old notion, that the overall structure of an enzyme serves the 
singular role of maintaining statically a requisite three-dimensional ar­
rangement of active—site residues, is now outmoded (24-26). Accumulating 
evidence has revealed a wide variety of internal motions in proteins, span­
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ning the gamut of time domains and encompassing various structural levels 
in the protein matrix. Realization of the dynamic nature of the protein 
molecule has led to the development of a number of theoretical models of en­
zyme action (reviewed in refs. 27-29). These models propose that particular 
classes of fluctuations in the protein provide for high free-energy events 
at the active site. One finds an emerging view, that the enzyme molecule 
is an intricate free-energy transducer, serving to link the molecular chaos 
of the environment and the localized chemical-reaction coordinate. What 
differentiate the various models are the types of surface phenomena assumed 
to serve as the source of the free energy ("borrowed" from the medium), and 
the suggested mode of linkage between the ambient source and the enzyme act­
ive site.
Although the mechanistic picture is far from clear, it is apparent 
that "something" (e.g., collisional processes, binding/relaxation of solvent 
or ionic species) at tue protein-solvent interface, acting through the pro­
tein "mediator", is involved in generating the proper phase-space correla­
tion of active-site variables. Viscosity, p, is an appropriate parameter 
relating to the modality of thermal interaction (at a given temperature) 
between the protein and solvent medium. At the microscopic level, the mo­
bility of the particles composing the system is proportional to (1/ri). The 
thermal "(de)energization" of an enzyme-substrate complex must be determined 
by that "mobility” —  whether it specifies direct diffusional-collisional 
interaction of the solvent molecules with the protein or binding/relaxation 
of the solvent/solute particles with the protein. Indeed, numerous theoret­
ical and experimental treatments have demonstrated an explicit role of med­
ium viscosity in enzyme catalysis (reviewed in refs. 26-28).
The rate constant, k - characterizing the conversion ES->EP, is our cat
concern here. The overall free-energy change associated with the transi­
tion-state passage may be decomposed into two contributions: that from 
chemical processes (e.g., E-S binding, solvation/desolvation effects) local­
ized specifically at the active site, and that from the protein matrix 
interacting with the bound chemical subsystem. Considering only the latter 
contribution, we assume that the rate process can be characterized by a 
fluctuation enthalpy. Hence, if a catalytic event demands an enthalpy h^ 
in the protein, the rate will be given by the rate of occurrence of fluc­
tuations, i.e.,
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(4)k'cat = kv - W(h*, T)
where k^ is a frequency factor and W a probability distribution function 
describing the fluctuating enthalpy of the protein (ES complex) at tempera­
ture T (27,28). (The "prime" on k reminds us that we are considering 
only the protein contribution.)
An explicit dependence of k on viscosity enters through k^ . The 
first mathematical derivation of such dependence was by Damjanovich and 
Somogyi (30,31), who showed from statistical-mechanical considerations that 
k^ varies as (l/ri) . This form has been derived from other theoretical ap­
proaches in more recent years (reviewed in refs. 27-29). In the context of 
protein dynamics, there has been much interest recently in the Kramers 
phase-space diffusion theory of chemical kinetics (32). Early on, Kramers 
showed how viscosity produces deviations from the transition-state formu­
lation of absolute reaction rates.
A (l/r|)-dependence for kca(_ agrees fairly well with empirical evidence 
in moderate viscosity ranges. Deviations at higher solvent viscosities 
have been attributed to the situation, that the reaction coordinate of the 
bound chemical subsystem is influenced by two viscosities: that of the sol­
vent and the intrinsic viscosity of the protein matrix (26,28,33).
We are just beginning to unravel the intricacies of the protein-dynam­
ical basis of enzyme action. However, one thing is eminently clear: viscos­
ity plays a distinctly deterministic role in the frequency with which the 
enzyme body generates high free-energy events at the active site.
VI. VISCOSIT! AND ENZYME ACTION IN VIVO
From th<_ empirical and theoretical information accumulated to date, 
what can we say about viscosity and biochemical dynamics in vivo? First, 
there is the question of diffusional transit, especially as it applies to 
larger eukaryotic cells. Experimental measurements thus far indicate that 
the translational motion of small molecules (e.g., metabolites) is retarded 
by less than an order of magnitude (compared to water) within the aqueous 
interstices of the cytomatrix elements. Questions of the physical proper­
ties of cell water, of the diffusional impedance of cytological structures, 
etc., are currently being investigated in a number of laboratories. Gen­
erally, one cannot ascertain the specific influence of the rate of material 
(e.g., substrate) diffusion on an individual enzyme in vivo unless one
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knows the mechanistic details of the given enzyme reaction, as well as the 
nature of the microenvironment in situ.
The transient time of a multienzyme sequence provides one indication 
of the significance of viscosity in tne overall dynamics of a metabolizing 
system. Using known values of cytoplasmic viscosity and average number of 
enzyme molecules per cell, we find calculated values of transient time which 
seem too high —  if we presume that the enzymes of intermediary metabolism 
are homogeneously dissolved in the cellular space. This predicament has 
been invoked as one factor in support of the general notion, that much of 
the enzymatic machinery is structurally organized in vivo (18,23). That 
there is increasing evidence showing intermediary metabolites and enzymes 
to be at roughly equimolar concentration in vivo, further attests to the 
validity of this notion.
It is known that the organizational state of many enzyme systems in­
volves association with subcellular surface elements. But, merely binding 
the enzymes of a metabolic sequence, say to a membrane, does not, in itself, 
solve the diffusional-transit problem. The local viscosity at the cytosol- 
surface interface may be higher than that in the bulk (22). This situation 
would imply, theoretically, that the localized enzymes must be placed in 
rather close proximity on the surface. Interestingly, studies have shown 
protein-densities on subcellular membranes to be very high (see Section II).
A problem of perhaps equal importance for these membrane-adsorbed en­
zymes concerns the effect of thé locally high viscosity on the protein- 
dynamical basis of catalytic turnover. To date, rigorous viscosity studies 
have been performed on relatively few enzymes in vitro. Extrapolating the
available data (viz., k vs. ri plots), from in vitro conditions to the ---  cat --  -------
kinds of viscosity values potentially extant in localized microenvironments 
in vivo, would suggest that many enzymes catalyze reactions at somewhat 
depressed rates —  if activation of the catalytic complex is by purely 
thermal means. This raises the bizarre possibility that some membrane- 
associated enzvmes may actually be activated by nonthermal means, i.e., are 
designed to "plug into" local nonequilibrium energy sources. One obvious 
source would be "active protons", which are generated by virtually all 
energy-transducing biomembranes. This possibility is rendered more palat­
able, with the realization of the central role of "mobile protons" in the 
structure, dynamics, function, and evolution of enzymes (34). While highly 
speculative at present, this idea seems to be physically plausible (35).
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Despite the relative paucity of empirical and theoretical information 
presently accessible to us on viscosity and enzymology, it is imperative 
that this subject be pursued with exactitude. A knowledge of viscosity ef­
fects will provide us a real understanding of the thermal interaction of the 
enzyme molecule with its surroundings. The road to such an understanding 
is a convoluted one. Not only must we know more about the enzyme itself, 
but we must turn increasingly to cell biology to relate to us the physico­
chemical nature of the local microenvironments. And, we must rely on the 
rigor of physical chemistry and statistical mechanics, to give us a more 
exact grasp of the concept of "viscosity" at the microscopic level. This 
pursuit is sure to yield a fuller appreciation of the unity of the enzyme 
and its biological habitat in the living cell.
A more detailed discussion of this topic is presented elsewhere (36).
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DISCUSSION
ATKINSON:
Do you have a feeling for how close together, in terms 
of substrate molecular dimensions for example, two sites 
must be in order that there can be effective channeling 
in the absence of physical constraints on diffusion away 
from the region?
W E L C H :
No, for the moment we do not have an exact idea of the 
closeness of the active sites. In a pure aqueous medium, 
preliminary results indicate than the distance cannot be 
more than about one substrate-molecular diameter (Welch,
G.R. et al., J. Theor. Biol. 100, 211. 1983).
CHERRY:
I feel somewhat uneasy about the use of microviscosity in 
your discussion. I think it is very important when giving 
a number for microviscosity to know how it was measured 
and whether ^he particular number is relevant to the prob­
lem. For example, in membranes one might determine a mi­
croviscosity from measuring the rotational diffusion of a 
small lipid probe, but this wouldn't necessarily enable 
you to predict lateral diffusion coefficients. My question 
is, therefore, how were the microviscosities in cell 
cytoplasm which you quoted obtained and are you sure the 
numbers are the right ones to apply to substrate diffusion 
and to viscous damping of protein fluctuations?
W E L C H :
The actual numerical value of cytoplasmic viscosity 
(viz., 3-5 X that of water) which I cited in my lecture 
and used, for example in the calculation of substrate 
diffusional transit, represents the latest experimentally 
determined estimate from ESR, NMR, and neutron-scattering 
techniques applied to intact cells. These techniques
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measure the translational mobility of probe molecules (and 
in some cases water itself) averaged over the entire cell. 
Of course, various sizes of diffusing probe molecules have 
been used, in order to get a wide spectrum of viscosity 
values. The value which I used was for something the size 
of a glucose molecule. These kinds of experimental results 
are, at best, crude; but they represent the best assess­
ment of the average viscosity of the bulk cytoplasm pres­
ently available. (I would say that the value, 3-5 X that 
of water, is reasonable, considering the large amount of 
polyelectrolytic surface and bound water in cells.) The 
local viscosity on particulate surfaces is certain to be 
higher. It has not been possible as yet to measure such 
a "local viscosity" in actual cells. But, a value 10 X 
that of water would not be unrealistic. In my lecture I 
wanted just to draw attention to the gross effect of 
viscosity on substrate/product transit. At short range, 
the viscosity takes on a discontinuous character - defin­
able theoretically (via statistical mechanics) but rather 
unapproachable experimentally. This consideration is es­
pecially important in trying to understand the effect of 
viscosity on protein dynamics. To date, there is relative­
ly little reliable data on the actual influence of vis­
cosity on protein motions; only a few proteins have been 
studied rigorously. Although one can intuit (and show 
theoretically) that protein dynamics are affected by 
viscosity, we don't yet have a "local" picture of the 
phenomenon (see Welch, G.R. et al., Prog. Biophys. Mol. 
Biol. 3^, 109. 1982). Again, in extrapolating to in vivo 
conditions, I just wanted to draw attention to a gross 
effect.
BARDSLEY:
Can you clarify whether your theory relies on time-depen­
dent distribution functions or are you really dealing 
with well-stirred solutions?
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Viscosity effects could well be far more complicated if 
you allowed for tne increase in viscosity to set up steep­
er diffusion gradients. In such a model the empirical ef­
fect might be almost entirely a solvent effect on the 
"on/off" rate constants and the effect on catalysis could 
be much less important.
WELCH:
No, we did not include explicitly any time dependence.
I agree that one should incorporate such consideration, 
especially at higher viscosity (where local diffusion 
gradients may be important).
I agree with your assessment of the total effect of vis­
cosity, on the overall kinetics of enzyme action. In my 
lecture I dissected the viscosxty effect (for illustrative 
purposes) into its influence on substrate/product inter­
action and on catalytic turnover. In a highly viscous 
medium it is quite possible that the effect on product 
release might dominate (see Welch, G.R. et al., J. Theor. 
Biol. _1_00, 21 1 . 1 983. ) .
30SENBERG:
I would like to point to another factor to be considered 
in case a reaction takes place in a non-ideal solution. 
Excluded volume is defined as the solution space not 
available for a molecule by the physical presence of other 
molecules. The factor is negligible even at quite respect­
able protein concentrations however, as shown by Ross and 
Minton it increases very rapidly at protein concentrations 
around 30-40 %. The models for mitochondrial structure 
presented at this meeting imply even higher packing den­
sities. The activity coefficients for proteins in such 
systems are high. The effect on reactions is in opposite 
direction to the effect predicted for high friction co­
efficients. The experimentally observed effects on rates 
are thus sums of at least two functions, microviscosity 
and excluded volume.
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WELCH:
The excluded-volume effect is likely to be very important 
for in vivo microenvironments. It is certainly a factor 
which we must include in further theoretical analyses.
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THE GENERAL PRINCIPLES OF THE CONTROL OF FUNCTIONING ENZYMES 
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In any object of the material world levels of the organi­
zation of the matter can be detected. As far as biological ob­
jects are concerned the levels of material organization may be 
represented as follows: enzyme multienzyme complex -*■ subcel- 
lular structure ■+■ cell ■+ tissue -*- organ + functional systems-*-... 
When discussing the functioning and the control of biological 
systems, their structural characteristics should be taken into 
account. In my opinion the hierarchy of the levels of the con­
trol of functioning biological systems is predetermined by the 
multilevel organization of the matter in living organisms. One 
can expect that the mechanisms of the control operative on dif­
ferent levels have common features.
The aim of the present paper is to discuss the regulatory 
mechanisms which are exerted on the levels corresponding to en­
zymes and to multienzyme complexes. The idea has been suggest­
ed that second messengers play the key role in the control of 
functioning the multienzyme complex as a whole.
ENZYMES AS CONTROLLABLE SYSTEMS
Certain protein molecules exert catalytic functions, the 
catalytic efficiency of high-molecular biocatalysts being much 
higher than that of low-molecular analogs. In other words, the 
assembly of aminoacids in the macromolecule possessing a spa­
tial structure provides the formation of an active site per­
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forming the efficient chemical transformation of substrates. 
However, one should keep in view that the transition to a struc­
turally organized polypeptide system forms simultaneously the 
pre-conditions for the creaton of sites participating in the 
control of such a catalytic system. The molecules of enzymes 
occupying the key positions in the metabolic pathway contain 
the spatially distinct sites of binding of metabolites exert­
ing regulatory functions. Metabolite, regulators differ by 
their chemical nature from the substrates and the products of 
the enzymic reaction. In other words, metabolites-regulators 
are the "external" factors for a given enzymic process. Metab­
olites exerting their regulatory functions by interactions 
with spatially distinct binding sites are designated as allo­
steric effectors.
The following events are involved in the realization of 
the control mechanism in which the regulatory functions are 
exerted by metabolites-regulators. The mechanism is initiated 
by recognition and binding of the metabolite-regulator in a 
specific site ("allosteric site") of the enzyme molecule. The 
binding of the metabolite-regulator induces the change in the 
conformational state of the enzyme molecule (the "classical" 
allosteric mechanism), the change in the oligomeric state of 
the enzyme molecule (the dissociative mechanism) or the change 
in the adsorptive state of the enzyme molecule i.e. the posi­
tion of the equilibrium between free enzyme and the enzyme ad­
sorbed to subcellular structures (the adsorptive mechanism). 
Changes in the conformational, oligomeric or adsorptive state 
cause alterations of the catalytic properties of the active 
site (the affinity of the enzyme with respect to substrates, 
the rate of the catalytic breakdown of the complex between 
the enzyme and substrates, the character of the interactions 
of the substrate-binding sites in the enzyme oligomer and so 
on). The final stage of the allosteric and related regulatory 
mechanisms is the chain of feed-back which is signalled about 
the achieved result. The change in the rate of the formation 
of the enzymic reaction products which enters into the metab­
olic pathway will lead to the alteration of enzyme-functioning 
producing the metabolite-regulator.
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It should be noted that allosteric, dissociative and ad­
sorptive enzyme systems exhibit similar kinetic behaviour (Kur­
ganov, 1982, 1985a,b).
Thus the evolution of low-molecular catalysts has led to 
the appearance of macromolecules which are characterized not 
only by the high catalytic efficiency but also by the sensitiv­
ity to the control by new material signals. These governing 
factors are metabolites and they provide the optimum function­
ing of a given enzyme in the system of a higher order of com­
plexity i.e. in the definite metabolic pathyway.
MULTIENZYME COMPLEXES AS CONTROLLABLE SYSTEMS
The understanding of the fact that each level of material 
organization gives birth to new control laws which are real­
ized with the participation of new ("external") governing fac­
tors allows to analyse the problem of the regulation of cel­
lular metabolism from new positions.
Enzymes participating in the metabolic pathways tend to 
form ordered multienzyme complexes (Welch, 1977; Keleti, 1984). 
It is generally accepted that the formation of multienzyme com­
plexes is biologically advantageous from the following points 
of view. The association of the enzymes of the metabolic path­
way leads to the formation of microcompartments where the me­
tabolic process may proceed with higher overall rate in com­
parison with the rate of the process proceeding in the system 
with homogenous distribution of enzymes. The reason of this is 
the diminishing of the time of diffusion of the active sites 
of corresponding enzymes (Snol', Ermakova and Frank, 1979; 
Keleti, 1984). It should also be noted that metabolic inter­
mediates are not released into the medium. This circumstance 
exclude the undesirable involvement of intermediates of other 
metabolic pathways.
However, the enhancement of the efficiency of proceeding 
of the metabolic pathway in the microcompartment of the multi­
enzyme complex is not the only advantage of the formation of 
organized multienzyme structures. The physiological sense of
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the formation of multienzyme complexes is that the cell has the 
possibility to control the metabolic pathway represented by the 
multienzyme complex as a whole.
The assembly of the complex of glycolytic enzymes
The complex of glycolytic enzymes may serve as an example 
of the complex of enzymes participating in the common metab­
olic pathway. In skeletal muscles glycolytic enzymes are local­
ized near the I-band of muscle fibers (Sigel and Pette, 1 969; 
Dölken, Leisner and Pette, 1975). According to the data of bio­
chemical investigations individual glycolytic enzymes are able 
to bind reversibly to F-actin which is the main structural pro­
tein of the I-band (Arnold and Pette, 1968, 1970; Arnold, Hen­
ning and Pette, 1971; Westrin and Backman, 1983; Sugrobova et 
al. , 1983). The regulatory proteins of I-band, troponin and 
tropomyosin, play important role in the adsorption of glyco­
lytic enzymes (Clarke and Morton, 1976: Clarke and Masters,
1976; Stewart, Morton and Clarke. 1980). High affinity to struc­
tural proteins of skeletal muscles has been revealed by 6-phos- 
phofructokinase, fructose-bisphosphate aldolase, glyceraldehyde- 
phosphate dehydrogenase, lactate dehydroqenase and glucosephos- 
phate isomerase (Clarke and Masters, 1975). When analysing the 
data on the intracellular distribution of glycolytic enzymes, 
Pette (1975) has drawn the conclusion that high local concen­
trations of glycolytic enzymes in the adsorption layer should 
favour the formation of the ordered multienzyme complex.
The ability to bind some glycolytic enzymes is revealed 
also by the glycoprotein of the erythrocyte membrane, the so 
called band 3 protein. This glycoprotein is responsible for the 
transport of anions through the erythrocyte membrane. The bind­
ing site formed by band 3 protein may reversibly attach one 
tetrameric molecule of 6-phosphofructokinase (Higashi, Richards 
and Uyeda, 1979), two tetrameric molecules of glyceraldehyde- 
phosphate dehydrogenase (Yu and Steck, 1975) or two tetrameric 
molecules of fructose-bisphosphate aldolase (Strapazon and 
Steck, 1977). The formation of the complex of glycolytic en­
zymes adsorbed to the erythrocyte membrane has been postulated
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by Green et al. (1965), Tillmann, Cordua and Schröter (1975) 
and Higashi, Richards and Uyeda (1979).
Kurganov and colleagues (Kurganov, 1984, 1985a; Kurganov, 
Sugrobova and Mil'man, 1985) have used the data on adsorption 
of glycolytic enzymes to the structural proteins of skeletal 
muscles and erythrocyte membranes, the data on protein-protein 
interactions among glycolytic enzymes and the data on the reg­
ulation of glycolytic enzymes by cellular metabolites for con­
struction of the tentative spatial structure of the complex of 
glycolytic enzymes. The complex contains one tetrameric mole­
cule of 6-phosphofructokinase and two molecules of each of 
other glycolytic enzymes (glucosephosphate isomerase, fructose- 
bisphosphate aldolase, glyceraldehyde-phosphate dehydrogenase, 
phosphoglycerate kinase, phosphoglyceromutase, enolase, pyru­
vate kinase, lactate dehydrogenase, triosephosphate isomerase 
and glycerol-3-phosphate dehydrogenase). 6-phosphofructokinase 
plays the central role in the formation of the multienzyme com­
plex. The adsorption of 6-phosphofructokinase to the anchor 
protein of the support is the first steo in the assembly pro­
cess. The tetrameric molecule of 6-phosphofructokinase has 
three symmetry axes of second order and the enzyme is adsorbed 
to the support along one of the symmetry axes. Then the attach­
ment of two molecules of fructose-bisphosphate aldolase, two 
molecules of glyceraldehyde-phosphate dehydrogenase and two mo­
lecules of each of other glycolytic enzymes takes place. The 
fixation of the complex of glycolytic enzymes on the erythro­
cyte membrane is shown in Fig. 1.
The complex of glycolytic enzymes has a symmetry axis of 
second order which is perpendicular to the plane of the eryth­
rocyte membrane. There are two microcompartments where glycol­
ysis proceeds without releasing glycolytic intermediates into 
the medium. The formation of the ordered multienzyme structure 
ensures the channeling of formed ATP to the ATP-consuming en­
zyme systems, for example, to myosin ATPase site in muscle 
fibers.
It should be noted that the complex of glycolytic enzymes 
has a dynamic structure and a dynamic equilibrium exists be­
tween the complex and the free enzymes of the cytosol. The corn-
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The schematic representation of the attachment of the complex 
of glycolytic enzymes to the dimers of band 3 protein embedded 
in the erythrocyte membrane. The used designations are: 1 - band 
3 protein; 2 - glucose phosphate isomerase; 3 - 6 -phosphofructo- 
kinase; 4 - fructose-bisphosphate aldolase; 5 - glyceraldehyde- 
phosphate dehydrogenase; 6 - phosphoglycerate kinase; 7 - phos- 
phoglyceromutase; 8  - enolase; 9 - pyruvate kinase; 1 0  - lactate 
dehydrogenase; - 11 - triosephosphate isomerase and 12 - glyc- 
erol-3-phosphate dehydrogenase.
pleteness of the formation of the complex of glycolytic enzymes 
is sensitive to the variations of the concentrations of cellu­
lar metabolites. For example, it is known that fructose-1,6- 
bisphosphate diminishes the affinity of fructose-bisphosphate 
aldolase to F-actin (Arnold and Pette, 1970; Clarke and Masters, 
1975) and to the erythrocyte membranes (Strapazon and Steck, 
1977). Simultaneously fructose-1,6-bisphosphate strengthens the 
binding of 6-phosphofructokinase to dimers of band 3 protein 
(Higashi, Richards and Uyeds, 1979). Thus the desorbing effect 
of fructose-1,6-bisphosphate with respect to fructose-bisphos­
phate aldolase and the reverse effect of this metabolite with 
respect to 6-phosphofructokinase favour the formation of the 
complex of glycolytic enzymes. In addition to the ability to 
affect the affinity of glycolytic enzymes to the support, 
fructose-1,6-bisphosphate strengthens the associates between 
qlycolvtic enzymes (Clarke and Masters, 1974). Therefore one
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can assume that fructose-1 ,6-bisphosphate acts as a factor 
which stabilizes the complex of glycolytic enzymes adsorbed to 
the support.
The control of functioning of multienzyme complexes
The fixation of the multienzyme complex on the biological 
support results in the formation of a system having a special­
ized control site. In our opinion, the function of this control 
site is exerted by the anchor protein of the support. The con­
trol site provides the sensitivity of the multienzyme complex 
to new control factors which are not metabolic intermediates 
but substances of other chemical nature. We assume that the 
anchor protein undergoes definite changes with the participa­
tion of second messengers (Ca + ions, cyclic AMP, inositol 
1,4,5-triphosphate, diacylglycerol and so on). The appearance 
of second messengers in the cell is the result of interaction 
of hormones and neurotransmitters with the corresponding cell 
receptors (Iyengar et al., 1980 ; Berridge,, 1983, 1984).
The following experimental data may be attracted to sup­
port the proposed hypothesis.
It is known that Ca + ions in concentrations up to 10  ^M 
do not effect the enzymic activities of glycolytic enzymes in 
solution (Vaughan, Thornton and Newsholme, 1973). However, 
when bound to the filaments formed by F-actin, troponin and 
tropomyosin, one of the glycolytic enzymes, fructose-bisphos- 
phate aldolase, becomes sensitive to Ca + ions. Ca + ions en­
hance the affinity of adsorbed enzyme to substrate, fructose- 
1, 6-bisphosphate (Walsh, Clarke and Masters, 1977). Therefore 
one can assume that the complex of glycolytic enzymes formed 
within the I-band of myofibrils containing Ca2+-binding pro­
tein (troponin C) is regulated by Ca^+-ions. The concentration
2+ - 7of Ca ions in the resting muscle is about 10 M. The in­
crease in the content of Ca2+-ions up to 10 5 M in response to 
nervous exitation initiates muscle contraction which is exert­
ed with the use of the energy of ATP hydrolysis. The activation 
of myosin ATPase by actin becomes possible after the binding 
of Ca2+-ions by troponin C. It is evident that Ca2+-ions should
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stimulate the glycolytic process producing ATP. This stimula­
tion is realized through the anchor protein, troponin C. The 
complex of glycolytic enzymes adsorbed on the structural pro­
teins of skeletal muscles remains inactive until the binding 
of Ca2+-ions to troponin C takes place. The binding of C a t ­
ions to troponin C produces conformational changes in the 
anchor proteins and neighbouring proteins of the complex. This 
gives the possibility for the substrates to get into the micro­
compartment and be chemically transformed.
The anchor protein fixing the complex of glycolytic en­
zymes to the erythrocyte membrane is able to interact with 
Ca2+-ions like anchor proteins in skeletal muscles. The inter­
action of Ca2+ ions with band 3 protein leads to the inhibition 
of the transport of anions through the erythrocyte membrane 
(Passing and Schubert, 1983). One can expect that the function­
ing of the complex of glycolytic enzymes fixed on the dimers 
of band 3 protein will be sensitive to Ca2+ ions.
CONCLUSION
In summary, I should like to formulate some principles oi 
the regulation of cellular metabolism.
The control of cellular metabolism has multilevel nature. 
The hierarchy of the levels of the control of cellular metab­
olism is based on the multilevel material organization of bio­
logical objects. The biological system of each level of the 
complexity has elements which exert working and control func­
tions (for example, active and allosteric sites for the en­
zymes, the microcompartment and the anchor protein for the mul- 
tienzyme complexes adsorbed on the biological supports). The 
regulatory factors which interact with the control site of the 
system are external ones with respect to the given system. In 
other words, these factors are not the substrates or the prod­
ucts of the enzymic reaction in the case of single enzymes and 
are not the metabolic intermediates in the case of multienzyme 
complexes. The regulatory factors ensure the optimum function­
ing of the given biological system when included in the system 
of a higher level of complexity.
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As far as the regulation of multienzyme complexes is con­
cerned two levels of control may be identified. The lower level 
of control is exerted with the participation of metabolites- 
regulators (allosteric regulation). The higher level of control 
is exerted with the participation of second messengers affect­
ing the anchor protein of the support which ensures the forma­
tion of the multienzyme complex. The control mechanism of the 
higher level provides the rough regulation of the functioning 
of the multienzyme complex (switching on - switching off the 
metabolic pathway), whereas owing to the control mechanisms of 
the lower level a fine adjustment of the catalytic action of 
the multienzyme complex is achieved. It should be noted that 
the control mechanisms which are operative at the higher levels 
are more rapid.
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DISCUSSION
WELCH:
I have a question concerning the regulatory significance 
of such reversibly adsorptive systems as in the case for 
the association of phosphofructokinase with erythrocyte 
membrane. Of particular concern with this enzyme is the 
fact that its substrate-saturation curve changes from 
sigmoidal to more hyperbolic when it is bound to the mem­
brane .
KURGANOV:
The changes in the shape of v vs (S) plot which accompany 
the adsorption of phosphofructokinase to the erythrocyte 
membrane mean the diminishing of sensitivity of the en­
zyme reaction rate to the variation of substrate concen­
tration and the weakening of contribution of this enzyme 
in the regulation of glycolytic processes.
Vie should realize that the adsorbed phosphofructokinase 
is a component of the multienzyme complex. The spatial 
organization of the glycolytic enzymes leads to the for­
mation of the microcompartment where glycolytic process 
proceeds without the release of the glycolytic inter­
mediates in the medium. The multienzyme complex adsorbed 
to the dimer of band 3 protein embedded in the erythro­
cyte membrane has symmetry axis of second order and con­
tains two such compartments. All glycolytic enzymes (with 
exception of phosphoglycerate kinase) possess oligomeric 
structure. The definite part of active and effector sites 
of the glycolytic enzymes face to the microcompartment 
whereas the other one is located on the surface of the 
multienzyme complex. The former active and effector sites 
participate in the glycolytic process which proceeds in 
the microcompartment. The main product of glycolytic 
process, ATP, should be channelled to corresponding ATP- 
consuming enzyme systems (for example, to the active 
sites of myosin ATPase in myofibrils). The regulatory
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links in the microcompartment should be weakened. In par­
ticular, effector sites of phosphofructokinase located in 
the microcompartment should be characterized by less af­
finity to ATP in order not to prevent the ATP production 
in the working microcompartment.
On the other hand, active and effector sites located on 
the surface of the multienzyme complex should retain theii 
sensitivity to metabolites-requlators in order to provide 
the control of functioning the multienzyme complex by 
cellular metabolites accumulated in the surrounding (i.e. 
in the macrocompartment).
Another aspect of functioning phosphofructokinase concerns 
the appearance of the sensitivity of adsorbed form of the 
enzyme to new regulatory factors. I assume that phospho- 
fructokinase adsorbed to the support of the biological 
nature becomes sensitive to second messengers. It is
known that anchor proteins revealing the affinity to phos-
2 +phofructokinase interact with Ca ions. One can expect 
that 0a^ + ions will be important regulators of the enzyme 
activity of adsorbed phosphofructokinase and of the cat­
alytic action of the whole organized glycolytic system.
FRIEDRICH:
The evidence available about the three glycolytic enzymes 
examined in considerable details, i.e. phospxiafructokinase, 
aldolase and glyceraldehyde-3-phospnate dehydrogenase 
(GAPD), indicates that these enzymes bind to the red cell 
membrane mainly under hypotonic conditions, when examined 
in vitro. This, however, does not exclude that they are 
bound to the membrane in vivo, in the intact cell. Two 
papers addressed to the question of localization of GAPD 
in intact erythrocytes: Kliman and Steck (J. Biol. Chem. 
255, 6314-6321 , 1980) analysed the kinetics of saponin- 
induced partial haemolysis and Solti et al. (J. Biol.
Chem. 256. 9260-9265, 1981) determined the distribution 
of ^H-labelled GAPD in fixed erythrocytes by electron- 
microscopic autoradiography. Both approaches gave the
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result that about two-thirds of the total GAPD in red cells 
is located at the membrane. The model proposed by Dr. Kur­
ganov for a submembrane overall glycolytic complex can only 
be regarded as a working hypothesis, since only some as­
pects of it can be supported by experimental evidence.
KURGANOV:
The experimental data which have allowed to suggest the 
idea about the existence of the ordered complex of the 
glycolytic enzymes and to dispose the glycolytic enzymes 
in the complex in the definite manner include the data on 
the adsorption of the glycolytic enzymes to the erythro­
cyte membranes and to the structural proteins of the myo­
fibrils, the data on the protein-protein interactions for 
the glycolytic enzymes and the data on the regulation of 
the glycolvtic enzymes by the glycolytic intermediates.
The analysis of these experimental data and the tentative 
structure of the complex of the glycolytic enzymes will be 
represented in our paper (Kurganov, B.I., Sugrobova, N.P., 
Mil'man, L.S., J. theor. Biol, in press).
OVÁDI:
You mentioned that it is known that the mitochondrial AAT 
dissociates on dilution. Where do those data come from?
Do you have any evidence for the occurence of glycolytic 
multienzyme complex as well as for the location of each 
enzyme in such a complex?
KURGANOV:
I have discussed the sedimentation of cytoplasmic aspar­
tate aminotransferase from pig heart. The dissociation of 
the dimeric form of this isozyme into monomers in diluted 
solution is a well documented fact.
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INTRODUCTION, GENERAL PROBLEMS: The continuously increasing 
number of experimental data of the past ten to twenty years, 
as well as theoretical considerations, give us more or less 
the evidence that the macromolecular constituents both of the 
cytoplasm and the mitochondrial matrix are somehow organized. 
Let us only briefly refer to the observations concerning the 
existence of enzyme-enzyme interactions, multienzyme aggre­
gates, protein-membrane interactions, the microcompartmentation 
of metabolic intermediates etc./cf, 1-4 and references therein/ 
Beyond these, however, there are examples in which such 
interactions were not observed /cf. 5-7/. It is also a fre­
quently found discrepancy that interactions clearly demon­
strated kinetically could not be detected by ultracentrifuga­
tion method /cf. 9,10/. Reasons of this may be the rather high 
instability of these systems at least in vitro conditions, as 
well as their sensitivity to even small changes of environ­
mental factors /8/. Influence of such a technical factor as 
for instance the effect of pressure on the equilibria during 
ultracentrifugation /cf. 11/ may also be determinative. In 
short, the choice of the appropriate technique/s/ is one of 
the most important requirements of the successful detection.
For the analysis of macromolecular interactions in solu­
tion nowadays, the use of covalently attached fluorescence 
probes seems to be the most fruitful technique. This method 
has several advantages over others, such as the extreme sen­
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sitivity, the less time-consumption of the experiment compared 
to other techniques, the possibility to detect rapid changes 
/in stopped flow/ and above all its excellent suitability for 
quantitative analyses. These characteristics determined our 
choice to apply fluorescence methods, since we wanted to 
characterize the enzyme-enzyme interactions in quantitative 
terms.
AIMS: Our present aim is to compare the ability of cytoplasmic 
enzymes for interactions in phylogenetically distinct species 
/like a mammal and yeast/. Our attention is focused on 
fructose-1,6-bisphosphate aldolase /aldolase/ and the enzymes 
functionally related with it, namely glyceraldehyde-phosphate 
/GAPD/ and glycerolphosphate /GDH/ dehydrogenase, triosephos- 
phate isomerase /TPl/, phosphofructokinase /PFK/ and fructose- 
-1,6-bisphosphatase /F-l,6-Pase/. These enzymes participate 
directly in the production and conversion of triosephosphates, 
glyceraldehyde- and dihydroxyacetone-phosphate, which are 
common intermediates of at least the glycolysis, the 
glycerolphosphate-shuttle and the pentose phosphate pathway.
At a metabolic crossroad like this, the existence of certain 
mechanism which would control the proportion of the transform­
ing common intermediates towards various directions are pos­
sible. We assume that if such regulation exists, then this is 
based on the ability of the appropriate enzymes to form com­
plexes in a competitive manner. In such "functional complex­
es" the intermediate is directly transferred /channelled, 
cf. 13 and references therein/ to the "next" appropriate 
.enzyme. The competition of the "starting" enzymes of alterna­
tive routes to form complex with the enzyme producing the 
common intermediate will dictate the ratios of the actual 
metabolic fluxes. Our present experience suggests a dinami- 
cally organized assembly of enzyme complexes with a few 
participants rather, than a large "static"multienzyme aggre­
gate containing all the glycolytic enzymes /glycosome/. 
HOMOLOGOUS /SUBUNIT-SUBUNIT/ INTERACTIONS; The•susceptibility 
of the above mentioned enzymes /aldolase, GAPD.../ to form 
complexes with each other in a buffered system /standard 
condition: 0.05 M  Tris-HCl buffer, pH: 7.5 or 8.5, 20°C/ has
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been analysed with purified rabbit-muscle and baker’s yeast 
/Saccharomyces cerevisiae/ enzymes. However interpretation of 
the results was rendered difficult by the fact that some of 
these enzymes proved to be dissociable oligomers, as this was 
indicated by the enzyme concentration dependent characteristic 
change of their fluorescence anisotropy or specific fluores­
cence intensity of the fluorescence probes attached covalent­
ly to the enzymes. According to these observations yeast 
aldolase /22/ and muscle GDH /12/ exist in rapid dimer-monomer, 
while muscle GAPD /15/ in a rapid tetramer-dimer-monomer 
equilibrium in the range of 10-0.01yuM. On the contrary, 
tetrameric yeast GAPD /20/ and tetrameric muscle aldolase /17/ 
do not dissociate in the same concentration range in standard 
conditions.
In such cases if the specific enzymatic activities as 
well as fluorescence anisotropies were changed /muscle GAPD 
and yeast aldolase in Fig.l/ we concluded that the different 
oligomeric forms have distinct specific catalytic activity.
Fluorescence anisotropy ( • > )  Relative
i’IG.l The r.hanre of fluorescence anisotropy of mseié GAT'D /•/ and 
yeast aldolase /A //both enzymes labeled withal equivalent 
FITC/.ancl the change of relative specific enzymatic activities 
/open symbols/ as the function of their concentrations at our 
standard condition /see the text,at pH:7.rV. -H'or details see 
references/15,12»22/.5olid lines indicate computed curves as­
suming tetramer-dimer-mononer and dimer-monomer equilibria of 
GAPD/14,15/ and aldolase /2?/,respectively,with the dissocia­
tion constants given in Table I.
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T a b l e  I : S u m m a r y  o f  t h e  v a l u e s  o f  t h e  d i s s o c i a t i o n  c o n s t a n t s  
/ K  / ,  t h e  a s s o c i a t i o n  / k  /  a n d  d i s s o c i a t i o n  / k _ /  r a t e  c o n s t a n t s
o f  t h e  h o m o l o g o u s  / s u b u n i t - s u b u n i t /  a n d  h e t e r o l o g o u s  i n t e r a c  -  
t i o n s  o f  v a r i o u s  r a b b i t  m u s c l e / m /  a n d  y e a s t  / y /  c y t o p l a s m i c  e n ­
z y m e s  .  C o n d i t i o n s  a r e  p H : 7 . 5  o r  8 . 5 ,  0 . 0 5  M T r i s - H C l  b u f f e r ,
2 0 °  C .
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On the other hand, if anisotropy vs. enzyme concentration was 
constant /muscle aldolase and yeast GAPD in Fig.2/ and no
Specific activity 1°,^) kat/mole
300
150
0
— 8-
Fluorescence anisotropy (• , J
4-
•0.3
■0.2
0.1
-Ö -7 -6 -5
10 10 10 10
[m-Aldl (A)  or [Y-GAPD ] (o), M
FIG.2 The fluorescence anisotropies /• , */ and the specific enzyraa- 
tic activities /o ,A / of yeast GAPD /circles/ and muscle aldo-
lase /triangles/ measured at different enzyme concentrations at 
our standard conditions at pH:?« 5 and P.5 for aldolase and GAP," 
respectively. nie fluorescence probe, fluoreseamine was used 
since yeast GAPD labeled with PITO was 'completely inactive. For 
other details see references 22 and of. 17»2C,26.
change in specific activity was observed, then we concluded 
that dissociation of the oligomer does not occur. Otherwise 
these statements have been in good agreement with sedimentation 
velocity data referring to the non-dissociable character of 
muscle aldolase /23/ and yeast GAPD /20/, but indicating the 
dissociation of muscle GAPD /24, 25 and cf. 15/. Dissociation 
of dimeric GDH was also presented by ultracentrifugation /12/ 
and a rather good parallelism between the enzyme concentration 
dependence of the fluorescence anisotropy and specific 
enzymatic activity was found /Fig. 1. in ref 16/.
INTERACTIONS IN CYTOSOL: Any shift of the oligomeric equilibria 
of these enzymes may have regulatory consequences. Therefore 
we examined whether concentration dependences of the specific 
activities can be observed or not in a mixture of all the 
cytoplasmic enzymes, i.e. in a mixture which somehow mimics
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the macromolecular milieu of the cytoplasm. For this purpose a 
crude extract was prepared from-the disrupted cells by an 
appropriate centrifugation /100.000 g, 1 h/. The supernatant 
which contained the cytoplasmic constituents was occasionally 
filtered on a Sephadex column in order to eliminate small 
molecular-mass intermediates from the macromolecular components. 
The activities of the above mentioned enzymes were then 
determined at different concentrations of this "cytoplasmie- 
-like" macromolecular mixture and the specific activity vs, 
the dilution of the cytoplasm was calculated. The result was 
rather surprising since the specific activity even of the 
non-dissociable muscle aldolase and the yeast GAPD /in muscle 
and yeast cytosols, respectively/ showed a characteristic 
concentration dependence /Fig. 3./.
10* 103 « '  10'1 
Approximate dilution of cytoplasm
FIG.3 Chanres of the relative specific activities of rabbit muscle aldo- 
lase/o/ , yeast GAPD /x/ and rabbit liver GAPD / a / in cytosol as 
the function of the approximate dilution of the cytoplasm, at our 
standard conditions /pH :C. 5/. For details see reference /2?/ and 
the text.
A possible explanation of such changes is the dissocia­
tion of heterologous complexes during the dilution, since in 
purified form both aldolase and GAPD /muscle and yeast/ con­
stitute complexes with each other and alternatively with other 
enzymes /cf. Table I and the references therein/ too.
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We should like to note here that the characteristic 
decrease of specific activities- towards the high cytosol con­
centrations - indirectly suggests the - channelling of the 
intermediate/s/ in the enzyme complex. The added substrate 
seems to be transformed into product only by the free /non- 
complexed/ form of the enzyme, while the enzyme which is in 
the heterologous enzyme complex is-not or partially available 
for the external /added/ substrate. The time-while the initial 
velocity is determined in the stopped flow measurement /in 
several 20-40 milliseconds after-mixing the substrate with the 
cytosol/ - is too short for the diffusion of the substrate-to 
the active centre of the appropriate enzyme in the complex. 
Otherwise other possible reasons of such a decrease of the 
specific activities at-higher enzyme concentrations were 
carefully analysed /cf. 22/: i./ Activities were measured at 
substrate saturation and the substrate saturation curves were 
found to be Michaelis-Menten type even at high cytosol con­
centration. Moreover the values proved to be independent of 
the cytosol concentration, ii./ The absorbance changes at 
340 nm caused by side reactions after the addition of NAD+ to 
the cytosol were negligible compared to the change after mixing 
NAD++glyceraldehyde-3-phosphate+arsenate in the GAPD activity 
test, iii./ Initial velocities /in stopped flow/ were carefully 
determined from the very linear, initial part of the time 
curves where not more than 5 % of the added substrate had been 
transformed.iv./ The possible rate limiting effect of the diol- 
-aldehyde conversion of the gl yceraldehyde-3’-phosphate /cf.34/ 
at higher enzyme concentrations was excluded, v./ The rate 
reducing effect of the increased viscosity even at the highest 
cytosol concentrations where measurements were carried out was 
negligible.
In any case the concentration dependence of the specific 
activities seems to reflect the very complex relations both of 
the heterologous and homologous enzyme-enzyme interactions in 
this cytosol fraction. Such a complicated system is not an 
appropriate subject for a rigorous quantitative analysis, 
however, conclusions can be drawn from the measurements of 
interactions between pairs of purified enzymes.
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QUANTITATION OF HETEROLOGOUS INTERACTIONS; CONCLUDING REMARKS: 
Equilibrium and rate constants of complex formation and 
dissociation were calculated from the changes of specific 
fluorescence intensities /relative quantum yields/ and of 
anisotropy of the fluorescent probe, fluorescein isothiocya­
nate /FITC/, attached covalently to one of the enzymes analysed. 
As an illustration, the titration of yeast aldolase /labeled 
with FITC/ by unlabeled yeast GAPD or yeast PFK is presented in 
Fig.4. Similarly, the formation or the dissociation of the 
yeast aldolase-GAPD complex are shown in Fig. 5. Details of
unlabeled |Y-GAPD1I»°I or |Y-PFK]|ü ) .fJM
Í/IG.4- The titration of labeled yeast alclolo.se /O. Od /if:, containing 
^ 1 equivalent FITC/ with unlabeled yeast GAPD /circles/ or 
with yeast 1VK /triangles/ followed by measurin'" the chaiu-e of 
nnisotrony /dense symbols/ and the specific fluorescence /open 
symbols/ at our standard conditions / p l ! . V . Golid lines are 
computed curves assuming 1:1 stoichiometry of hindin;:; with dis­
sociation constants 0.2 and o.l yuH for GAI'D and ar.dolase, respec­
tively. ?or other details see reference /22/.
the calculations are given elsewhere /22/. Data summarized in 
Table I indicate that heterologous interactions are somewhat 
stronger /K’s are near 0.1 pM/ than homologous ones /K’s are 
near 1 juM/, however essential differences do not exist in 
yeast and muscle types of interactions. This similarity, but 
rather the observation that also hybrid interactions between 
yeast and muscle enzymes can appear In vitro /and the
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Fluorescence intensity(Arb.units)
FIG.5 The kinetics of the dissociation /o/ and the formation / A / of 
the yeast aldolase-GAPD complex followed by the change of fluor­
escence intensity at our standard condition at pH:8.5. The dis­
sociation kinetics was measured as follows:1.8 and 6 jiM aldolase 
/FITC labeled/ and GAPD, respectively were incubated for 10 min­
utes, then it was diluted 50 times and the change of fluorescence 
intensity recorded. Solid line is an exponential / e - / com­
puted curve with k_:0.45 min”^ .The dissociation kinetics was 
measured by mixing 0.09 JiM aldolase /labeled with FITC/ and 0.65 
/iM GAPD, and ^he change of fluorescence intesity was followed. 
Insert indicates the semilogarithmic plot of the reversible birao- 
lecular complex formation of aldolase/A/+ GAPD/G/ complex 
calculated with the K,:o.2 /iM /from Fig.4/.The slope of this plot 
is k+:1.4xl06 M^min . The ratio of k_/k+ :o.3 /uM is in good ag­
reement with the value of O.í^ liM determined independently from 
Fig. 4.
K values are also in 0.1 pM range!/ suggests the possible 
ancient origin of the organization of these enzymes in the 
cytoplasm.
The rate constants of the complex formation /k + : 10^-10J 
M ^min "V and that of the the dissociation /k_:10°-10 '’min-1/ 
show larger variability, but as a whole, all cases indicate 
rapid processes. This high speed of the transformation of 
enzyme complexes ensures-the flexibility of the system in 
regulatory responses /cf. 21/.
Although the effect of intermediates, pH, temperature 
and ionic strength on these enzyme-enzyme interactions has not 
been exhaustively examined.in all details, however, a few 
statements can be made /cf. 22/: i./ Intermediates seem to 
have an essential effect on homologous interactions, i.e. the 
presence of substrates or products /or both/ weakens the
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associative forces, ii./ increasing ionic strength has the same 
weakening effect, but iii./ the change of temperature /between 
10-25°C/ and the pH /between 6.8-8.5/ have no essential 
influence on these interactions.
The values of the dissociation constants of the enzyme 
complexes /determined in the absence of substrates, intermedi­
ates/ are near to the 0.1-1 juM range /Table I/, while the 
physiological "average" concentrations of the glycolytic 
enzymes are near to the 0.1 mM, so dissociation seems to have 
no significance in vivo. But the known ability of cell 
membranes and cellular particules to bind enzymes considering 
/cf. references in l/, the differences between K values and 
the "effective" concentrations of the appropriate enzymes 
become smaller. Moreover the above mentioned weakening effect 
of the intermediates as well as the rather high ionic strength 
in the cell also bring these two factors closer together. In 
short, dissociation-association dynamics may be important in 
the physiological effects at in vivo concentrations.
Finally let us consider the possible maximal size of a 
multienzyme complex in the cytoplasm. Mowbray, Moses and others 
/30-32/ have demonstrated an enormously large multienzyme 
aggregate, the glycosome, in E. coli cytosol, which contained 
all the glycolytic enzymes. Our experience does not provide 
such a big complex in yeast or in muscle cytosol, since we 
could never detect any of the glycolytic activities near the 
exclusion volume of our Biogel A 5M column in the cytosol 
preparations /corresponding to Mr ~>2 million/, only in the 
cases if our preparations contained contaminating cell 
particles or disruption fragments. However, in cytosols, free 
from these particles, we have never found any glycolytic 
activities in this extremely high molecular-mass elution region. 
But even if such a large complex exists, this in itself would 
not answer the question how the alternative transformations of 
the intermediate/s/ are regulated. From the standpoint of 
regulation such a large "static" complex is equivalent to a 
non-associated, densely packed system. On the other hand, the 
comparable dissociation constants /cf. Table 1/ of the 
heterologous complexes of aldolase with its functionally
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related enzymes suggest the chance of a competition among 
these enzymes to form distinct complexes with aldolase. The 
direct transfer /channelling/ of the intermediate/s/ can occur 
in these complexes into different directions and reorganiz­
ation of the complexes will determine the changes in the 
ratios of the fluxes. Unfortunately an experimental demonstra­
tion of the competition of GDH and GAPD was not successful, 
since the two dehydrogenases proved to form complex with each 
other too /not published/. However recently Ovádi /personal 
comunication/ succeeded in finding competition betwe.en TPI and 
GAPD /muscle enzymes/ in the alternative formation of com­
plexes with aldolase.
SUMMARIZING A dynamically organized assembly of alternative 
complexes of aldolase and enzymes functionally related to it 
is assumed to govern the transformation of triosephosphates in 
various directions. Regulation of these fluxes would occur by 
channelling of the intermediates in these complexes. The flex­
ibility of the system, via the chance of fast reorganization 
of the enzyme complexes, may be the base of an efficient 
regulation. The interaction of these enzymes can be considered 
as an ancient characteristic of the cytoplasm, Since it is 
common in phylogenetically distant species like the yeast and 
a mammal.
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DISCUSSION
KACSER:
I would like to know whether there is a common definition 
of "channelling". It seems to me that different people use 
different definitions not simply different methods.
BATKE:
Channelling (perfect, leaky, etc.) means certain kinds of 
mechanisms having functional importance in order to more 
or less avoid the diffusion of the intermediate into the 
bulk medium. Beside indirect evidences there is one di­
rect method for the experimental verification of channel­
ling, the isotope dilution technique.
SRERE:
Channelling of a substrate occurs if that substrate (in­
termediate) is out of diffusion equilibrium with the bulk 
medium.
I think in relation to Ovádi's work the separation of 
leaky vs perfect channelling is not useful for it de­
tracts from the important point that specific protein- 
protein interaction occurs.
BATKE:
I agree with the definition of channelling.
DYNNIK:
I agree with Professor Kacser. If a whole system might 
operate as a cluster, its regulation (control) would be 
inflexible, owing to the low number or independent vari­
ables, the disappearance of a number of feedback loops 
and the drastical changes in the control coefficients. 
Referring back to the tricarboxylate cycle, we see that 
such a system with multiloop control behaves as a closed 
segment (from CS to SDH) as if this segment is spatially 
separated from the rest of the mitochondria, or is orga­
nized in a multienzyme complex.
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At the same time, some parts of various metabolic path­
ways may operate as cluster complexes. It has been shown 
in the laboratory of Professor B. Hess, that the sum of 
the total intermediates in the intact yeasts is several 
times lower than that in the extracts. Such experiments 
may give further in vivo - in limbo support for the re­
sults presented by Dr. Batke, about the organization of 
these complexes.
BATKE:
Thank you for your comments and suggestion.
MANNERVIK:
It is known that many proteins are composed of more than 
one domain and it appears that in eukaryotes they may 
sometimes be encoded in separate exons in the genome. 
Further, some proteins are multifunctional enzymes with 
two distinct active sites catalyzing different reactions. 
It seems conceivable that some enzymes may nave been 
evolved by gene duplication to form a bifunctional poly­
peptide chain with two separate catalytically active 
domains, the coding DNA sequences of which were later 
separated by introns or otherwise. If so, this evolution­
ary process might be reflected in the genomic structure 
so that the genes of some of the enzymes, that interact 
and express channelling, would be adjacent on the chromo­
some. In other words, this would explain the association 
of heterologous protein subunits as a vestige of domain 
interactions in a common ancestral protein. My question 
is whether there is any information about the organisation 
of the genes of the enzymes that we are discussing.
WELCH:
In response to Dr. Mannervik's question, the glycolytic 
enzymes in bacteria, generally, are not encoded by con­
tiguous genes on the chromosome. There is no direct cor­
relation between gene-contiguity and protein-complex for­
mation, except for the case of "multifunctional proteins"
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(which represent single polypeptides with multiple catal­
ytic active sites).
FRIEDRICH:
Pertaining to Dr. Kacser's problem of our definition and 
detection method of "channelling" of metabolites, I think 
we all agree that "channelling" is the direct transfer of 
metabolite from one enzyme to the other without mixing in 
the bulk medium. It is another question how we can demon­
strate such a phenomenon. In fact, there are several ways 
of doing that, but each approach has certain limitations. 
A compilation of these can be found in my monograph enti­
tled "Supramolecular Enzyme Organization" Akadémiai Kiadó 
- Pergamon Press, 1984.
EASTERBY:
Particularly in vitro one may quantify the effects of 
channelling by comparison of measured transient times 
with those expected from the known properties of the 
isolated enzymes.
BATKE:
Thank you for the comment.
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MODEL DISCRIMINATION. CONDITIONS WHEN THE CORRECT MODEL CAN 
BE IDENTIFIED FOR TRANSIENT, STEADY-STATE AND BINDING DATA
W.G. BARDSLEY
Department of Obstetrics and Gynaecology,
University of Manchester, at St. Mary's Hospital,
Whitworth Park, Manchester, M13 0JH, UK
1. INTRODUCTION
A common problem is where experimental measurements, y, are observed 
with some control variables, x, and it is believed that a functional 
relationship of the form
yi = fj (xi»0) + ei (*)
exists. Here e is the error, 9 is a vector of parameters to be estimated
and fj is the correct model from a set of possible models
f = (f.,f„,...,f ). When f . is a linear model and e = (e..en9...te ) is ' 1 2 ’ ’ m 7 2  j ' 1 ’ 2 ’ * n'
distributed as N (0,I^y ) then exact small sample results are possible 
(Draper and Smith, 1981) but this is seldom the situation encountered in 
the biochemical laboratory as the models f . are usually non-linear. Such 
non-linearity of f^  has been considered by Beale (i9 6 0 ), Box (1 9 7 1 ) 
and Bates and Watts (l980).
If the correct model is known, then the statistical properties of 
estimates, the redundancy of parameters and the design of experiments to 
ensure economical use of data have been summarised by Endrényi (l98l). 
However, there are many situations when a choice of the appropriate model 
f has to be made either by an examination of residuals or by comparing 
relative goodness of fit with possible alternative models. This subject 
has not received so much attention.
With linear models, the variance ratio tests for goodness of fit and 
relevance of parameters have optimum properties and are widely used. 
Pettersson and Pettersson (1970) suggested using the F test to fix the 
empirical rate equation for steady-state enzyme kinetic models but did not 
consider the effect of non-linearity. When multiple linear regression
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models are being investigated, the control variables can often be fixed 
experimentally in such a way that the relevance of any sub-set of 
coefficients can be tested. However, with non-linear models, a design 
matrix cannot be manipulated in this way and the law of diminishing returns 
operates. As further parameters are added to the model, the ability of any 
statistical test to detect new coefficients rapidly becomes limited. In 
this paper I shall attempt to bring these problems into sharper focus.
2. THE DETERMINISTIC MODELS
Often biochemists deal with systems where concentrations of species,
X say, are observed as functions of time, t, and rate constants, k, are 
involved in functional forms such as F(X,dX/dt,k,t) = 0. Regression 
analysis of such stiff systems of non-linear differential equations can be 
achieved using, for example, Gear's method, but the drawbacks are the need 
for good starting parameter estimates, expense in computer time and 
frequently unreliable estimates of k since the equations can be rather 
overdetermined. Sometimes the system is, or can be, manipulated 
experimentally to become autonomous and linear with square matrix A as in
dX/dt = AX. (2)
Thus we have transient kinetics, pharmacokinetics, denaturation of 
macromolecules or time dependent inhibition of enzymes. Another procedure 
is to study the zero eigenvalue solution i.e. the pseudo-steady-state, 
leading to positive rational functions of the form
v/Eo = P(X)/Q(X). (3)
An even more extreme example is where t -» oo or when a rapid equilibrium 
is assumed,for then all of the saturation behaviour, y, of the system can 
be obtained from the binding polynomial N(x) as in
1 d lp& N(x) , ,
y " n d log X v '
Now statistical tests for model discrimination require that the 
number of degrees of freedom in the deterministic equation be defined and 
so we had better be clear what is involved in this. Generally we have a 
vector of coefficients 0, each component, 0^ , being a function of some 
directed trees, t, which are functions of rate constants, k. Also there 
will be constraints such as F(k) = 0 due to microscopic reversibility,
G(t) = 0 caused by degeneracy or H(0) = 0 resulting from boundary 
conditions etc.
2 6 8
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t± = ^(k) ; i = 1,2, ...,m
9^  = ß^ (t) ; i = l,2,...,n
ki = 7i^ k  ^ 5 1 = 1’2>-‘’>n
and the restrictions F, G and H lead to dim(k) = 1^ , dim(t) = and
dim(e) = nQ, then the number of degrees of freedom of eq.(l) will be the
rank of the Jacobian matrix J„, = ("öy./^k.).V \ j/ J'
Since J„, = J J.y aß
then rank J., ^  min (rank J -rank J„)y v a’ ß'
^ min (l ,m ,n ) $ min (l,m,n).
3. STATISTICAL TESTS FOR MODEL DISCRIMINATION
Most methods for fitting eq.(l) to experimental data involve 
optimisation where the objective function is the p-norm of a residual 
vector r, i.e. Í 2  h i  I p ] 1/p- Minimising the 1-, 2- or oo -norms are 
equivalent to maximising the likelihoods if the error is distributed bi- 
exponentially, normally or uniformly respectively.
Maximian likelihood parameter estimates have well known asymptotic ^  “1properties, i.e. 0 'vN(0,(nBo) ),where B is the information matrix, and
a likelihood ratio test can be constructed (Keeping, 1962; Silvey, 1975). 
If the test is to discriminate between
H : f. is the correct model (and f . , is correct since f. c f.
0 J v J+1 j  J+17’
H. : f. _is the correct model but f . is incorrect,
1 J+1 J ’
then the likelihood ratio will be
max L(f . )
1 - 1+1 ^ max L(f.)
'  J
where L(f .) is the likelihood function restricted to model f. and L(f . )
J7 J V J+17the likelihood under model fj+ .^ The test would be chosen, if possible,
to reject when 'X >• c where
P( X > c |Ho) = a
a being the size of the Type I error. If model f. has m. degrees of
J Jfreedom and gives a sum of squares Q. with n data points then the test 
statistic
If 9 — (9^,0^ , • öjj) > t — (t^, t^, • • • » ■fc^) and k _ (k^jk^,•••,k^) but
F.3 ( 5 )
(yViVí-yr^)
V i 7 ^ m  • 7 T  3+1
is distributed as F(m. .-m.,n-m. .) for linear models under H (Lindgren, 3+1 3 3+1 o
1976). With non-linear models the statistic (5 ) will be approximately F
distributed if the non-linearity in f^  and f  ^is not too great. Also a
large value for F would be strong evidence for the superiority of model
j+l against model j. So it seems worthwhile then to see how such an
uncorrected statistic is distributed with the sort of models and data
encountered in biochemistry.
4. THE F TEST. THEORETICAL CONSIDERATIONS
Suppose that we fit models f . and f . . with m. and m. , degrees ofF J 3+1 3 3+1
freedom to n data points giving the weighted sumsof squares and Q.+^
where n 2
Qj = §  wi íyi - fj •
If f^  c. f  ^in the sense that restricting parameter values in fj+  ^yields
^  then, under H^ , F^ of eq.(5) will be approximately F distributed but
under H., F. will be inflated. If f .et f . . then it is also possible for 1 3 3 ' 3+1
F . to become negative as we shall see later.3
With simple Eq and simple we can define the sizes of a test, a and 
ß, in terms of the probability of a test statistic falling in a critical 
region under Hq or H^ , and thus leading to Type I or Type II errors. With 
composite hypotheses there is the power function,! | (8 ), defined as the 
probability of rejecting Hq as 0  varies, using a specified test statistic. 
Clearly the F test could be used in model discrimination even though the 
size might not be known accurately as long as the power could be shown to 
be high on H ,^ low on Hq and understood as a function of 0 , the parameters 
of the model.
Considering the form of the numerator of eq.(5) it is natural to 
investigate the distance measure
OO
Q = J  £ fj(x,0 ) - fj+1 (x,0 )^ dx (6)
where 0  is the actual parameter set for the correct model f a n d  0  is
the estimate obtained for the deficient model f .. Q as defined by eq.(6 )3
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is a function of 8 only since it has been minimised with respect to 8. So 
by varying 8 the conditions under which model f can i)e discriminated 
from f. can he explored. Some results from the application of this 
technique will he presented shortly.
5. THE F TEST. COMPUTER STRATEGY
To extend this type of analysis to higher order cases we have to
generate data using known parameter values, add error according to some
specified distribution, calculate Q. and F. values along with 0 estimatesJ Jand then attempt to analyse the sampling distributions generated.
I have put together a software package to create, then add error 
repeatedly to an exact data set. Regression analysis is performed in 
sequence to a hierarchy of models, estimating parameters, covariance 
matrices and weighted sums of squares. Then F statistics are accumulated, 
probability integral transforms applied and Kolmogorov-Smirnov and chi 
squared tests used to test Hq: the transforms are uniform on (0,l). It 
uses NAG routines C05AZF, E04HBF, E04JAF, E04JBF, F01ABF, F02AAF, G01BAF, 
G01BEF, G01BCF, G01CBF, G05DDF, G05DYF, G08CAF, M01ANF and S14AAF.
6. THE F TEST WITH EXPONENTIAL FUNCTIONS 
Eq.(2) leads to the deterministic equation
j
fj = ai exP ( *) (7)
i=l
which is one of three distinct types (Bardsley et al, 1986).
a) Matrix A is diagonal
When a system is uncoupled, as for instance when n distinct, 
independent first order processes take place, the a^  are constants, 
independent of the In the case of 1 or 2 components, Q of eq.(6)
increases monotonically as the rate constants separate as illustrated 
in figure 1.
b) Matrix A is not diagonal
When several species are interconnected in sequence, the a^  and 'X j 
of eq.(7) are not independent. They are all functions of the rate 
constants. For 1 or 2 components, the Q of eq.(6) decreases 
monotonically as the rate constants separate as illustrated in figure 2.
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-2 0 2 A
log 010
Fig. 1. Q defined by eq.(6) for f. = X^(t) and f = ^ (X^^+X^t)) 
■with a parallel uncoupled scheme. The Q(0) and ^ 0(0) profiles 
can be established analytically (Bardsley et al, 1986) but the 
values shown were calculated using NAG routine GO2AEF.
c) The generating scheme is cyclic
When this occurs, the eigenvectors and eigenvalues are again 
dependent. A new feature is that the characteristic polynomial can have 
non-real zeros. For a simple cyclic scheme, Q of eq.(6) attained a 
maximum value when matrix A had non-real eigenvalues and the time profile 
was a damped oscillation as shown in figure 3- The discriminant of the 
characteristic polynomial for this cyclic scheme is 0(0+4) and so damped 
oscillations occur when -4 <0 <0.
A simulation study was undertaken to see if the principles found to 
apply with these simple schemes were relevant with higher order models.
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- 2 0 2 A
1 og 010
Fig. 2. As for Fig. 1 with = C(t), fj = B(t) hut = 0.
-A -2 0 2 A 6
0
Fig. 3. As for Fig. 1 with f  ^= X(t), f = X(t)butYandZnode compressed
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Computation supported these predictions with more complicated schemes 
(Bardsley et al, 1986). We studied 4 types of data with 15 logarithmically 
spaced points as follows:
i) 2.5$ relative error, range of 5 -95$ of f(t) covered,
ii) 5.0$ relative error, range of 10-90$ of f(t) covered,
iii) 7.5$ relative error, range of 15-85$ of f(t) covered,
iv) 10.0$ relative error, range of 20-80$ of f(t) covered.
The kj values in an example of scheme (a) were varied until the power of 
the F test was high. As shown in figure 4, the ratio had to
increase as the order of the model increased to identify correctly the 
number of relaxing components. The time scale increased steadily as the
Number of exponentials
Fig. 4. Vertical hars represent transition regions where the power 
function of the F test became high using a critical region 
defined by the 99$ F point. The indications (i), (ii), (iii) 
and (iv) refer to the data structures defined in the text. The 
deterministic equation was for parallel, uncoupled first order 
processes as in figure 1. The power was high above the vertical 
bars, low below them. The F test failed beyond terminated lines.
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number of parameters increased. Similarly the values of scheme (b) 
were varied until the power of the F test was high. As shown in figure 5
2 3 U
Number of exponentials
Fig. 5. Details as for Fig. k, except that the deterministic equation 
was for a consecutive, coupled series of first order processes 
as in figure 2. The power was high below the vertical bars, 
low above them.
the ratio of k. ,/k. had to decrease as the order of the model increased l+r l
to identify the number of relaxing components correctly. The time scale 
altered very little as the number of parameters increased. With the 
data structures of (i) and (ii) it was possible to detect up to four 
exponentials but with (iv) only two could be reliably detected. The 
seeming anomaly, that rate constants had to come close together to be 
detected, can be easily rationalised by considering what happens if 
any step in a consecutive scheme becomes rate-limiting.
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7. THE F TEST WITH POSITIVE RATIONAL FUNCTIONS
When only one substrate is varied, the steady state solution of 
eq.(3) can be written as
f . J
jE
i=l
e. xi / (i
2jE
i=j+l
0. xl i-J)• (8)
Equation (8) has 2 j independent parameters and the equation for the model
E ESn
can he expressed with just 2j parameters IL ; i=l,2,...,j and
; i=l,2,,,.,j to equal any set of 0^  ^  0, Hence no statistical test 
could ever indicate a mechanism more complex than this one (Bardsley,
1983)« As the degree j in eq. (8) increases, a number of facts can be 
established by analysis or computation.
i) The number of possible curve shapes, fj(x), increases rapidly since 
multiple inflexions and turning points can occur (Bardsley and Wood, 1985).
ii) The maximum complexity in terms of such geometric concepts as 
sigmoidicity or turning points can be understood by constructing extreme 
examples (Bardsley and Wright, 1983; Bardsley et al, 1983). Study of 
these limiting examples as j increases shows that the relative difference 
between consecutive members decreases rapidly as j exceeds 2.
iii) Although simulation shows that complex profiles are possible 
(Wardell et al, 1982) nevertheless most examples will look much like 
second order curves over physiological ranges of substrate concentrations 
with chemically reasonable rate constant values.
iv) It is easy to detect second order terms by the F test and third 
order terms can often be identified. However, fourth and higher order 
terms are extremely difficult to detect (Burguillo et al, 1983).
v) The test statistic for j=l and 2 is distributed very much like an 
F variate.
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8. THE F TEST WITH SATURATION FUNCTIONS
When the deterministic equation is eq.(4), or a scalar multiple of it 
as in dose-response curves, analysis is particularly easy. Thus for N, a 
binding polynomial of order n, we use the form
2 nN = 1 + K.x + K x +...+K x1 2  n
for curve fitting hut
N = 1 + (l )01X + (2) ei92x2+” -+eie2--*enXn
for theoretical discussion, the connection between 0 and K being
j K ie. = 7— --rri-- , k = 1.J (n-j+l) K o
The ratios 0. ,/0 . have been of interest since they define the intrinsic 
J + l  j
cooperativity of the system as opposed to the apparent cooperativity 
defined by the Hill slope (Bardsley and Waight, 1978).
At this point it should be emphasised that the saturation functions 
of order n > 2  are disjoint. They do not belong to a hierarchy such as 
f^ d  fg d  fj ... C f ^  since by selecting specific 0^ values we cannot 
pass from f t o  f^ except for j=l. To do so would require that two 
polynomials p(x) of degree n and q(x) of degree m satisfied 
m p'(x) q(x) = n p(x) q'(x)
for all x. This is only true when p(x) and q(x) are powers of some
polynomial r(x) of degree d where (m,n) = d. Hence it is possible for
the constrained sum of squares Q. for the correct model f . to be less
J 1
than the unconstrained sum of squares Q . . even though model f has
J+l ^  J+l
more degrees of freedom than model f . This frequently occurs when 
fitting saturation data and is not necessarily a deficiency in the 
optimisation routine.
To apply the method leading to eq.(6), consider data with y(l)=l/2 
for all 6enerated by the true model f(x) defined by
J 0,/0„ x + x2
f(x) = -------■— =--- — g- (10)
1 + 2 x + x
and let the false model g(x) be fitted where
g(x> = F T T  (n)
and 6 is chosen to minimise
Q (12)
As figure 6 shows, a unique value of 6 minimises Q and also Q=0<==> 6^=0^.
Fig. 6. Q defined by eqs.(6) and (12) with the saturation functions of 
eqs.(lO) and (ll). The Q(0) and'©'(o) profiles were calculated 
using NAG routines C05AZF and D01AMF.
For positive cooperativity Q increases monotonically to an asymptote 
but Q increases without limit as the intrinsic cooperativity becomes 
increasingly negative. Hence the cases 0^ > 0^ and 0^ < 0^ are not 
symmetrical and we could say that it is easier to detect negative than 
positive cooperativity. This can be rationalised when it is realised 
that 0£ > 0^ generates a family of curves that rapidly approach a curve 
of maximum sigmoidicity whereas 0^  < 0^ gives a long slow approach to 
the asymptote y(oo)=l.
The power of the F test and the distribution of the test statistic 
have been studied by computation using 15 logarithmically spaced points
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for yC^) = 0.05, y(xn ) = °*95 ■with %  constant relative error. Figure 7 
shows estimates of the power as a function of for the cases n=2,3,4 
and 5.
log { d . / Q , )
10 L
Fig. 7. Power functions for the deterministic eqs.(4) and (9). Sample 
size was 20 (O) or 100 (•). For the cases n^3, ®j=®2 ^or 
j=2,...,n. The null hypothesis, Hq: model j is correct, was 
rejected when the test statistic F^  of eq.(5) exceeded the 95$ 
point of the appropriate F statistic. From the top downwards 
the true models were n=2, n=3, it=4, then n=5.
These figures show that n=2 is almost an ideal power curve. The cases 
n=3,4 show how the cusp widens with increasing numbers of parameters and 
for n=5 the cusp has become very wide and asymmetrical. Hence the second 
order term can be easily identified, third and fourth order terms are 
increasingly difficult to identify and fifth order terms can only be 
detected when the parameter values are very widely separated.
Estimates for the distribution of the test statistic are to be found 
in table 1 for values of the parameters 8. on the edges of the cusps in the 
power functions. When fj is the correct model it often happens that
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TABLE 1« Distribution of F test statistics for saturation functions*
Order of
true model D P(>D) c P(>C) S(95) F(95) S(99) F(99)
1 .07 .67 13 .16 3.64 4.67 8.82 9.07
2 (a ) .12 .09 9 .44 3.93 4.75 9.40 9.332(b) .15 .03 11 .26 4.98 4.75 9.76 9.333 .17 .01 21 .01 4.16 4.84 7.83 9.654 .51 .00 204 .00 2.33 4.96 8.63 10.00
H^: probability integral transform is uniform on (0,l) 
Sample size = 100
D - Kolmogorov Smirnov statistic
P(> D) - probability of exceeding D
C - Chisquared statistic
P(>C) - probability of exceeding C
S(95)> SÍ99) - average of boundary points for 95% and 99% class intervals
F(95), F(99) - F statistics for the appropriate degrees of freedom
1 , »1 = 1.0
2(a), 9 1 = 0.5 , 0 2 = .28
2(b), 9 1 = 0.5 , e 2 = .89
3 , 6 1 = 0.33 , e 2 = = 3.334 , 6 1 = 0.25 , e 2 = = e 4 = 2500
Data: 15 logarithmically spaced points between y ^ )  = 0.05, y(x ) = 0.95 
with 5$ constant relative error.
Q_.+1 > Q . so i n  p e r fo rm in g  th e  p r o b a b i l i t y  i n t e g r a l  t r a n s fo rm s  F .  was s e t  
e q u a l to  z e ro  when t h i s  o c c u r re d .  The c h i  sq u a re  t e s t  and a ls o  c o m p a riso n  
o f  th e  p o in t s  s e p a ra t in g  95$ and 99$ c la s s  in t e r v a ls  o f  th e  s im u la te d  
s t a t i s t i c s  w i t h  th e  t h e o r e t i c a l  95$ and 99$ F v a lu e s  showed good a g reem en t 
be tw e en  th e  t e s t  s t a t i s t i c s  and th e  a p p ro p r ia te  t h e o r e t i c a l  F d i s t r i b u t i o n .  
The K o lm o g o ro v -S m irn o v  t e s t  has h ig h e r  pow er and i t  showed some e v id e n c e  
f o r  skewness t o  th e  lo w e r  end o f  th e  F d i s t r i b u t i o n .
9. CONCLUSIONS
T he re  a re  no e x a c t  s m a ll sam ple  t e s t s  f o r  m odel d is c r im in a t io n  w i t h  
n o n - l in e a r  m ode ls  h u t  i n  t h i s  p a p e r I  have a rg u e d  t h a t  th e  F t e s t  can  he 
used  w i t h  b io c h e m ic a l m od e ls  even  th o u g h  th e re  a re  c o m p lic a t io n s  and  th e  
s iz e  i s  n o t  known a c c u r a te ly .  The F t e s t  has h ig h  pow er i n  d is t in g u is h in g  
tw o  e x p o n e n t ia ls  fro m  o ne , a second o rd e r  r a t i o n a l  f u n c t io n  fro m  a 
h y p e rb o la  and i n  d e te c t in g  tw o o r  th re e  b in d in g  s i t e s .  I n  th e s e  
c irc u m s ta n c e s  th e  t e s t  s t a t i s t i c s  behave v e r y  much l i k e  F  v a r i a t e s .
I f  d e n se , a c c u ra te  d a ta  o v e r  a w id e  ra n g e  can  he r e a l i s e d  th e n  th e  
pow er o f  th e  F  t e s t  can  be s u f f i c i e n t l y  h ig h  to  d e te c t  f o u r  e x p o n e n t ia ls ,
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a fourth order enzyme kinetic model or four binding sites. In order to 
detect models more complicated than these it is necessary for experimental 
data to be of a very high quality and for the true parameters to have 
extreme values, outside of the critical regions described in this paper.
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DISCUSSION
ENDRÉNYI:
The distance measure Q integrates from 0 to infinity and, 
therefore, aims at discrimination over the whole sample 
space. Would the results be different if discrimination 
were restricted to a region of interest to an investiga­
tor, such as the design measure 1 which integrates from 
x^  to x2?
In the scheme of consecutive reactions, the subsequent 
rate constants increase in magnitude in the demonstrations 
shown. This means that intermediate products are depleted 
as soon as they are formed, and that the first reaction 
dominates the scheme to an extent which increases with 
larger ratios of consecutive rate constants. Would the 
results be different if the rate constants of the earlier 
reactions were higher and the intermediate products had 
opportunity to accumulate?
BARDSLEY:
You are quite correct to point this out. The range from 
zero to infinity was used in the integrations for anal­
ytical convenience. However, I had in mind a dedicated 
worker obtaining data over a time interval covering most 
of the span of total response. So integration over a time 
range spanning say 5 % to 95 % of the vertical scale of 
response, would give a very similar result to that ob­
tained for the interval zero to infinity.
Actually all of the schemes that I considered were sym­
metrical with respect to permutation of the rate constants. 
I deliberately chose initial conditions and compartments 
sampled so that the deterministic equation, had this sym­
metry with respect to the interchange of rate constants.
So the rate constants could not be described as either 
increasing or decreasing in a geometric progression.
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CORNISH-BOWDEN:
In considering consecutive reactions you appeared to be 
assuming that you could only measure the appearance of the 
final product. In practice, however, spectroscopic methods 
are often available that allow one to observe intermedi­
ates as well. When this is true one has considerably more 
information available to determine the number and param­
eters of exponential terms. Also, in this case, monoton- 
ically decreasing rate constants will lead to more tract­
able results than monotonically increasing rate constants. 
As a separate point, I was disappointed that you dismissed 
half a century of development of distribution-free methods 
and about a decade of development of robust regression 
methods when you said that you need to know the error dis­
tribution in order to discriminate between models. Although 
model-discrimination techniques in the context of robust 
regression are in their infancy, I cannot agree that model 
discrimination is impossible without knowledge of error 
distribution, and I am sure that in the future these 
methods will improve.
BARDSLEY:
Of course it matters very much which compartments are 
sampled. A consecutive, reversible, first order, topo­
logically linear scheme, dX/dt=AX, has real negative 
eigenvalues and has a matrix, A, that can usually be 
diagonalised. So we can then find a real invertible ma­
trix, P, and make the transformation Y=PX. Then the 
scheme becomes dY/'dt=DX, where D is diagonal and has the 
same eigenvalues as A. Now the physically observed recip­
rocal relaxation times are not always rate constants, 
but they are always the eigenvalues. I have demonstrated 
that sampling the last compartment in such a scheme leads 
to higher power in the F test as the eigenvalues come 
closer together i.e. the condition number of A approaches 
unity. However Y=PX corresponds to a specific linear com­
bination of the signals measured in all compartments.
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With this particular linear combination the system is un­
coupled and, by my earlier argument, the power of F test 
will then be high as the eigenvalues separate.
So I have drawn attention to two extreme possibilities and, 
in any given experiment, the power of the F test as a 
function of the eigenvalues will depend upon the precise 
combination of compartments sampled.
You have misunderstood my attitude as I didn't intend to 
dismiss robust methods. There are experiments involving 
expensive reagents, or even human subjects, where only a 
limited quantity of data of poor quality is available.
Here robust methods come into their own. I have in mind 
a determined experimenter who has gone to a lot of trouble 
to prepare good reagents and who is prepared to measure 
sampling variance. If the covariance matrix of data is 
known with reasonable accuracy, then a likelihood ratio 
test will have higher power than a robust method. Of 
course, if the error is not normal, the L2 norm and F test 
would not be appropriate and other objective functions and 
test statistics would be required. I only claim to have 
identified constraints on parameter values and limitations 
imposed by data quality in order for the power of the F 
test to be usefully low on Hq and high on .
Robust tests for model discrimination in a hierarchy of 
models can, in any case, only be evaluated and compared 
with likelihood ratio tests when such methods become 
generally available.
EASTERBY:
I think you have proved what I suggested intuitively 
yesterday. Namely that when you have a sequence of ex­
ponential processes, as in a coupled enzyme system, you 
can only gain useful information by measuring end-product 
if you add all enzymes in proportion to their K^'s. Then 
the coefficient matrix has a single eigenvalue of multi­
plicity n and the equations can be normalised. Normally 
the equations are symmetrical with respect to transient
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times and the order of enzymes in the sequence has no 
kinetic consequence for product formation.
BARDSLEY:
If the equations are correct then I don't see why you can 
only gain useful information in the singular case. Don't 
forget that in this singular case of coincident eigen­
values the approach to the steady state is determined by 
a polynomial in time multiplied by a single exponential.
As time increases, the polynomial increases thus balanc­
ing the decreasing exponential and this is the reason why 
the relaxation time is greater than that for the single 
experimental term alone. I see no difference in analysis 
of data treatment whether the eigenvalues are coincident 
or not. It is true that for coincident eigenvalues the 
entire behaviour has only one degree of freedom in that 
there is only one rate constant. Nevertheless, the scheme 
is not topologically first order (i.e. 2 compartments) it 
is still topologically of order n-1 (i.e. n compartments).
SLUSE-GOFFART:
When an equilibrium-binding curve exhibits jumps (the 
data are supposed to be reliable and jumps reproducible), 
the number of inflexion points imposes a minimum degree 
to the Adair's equation. In such a case, a degree higher 
than 4 could be evidenced. This is the case for the ex- 
ternal-oxoglutarate binding to its translocator in rat- 
heart mitochondria.
BARDSLEY:
The jumps to which you refer may well be highly reproduc­
ible. They may therefore contain all sorts of useful in­
formation about the mechanism. What is in doubt is whether 
they can be used to support a high order Adair type of 
model. I don't think you can use arguments based upon the 
number of inflexion points to achieve this aim. You may 
be able to convince yourself this way, but to convince
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anybody else you will have to use statistical methods.
The advantage of such an approach is partly that every­
body will get the same answer, whereas nobody will ever 
agree to the number of inflexions. Another reason is that 
a computer fitted curve proves that the mechanism can 
actually fit the data. Furthermore it yields parameter 
estimates that can be examined in the light of chemical 
commonsense.
SLUSE-GOFFART:
If common sense tells us that the jumps are actual struc­
tures, we must take them into account. The particular 
case of the oxoglutarate translocator could be discussed 
after my lecture.
BARDSLEY:
Perhaps we can discuss this after your talk.
ENDRÉNYI:
Cornish-Bowden and Koshland in a paper published in Bio­
chemistry around 1970, inserted a footnote. This consider­
ed a set of binding experiments in which the binding curve 
showed a masked depression around the binding of the 
second out of 4 ligands.
The authors noted that if an F-test analyzing the entire 
binding curve was performed, the models with and without 
the depression in the binding curve could not be dis­
tinguished. Therefore the question was raised whether 
discrimination should be applied to the whole experiment 
or only within the experimental region of interest? In­
tuition would suggest the latter. However, formal pro­
cedures are not available for deciding this question.
CORNISH-BOWDEN:
Dr. Endrényi is referring to a paper in which Dan Koshland 
and I were examining a paper of Anderson and Weber in 
which they claimed to have observed a highly "kinked" sat­
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uration curve in fluorescence measurements for lactate 
dehydrogenase (Cornish-Bowden, A. and Koshland, D.E.jr., 
1970. J. Biol. Chem. 245, 6241-6250; Anderson, S.R. and 
Weber, G. 1965. Biochemistry, _4, 1948-1957). We applied 
an F test to the entire curve that appeared to show that 
the kinked line drawn by Anderson and Weber did not fit 
significantly better than a smooth curve obeying a 4th 
degree Adair equation. However, after receiving Weber's 
comments on a preliminary draft of our paper, we included 
a footnote conceding that an F test applied to the entire 
curve might be misleading and that one really ought to 
examine the significance of the kinked region of the curve 
in isolation from the rest of the data. For the record,
I should add that our actual calculation of the F value 
was incorrect, though this does not affect the general 
point in relation to today's discussion.
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PARAMETER ESTIMATION BY UNWEIGHTED AND WEIGHTED LEAST SQUARES
Parameters of kinetic models are frequently evaluated by nonlinear 
regression, a procedure based on the principle of least squares. This 
aims at selecting those model parameters which minimize the sum of 
squares (SS), the sum of the squared differences between the observed 
responses (reaction velocities) and those predicted by the model.
The approach has a variety of theoretical and practical advantages 
[1-4]. With asymptotically large numbers of observations, the calculated 
parameters are accurate and precise or, in statistical parlance, unbiased 
and efficient. This means that the errors of evaluating the parameters 
average to zero, and therefore that the estimated parameters average to 
their true but actually unknown value; also, that their variation (ex­
pressed by their variance or standard deviation) is as small as possible. 
Furthermore, asymptotically, the calculated parameters follow the normal 
distribution.
These favourable properties are preserved to a large extent at 
moderate sample sizes. However, they imply that the assumptions behind 
the least-squares approach are fulfilled. These include the belief that 
the model being considered is in fact correct, that the errors of the 
observations are additive to the true prediction of the model, that the 
predictor, independent variables have no error, that the errors are 
independent, and that all observations have the same distribution and, in 
particular, the same variability.
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If, for instance, the latter assumption for the constancy of variance 
is not satisfied then the least-squares criterion should be modified. The 
parameters are chosen to minimize the weighted sum of squares (WSS) in 
which the squared difference between each observed and model-predicted 
response is multiplied by a weight. The weight should be proportional to 
the reciprocal of the variance of the observation. This means, sensibly, 
that higher weight is assigned to a precise reading (having a small 
variance), and lower weight is given to an imprecise one.
UNCERTAIN WEIGHTS: THE NEED FOR ROBUST PROCEDURES
The application of weights implies (even when no weights are used in 
SS) that the variances of the observations are known, at least in compar­
ison with each other. This is true only very infrequently. Usually, such 
information is either completely absent or is simply quite vague and 
uncertain. As a result, the weights applied in the calculations, and 
their relationship, may not be correct.
However, when an inappropriate weighting scheme is used, the esti­
mated parameters can easily lose their favourable properties. They could 
be biased and their variances can become substantially inflated. Examples 
of this will be seen later.
Thus, the uncertainties about the behaviour of the variances (the 
variance model) can have distressing consequences on the calculated 
parameters. Therefore, it is desirable to consider estimating procedures 
which are insensitive to the different, possible assumptions about the 
variances. Two such robust methods will be discussed. The first of these 
will evaluate the weights from the observations themselves and from the 
last updated prediction of the model. These calculations will be repeated 
at each update (or iteration). The second approach will be nonparametric 
and will not rely on the assumption of a distribution for the errors. In 
addition to these procedures being robust, they satisfy also a second 
requirement: they yield parameters quite precisely, i.e. efficiently.
These considerations apply when experiments are designed with the 
goal of estimating parameters as precisely as possible. The favourable 
designs also vary sensitively with the assumed behaviour of the vari­
ances. Therefore, robust approaches will be considered also for experi­
mental designs. Again, the resulting sampling schemes will yield not only 
robust parameters but also quite efficient ones, i.e., values with high, 
close-to-optimal precision.
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HILL EQUATION
The robust approaches for the design and analysis of experiments will 
be illustrated on the example of the Hill equation:
Vch
V =  ____________
Kh + ch
Here, v is the response, the reaction velocity in enzymology, measured 
at various concentrations, c. The purpose of the supposed experimental 
studies is the evaluation of the 3 model parameters. They are the 
maximal response (maximal velocity, V), the concentration yielding half of 
the maximal response (a Michaelis-type constant, K), and the Hill coeffi­
cient (h) which determines the steepness of the response curve and can 
characterize the cooperativity of an enzyme system [5,6].
Essentially, the Hill equation provides an empirical description of 
the dependence of a response (in our case, the reaction velocity) on 
concentration. The empirical relationship characterizes a variety of 
systems, such as the effect of drug doses or concentrations on graded or 
quantal response [7,9]. The logistic function, favoured by statisticians, 
is also equivalent to the Hill equation [10,11],
LEAST-SQUARES ESTIMATION OF PARAMETERS
Simple Least Squares
The principles of the method of least squares were described earli­
er. Now they will be formally presented.
A true, error-free response (y°) depends on the form of the model 
being considered (f), the value of its controlling, independent variable 
(x), and the magnitudes of its p parameters (Px, P2, ..., Pp):
y° = f(x, Pj, P2..... Pp) .
In the case of the Hill equation, the response is the reaction velocity, 
the independent variable is concentration, and the 3 parameters to be 
evaluated are V, K, and h:
v° = f(c , V, K, h) ,
where f has the form of the equation given above.
The measured responses (y) contain an experimental error (e) in 
addition to the true response:
y = y° + e .
Consequently, the error is the difference between the observed and true
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e = y - y° .
The true response is not known. It is best estimated from its value 
predicted by the model (ypre(j)- Consequently, the estimated error (e), 
is:
6 - y - ypred '
The errors of the observations are generally minimized if the 
parameters of the model are chosen to yield such predicted responses 
(ypred) which result in the least sum of the squared errors:
SS = Min[Ee2] = Min[E(y - ypred)2]
We shall refer to the evaluation of this least sum of squares (SS), or 
"least squares", by iterative calculations as the simple least-squares 
(LS) analysis. It assumes that the variances (o2) of all errors, £, are 
the same.
Weighted Least Squares
If the variances of the various errors, and the corresponding 
observations, are different, then weights should be used in order to 
compensate for this divergence. As already noted, the weights (w) should 
be proportional to the reciprocals of the error variances:
w a l/o2
responses:
The squared errors to be minimized should be multiplied by these 
weights:
WSS = Min[Ewe2] = Min[£w(y - ypred)2]
The weighted sum of squares (WSS) is computed by the iterative weighted 
least-squares (WLS) procedure. As a limiting case for the behaviour of 
errors, the condition of constant relative (or percentage) error:
o/y° = constant ,
will be considered. Replacing again the true response by its value 
predicted by the model, the weights applied by WLS are:
W = ^pred
(taking unity as the proportionality constant).
We shall now discuss approaches which do not require that the 
relationship between variance and response, i.e. the error behaviour, be 
known.
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ROBUST ESTIMATION 1: METHOD OF VARIANCE RATIO (SIGMA RATIO)
Variance Model and Its Evaluation
The variance conditions of constant errors or relative errors can be 
thought of as limiting cases of a more generally prevalent error behav­
iour :
2 2 2 o ^0 = 0  o + °2y
Of the two components of variance, the first dominates at low levels of 
the response (such as the constant, background error or white noise 
observed in many systems of measurement). At high levels of the response, 
the second component of the variance dominates and constant relative (or 
percentage) errors are observed.
A procedure will be described which evaluates the two components of 
variance from the observations. This will enable the direct calculation 
and application of the appropriate weighting scheme.
If observations are obtained and a preliminary least-squares analysis 
is performed then the true response is estimated again by its value 
predicted by the model, and the variance of the error by the square of the 
estimated error. Consequently, approximately:
2 2 2 2 
e = s0 + s2 V e d  •
(Here s2 and s2 refer to estimated values of O2 and 02, respectively.) 
Therefore, in a plot contrasting e2 with yprecj a straight-line relation­
ship should be obtained with a slope of s2 and intercept of s2. The 
slope and the intercept can be actually calculated from just two points. 
The computations can be repeated for all combinations of point-pairs, and 
a value of s2 and s2 calculated for each. Finally, overall estimates of 
s2 and s2, such as their medians, can be obtained.
In practice, it is not necessary to evaluate separately s2 and s2. 
We are essentially interested in the relative contributions of the two 
components of variance since they unambiguously determine the relative 
weights of the various observations. Therefore, it is sufficient to 
estimate 0o/o2 (the "sigma ratio") from pairs of points, and take the 
median of these values. The following weights can then be used, in the 
next calculation of the weighted sum of squares, for the observations:
(s^/s2) + y2pred
(so/s2) + V^red
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(Here the numerator is included only to yield a reasonable order of 
magnitude for w.)
With these weights, the parameters can be modified in order to obtain 
a reduction of the weighted sum of squares. New predictions by the model 
are obtained, these yield new error estimates (residuals, e), the sigma 
ratio is estimated again, and new relative weights are calculated. This 
process is continued until all of its components, especially WSS, remain 
unchanged between consecutive updates (iterations).
The method of variance ratio, and its robustness, has been demon­
strated for linearizable enzyme kinetic models [12-14] and for exponential 
functions [15]. It is a procedure which can be applied generally for 
linear and nonlinear models. We shall illustrate its features on the 
example of the Hill equation. The method can be combined with protective 
weighting procedures against the possible presence of unusual, outlying 
observations. We shall not consider this aspect which has been dealt with 
elsewhere, in particular in a report in this volume [14].
Illustration of the Robust Method: Hill Equation
1000 computer-simulated experiments were performed by assuming the 
following conditions. The parameters of V = 1 and K = 1 were chosen 
arbitrarily but maintaining generality since v and c could be expressed in 
terms of V and K, respectively. h = 2 was assumed. 6 observations were 
arranged with concentrations between the limits of c/K = 0.143 and 2.0 
(corresponding to the relative velocities of v/V = 0.02 and 0.80) in 
geometrically increasing progression. The measurement errors were taken 
to be normally distributed around the true velocities with a mean of zero 
and a standard deviation which was, at it limits, aQ = 0.05 (with a£ = 0) 
and 0 2 = 0.10 (with oQ = 0) for constant and relative errors, respective­
ly. Between these limits, GQ/a2 was varied again in geometric progression 
in such a way that the variance of an observation at v/V = 0.50 (at 
half-maximum) would remain the same.
Results of the simulations are shown in Fig. 1 for the precision 
and accuracy of parameter K. The other two parameters had similar proper­
ties. Fig. IB illustrates a nonparametric measure of the variation among 
the 1000 K-values calculated by each of three weighting schemes (in 
addition to a reference scheme). The 1000 values were ordered in each 
case by magnitude and the difference between the 750th and 250th value was 
recorded, the so-called inter-quartile interval (IQ or "hinge" [16]). 
This was related to the IQ obtained by the reference weighting scheme
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Figure 1. Effect of the error behaviour on the precision and 
accuracy of parameters estimated by the method of variance ratio.
For comparison, properties of parameters calculated by 3 
other methods in 1000 computer-simulated experiments are also 
shown. (See text for conditions of the simulations.) The 
illustrations refer to parameter K of the Hill equation'.
The error behaviour varies from constant (C) to relative (R) 
errors with 3 intermediate, mixed conditions in-between. The 4 
estimating methods are: LS - unweighted least squares (assuming 
constant variance), WLS - weighted least squares (with weights 
assuming constant relative errors), VR - method of variance ratio 
(error behaviour and weighting scheme evaluated from the observa­
tions), IDEAL - ideally-weighted least squares (with weighting 
schemes corresponding to the true, and supposedly known error 
behaviour; the condition is useful for simulations but not 
realistic in practice).
(A) Bias of the estimated parameters. The nonparametric 
median (m) is calculated, and the percentage bias is evaluated by 
comparison with the true parameter value (P°): 100(m - P°)/P°. 
An accurate parameter has zero bias. (B) Precision of the 
estimated parameters. The nonparametric measure of the interquar­
tile interval (IQ) of the 1000 estimated parameters is shown in a 
logarithmic scale. The "Ideal" method is used as a reference and, 
therefore, its IQ is always 1. For the other methods, a relative 
IQ close to 1 indicates high estimating precision.
LS is the appropriate method when the variance is constant, 
WLS is ideal with constant relative errors. When the error 
properties are removed from these favourable conditions then the 
variability of the estimated parameters increases and, in some 
cases, so does their bias. In contrast, parameters calculated by 
the method of VR show, under all error conditions, high precision 
and accuracy.
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which applied weights corresponding to the true sigma ratio, i.e. implied 
that the sigma' ratio was known. Thus, the IQ ratio for this "Ideal" 
procedure is always 1.
With constant errors (on the left of the diagram) the unweighted LS 
is the ideal method of analysis. However, as the sigma ratio shifts 
towards relative error (on the right), the comparative performance of LS 
deteriorates and yields a much higher than ideal variability of the 
estimated parameter. Conversely, WLS with weights corresponding to 
constant relative error is the ideal method for this error behaviour (on 
the right). The performance of WLS becomes very much poorer as the error 
conditions shift towards constant variance.
Throughout the range of error conditions the method of variance ratio 
yields almost as favourable results as the ideal, but usually unknown, 
weighting scheme. At the same time, the parameters calculated by the 
variance ratio procedure are vastly superior to those obtained from least 
squares using incorrect weights. Thus the VR method is robust against the 
uncertainty of error behaviour and efficient in comparison with the ideal 
analysis.
VR performs satisfactorily also when the bias of the parameters is 
considered (Fig. 1A). In contrast, WLS can yield strongly biased para­
meters when applied with the incorrect error assumption.
ROBUST ESTIMATION 2: NONPARAMETRIC ANALYSIS
Nonparametric Evaluation of the Hill Parameters
It has been known for over a decade that nonparametric procedures can 
be usefully applied to the analysis of enzyme kinetic data. The method of 
the Direct Linear Plot (DLP) was proposed for the evaluation of Michaelis- 
Menten parameters [17—19]. The estimated parameters of the rectangular 
hyperbola were demonstrated to be robust against incorrect error assump­
tions and remarkably efficient with respect to the correctly weighted 
least-squares analysis [18,20].
The procedure expresses the 2 model parameters by 2 data points and 
essentially solves 2 equations with 2 unknowns. This is repeated with 
different pairs of data points and, in each case, the 2 parameters are 
evaluated. Finally, a single estimate of each parameter is obtained from 
their numerous values calculated pairwise, for example by taking their 
medians.
We shall illustrate features of nonparametric estimation on the
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RANGE OF RELATIVE VELOCITIES (v/V)
FIGURE 2. Precision of the Hill parameter K evaluated by the 
nonparametric method of DDLP (Direct Double-Linear Plot).
Coefficients of variation of parameters estimated under 
various conditions in 100 simulated experiments are shown. The 
diagrams illustrate the effect of 3 experimental designs (indica­
ted in terms of the range of relative velocities) and 2 limiting 
error behaviours (Fig. 2k: constant variance, O = 0.02V,
Fig. 2B: constant relative errors, 0 = 0.04v). For comparison, 
the precisions of the parameters calculated by unweighted and 
weighted least squares are also shown. (These methods are 
appropriate when the limiting error conditions actually prevail.)
The parameters estimated by DDLP are, under favourable 
conditions (e.g., with wide range of designs), almost as precise 
as those yielded by least squares applying the correct weighting 
scheme. Under unfavourable experimental conditions, the preci­
sion of the DDLP parameters in fact exceeds that of the least- 
squares values even when correct weights are used. The DDLP 
parameters are always much more precise than the least-squares 
values based on the inappropriate weighting scheme.
example of the Hill equation. If the ratio of consecutive concentrations 
is constant (i.e., if the concentrations are spaced logarithmically, or in 
geometric progression) then the two corresponding, consecutive responses, 
characterized by the Hill equation, are related according to a rectangular 
hyperbola [21]. Consequently, from 4 observations (pairs of pairs), the 3 
parameters of the Hill equation (V, K, and h) can be evaluated [22]. The 
calculation can be repeated and the 3 parameters calculated for various 
selections of 4 readings. Finally, overall estimates of the parameters 
can be obtained from the medians of their separately calculated values.
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Evaluation of the Method of the Direct Double-Linear Plot
Figure 2 illustrates some of the results obtained by the nonpara- 
metric procedure. Since it utilizes the principles of the DLP method, and 
since it doubles-up the required pairs of observations, we shall refer to 
the approach as that of the Direct Double-Linear Plot (DDLP). In 100 
computer-simulated experiments, 6 observations were arranged in geometric 
progression between concentration limits which yielded the 3 ranges of 
relative velocities shown in the diagrams. True h = 1 was used in these 
simulations. The experimental errors were assumed to be normally distri­
buted with means of zero and standard deviations of either a = 0.02V when 
constant variance was simulated or a = 0.04v for constant relative errors.
Figure 2 shows coefficients of variation (standard deviations 
expressed as percentages of the true parameter values) of the 100 K— 
parameters estimated by 3 procedures: unweighted and weighted least 
squares (LS and WLS assuming constant and relative errors, respectively), 
and the nonparametric DDLP procedure. Similar results were obtained under 
various simulated experimental conditions and for the other parameters of 
the Hill equation. It should be noted that the accuracies of the parame­
ters were similar when calculated by the 3 methods.
The precisions of the parameters calculated by DDLP are not much 
lower, and in some cases even substantially higher, than those yielded by 
the ideal weighting scheme for the true error behaviour: LS for constant 
variances (Fig. 2A) and WLS with constant relative errors (Fig. 2B). The 
parameters computed by DDLP are consistently and substantially more 
precise than the corresponding values estimated by the inappropriate 
weighting procedure (WLS in Fig. 2A and LS in Fig. 2B).
Consequently, the parameters calculated by the method of DDLP are 
robust with respect to the uncertainty of the error behaviour. They are 
also quite efficient since their precision is close to the approximately 
optimal precision when the error features are known. As seen above, the 
variability of the DDLP parameters is much lower than that yielded by an 
incorrectly guessed weighting scheme.
Evaluation of the Hill parameters by DDLP is particularly effective 
and robust under unfavourable experimental conditions. For example, 
Figure 2 illustrates that with a restricted experimental design the 
parameters estimated by DDLP show particularly small variation (high 
precision) in comparison with the least-squares values, regardless of 
whether these are obtained by applying correct or incorrect weights. The
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comparative robustness of the DDLP parameters is also seen when, in the 
simulations, the observational error is increased.
OPTIMAL AND ROBUST DESIGN OF EXPERIMENTS
Optimal Design of Kinetic Experiments
Before discussing robust approaches to parameter estimation, we 
considered the method of least squares. It was seen to yield parameters 
which had favourable properties provided that the assumptions of the 
method were satisfied. We were especially concerned with the proposition 
that the scheme of weights applied in the calculation of WLS should 
correspond to the behaviour of the error variances. Robust procedures 
were necessitated by the belief that these error features are, in prac­
tice, often not known.
In a similar manner, we shall initially consider methods for develop­
ing experimental designs which are based on the principle of least 
squares. They share its favourable properties but also rely on its 
assumptions. Following this, approaches to experimental design will be 
discussed which are insensitive to the behaviour of the experimental 
error. The procedures will be illustrated again on the example of the 
Hill equation.
Optimally effective experimental designs minimize one of the features 
of the variance-covariance matrix (V) for the parameters or of a quantity 
related to this [23-25]. The measures include minimizing the determinant 
of the matrix (D-optimization) which aims at designs yielding the smallest 
standard errors (highest precision) of all parameters and their smallest 
correlations. In the first-order approximation, the design criterion 
minimizes the (hyper)volume of the joint confidence region of the para­
meters. When an investigator wishes to reduce only the standard errors of 
the parameters (but not their correlations), (s)he would minimize only the 
trace of the matrix V which involves only its diagonal elements (A-opti- 
mization). If, on the other hand, protection is sought against the pre­
sence of redundant parameters then one might wish to establish designs 
maximizing the smallest eigenvalue of V (E-optimization). At other 
times, the smallest errors for predicting the responses would be evaluated 
(G-optimization).
Thus, the goals of the investigator determine the criterion to be 
applied for designing efficient experiments. In recent years, the 
criterion of D-optimization was used in order to explore designs of
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biological experiments. These included investigations in enzyme [27-30], 
tracer [31-33], and pharmacokinetics [30,34-36].
The D-optimal design is often favoured because of an additional 
useful property: it yields comparatively simple sampling schemes which can 
be interpreted easily. The number of optimal design points generally 
equals the number of model parameters, and the points are replicated 
(nearly) equally. The designs are independent of transformations of the 
variables or parameters. All these features are not shared by the other 
design criteria for parameter estimation.
Optimal and Robust Designs for the Hill Equation
In the case of the Hill equation, the optimally efficient designs 
involve 3 repeating sampling points [37], One of these is always the 
highest attainable concentration (cx ■+■ °°) yielding the largest possible 
velocity (Vj -*■ V). This is necessary for the evaluation of a precise 
asymptotic velocity, V.
The other two design points depend on the features of the observa­
tional errors. If their variance is constant then the parameters are 
estimated with the highest precision if (c'2/K)h = 2.84 and (c /K)h = 0.352 
yielding the relative velocities of v2/V = 0.740 and v3/V = 0.260, 
respectively [37]. If the relative errors are constant (constant percen­
tage error and constant coefficient of variation) then two of the optimal 
concentrations and velocities should be as small as possible (c2, c3, v2 
and v3 -*■ 0). This is reasonable since the error model assumes that the 
smallest velocities are observed with the lowest errors.
For intermediate error behaviour the optimally efficient experimental 
designs can be determined similarly [37], As the examples given above 
indicate, these designs depend sensitively on the assumption about the 
error behaviour. This does not create a problem if the investigator knows 
the features of the errors. However, if these properties are not known 
then designs based on a possibly incorrect assumption can yield quite 
imprecise parameters (with low efficiency) [37],
Various strategies were proposed for dealing with the uncertainty 
about the error behaviour [37,38], If the investigator wishes to provide 
protection against the possibility of a very low estimating efficiency 
then the minimum efficiency that can be calculated over the range of 
possible error behaviour should be maximized. However, this approach can 
result in fairly complicated designs [38].
In contrast, a simple strategy can be applied for the design of
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Figure 3. Effect of error behaviour on efficiency when the 
parameters of the Hill model are estimated from 3 different 
experimental designs.
The diagrams show the estimating efficiencies obtained at 
various true error behaviours when 6 concentrations are arranged 
to yield a range of relative velocities (A) between 0.05 and 0.80, 
and (B) between 0.05 and 0.99. The effect of 3 sampling schemes 
is illustrated: the concentrations are arranged within their 
limits (1) uniformly, (2) in geometrically increasing intervals 
(logarithmic spacing), and (3) in a replicating design recommended 
when the behaviour of the experimental error is not known (indica­
ted by X = 0.5). Details of this scheme are described below and 
in the text.
X (lambda) is a measure of the error behaviour: X = 0 
indicates constant variance, X = 1 corresponds to constant 
relative errors. The estimating efficiency is reciprocally 
proportional to the number of observations which are needed to 
achieve a given magnitude of the parameter errors. (A measure for 
these errors is now the determinant of the variance-covariance 
matrix for the parameters.) The efficiencies at each X are 
referenced by the optimally attainable measure of parameter 
errors. For instance, the design optimal at true errors indicated 
by X = 0.5 yields 100% estimating efficiency when the behaviour 
of the errors actually corresponds to X = 0.5. At other actual 
error behaviours, the efficiency is lower.
The design optimal at A = 0.5 is recommended when features of 
the measurement errors are not known. The design has 3 optimal 
sampling points which are to be replicated evenly: c -*■<», c =
1.38^/h K and c = 0.094l/h K. The resulting relative velocities 
are v/V = 1.0, 0.58, and 0.086.
The recommended design is seen to yield generally higher 
estimating efficiency than the customarily used schemes. Still, 
geometrical (logarithmical) spacing of the concentrations usually 
results in quite precise parameters. In contrast, uniformly 
distanced concentrations yield imprecise parameters.
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experiments when the average estimating efficiency is maximized within the 
uncertain region of error behaviours. In this case, the most favourable 
design is very similar to the optimal scheme which is calculated by 
assuming that the variance (and not the standard deviation) of the
observations is proportional to the true response. This parallelism 
holds for the Hill equation [37] as well as for other models [38],
As a result, the following design is recommended for the Hill
equation when the error behaviour is not known: in addition to the
highest possible concentration (as before, c a- °°), the other two, 
repeating sampling points are (c2/K)h = 1.38 and (c3/K)h = 0.094, yielding 
the relative velocities of v2/V = 0.581 and v3/V = 0.086, respectively.
Figure 3 compares the estimating efficiencies obtained by the 
recommended design with those provided by customarily applied sampling
schemes. A is a measure of the error behaviour; a value of 0 indicates 
constant errors, a value of 1 corresponds to constant relative errors.
Figure 3 illustrates that the precision of parameters obtained by the 
recommended design compares favourably with that yielded by the frequently 
applied sampling schemes containing the same number of observations. The 
calculated parameters are particularly imprecise when the concentrations 
are spaced uniformly.
CONCLUSIONS
1. Parameters of kinetic models can be evaluated precisely and 
efficiently (i.e., with small error and comparatively little effort) by 
applying the method of least squares, provided that its assumptions are 
satisfied. For instance, it is essential for the effective design and 
analysis of kinetic experiments that the behaviour of the observational 
errors (their relationship to the magnitude of the response) be known.
2. If the error behaviour is not known then it is advisable that 
robust approaches be followed for the design and evaluation of experi­
ments. These procedures should yield parameters which are not sensitive 
to the various possible error features and are, at the same time, quite 
precise, even though not optimally so.
3. 2 procedures are illustrated for the robust estimation of the 
parameters of the Hill equation. The method of Variance Ratio evaluates, 
not only the model parameters, but also the error behaviour and the 
consequent weighting scheme. The method of Direct Double-Linear Plot 
provides a nonparametric approach for the calculation of Hill parameters.
Computer^simulated experiments demonstrate that both methods
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yield robust and efficiently estimated parameters. The precisions of 
these parameters is close to those yielded by the correctly weighted 
least-squares calculations. On the other hand, the parameters evaluated 
by the robust procedures are very substantially more precise than those 
obtained from least squares when it is incorrectly weighted. The accu­
racies of the parameters estimated by the various.methods are similar.
4. Experiments can be designed for the evaluation of precise 
parameters again when the error behaviour is known. If this is not the 
case then the average estimating efficiency can be maximized within the 
range of plausible error features. The resulting designs compare favour­
ably with frequently applied schemes.
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DISCUSSION
MÁTRAI:
You detailed that it is very important to know the exact 
value of A, because if it is not correct the evaluated 
model will be misleading. How can we determine this value 
in the daily laboratory practice?
ENDRÉNYI:
Dr. Mannervik demonstrated in his lecture that the loga­
rithm of the squared residuals can be plotted against the 
logarithm of the squared response predicted by the model. 
The slope evaluated in this plot equals A.
The same plot can be applied, as Dr. Mannervik showed, if 
replicate observations are available. (It should be em­
phasized that true replicates are required for this pur­
pose, those which are separated by all sources of variation 
of the experiment.) In this case the logarithm of the vari­
ance (or the standard deviation or the range) of the rep­
licates can be plotted against the logarithm of their 
squared averages (or their averages or medians). The slope 
should again be A.
BARDSLEY:
What do you think are the differences between using the 
determinant, trace or condition number etc., of the in­
formation matrix as a design criterion? Surely some sort 
of mean of the relative errors would be better?
I believe you have used the Jacobian exclusively to con­
struct a linear approximation to the covariance matrix. 
Don't you think the Hessian matrix of the objective func­
tion would be better? Surely a second order correction is 
always an improvement and the Hessian matrix does have 
such curvature information?
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ENDRÉNYI:
The various design criteria place emphasis on different 
aspects of the estimated variances. If the determinant of 
the variance-covariance matrix (V) is minimized (D-optimi- 
zation) then the investigator may aim at the simultaneous 
optimization of the parameter variances and covariances.
The criterion minimizes the (hyper)volume of the joint 
confidence intervals of the parameters and maximizes their 
posterior probabilities.
If the trace of V is minimized (A-optimization) then the 
standard errors of all parameters are to be reduced 
without any regard of their correlation. Thus, in princi­
ple, it is possible to get parameters with small standard 
errors but high correlations. In such a case, the estimat­
ed values of the parameters may be rather meaningless.
The investigator is more concerned with the quality of 
the model and of the estimated parameters if he intends 
to obtain a design which maximizes the smallest eigen­
value of V (E-optimization). This would ensure that the 
estimation would not result in a strange mixture of very 
good and very poor parameters.
On the other hand, it is possible that the interest of an 
investigator is focussed on only some, or just one, of the 
model parameters. In the case of the Hill equation, for 
example, one often wishes to evaluate the Hill coefficient 
with little or no interest in the other two parameters. In 
this case, a subset criterion of D-optimization should be 
utilized.
In other circumstances, an investigator may wish to mini­
mize the error for predicting the response in a region 
(G-optimization).
The priorities set by the investigator should determine 
which one of these criteria would be used for the design 
of experiments. It is also possible to apply criteria in 
(linear) combinations. Once the investigator sets a design 
criterion, and provides the necessary additional informa­
tion (structural model, variance model, guessed parameters), 
numerical optimization is generally straight-forward.
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Nevertheless, the criterion of D-optimization which is 
considered in the manuscript, has useful advantages. In 
practice, perhaps the foremost among these is the observa­
tion that the criterion yields simple results. To various 
degrees, this is not true about the results of the other 
criteria which can depend on experimental conditions or 
the approach to the formulation of the problem. The results 
of D-optimization are also independent of the units of the 
variables and (monotonic) transformations of the parame­
ters; again not general features of the other criteria.
It is very true that for nonlinear models, first-order 
statistics represent an approximation. It is also a useful 
question whether the approximation is satisfactory and 
useful?
Certainly at the minimum of the (weighted) sum of squares 
optimization criterion, the linear approximation holds 
perfectly. The farther away we move from the minimum, in 
terms of parameter combinations and up on the surface of 
(weighted) sum of squares, the cruder the approximation 
will become. The closeness of the approximation depends 
then on the height of movement on the surface (this is 
determined by the magnitude of the error variance) and 
also on the nature of the model.
A practical approach to the design and analysis of experi­
ments involving nonlinear models would evaluate if, with 
a given variance level and model, tests according to the 
curvature measures of Bates and Watts would indicate the 
acceptability of the linear approximation, - or the lack 
of it. If the first-order approximation is not satisfac­
tory, second-degree statistics involving Hessians should 
be pursued.
For the design of experiments, Hamilton and Watts will 
publish in a 1985 issue of Technometrics a paper which 
will consider the effect of second-order approximation 
to D-optimization. It is clearly an improvement over the 
linear treatment. However, it has again the disadvantage 
of being dependent on the magnitude of the error variance.
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Therefore, it could be wise to resort to this higher 
approximation only when it is sufficiently merited, and 
apply more generally the linear approximation of D- or 
other optimizations.
MARKUS:
Instead of using much global design criteria as D- and A- 
optimality we have had cases where it was useful to mini­
mize just single elements of the covariance matrix.
CORNISH-BOWDEN:
As Dr. Markus says, one may often need to fit a multi-pa­
rameter model even though not all of the parameters are 
of any interest. A familiar example occurs in the prelim­
inary characterization of an unpurified enzyme: we may
wish to obtain an estimate of K , but we can only getm
this by estimating V as well, even though the value of V
is a function of the unknown enzyme concentration and may
be of little interest. In such a case we need a design
that maximizes the precision of K , not one that maximizesm
some index of the variance-covariance matrix as a whole.
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The method of least squares is the most widely known and used 
for fitting theoretical equations to experimental data. It depends, 
however, on numerous assumptions that are often unjustified in
practice, and for that reason performs much less well than its
idealized properties might lead one to expect. The whole set of
assumptions are well set out and discussed by Watts (1981), and here 
we shall consider only two of the most important reasons why least- 
squares calculations may be unsatisfactory: (i) the least-squares 
method gives poor estimates if the errors in the observations are not 
normally distributed and in particular it is very sensitive to isolated 
bad observations, or outliers; (ii) if the errors are not all drawn 
from the same population, i.e. they are heteroscedastic, the proper
weighting function must be known and applied.
For fitting the Micnaelis-Menten equation or, in principle, any 
other equation of two parameters, these two problems may be 
circumvented by avoiding the method of least squares altogether. For 
example, the median estimates derived from the direct linear plot 
(Eisenthal and Cornish-Bowden, 1972; Cornish-Bowden and Eisenthal, 
1974, 1978) prove to be almost as satisfactory as least-squares
estimates when the least-squares assumptions are true, and much 
better than least-squares estimates when the least-squares assumptions 
are false. Unfortunately, however, this approach cannot easily be 
extended to equations of three or four parameters, because the amount 
of computation required increases very steeply both with the number of 
parameters and with the number of observations. If one wishes to fit
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the equations for two-substrate kinetics or inhibition, etc., one must 
either proceed in stages, in a computational analogue of using primary 
and secondary plots, or one must use a robust modification of least 
squares.
There has been a considerable amount of attention in the statist­
ical literature to the development of robust regression procedures that 
overcome the problem of outliers. The biweight method of Mosteller and 
Tukey (1977) is one such procedure that gives excellent protection 
against outliers in studies with the Michaelis-Menten equation when the 
correct weighting function is used (Cornish-Bowden, 1981), and it
would be optimistic of biochemists to expect to improve appreciably on 
this. There has, however, been almost no corresponding attention to 
the second of the problems noted above, possibly because professional 
statisticians suppose that the correct weighting function is always 
either known or easily determined. In reality, at least in enzyme 
kinetics, the correct weighting function is almost never known, and 
experiments to determine it are rarely carried out. Moreover, when 
they have been carried out (Storer _et^ al_., 1975; Siano £t_ al., 1975; 
Askelöf £t_ al., 1976; Nimmo and Mabood, 1979), they have indicated 
that the advice to assume that each measured rate has the same error 
distribution (Cleland, 1979) is normally incorrect. It appears, there­
fore, that in the development of methods of robust regression one 
should pay at least as much attention to the weighting function as to 
outliers.
Considerations such as these led us to propose a new method of 
robust regression in which the biweight method of Mosteller and Tukey 
(1977) is combined with a method of estimating the weighting function 
from information contained within the data (Cornish-Bowden and 
Endrényi, 1981). Tests of this method for fitting the Michaelis-Menten 
equation were very promising, indicating that in this case it was as 
effective as the median method, but with the major advantage of being 
generalizable to equations of more than two parameters. In this 
chapter we discuss its application to the equations of steady-state 
enzyme kinetics, most of which can be handled by linear methods. We 
give particular attention to the equations for two-substrate reactions, 
but we have elsewhere considered inhibition equations and pH 
dependences, such as bell-shaped pH profiles (Cornish-Bowden and 
Endrényi, 1985). In the following chapter, we consider the more
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general problem of non-linear regression of equations that cannot be 
linearized.
METHODS
Implementation
The method of fitting enzyme kinetic equations described and 
tested in this chapter has been implemented as a computer program 
written in Fortran and suitable for use on any computer that accepts 
standard Fortran. Both the program and a full description of its use 
have been published (Cornish-Bowden, 1985), and thus only a brief 
indication of its capabilities is needed here. It can fit any equation 
of two or three variables and two, three or four parameters that be­
comes linear when written as an expression for the reciprocal of the 
dependent variable. This includes all of the equations commonly 
encountered in studies of steady-state enzyme kinetics except the equa­
tion for pure non-competitive inhibition (i.e. mixed inhibition with the 
constraint that the two inhibition constants are equal), and thirteen of 
these are built in to the program: these include the Michaelis-Menten 
equation, the common types of inhibition, two-substrate reactions, 
bell-shaped pH profiles, etc.; none of these need to be defined by the 
user, but if additional ones are required they can be defined as data.
As well as implementing the robust method described in this
chapter, the program also allows the sigma ratio to be specified in 
the data and it allows the biweight method to be suppressed. It can,
therefore, be used to obtain a conventional least-squares fit if desir­
ed, and as an alternative to the kind of intermediate weighting
function embodied in Eq. (1) it allows the use of a different approach 
advocated by Askelöf £t_ al_. (1976).
T e s t i n g
Computations reported in this chapter were done on a Honeywell 
Multics computer, using a special version of the program that allows 
experimental data to be simulated in the computer according to various 
hypotheses about the error behaviour. Routines from the NAG Library 
were used for generating random numbers from specified distributions.
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THEORY
Error variance
When the true function defining the variance of a measured quant­
ity, such as a rate v, is unknown, it is reasonable to assume that it 
lies between two limiting hypotheses: (i) "simple errors", where the 
standard deviation is a constant, and (ii) "relative errors", where the 
coefficient of variation is a constant. These may be considered as 
limiting cases of the following equation:
o2 {v ) = ej; + ofu2 (1)true
in which o2(v) is the variance of v, v. is the true value of v, andtrue
a„ and cr2 are constants. In a real experiment all three of the 
quantities on the right-hand side of Eq. 1 are unknown, but fortunate­
ly it is possible to estimate a0/o2, the "sigma ratio", from the data, 
and this provides sufficient information to define a weighting function 
(Cornish-Bowden and Endrényi, 1981). An initial fit must be obtained 
with arbitrary or assumed weights, but subsequently one can use this 
to obtain calculated rates v . For any rate, one can estimate the error 
as e = (v - v), and regard e 2 as a rough estimate of the variance. 
If one considers all of the observations in pairs (excluding any for 
which the two v values are equal), one can obtain an estimate of the 
sigma ratio from each pair, defined as shown in Fig. 1. Note particul­
arly that in neither of the situations illustrated in Figs, la and lc 
can the two points be realistically connected by a straight line, 
because this would imply negative variances at some positive rates. 
Instead, therefore, one must take these cases as indicating the most 
extreme values allowed, 0 (relative errors) for Fig. la, or +» (simple 
errors) for Fig. lc. The best estimate of the sigma ratio is taken as 
the median of all the individual values, including the zero and 
infinite values, and is used to calculate new weights w, as follows:
( < J , / o 2 ) 2 +  V2
w = -------------  (2)
( a „ / a 2 ) 2 +  V2
The numerator of this expression is strictly arbitrary, as it can be 
given any constant value without affecting the final estimates, but if
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Fig. 1. Estimation of the Sigma Ratio
After a preliminary fit has been obtained, the observations are 
considered in pairs, with the squared estimated error plotted against 
the squared calculated rate. When the straight line drawn through the 
two points gives a negative intercept on the abscissa (Fig. lb), the 
square root of the absolute value of this intercept is taken as an 
estimate of the sigma ratio. When the intercept is positive, the 
corresponding estimate of the sigma ratio is taken as zero if the slope 
is positive (Fig. la) or infinite if it is negative (Fig. lc). The best 
estimate of the sigma ratio is taken as the median of the individual 
estimates.
v is defined as the mean of all the observed rates the resulting 
weights fall in a numerical convenient range. These weights can then 
be used to obtain improved parameter values and calculated rates, and 
the process can be repeated until the results are self-consistent.
Outliers
The traditional approach to handling outliers in least-squares 
calculations is to try to identify them and then reject them from the 
regression. However, unless there is independent evidence to justify 
rejecting a particular observation, rejection must either depend on a 
subjective assessment of what is a "reasonable" amount of deviation or 
on some predetermined and ultimately arbitrary criterion. Moreover, if 
one considers a parameter estimate as a function of the magnitude of 
one particular error, one will observe that as the error increases its 
effect on the parameter estimate increases correspondingly but then 
abrupts vanishes when the error passes the rejection level. This jerky 
behaviour, reminiscent of the sudden breaking of an elastic band as it 
is stretched, is hardly very satisfactory.
One can avoid the arbitrariness of choosing a rejection level in 
advance by allowing the observations themselves to define what is a
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"reasonable" amount of deviation, for example by defining an outlier 
as an observation that deviates from the fitted equation by more than 
six times the median absolute deviation. This does, however, leave the 
problem of jerkiness, which can best be handled by smoothing out the 
rejection: instead of proceeding abruptly from full inclusion to full 
rejection in one step, one can decrease the weight of deviant observa­
tions smoothly from full weight for an observation fitting the model 
exactly to zero for one deviating by more than six times the median 
absolute deviation. This approach is implemented in the biweight (a 
contraction of bi-square weight) method of Mosteller and Tukey (1977). 
As with the estimation of the sigma ratio, one requires a preliminary 
fit to the data, which is obtained by giving all observations full 
weight, i.e. weight of unity if the sigma ratio is not used, but 
preferably weight w, defined by Eq. (2), using an assumed value of 
the sigma ratio if no better value exists. One can then define a 
scaled deviation u, as follows:
u = w2 (v - v)/6S (3)
where 5 is the median value of \u2(v - v)\ and the constant 6 defines 
the criterion for complete rejection. New weights W are now defined as 
follows:
w(l - u2)2 if |u| < 1
W = { U)
0 if \u\ > 1
These weights are then used to refine the calculation, which continues 
until the results are self-consistent. The quantitative effect of Eq. (4) 
is shown in Table 1.
C o m b i n i n g  t h e  t w o  m e t h o d s
As both the estimation of the sigma ratio and the application of 
the biweight method are inherently iterative in character, one might 
suppose that the whole computation would be very lengthy, requiring a 
complete set of biweight iterations between each pair of sigma-ratio 
iterations, or vice versa. In practice, however, we have not found
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Table 1. Treatment of Outliers
The Table shows the effect of modifying the 
weight given to the most deviant observations by 
the biweight method. As discussed in the text, u 
represents a weighted measure of the deviation 
of an observation from the fitted equation, scal­
ed such that 50% of observations give values of 
u  less than The final weight W  is calculated 
from Eq. (4) with w = 1; thus the values tabul­
ated show the extent to which the weight of a 
deviant observation is decreased relative to the 
value calculated from the sigma ratio. Note that 
almost 50% of observations are assigned more 
than 95% of full weight.
\6u | w
0.0 1.000
0.5 0.986
1.0 0.945
1.5 0.879
2.0 0.790
2.5 0.683
3.0 0.563
3.5 0.435
4.0 0.309
4.5 0.191
5.0 0.093
5.5 0.026
> 6.0 0.000
this to be necessary, as both sets of calculations are done 
simultaneously: in each iteration the same calculated rates are used 
both for improving the estimate of the sigma ratio and for modifying 
the weights according to the biweight method. The only complication 
that sometimes arises is that if the sigma ratio is allowed to vary 
between iterations without any restriction it can enter an infinite 
cycle of oscillation between two values. We overcome this by "damping" 
the oscillations: in the first iteration there is no restriction on the 
value, but subsequently it is not allowed to change by more than a 
preset limit, which is decreased in each iteration.
RESULTS
Estimation of the correct weighting function
We have tested the capacity of the proposed method for estimation 
of the correct weighting function by reference to the equation for a 
ternary-complex mechanism:
(5)
in which v is the rate measured at concentrations a and b of two 
substrates A and B respectively, and V ,K. ,K„ and K are the para-
meters to be estimated. For purposes of simulation we take the true 
values of these parameters to be 100, 5, 1 and 1 respectively. Apart
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v  =  V a b / ( K .  K  „ +  K  a  +  K  b  +  a b )  
1 A mB mB mA
Each line of the Table shows the number of times the estimated
value of the sigma ratio obtained in 100 simulated experiments fell in 
the specified ranges, for data obeying Eq. (5) with the true parameter 
values specified in the text. Each experiment consisted of 25 observa­
tions obtained for all combinations of five values (0.5, 1.0, 2.0, 5.0
and 10.0) of a and b. In all cases the errors were normally distribut­
ed, but the values of the "constant" standard deviation a0 and the 
"proportional" standard deviation cr2 were varied as indicated. In the 
classification of estimated values, "moderate" values of the sigma ratio 
are between 0.577 and 1.732 times (i.e. between 1//3 and /3 times) 
the mean observed rate, "low" values are below this range but 
non-zero, and "high" values are above this range but finite. The
results shown in the first five lines (A) were obtained with the full 
robust method, whereas those in the second five lines (B) were obtain­
ed with the biweight facility suppressed.
True values Estimated values of a0/a2
Table 2: Estimation of the Sigma Ratio
c2 o0/a2 - High Moderate Low Zero
A 1.0 0.00 oo 56 26 12 6 0
0.8 0.01 80 29 37 31 3 0
0.5 0.02 25 5 12 59 21 3
0.3 0.03 10 1 3 35 47 14
0.0 0.05 0 0 0 13 43 44
B 1.0 0.00 00 62 19 16 3 0
0.8 0.01 80 3-4 30 33 2 1
0.5 0.02 25 4 9 62 22 3
0.3 0.03 10 0 2 24 59 15
0.0 0.05 0 0 0 7 34 59
from the arbitrary value of 5 assumed for K.. /K there is no loss of J lA mA
generality implied by these values.
Table 2 shows the results obtained in simulated experiments when 
the true sigma ratio varied from infinity (simple errors) to zero (rel­
ative errors). It may be seen that the estimated sigma ratio was in 
either the' correct range or an adjacent range in about 90% of 
experiments. Thus although one cannot normally hope to estimate the 
sigma ratio accurately one can certainly obtain an approximate value, 
and there is no difficulty in distinguishing the extreme cases from one 
another. The lower part of Table 2 shows that the sigma ratio can be 
estimated marginally more accurately if the biweight method is not 
used. However, the improvement is rather slight and one may question 
whether it is worth the cost of abandoning protection against outliers.
Given that we cannot expect to estimate the sigma ratio exactly 
from finite data sets, we need to know whether the classification into 
the approximate range as indicated by the results in Table 2 is ade-
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The Table refers to the same sets of simulated data as those of 
Table 2, but it shows a comparison between the values of K obtained 
by fitting the data in various ways, this parameter being chosen 
because it is the least well-defined for the experimental design con­
sidered. The other parameters were, however, examined and showed 
qualitatively similar behaviour. The values tabulated are root-mean- 
square deviations from the true value, 5.0. The "full robust" method 
was as described in the Theory section; in the "variable sigma ratio" 
method the biweight adjustment was suppressed; in "relative least 
squares" the coefficient of variation was assumed to be constant; in 
"simple least squares" the standard deviation was assumed to be con­
stant.
T a b le J. C o m p a r iso n  o f  M e th o d s  fo r  P a r a m e te r  E s t im a t i o n
Full
Robust
Variable Relative Simple
0. Sigma Least Least
Ratio Squares Squares
1.00 0.00 0.669 0.592 1.162 0.596
0.80 0.01 0.581 0.502 1.085 0.488
0.50 0.02 0.476 0.442 0.647 0.511
0.30 0.03 0.512 0.499 0.497 0.727
0.00 0.05 0.746 0.641 0.590 1.016
quate for parameter estimation. This may be judged by considering the 
results in Table 3, where the estimates of K obtained by the robust 
method are compared with those given by least squares with an 
assumed weighting function, assuming either simple errors or relative 
errors. It may be seen that the behaviour with this more complex 
model is entirely consistent with what we observed previously with the 
Michaelis-Menten equation (Cornish-Bowden and Endrényi, 1981): the 
robust method always gives parameter estimates that are almost as 
good as those given by the best method, and it is sometimes much 
better than least squares with assumed weights. When there are no 
outliers in the data (as here) the inclusion of the biweight method has 
a deleterious effect on parameter estimation, but this is not serious.
Protection against outliers
To test whether the full robust method gave the expected protec­
tion against outliers, we carried out further simulations in which 
outliers were introduced into the data in various proportions. In these 
experiments the sigma ratio was not varied but was set at 10, i.e. a 
low value in relation to the majority of observed rates: this accords 
with the reasonable view that although for large rates the coefficient
317
Table k- E ffect of Outliers on Parameter Estimation
Simulated experiments similar to those in Tables 2 and 3 were 
carried out. However, the sigma ratio was not varied; instead o0 and 
a2 were held constant at 0.30 and 0.03 respectively. In addition, 
outliers were introduced in a proportion varying from 0 to 20%, with 
standard deviation 5-fold higher than that of the other observations. 
The top line, for 0% outliers, corresponds to line 4 of Table 3, but 
the details differ somewhat because of sampling variation. For further 
explanation, see the caption to Table 3.
Percentage Full
Robust
Variable Relative Simple
of
Outliers
Sigma
Ratio
Least
Squares
Least
Squares
0 0.507 0.A73 0.550 0.635
a 0.38A 0.A21 0.606 0.531
8 0.306 0.A83 O.A75 0.676
12 0.351 0. A66 0.A93 0.5A3
16 0.3A5 0.A81 0. A60 0.7A3
20 0.309 0.399 0.A35 0.619
DISCUSSION
As the robust method discussed in this chapter is intended to 
fulfil a dual role, not only overcoming the usual need in least-squares 
calculations for prior knowledge of the weighting function, but also 
offering protection against outliers in the data, we need to consider 
these two points separately when examining its performance. In 
principle, and depending on what prior knowledge one has, the two 
features can be applied independently of one another, and the 
computer program based on the method (Cornish-Bowden, 1985) does
allow this in practice: if one is confident that there are no outliers 
in the data one can suppress the biweight adjustment, and if one has 
independent information about the weighting function one can specify 
the sigma ratio, or, if preferred, the weighting exponent a favoured 
by Askelöf et_ al. (1976).
Considering the results in Table 3, one can see that adjustment of
318
of variation may be virtually a constant one cannot expect to measure 
a zero rate with perfect accuracy, and so there ought to be a "base­
line" effect at small rates. The inclusion of the biweight adjustment in 
the robust method does indeed provide protection against outliers 
(Table A), and there is a marked advantage in using it even with 
only A% outliers, i.e. an average of one outlier per experiment.
the sigma ratio without use of the biweight method incurs virtually no 
cost: in the top line, it gave a slightly better result than correctly 
weighted least squares (simple least squares in this case), whereas in 
the bottom line it was only marginally inferior to correctly weighted 
least squares (now relative). Nonetheless, the biweight method does 
provide excellent protection against outliers (Table 4), and it incurs 
relatively little cost in precision when no outliers are in fact present 
(Table 3). One can conclude, therefore, that the full robust method 
should be the method of choice in most circumstances.
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DISCUSSION
ENDRÉNYI:
Drs. Mannervik and Cornish-Bowden called attention in 
their presentation at the importance and usefulness of 
residual plots. These can be applied even when the data 
are not collected as carefully as in Dr. Mannervik's in­
vestigations and, therefore, a single residual plot can 
be quite scattered and yield little information.
Quite frequently, only a few observations are collected 
in one experiment, but then other experiments are obtained 
either repeating the earlier ones or by changing the ex­
perimental conditions such as the concentration of an in­
hibitor or modifier, the pH or temperature. In such cases 
it can be recommended that the residual plots drawn in all 
studies be spread out on a table and viewed together. Even 
when the information from any one of them is slight, col­
lectively they provide a powerful indication about the 
correctness of the model and about the features of the 
errors.
MANNERVIK:
I would not like to leave the audience with the impression 
that we suggest that one should restrict the evaluation of 
error structure to the use of replicates. As I referred to 
in my contribution earlier, we have suggested a method to 
determine the error structure based on analysis of resid­
uals obtained by regression analysis (Mannervik, B., 
Jakobson, I. and Warholm, M., Biochim. Biophys. Acta, 567, 
43. 1979). A precondition is the availability of residuals 
from a good fit of the data. The rationale for the proce­
dure being that the residuals of a precise and unbiased fit 
should reflect the experimental variance. Neighbouring 
residuals are grouped in clusters of at least 5 and the 
mean of their squared values is used as a measure of the 
local variance. These estimates are then used to formulate 
an empirical function expressing the error as a function
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of velocity or, more accurately in our case, of substrate 
and inhibitor concentrations. Thus, the kinetic data set 
itself, rather than separate replicate measurements, is 
used to elucidate the error structure.
CORNISH-BOWDEN:
I don't think this requires any addition from me. 
KRETSCHMER:
How can one come to the minimum in parameter space; are 
there reasons for a Monte Carlo (evolution) method to be 
applied instead of the steepest descent method? This 
question arises in cases of complicated model equations, 
perhaps with more than one "best solution".
CORNISH-BOWDEN:
In the particular context of my paper there is no diffi­
culty, because I have been dealing solely with lineariz- 
able equations, specifically equations that are linear 
when written in reciprocal form. The program that I have 
described also has this restriction, though it is not a 
necessary one and there is no reason why our approach 
should not be extended to intrinsically non-linear models. 
Dr. Endrényi will show shortly that this gives excellent 
results. As a more complete answer to the question, I have 
rarely had occasion in recent years to use a general non­
linear regression program, but when I have done so I have 
used a combination of a Nelder-Mead simplex method (Neider
J.A. and Mead, R. , Comput. J. 1_, 2C8-313, 1965) in the 
early stages with a derivative-based method in the vicin­
ity of the minimum (Wharton, C.W., Cornish-Bowden, A., 
Brocklehurst, K. and Crook, E.M., Biochem. J. 141, 365-381 
1974). However, I make no special claims for this approach 
and I am sure that there have been advances in non-linear 
regression methodology during the past 15 or so years 
that I have not been aware of. If there is reason to 
believe that multiple minima exist then it is certainly
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worthwile to use some form of grid search or a Monte Carlo 
search of the kind you refer to; in many problems this is 
not necessary, however, and it can greatly increase the 
amount of computation needed.
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INTRODUCTION
Rigorous kinetic analysis of enzyme systems should involve statis­
tical methods for optimal design of experiments and proper parameter 
estimation. Graphical methods, although valuable adjuncts for prelimi­
nary evaluation of experimental data, have been largely replaced by 
regression analysis for more objective discrimination between rival 
mathematical models as well as for the determination of the constants 
in the rate equations. The refined techniques for analyzing experimen­
tal data make it possible to solve previously intractable problems that 
are necessary for unravelling the complexities of biochemical phenomena. 
For example, in steady-state enzyme kinetics it can no longer be consi­
dered adequate to restrict the analysis to the Michaelis-Menten equa­
tion and to the determination of the values of the kinetic constants 
V and Km . The first problem to be addressed is the choice of the "best" 
model out of a set of alternatives. The second, but not independent, 
problem is the estimation of accurate and precise parameter values in 
the model selected. For both these purposes the design of the experi­
ments should be optimized. Since the "best" model and the values of its 
constants are not known a priori, the optimal experimental conditions can 
not be defined. Therefore, a sequential procedure involving preliminary 
assumptions about model as well as constants is normally adopted. The 
results of the subsequent analysis will then serve as the basis for new 
and improved acquisition and treatment of data. The experimental and 
analytical protocol thus becomes an iterative procedure which is expec—  
ed to converge towards the optimal solution. Fig. 1 depicts such a
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strategy for design and analysis of enzyme kinetic experiments. Detailed 
accounts of procedures used in our laboratory have previously been pub­
lished (Mannervik and Bártfai, 1973; Mannervik 1981, 1982). Special em­
phasis has been put on the fundamental problem of discrimination between 
alternative models and how the analysis is affected by the location and 
spacing of the independent variables such as substrate and inhibitor 
concentrations. For example, a mathematical expression, the discrimina­
tion function, has been defined, which can be used for finding the opti­
mal experimental conditions for discrimination between two rival models 
(Bártfai and Mannervik, 1972). For optimal overall design, the integral 
or the sum of the values of the discrimination function in all experimen­
tal points should be maximized (Markus and Plesser, 1981; Mannervik,
1982).
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Fig. 1. Sequential strategy of design and analysis in mathematical model­ling of enzyme kinetic data. The design matrix for the experiments should be optimized with proper consideration of the error structure of the experimental system as well as the primary goal of the particular experi­ment (model discrimination or parameter estimation). For each point, the 
emphasis may shift as the investigation proceeds and the cycle is repea­
ted. (From Mannervik, 1981).
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However, neither the design for model discrimination nor the de­
sign for parameter estimation, which are normally not the same, can be 
adequately optimized without considering the error structure of the 
experimental data (Endrényi, 1981; Duggleby, 1979, 1981; Mannervik 1981, 
1982). The following section will therefore address the experimental 
variance in some detail.
EXPERIMENTAL ERROR
In enzyme kinetics determinations of reaction rates are used for 
elucidating the relationships between enzymatic activity and indepen­
dent variables such as substrate and inhibitor concentrations, pH, and 
temperature. The determinations are not error-free and it is important 
to know their nature and how they influence the analysis of experimen­
tal data. Traditionally, the experimental error can be divided into 
systematic error and random error. Most theoretical treatments tacitly 
assume that systematic errors, in cases where they exist, have been 
eliminated. In practice, however, it takes great care in the execution 
and evaluation of kinetic measurements in order to detect and minimize 
the effect of systematic deviations from the "unbiased" values. Some 
practical hints have been summarized by Nimmo and Atkins (1981).
The random experimental error is normally referred to as the depen 
dent (measured) variable and is considered due to factors that cannot 
be controlled by the investigator. For example, fluctuations of tempe­
rature in a reaction vessel or random oscillations in the electric 
current fed into the instrument used to monitor the reaction may contri­
bute to the random error. The following treatment is restricted to what 
would normally be regarded as random error. However, it will become evi­
dent that the error is not necessarily random with respect to the depen­
dent variable, but may be a function of the independent variables (Man­
nervik 1981, 1982; Mannervik et d L , 1986).
In enzyme kinetics, the experimental error has generally been 
associated with the measured velocity. Two types of errors have been assu 
med, constant absolute error (jLe.. independent of velocity) and constant 
relative error (_i_.e. proportional to velocity). Rigorous experimental
studies have demonstrated that different systems may display different 
error structures and that neither of these two types may apply. It is 
therefore mandatory to examine the particular system under investigation 
for adequate evaluation of its error properties (for references, see 
Mannervik, 1981, 1982).
In order to study the experimental error, the scatter in a set of 
measured data should be analyzed. A direct approach is to make repli­
cate measurements (n > 5) in several experimental points. This procedure 
will often necessitate a separate experiment exclusively for investiga­
ting the error. This may not appear attractive in many cases and an al­
ternative method based on the analysis of the residuals of an adequate 
fit of data set has been introduced (Mannervik et al_., 1979). The ratio­
nale behind the latter method is that the residuals of a good fit should 
be unbiased and reflect only the random error.
In studies of the error structure of enzyme kinetic data, we have 
demonstrated that in many cases the error is best described as a func­
tion of substrate and inhibitor concentrations (Mannervik, 1981, 1982; 
Mannervik et ^1_., 1986). For some experimental systems, the expression of 
error as a function of velocity is not only inferior but mathematically 
inadequate, since a particular velocity value may be generated by several 
combinations of, substrate and inhibitor concentrations and the
different combinations may be associated with different errors in the 
measured velocity (Mannervik et jil_., 1986). In the following, an example 
illustrating this phenomenon will be given.
EMPIRICAL ERROR FUNCTIONS - AN EXAMPLE INVOLVING GLUTATHIONE TRANSFERASE
It has been proposed that an empirical function should be used to 
model the error structure (Askelof et _al_., 1976). Originally, the treat­
ment involved the variance of the velocity, but in the case that reactant 
concentrations are used as variables in the modelling, we have found it 
simpler to use the square root of the variance, j_.!• > the standard devia­
tion, as the expression of error. Since in the practical applications we 
are restricted to the use of estimates of the standard deviations, it 
will be denoted by "s". Thus, the classical models of constant absolute
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and constant relative error can be expressed by the following equations, 
respectively:
s = <! (1)
s = Kj-v (2)
where K3 is an empirical constant, which can be estimated from experi­
mental data, and v is the velocity measured.
In order to account for other error types a more general error 
function was introduced (Siano et ^1_., 1975; Askelbf et jal_., 1976):
s = K]/ v^2 (3)
where l<2 is an additional empirical constant. (Eq. (3) was actually 
given in squared form since the variance of v, Var(v) = s^, was consi­
dered, but the expressions are equivalent). The previous models, Eqs. (1) 
and (2), are contained as the special cases where <2 = 0  and <2 = 1, 
respecti vely.
In the search for the best error model, it was found that for many 
experimental systems a function of substrate and inhibitor concentration 
was superior to Eq. (3) (or its special cases). Originally, power func­
tions similar to Eq. (3), but expressed in reactant concentrations, were 
tried (Mannervik, 1981). However, more recent studies demonstrated that 
in many cases an error function similar to the rate equation was a su­
perior alternative (Mannervik et ^1_., 1986). Thus, butyrylchol inesterase 
data that could be described by the rate equation (Augustinsson et al., 
1974):
Ki [A] + K2 [A]2
v = - - - - - - - - - - - - -  (4)
K3 + [A] + K4 [A]2
where A is the substrate and K] (i = 1-4) are constants, was found to 
have an error structure best described by Eq. (5) (Mannervik et al., 
1986):
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K 5 [A] + K g [A ]2
s = - - - - - - - - - - -  (5)
[A] + K 7 [A]2
The error function (Eq. 5) lacks the constant term in the denominator, 
but is otherwise of the same algebraic form as the rate equation, Eq.
(4). It was concluded that empirical error functions could mimic the 
rate equation or its degenerate forms.
A similar, but more extensive study with glutathione transferase 
4-4 purified from rat liver (Alin et al_., 1985) is summarized below. 
Steady-state kinetic experiments involving the concentrations of a sub­
strate (l-chloro-2,4-dinitrobenzene) and an inhibitor (indomethacin) 
as independent variables have been carried out. Replicate measurements 
(n = 5) were made for all combinations of 9 inhibitor concentrations 
(0-100 pM) and 6 substrate concentrations (3-1000 yM). The standard de­
viation, s, was calculated from the replicates in each experimental point 
and were analyzed by fitting alternative mathematical models to the data. 
In addition to Eqs. (1) - (3), several models derived from a general rate 
equation involving second-degree terms of both substrate and inhibitor 
concentrations were tested. The simplest model that still accounted for 
the essential traits of the nonlinear dependence of s on the independent 
variables was
Ki [A] + K2 [I]
s = - - - - - - - - - - -  (6)
K3 + [A] + K4 [I ]
where I denotes the inhibitor. Table 1 shows the results of the model­
ling. The residual sum of squares, obtained upon fitting a model to the 
estimated errors, shows that Eq. (1) (constant absolute error) is in­
ferior to the alternatives. Eq. (3) is clearly superior, as evidenced by 
its significantly lower residual sum of squares. It is also noteworthy 
that the value of K2 in Eq. (3) is significantly lower than 1.0, which 
excludes the assumption of constant relative error, úe.. Eq. (2). Equa­
tion (6) gives the lowest residual sum of squares and is the best alter­
native even though the standard deviations of its constant are high. The
Table 1. Alternative empirical models of the error structure of kinetic 
data obtained with rat glutathione transferase 4-4 using the concentra­
tions of l-chloro-2,4-dinitrobenzene (substrate) and indomethacin (inhi­
bitor) as independent variables. The initial velocity (v) is the depen­
dent variable, which was measured spectrophotometrically (Alin et al., 
1985). The standard deviation, s, was estimated by replicate measurements 
(n = 5) at 5 substrate and 9 inhibitor concentrations. Proper units are 
obtained by considering that concentrations are expressed in yM and velo­
city in s~l. SD is the asymptotic standard deviation obtained from the 
regression analysis.
Error model 
s =
Parameter 
+ SD
Kl IIiH 0.492
KlvK2 Ki = 0.161
K2 = 0.484
Kl [A]+K2 [I ] IIr—12Z 16.6
K3+[A]+K4 [I ] K2 = 352
*3 = 6060
K4 = 1730
al ues Residual sum 
of squares
+ 0.091 23.8
± 0.017 3.86
± 0.074
+ 21.5 2.60
+ 509
± 9010
± 2340
reason why an even simpler model was not chosen is that the dependence of 
s on the substrate and inhibitor concentrations requires terms of each in 
both numerator and denominator. Lower standard deviations of the con­
stants may be obtained by use of a larger number of experimental data.
The results of modelling the error are also illustrated by plots. 
Fig. 2 shows standard deviation versus velocity and the corresponding 
residual plot after fitting Eq. (3) to the data. The left panel appears 
to show a good fit of the model to the experimentally estimated values, 
but the right panel reveals the defect that the majority of the resi­
duals are negative and appear in a domain at the lower left corner of 
the residual plot. Fig. 3. displays standard deviation versus inhibitor
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Fig. 2. Error expressed as a function of velocity (dependent experimen­tal variable). The error was estimated by replicate measurements of the velocity of the glutathione transferase 4-4 catalyzed reaction at various combinations of substrate and inhibitor concentrations (£f. Table 1). Equation (3) was fitted to the experimental error values by nonlinear regression. The left panel shows observed (0), predicted (P) and coinci­ding observed and predicted values (*) plotted versus velocity. The right panel shows the corresponding residual plot; the numerals give the num­ber of coinciding residual values at a given point.
I I M I B
Fig. 3. Error expressed as a function of inhibitor concentration (one of the independent experimental variables). The effect of the inhibitor concentration was tested at several fixed concentrations of substrate.The data are identical to those in Fig. 1 and Table 1, but the error was fitted using Eq. (6), which is a function of substrate and inhibitor con­centrations. The cluster of nonrandomly distributed residuals in Fig. 2 was not obtained (in any of a variety of residual plots) upon regression 
analysis according to Eq. (6).
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concentration and the corresponding residual plot after regression accord­
ing to Eq. (6 ). The nonlinear dependence on inhibitor concentration is 
evident (left panel) and the residuals (right panel) are distributed more 
randomly than for the other models. Even though the advantage of using 
Eq. (6 ) rather than Eq. (3) is not dramatic, it is still clear that it 
represents an improved account of the relationship between error and the 
experimental variables.
In order to examine the effects of different weighting factors on 
the estimation of the parameters in the rate equation, the results pre­
sented in Table 1 were used. The rate equation that provides the "best" 
representation of the data was fitted by nonlinear regression according 
to various weighting schemes. Table 2 shows the equation and the kinetic 
parameters obtained in three different cases. It is clear that the values 
of the constants differ significantly when the values computed under the 
assumption of constant absolute error are compared with the corresponding 
values computed by use of the alternative error structures. The diffe­
rences between the values obtained in the last two cases are relatively 
small, but it may be noted that the ratio between the standard deviations 
and the parameter values for Ki, K4 and Kg are lower when Eq. (6 ) is 
used. The values of Ki and K4 are of special importance since they con­
tribute heavily to the rate-behavior of the kinetic model. Thus, on the 
basis of the overall analysis of the results, we conclude that Eq. (6 ) is 
the best representation of the experimental error of the alternatives 
tested.
Since the improvement of using an error model based on substrate 
and inhibitor concentrations, rather than on velocity, was only mode­
rate for the experimental system presented here, it is worth emphasi­
zing that in the case of acetylcholinesterase, Eq. (3) was clearly in­
adequate and a model similar to the rate equation was significantly bet­
ter (Mannervik et a K , 1986). The establishing of the best error function 
may be of importance for the computing of the kinetic constants, and, 
consequently the prediction of the rate-behavior of the system. This, in 
turn, will affect the optimal design of experiments both for model dis­
crimination and for parameter estimation.
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Table 2. Effect on parameter estimation of using different weighting pro­
cedures. Kinetic data for rat glutathione transferase 4-4 were analyzed 
by weighted nonlinear regression analysis using the rate equation
K i [A]+K2 [A]2+k 3 [A]2[I]
v = - - - - - — - - - - - - - - - - - - - - - - - - - - - - - - - - - -
K4+ [A]+K5 [A] [I]+K6 [A][I]2+K7 [A]2[I]+Kg[A]2[I]2
where v is initial velocity, A is l-chloro-2,4-dinitrobenzene (sub­
strate), I is indomethacin (inhibitor), and K-j (i = 1-8) the constants 
of the equation that should be estimated. The values of the constants 
are given ± the asymptotic standard deviations obtained from the re­
gression analysis. Initial velocities were determined spectrophotometri- 
cal 1 y (Alin et al_., 1985). Proper units are obtained by considering that 
concentrations are expressed in pM and velocity in s*l.
Parameter Weighting factor (wi = s^*2 )
s= 0.492
16.6[A]+352[ I ]
s- 0.158 • v 0-849 s-
6060+[A]+1730[I]
Kl 4.306 ± 0.813 5.472 + 0.813 5.659 + 0.563
k 2 0.033 + 0.001 0.031 + 0.001 0.032 + 0.002
l<3 0.010 + 0.003 0.011 + 0.003 0.017 + 0.007
k 4 21.30 ± 8.93 34.68 + 7.57 33.44 + 3.93
K5 0.114 + 0.060 0.129 + 0.046 0.169 + 0.069
k6 0.0020+ 0.0018 0.0023+ 0.0008 0.0033+ 0.0017
K7 0.0016+ 0.0017 0.0016+ 0.0002 0.0022+ 0.0007
<8 ( 1 . 3 + 1 . 5 M 0 - 5 ( 1 . 3 + 1 . 2 M 0 - 5 (3.1±2.6)-IO"5
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CONCLUSION
The results showing that experimental error can be adequately re­
presented by an empirical function of substrate and inhibitor concen­
trations suggest that errors in the independent variables are more im­
portant than errors in the determination of the velocity. This conclu­
sion contrasts with the general views on the nature of experimental error 
in enzyme kinetic experiments. The finding that the rate equation can 
serve as a model for the error structure raises the question about the 
origin of the error. In the spectrophotometric assays used in our work, 
in which the velocities can be determined fairly accurately, it appears 
as if the error arises primarily in the pipetting of reactant solutions. 
These errors may be transmitted via the rate equation to be expressed as 
a composite error in velocity. It should be noted that under general 
statistical assumptions, the error in velocity, sv, can be expressed as 
a linear combination of the errors in substrate, s/\, and inhibitor con­
centrations, si, provided that the covariance between substrate and in­
hibitor concentrations is zero (which is probable):
The partial derivatives of the rate equation with respect to substrate 
and inhibitor concentrations may be calculated analytically (if the model 
is known), and it is clear that these values act as multipliers that may 
magnify a relatively small s/\ or sj. Therefore, as indicated by the pres­
ent analysis, it is not excluded that the small error that has been es­
timated for substrate concentration (Askelöf et al_., 1976) will contribute 
significantly to the error measured in velocity. This finding emphasizes 
even more strongly the necessity of examining the error structure for each 
experimental system (Mannervik, 1981, 1982).
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DISCUSSION
MARKUS:
I would like to remark that discrimination design, as you 
have described it, can be refined to yield more accurate 
predictions of experiments. In this refined method, which 
I cannot describe here in detail, the mathematical ex­
pectation of the minima of sum of squares fitting with 
one model and that fitting with the other model are 
evaluated and compared. This evaluation includes the er­
rors and covariances of the model parameters as well as 
those of the measurements (V.V. Fedorov and A. Pazman, 
Fortschr. Physik, 2_4 , 325-355. 1 968). Using simulated 
biochemical experiments, we tested this method, obtaining 
more accurate results than by just comparing the model 
predictions (M. Markus and Th. Plesser, in: "Kinetic Data 
Analysis", 1981, Plenum Press, N.Y., pp. 317-339.). The 
method can be used for initial rate measurements as well 
as for progress curves. However, it needs considerably 
longer computing times than your method.
MANNERVIK:
Thank you for this clarification of how our method can be 
extended. We have certainly thought about the effect of 
the experimental error, but we have not incorporated this 
in our calculations.
ENDRÉNYI:
Dr. Mannervik's excellent and refined experiments are 
more extensive and more careful than those of most in­
vestigators. Therefore, the thoughtful evaluation of the 
variance relationship may not be available to most. How­
ever, it may still be possible to look at the residuals 
and reach conclusions about the behaviour of the errors. 
It may also be possible to plot the logarithm of the 
squared residuals against the logarithm of squares of the 
velocities predicted by the model. These diagrams would
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show rather scattered data points but their trend and 
qualitative information should be similar to those given 
more carefully and thoughtfully by Dr. Mannervik.
MANNERVIK:
Let me first remind you that analysis of the residuals 
of a good fit is indeed a method that we have proposed 
and used in our studies. However, our attempts to base 
the analysis on individual residuals, using squared or 
absolute values, were not successful, since single values 
were too inaccurate as estimates of the error. Therefore, 
the error function had to be based on groups of residuals 
in order to obtain reasonable estimates of the variance. 
Nevertheless, inspection of plots of individual values, 
as you suggest, will give a qualitative picture that may 
be useful.
CORNISH-BOWDEN:
As Dr. Mannervik has shown us, residual plots can be 
very useful, and now that many experiments are analysed 
by computer it would hardly be an exaggeration to say 
that residual plots are the most important kind of plots 
there are. And the most important thing about them is 
that they must be plotted! They don't have to be drawn 
carefully and accurately, as a residual is almost by 
definition an inaccurate quantity, and they don't have 
to look beautiful or to be suitable for publication. It 
is much better to spend a few minutes drawing a residual 
plot roughly than to spend a week thinking about drawing 
one carefully and then not doing it. A good computer 
program should supply residual plots automatically and 
not rely on the zeal of user.
MANNERVIK:
I agree completely. As stressed in my lecture, examina­
tion of residuals is the most informative of the criteria 
we use for judging goodness-of-fit and for discrimination. 
The computer program we have adopted provides plots of
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residuals versus the dependent and all the independent 
variables (such as substrate and inhibition concentra­
tions) .
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INTRODUCTION
Antibody-dependent cellular cytotoxicity (ADCC) occurs when target 
cells coated with IgG anti-target antibodies bind to Fc receptors (FcyR) 
on effector cells, leading to effector-target conjugates and subsequent 
target cell lysis (Möller, 1965; Lovchik and Hong, 1977). Because FcyR 
have been extensively characterized using either solution phase IgG (Dower 
et al., 1981a) or anti-FcyR monoclonal antibodies (mAb) as ligand 
(Unkeless et al., 1981), and because target cell lysis occurs shortly 
after conjugate formation and is easy to measure, ADCC can serve as a 
convenient prototypic system for examining the process and consequences 
of cell-cell interactions. In this paper we will discuss the mechanism 
of conjugate formation between antibody-coated target cells and cells 
from the P388D^ mouse macrophage line. We will then show that conjugates 
can be formed artifically using hetero-cross linked antibodies, and 
examine the requirements for triggering lysis when effector:target 
conjugates are formed using cross linked antibodies.
RESULTS
Measurement of Conjugates. Figure 1 demonstrates the technique which 
we have used to measure FcyR-dependent conjugates (Segal and Stephany, 
1984a). P388Di cells and antibody-coated spleen cells were directly 
labeled with green and red-emitting fluorophores, respectively. They were 
then mixed and analyzed at various times for red and green fluorescence 
with a dual laser flow cytometer. After 2 min of incubation (Fig. 1A), 
most particles were either red (free spleen cells) or green (free P388D^).
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Even at this early time, however, a small number of conjugates could be 
detected (particles that were both red and green), and this number in­
creased progressively with the time of incubation, (Fig. 1B-D). The 
kinetics of both conjugate formation and the loss of unconjugated spleen or 
P388Dq cells were followed by measuring the relative percentages of parti­
cles within the areas designated in Figure ID at varying time intervals. 
Conjugate formation, spleen cell depletion, and P388D;l depletion, follow 
first order kinetics with similar rate constants for all three processes 
(Fig. 2).
Fig. 1. Formation of conjugates as a function of time. At 0 time, 
P388Di cells were mixed with antibody-coated mouse spleen cells.
Cells were then incubated at 4°C with slow rotation, and samples were 
taken for cytometric analysis at varying times. P388Di cells were 
labeled with a green fluorophore, fluorescein isothiocyanate, and spleen 
cells were labeled with a red fluorophore (substituted rhodamine 
isothiocyanate-XRITC). When analyzed by dual parameter flow cytometry, 
free spleen cells, free P388Di, and conjugates can be quantitated in a 
single sample as shown in panel D.
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Fig. 2. Kinetics of conjugate formation at 4°C. The percentages of 
cells in conjugates ( A), free spleen cells (O) and free P388D^ cells 
(□) were determined as indicated in Fig. 1. Data were fit to single 
exponential functions (curves drawn through data points), yielding first 
order rate constants of .048, .042, and .062 min-  ^for conjugate formation, 
spleen cell depletion, and P388D^ depletion, respectively.
Number of Spleen and P388Di Cells in Conjugates. In order to examine 
cellular distributions within conjugates, we mixed varying amounts of anti­
body-coated spleen cells with a fixed concentration of P388D^ cells and 
allowed conjugates to form. The cells were diluted and analyzed in the 
cytometer for free and conjugated cells. The fluorescence of cells with­
in conjugates was then compared with the fluorescence of unconjugated cells. 
In Figure 3A-C, the green fluorescence of conjugated P388D^ cells (i.e., 
particles which were both red and green) is plotted as the dashed curve, 
while the fluorescence of unconjugated P388D^ cells (cells which were 
red negative) is plotted as the solid curve. Because the fluorescence 
distributions of free and conjugated P388Di cells superimpose over a 
wide range of spleen:P388D^ ratios, the conjugates formed between 
P388D^ cells and antibody—coated splenocytes contain one P388D^ cell
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Fig. 3. Comparison of the fluorescence distributions of conjugated and 
unconjugated cells. In A—C the (green) fluorescence profiles of unconju— 
gated P388D^ cells (solid lines) are superimposed upon those of the con­
jugated cells (dashed lines). The curves have been scaled so that the 
fluorescence 1-positive peaks have identical heights. In D-F the (red) 
fluorescence profiles from spleen cells are plotted for the unconjugated 
(solid line) and conjugated (dashed line) cells, similar to A-C. Ratios 
of spleen:P388Dx cells in the original mixtures are indicated in the 
figure. The density of P388D^ cells was kept constant at 1x10^ cells/ml, 
and the density of spleen cells was varied to give the indicated ratios. 
Cell mixtures were maintained in suspension for 2-3 h at 4°C prior to 
analysis.
within experimental error. By contrast, the red fluorescence due to 
spleen cells in conjugates is greater than the fluorescence of unconju­
gated spleen cells, and the difference increases as the spleen:P388Dx
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ratio increases (Fig. 3 D-F). When spleen and P388Di cells were mixed at a 
ratio of about 7:1 (Fig. 3D) most P388D^ cells within the conjugates were 
associated with more than one spleen cell. The fluorescence values in Fig­
ure 3 are plotted on a logarithmic scale, and a factor of two increase in 
fluorescence corresponds to about six channels. Using this value we esti­
mate that the conjugate peak in Figure 3D is 2.7 times as bright as that 
for the unconjugated cells. This suggests that aggregates within this 
peak contain mainly two and three spleen cells bound to one P388Dq cell.
In addition the conjugates in Figure 3D also exhibited a small shoulder 
corresponding to one spleen cell bound to one P388D^. As the ratio of 
spleen cells:P388D^ decreases (Fig. 3E) the conjugate peak moves closer 
to that of the unconjugated cells, corresponding to an average of 1.9 
spleen cells per P388D^ cell. Moreover, the shoulder arising from 
doublets (i.e., 1 spleenrl P388D^) has increased in relative area; and 
a third shoulder, corresponding to conjugates which exhibit less red 
fluorescence than a single splenocyte also becomes apparent. At the lowest 
ratio tested (Fig. 3F), the major peak still corresponds to 1.9 spleen :1 
P388Di, but the two shoulders have become more pronounced. We are not yet 
certain as to the origin of the population of P388Dp cells that has bound 
less red flurophore than is present on an unconjugated spleen cell. Appar­
ently some spleen cells lose some of their bound flurophoresafter forming 
conjugates.
Aggregation Rates Plateau at High Cell Densities. Antibody-coated 
spleen cells were mixed with P388D]! cells at relative cell densities of 1, 
2, 4, 8, and 16. Conjugate formation was followed as a function of time 
at each cell density, and the kinetics were fit to single first-order 
equations (Segal and Stephany, 1984b). The kinetic parameters (rate con­
stants and extents of aggregation derived from these analyses) are plotted 
in Figure 4 vs relative cell density. Figure 4 shows that the rate of 
aggregation increases hyperbolically with cell density, approaching a 
plateau at high cell density; by contrast the final extent of aggregation 
is nearly independent of cell density over the range of densities examined. 
In the experiment shown in Fig. 4, the cells were constantly mixed in a 
turbulent suspension. If, Instead, the cells were rotated in a non- 
turbulent suspension so that they were constantly falling at 1 G, then 
the aggregation rate never became independent of cell density (data not 
shown). The following experiments were done under conditions where 
aggregation rate is independent of cell density.
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Fig. 4. Formation of conjugates at varying cell densities. Cells were 
mixed at varying dilutions, and conjugate formation was folowed as a 
function of time at 4°C. Kinetics of conjugate formation were then 
analyzed and the rate constants and extents of conjugate formation were 
plotted vs cell density. A relative cell density of 16 corresponds to 
1.1x10^ P388D^ cells/ml and 2.1x10^ antibody-coated spleen cells/ml. The 
ratio of spleen to P388D^ cells was kept constant at all dilutions.
C e l l  S u r f a c e  D e n s i t i e s  o f  A n t i b o d y  a n d  F c y R  D e t e r m i n e  A g g r e g a t i o n
1 ? sRates. Spleen cells were treated with various concentrations of I-labeled 
antibody, and after washing, the numbers of antibody molecules bound per 
cell were determined (Segal and Stephany, 1984b). Cells coated with 
different amounts of antibody were then mixed with P388D^ cells and 
aggregation was followed in the cytometer. In Figure 5A and B, the extents 
and rates of conjugate formation are plotted as a function of the antibody 
density on the spleen cells; these data show that the extent of con­
jugate formation approaches a plateau for increasing antibody density, 
in contrast to the rate of aggretation, which continues to increase as 
the amount of bound antibody increases.
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Fig. 5. Kinetics of conjugate formation at varying antibody (A,B) or 
FcyR (C,D) densities. Spleen cells were treated with varying concen­
trations of antibody, and P388D^ cells with varying concentrations of 
anti-FcyR to produce populations of spleen cells with varying cell 
surface antibody densities and populations of P388Dy cells with varying 
free FcyR densities. A and B, untreated P388Dp were mixed with the 
various populations of spleen cells; C and D, a single preparation of 
antibody-coated spleen cells was mixed with the various P388D^ populations. 
A and C, extents of conjugate formation, B and D, first-order rate 
constants.
In a second experiment, P388Dy cells were treated with graded concen­
trations of the 2.4G2, anti-FcyR monoclonal antibody, and after washing, 
the numbers of free FcyR were determined by measuring the amount of radio- 
labeled cross-linked IgG bound at saturation. Hiese cells were then mixed 
with spleen cells coated with a constant amount of antibody, and the rates 
and extents of aggregation were measured as a function of time (Fig. 5C 
and D). Again, the extent of aggregation approaches a plateau while the 
rate of aggregation continues to rise with increasing free receptor density. 
In this experiment, the aggregation rate appears to increase exponentially 
with receptor density, with exponent values of 1.5 to 2.5 giving satis­
factory fits to the data. The data of Figure 5 demonstrate that the 
rate-limiting step of aggregation is critically dependent upon both 
ligand (antibody) and receptor densities on the cell surfaces.
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Reversibility of Conjugate Formation. To test whether aggregation 
was reversible, antibody-coated spleen cells were mixed with P388Dp cells 
at a 6:4 ratio for 2 hr at 4°C (Segal and Stephany, 1984b). At this time 
24% of the particles were conjugates with approximately 1.7 spleen cell/ 
P388D|. Samples of these cells were then diluted 20-fold in either 
medium alone or in medium containing 10 pg/ml 2.4G2, 45 (ig/ml cross- 
linked IgG, or 100 pg/ml protein A, and were incubated for varying 
times at room temperature (24°C). Figure 6 shows that conjugates are 
relatively stable when diluted in medium, decreasing from 23.0 to 19.2% 
of the particles over a 160-min period. In the presence of reagents 
that bind to either FcyR (cross-linked IgG and 2.4G2) or the Fc 
portion of IgG (protein A), however, the conjugates rapidly disaggregate. 
These experiments demonstrate that conjugates are stable when diluted in 
medium, but are readily disaggregated by reagents that sequester free 
ligand or free receptor.
Fig. 6. The disaggregation of conjugates at 24°C. Conjugates between 
P388Dp cells and antibody-coated spleen cells were allowed to form for 2 hr 
at 4°C. Conjugates were then (time zero) diluted 20-fold into medium con­
taining (i\.) no additives; ( 0 )  100 pg/ml protein A; (Cl) 45 pg/ml cross- 
linked IgG; and (A) 10 pg/ml anti-FcyR antibody. Samples were then 
slowly rotated at 24°C and samples were taken for analysis at varying 
times.
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Mechanism of Conjugate Formation. Taken together, our data de­
lineate some of the essential features of the mechanism of intercellular 
aggregation between P388D^ cells and antibody-coated spleen cells at 4“C. 
First the observation that the rate of aggregation reaches a plateau 
with increasing cell density (Fig. 4) suggests that the rate-limiting step 
in conjugate formation, at high cell densities and with rapid mixing, is 
not the rate at which cells collide. If it were, then the rate of con­
jugate formation would increase fourfold for each doubling of cell density, 
in clear disagreement with the experimental results. Presumably, the 
collision step is relatively rapid, resulting in unstable intermediates 
that are not detected because they are disrupted by the flow stream of 
the cytometer. We can therefore represent aggregation as
kl k2
occurring by the mechanism P + S <--> PS* — > PS, in which P and S
k_i
are free P388D^ and spleen cells, respectively, PS* is the unstable 
intermediate, and PS is the stable conjugates. Also, because more than 
one spleen cell can bind to one P388D^ cell (Fig. 3), other steps must 
occur in which one or more spleen cells bind to PS* or PS, giving rise to 
PSn. Conceivably, PS* could result from nonspecific weak interactions 
between cells, or alternatively, from the rapid formation of a few 
ligand-receptor bonds, insufficient in number to stabilize the conjugate. 
Our data do not distinguish between these possibilities.
At high cell concentrations, the rate of conjugate formation is 
strongly dependent upon both antibody and FcyR densities (Fig. 5), 
suggesting that, on a molecular level, the stabilization of PS* (i.e., 
the rate-limiting step, k2) involves the formation of ligand-receptor 
bonds. In addition, data published elsewhere demonstrate that the 
formation of ligand-receptor bonds occurs over a small fraction of the 
P388D^ and spleen cell surfaces, and utilizes only a small fraction of 
available antibody molecules or FcyR. Taken together, our results are 
consistent with a mechanism in which small patches of membrane from the 
P388D^ cells rapidly come into contact with patches of spleen cell 
membrane, followed by a slower formation of bonds between the ligands and 
receptors present in the areas of intercellular contact. In these areas, 
we would expect the rate of bond formation to be dependent upon the cell 
surface densities of ligand and receptor molecules, both of which increase
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as the total amounts of bound antibody or free receptors Increase. This 
could explain why the rate of conjugate formation is highly dependent 
upon bound antibody or free receptors (Fig. 5), even though only a small 
fraction of the antibodies and receptors are actually used in the formation 
of conjugates.
Once spleen cells have bound to P388D^ cells, they remain bound for 
relatively long periods of time, even in dilute suspension (Fig. 6, upper 
curve). In previous studies (Dower et al., 1981b), we showed that soluble, 
multivalent immune complexes also bind stably to P388D^ cells, but that 
they rapidly dissociate from the cell surface in the presence of high 
concentrations of monomeric IgG. Accelerated dissociation of immune 
complexes occurs because bonds between FcyR and the individual IgG 
subunits of the complexes are constantly being broken and reformed at 
the cell surface (Segal et al., 1983). The addition of monomeric IgG 
accelerates dissociation of the bound complexes by binding to free FcyR, 
thus preventing the reformation of broken bonds between FcyR and the 
IgG subunits of the immune complexes. We reasoned that if ligand-receptor 
bonds were constantly breaking and reforming at the cell:cell interface, 
similar to the situation with bound immune complexes, then dilution of 
performed conjugates into media containing reagents that sequested free 
antibody (protein A) or free receptors (2.4G2 and cross-linked IgG), 
would markedly accelerate the disaggregation of the conjugates. The 
data of Figure 6 show that our prediction was correct, and provide strong 
evidence for a model in which ligand-receptor bonds, although constant 
in number in the areas of intercellular contact, are continually being 
broken and reformed.
Conjugate Formation and Lysis Using Antibody Heteroaggregates. In 
this section, we demonstrate that conjugate formation and lysis can be 
induced by using covalently cross-linked antibody heteroaggregates that 
contain both anti-FcyR antibodies and antibodies directed against a 
target cell determinant. When effector cells bind such heteroaggregates 
to their FcyR, they will then specifically bind and lyse target cells 
that have not been opsonized, but which express the appropriate antigen 
(Karpovsky et al., 1984). Cells which have been coated with hetero­
aggregates are termed "franked" effector cells.
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The anti-murine FcyR antibody 2.4G2 (Unkeless, 1979), was cross 
linked with rabbit anti-DNP antibodies using the heterobifunctional 
reagent, SPDP. P388D^ cells were incubated with this preparation 
("anti-FcyR x anti-DNP"), washed, and tested for lysis against TNP- 
coated chicken red blood cells (TNP-CRBC). Figure 7 shows that franked 
P388D;l cells are potent lytic agents against TNP-CRBC, but do not lyse 
the target cells in the absence of added antibody. Lysis of antibody- 
coated target cells (classical ADCC) is shown for comparison. Lysis of 
TNP-CRBC also occurred when P388D^ cells were franked with anti-FcyR 
(Fab) x anti-DNP [F(ab')2 ], thus demonstrating that the Fc fragments 
of the antibody heteroaggregates are not involved in promoting lysis by 
franked effector cells.
w
CO>
occ
£
8 0 r
60 - 
40 -
20 -
Effector franked with
_ _ _ _ _ _ _ _ _ -----D 2.4G2 x anti - DNP
□ — —Q Effector franked withj •— ' 2.4G2 Fab x anti-DNP F(ab')2
/ // // /
Target coated with anti-DNP 
(Regular ADCCI
A --------- - ----------^  No antibody
1 3  10
EFFECTOR:TARGET RATIO
Fig. 7. Lysis of target cells by franked effectors. Lysis of TNP CRBC 
by P388D^ cells in a 20-h ^^Cr release assay. (D) P388D^ cells franked 
with 25 pg/ml anti-FcyR x anti-DNP tested against TNP CRBC. (.O') P388D^ 
cells franked with 25 pg/ml anti-FcyR Fab x anti-DNP F(ab' ) 2  tested 
against TNP CRBC. ( A ) Untreated P388D^ cells tested against TNP CRBC 
coated with anti-DNP antibody. (A) Untreated P388Dj^  cells tested against 
TNP CRBC.
I n  o t h e r  e x p e r i m e n t s  ( n o t  s h o w n )  w e  d e m o n s t r a t e d  t h a t  l y s i s  o f  T N P -  
CRBC b y  f r a n k e d  e f f e c t o r  c e l l s  w a s  T N P - s p e c i f i c ,  a n d  t h a t  t h i r d  p a r t y  
c e l l s  w e r e  n o t  l y s e d  b y  f r a n k e d  e f f e c t o r  c e l l s .
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Inhibition of Lysis and Conjugate Formation by Immune Complexes. 
Classical ADCC (lysis of antibody-coated target cells) is readily inhibited 
by immune complexes (MacLenan, 1972). However, because of the extremely 
high affinity with which 2.4G2 binds to FcyR (Unkeless, 1979), we would 
expect lysis mediated by franked effectors to be much less sensitive to 
immune complex inhibition. We therefore tested the ability of immune com­
plexes to inhibit cytolysis and conjugate formation using franked, armed 
(effected cells incubated with anti-DNP antibody and washed) (Greenberg 
and Shen, 1973), or untreated effector cells (Karpovsky et al. 1984).
CONCENTRATION OF IMMUNE COMPLEXES 1,/g/ml)
Fig. 8. Inhibition of lysis and conjugate formation by immune complexes. 
Immune complexes were first added to effector cells, followed by addition of 
the target cells. In both assays, the immune complexes were present during 
the entire course of the assay. (A) Inhibition of lysis in a 20-h -^Cr 
release assay at a 10:1 effector-to-target ratio. (B) Inhibition of con­
jugate formation as measured by flow cytometry. (O) Untreated P388Di cells 
interacting with TOP CRBC coated with anti-DNP antibody. (0) Armed P388Di 
cells interacting with TNP CRBC. ( A )  Franked P388D^ cells (anti-FcyR 
x anti-DNP) interacting with TNP CRBC.
In Fig. 8A, graded concentrations of immune complexes were incubated with 
effectors and targets in a 20-h 51Cr release assay. This figure shows 
that both the lysis of antibody-coated target cells by untreated P388Di 
cells and the lysis of TNP CRBC by P388Ü! cells armed with anti-DNP 
antibodies are readily blocked by low concentrations of immune complexes.
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By contrast, lysis of TNP CRBC by P388D]_ cells franked with anti-FcyR 
x anti-DNP is totally resistant to inhibition. As expected, the inhibition 
of conjugate formation followed the same pattern (Fig. 8B); in this experi­
ment, armed effector cells could not be tested for inhibition because too 
few conjugates formed in the absence of immune complexes.
Linkage of Target Cells to FcyR is Necessary for Lysis. To test 
whether linkage to FcyR was required for lysis mediated by franked 
effector cells, we formed conjugates in which the target cells were bound 
to MHC class I molecules on the effector cells rather than to FcyR.
This was done by cross-linking F(ab' ) 2 fragments from 34-1-2, a monoclonal 
antibody with specificity for Kd and Dd molecules, to F(ab')2 fragments 
from rabbit anti-DNP antibodies. P388D-^  cells (which are of the H-2d) 
haplotype) were then incubated with this material [anti-KdDd F(ab' ) 2  x 
anti-DNP F(ab')2 ], and their abilities to form conjugates and lyse TNP 
CRBC were compared with those of P388D-^  cells franked with anti-FcyR 
x anti-DNP. P388D^ cells treated with anti-KdDd F(ab' ) 2 anti-DNP F(ab' ) 2  
were even more effective at forming conjugates than were the P388D-^  cells 
franked with anti-FcyR. x anti-DNP (Fig. 9A). By contrast, only the 
cells franked with anti-FcyR x anti-DNP mediated a high degree of 
lysis (Fig. 9B).
CONJUGATE FORMATION LYSIS
ANTIBODY CONCENTRATION lwg/mll
Fig. 9. The requirement of linkage to FcyR for lysis of TNP CRBC by 
P388Dq cells. P388Dq cells were treated with various concentrations of 
anti-FcyR x anti-DNP (D) or anti-KdDd F(ab')2 x anti-DNP F(ab')2 (O) 
and analyzed for conjugate formation with TNP CRBC (A) or tested for cyto­
toxicity against TNP CRBC in a 20-h 51Cr release assay (B) at a 10:1 
effector-to-target ratio.
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TABLE I
Inhibition of Conjugate Formation and Lysis
P388Dj treated with:
Inhibitor3 Anti-KdDd F(ab')2 x Anti-FcyR x
anti-DNP F(ab')2 anti-DNP
Percent conjugates with TNP CRBC
None 26.8 15.5
Anti-FcyR mAb 23.6 0.6
Anti-K^ mAb 6.2 14.6
Percent lysis of TNP CRBCb
None 3.1 (1.1) 36.7 (0.9)
Anti-FcyR mAb 0.7 (0.9) 0.5 (0.5)
Anti-KdDd mAb 3.8 (0.3) 29.9 (0.6)
P388D-^  cells were pretreated with 0.5 mg/ml antibody inhibitor or with 
medium for 30 min at 0°C. Cross-linked heteroaggregates (25 pg/ml) 
were then added and the cells were incubated for an additional 30-min 
period at 0°C and washed.
b Means of triplicate samples followed by standard errors in parenthesis.
At effector-to-target ratios of 10:1.
The data in Table I show the results of experiments in which P388D^ 
cells were preincubated with a 20-fold excesses of either anti-FcyR mAb 
or anti- K'V mAb before treatment with antibody heteroaggregates. As ex­
pected, preincubation with free anti-FcyR mAb prevented conjugate for­
mation and lysis mediated by P388Di cells treated with anti-FcyR x anti- 
DNP, and preincubation with free anti-KdDd mAb inhibited conjugate formation 
by P388D^ cells treated with anti-KdDd F(ab' ) 2  x anti-DNP Fiab'^. When 
cells franked with anti-FcyR x anti-DNP were pretreated with anti-K^D^, 
only minor effects upon conjugate formation and lysis were observed, 
which demonstrates that the anti-class I antibody did not suppress lysis.
In an attempt to trigger lysis in nonlytic conjugates, P388Di cells were 
first treated with anti-FcyR, then with anti-KdDd F(ab' ) 2  x anti-DNP 
F(ab')2, and finally with TNP CRBC. Instead of triggering lysis, pre­
treatment of the effector cells with anti-FcyR inhibited the small 
amount of lysis (3.1%) mediated by the anti-KdDd F(ab' ) 2 x anti-DNP 
F(ab')2 -treated effectors. This suggests that FcyR were involved
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in lysis mediated by even these effectors. Such an involvement could 
arise, for example, if the anti-K^D^ F(ab' ) 2  x anti-DNP F(ab' ) 2  pre­
paration contained a small amount of contaminating intact antibody.
Further attempts to trigger lysis in nonlytic conjugates by adding immune 
complexes or Sepharose-linked 2.4G2 to preformed conjugates also failed 
(data not shown). Therefore, the cross-linking of FcyR in conjugates 
where the target cells are linked to class I molecules instead of directly 
to FcyR is not a lytic signal.
Implications for the Mechanism of ADCC. By using antibody hetero­
aggregates to form effector-target conjugates, several interesting 
observations have emerged regarding the mechanism of ADCC. First, the 
data of Fig. 8 show that ADCC can occur when FcyR are linked to the 
target cells through interactions different from those that normally 
occur between the ligand and receptor. However, linkage of targets to 
effectors through at least two other cell surface components, the and 
D^  molecules, does not result in lysis (Fig. 9). therefore, conjugate 
formation per se is not sufficient for lysis. Rather, the data suggest 
that ADCC requires, in addition to conjugate formation, other processes 
involving FcyR. To test whether the binding of antibody or ligand to 
FcyR could trigger lysis in nonlytic conjugates, we treated such 
conjugates with either 2.4G2 (Table I), soluble immune complexes, or 
2.4G2 bound to Sepharose beads. In no case did treatment of FcyR in 
nonlytic conjugates lead to lysis, which suggests that FcyR must be 
linked directly to the target cell in order for lysis to occur. Since 
extensive cross-linking of FcyR in nonlytic conjugates (by immune 
complexes or 2.4G2 Sepharose) did not trigger lysis, we also conclude 
that either cross-linking of FcyR is not a lytic signal or alternatively, 
that cross-linking of FcyR does trigger lysis, but that it must occur 
locally at the region of intercellular contact. The precise nature of 
the lytic signal remains one of the most intriguing questions concerning 
the mechanism of ADCC.
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DISCUSSION
DAMJANOVICH:
Is there any shearing force in the stream of a flow cyto­
meter separating the weakly bound effector and target 
cells?
Roughly how many bonds are necessary between the effector 
and target cells to form strongly bound conjugates.
SEGAL:
There are certainly shearing forces between the effector 
and target cells. In control experiments, which I didn't 
mention in my talk, we determined that shear forces had 
little effect upon the number of conjugates measured.
For example the same number of conjugates was detected 
cytometrically and microscopically, and varying the shear 
forces by varying the flow rates and nozzle sizes did 
not affect our results. Vortexing the cells did however 
reduce the number of conjugates which we detected.
As to the number of bonds required to form conjugates,
I can say that it is a low percentage of the total possi­
ble number of intercellular bonds, since we have titrated 
both the free receptor and ligand within conjugates, and 
have found them to be nearly equivalent to the numbers 
seen in the unconjugated cells. George Bell has calculated 
that only a few bonds should be required to form stable 
conjugates.
TRÓN:
I find it interesting that you have not found higher 
aggregates in your experiments. I think of aggregates with 
two or more macrophages linked by spleen cells. You have 
varied the concentration and the ratio of both kinds of 
cells, so one would expect, at least in some cases, higher 
aggregates of this type, too. My question is: do you think 
it is possible that these do exist, but the primarily 
formed aggregates are falling apart due to the friction
when speeding up during hydrodynamic focusing.
SEGAL:
This is certainly possible. However, we do not see very 
many conjugates containing multiple macrophages when we 
look at cell mixtures in the microscope.
ELSŐN:
Is there any electron microscopic evidence for localized 
degranulation of macrophage in the region of contact with 
target cell, (in analogy with degranulation observed in 
cytotoxic T-cells)?
SEGAL:
This should certainly be possible to do, especially since 
the cytometric technique possesses the ability to sort 
conjugates. However, we have not yet done these experi­
ments .
LUKÁCS:
There should be some Fc receptor cells among the spleen 
cells which could interact with the other antibody-coated 
spleen cells. But you showed no conjugate formation 
among the spleen cells. Did you remove the FcR positive 
cells from your target cells?
SEGAL:
Thank you for bringing this up. I neglected to mention 
that the spleen cells had been pretreated with the anti- 
Fc receptor antibody prior to experimentation.
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INTRODUCTION
During the past ten years Fluorescence Photobleaching Recovery (FPR) 
[also known as "Fluorescence Recovery (or Redistribution) after 
Photobleaching" or "Fluorescence Microphotolysis"], has been extensively 
used to characterize the lateral mobility of fluorescence labeled molecules 
in living cells and in chemically defined systems (Cherry 1979, Peters 
1981, Webb et al. 1981, Axelrod 1983, Helmreich and Elsőn 1984, Elsőn 
1985). A closely related method, Fluorescence Correlation Spectroscopy 
(FCS), has similar capabilities in principle but has been little used in 
practice because of technical difficulties in its application to living 
cells. As will be seen below, however, these difficulties can be 
circumvented in some applications to cells and need not prevent the 
application of FCS to appropriate noncellular systems. Both methods can be 
used to characterize not only lateral mobility but also the kinetics of 
chemical reaction systems as well, although this latter capability has been
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little exploited. Recently FPR has been applied to study cytoplasmic 
diffusion in living cells (Wojcieszyn et al. 1981, Jacobson and Wojcieszyn 
1984) including the diffusion of actin (Wang et al. 1982, Kreis et al. 
1982). As discussed below FPR is also being used to study mechanisms of 
polymerization and interactions of resolved cytoskeletal components. New 
applications of FCS have also arisen in studies of polymerization and 
aggregation (Petersen 1984, Petersen 1985). This paper provides an 
introduction to the basic ideas underlying FCS and FPR and discusses some 
new directions in the applications of these techniques.
Both methods depend on the same basic experimental process: 
measurement of the number of molecules of specified types via their 
fluorescence in a defined open volume of the experimental system as a 
function of time. In a chemical reaction system these numbers can change 
due either to their moving into or out of the region (diffusion, flow, or 
drift) or to their being created or destroyed by the chemical reaction. 
Hence the standard phenomenological diffusion coefficents and chemical rate 
constants can be determined from the measured rates of change of the local 
concentrations of the system components.
In an FPR experiment the system is displaced from equilibrium by using
a brief, intense pulse of light to photolyse irreversibly a fraction of the
fluorescent molecules in the observation region. Hence there is a
macroscopic gradient, Ac(r,t) = c(r,t) - c, between the concentration,
c(r,t), at position r and time t in the interior of the region and the
equilibrium concentration, c, in the unperturbed surrounding parts of the
system. This is gauged by a corresponding macroscopic displacement of the
measured fluorescence, AF(t) = F(t) - F. The measurement consists of
observing the relaxation of AF(t) which results from the dissipation of 
the concentration gradient (Axelrod et al. 1976).
360
In an FCS experiment, however, the system rests in equilibrium 
throughout the measurement. Rather than macroscopic changes of 
concentration and fluorescence, in an FCS experiment one observes the 
microscopic changes, SF(t), that result from the spontaneous concentration 
fluctuations, őc(r,t), that occur in the system even when in equilibrium. 
Observation of the dissipation of a macroscopic concentration displacement, 
as in an FPR experiment or more conventional method for measuring transport 
or kinetics, allows the determination of the desired phenomenological 
coefficients from measurements of individual transients. The accuracy of 
the determination is limited in principle only by the experimental accuracy 
of the measurement of the fluorescence transient. In contrast many
microscopic fluctuations must be measured in an FCS experiment. This is 
not only because the fluctuations are small and difficult to measure. Even 
if an individual fluctuation could be measured with high precision, the 
measurement would not determine the desired phenomenological coefficients 
with high accuracy. This is because the rates of dissipation of
microscopic fluctuations are determined by the phenomenological
coefficients only in a statistical sense. Hence for each measurement many 
fluctuations must be registered and analyzed statistically. This is 
usually accomplished by computing a fluorescence fluctuation
autocorrelation function, G(x) (Elsőn and Magde 1974, Magde et al. 1974,
Elsőn and Webb 1975):
G(t) = <ŐF(0)ŐF(I)> r Lim 1/E SF(t)6F(t+t) dt (1)
— S> °G
where <...> denotes an ensemble average and the second equation supplies an 
operational definition. (We have supposed that the system is in 
equilibrium and therefore is stationary.)
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Hence the principal experimental difference between FCS and FPR is in 
the size and number of the fluorescence transients that must be recorded. 
Therefore the apparatus, typically based on a fluorescence microscope with 
a laser light source, is very similar for the two kinds of measurements 
(Koppel et al. 1976). The requirements differ mainly in that FPR
measurements must have specialized electronics, optics and shutters for 
controlling the photobleaching pulse while FCS measurements demand the 
capability for computing G(t) from the large number of observed 
fluorescence fluctuations.
RELATION OF MEASUREMENTS TO PHENOMENOLOGICAL COEFFICIENTS
The primary experimental datum is a measurement of the fluorescence 
emitted from a small open region of the system as a function of time. Then 
6F(t) [or AF(t)] must be related to the őci(t) [or Aci(t)]. The
fluorescence emitted by component i from a position r is proportional to the 
concentration of the component ci(r,t) weighted by the excitation 
intensity I(r), and summed (integrated) over all positions:
AF(t) i Ii Qi J I(r)ACi(r,t) d2r (2)
where Qj accounts for the instrumental constants and for the absorption 
and fluorescence quantum yield of component i and we are assuming for 
simplicity that the system is confined to a plane. Similarly,
G( t ) = jQiQjJI(r)I(r')<6ci(r,0)6cj(r',t)>d2rd2r ' (3)
The dependence of the concentrations on position, time, and the 
phenomenological coefficients is determined from a system of differential 
equations which account for diffusion, systematic drift or flow and 
chemical reaction:
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96ci(r,t)/9t D j V ^ ő c i ( r , t )
(4)
ViőciCr.t)
+
where is the diffusion coefficient and V^ , the uniform drift or flow 
velocity in the x-direction for component i, and the T-j^ j characterize 
the contributions via chemical reactions of component j to the rate of 
change of the concentration of component i. To use these equations to 
characterize the macroscopic concentration changes observed in FPR 
experiments we must assume that the displacements of concentrations from 
their equilibrium values are small enough so that the kinetic equations 
describing any nonlinear chemical reactions can be linearized. The 
systematic translation along the x-direction characterized by the constant 
velocity Vi could be due to drift in a field (e.g. electorphoresis or 
sedimentation), to uniform motion of the sample relative to the probe beam, 
or to a uniform flow process. Nonuniform flow fields, e.g. as in flow 
through a channel, can be much more difficult to analyze (Magde et al. 
1978).
These equations are most simply solved for systems in which the 
overall dimensions are large compared to the size of the observation area 
so .that Sc£(r,t) = 0 at r = (+/-)“>. The initial conditions are 
different for FCS and FPR experiments. For the former one supposes that 
the system behaves ideally, which is usually justifiable at the low 
concentrations at which these experiments are carried out. Then, the 
number of molecules of each component in any volume will be independent of 
the concentration of any other component and will be governed by a Poisson 
distribution. Hence the variance of the number of molecules (i.e. the 
mean square fluctuation) will equal the mean number: 
<6ci(r,0)6cj(r' ,0)> r "ej Őj j ő(r-r') (Elsőn and Magde, 1974).
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In an FPR experiment the initial concentration gradient, Ac-i(r,0), is 
determined by the duration, T, and the intensity profile, I'(r), of the 
photobleaching pulse and by the mechanism of the bleaching reactions.
In the simplest FPR experiments the photobleaching intensity profile 
is an intensified version of the monitoring intensity profile: I*(r) = 
BI(r) where the constant B is typically in the range 10^  to 10^ . The 
simplest mechanistic assumption would hold that each fluorescent component 
of the system is irreversibly eliminated from the system independently of 
the others by a single first order process. Then,
dci(r,t)/dt = -y^I'(r)c^(r,t) (5a)
so that
Aci(r,0) = Ci{1 - expt-YiBKrjT]} (5b) 
where is the photochemical rate constant. The assumption of an
irreversible first order process may be only approximate and should be 
checked experimentally. Even if the individual bleaching events are 
irreversible and first order, the assumption that each of the components is 
eliminated independently of the others is inappropriate for some systems, 
especially those in which several fluorophores reside on a single kinetic 
unit as in multiple binding and polymerization systems. Then a more 
general model is required. If we continue to suppose that all 
photobleaching processes are first order in fluorophore concentrations, 
then we can represent the kinetics of a system of coupled reactions as: 
dcj(r,t)/dt = I' (r) Zj Pi,jCj(r, t) (6)
Then a complete evaluation of Equation (2) would in general require the 
determination of the eigenvalues and eigenvectors of Pi,j and the 
evaluation therefrom of the Ac (^r,0). With these boundary and initial 
conditions one can conveniently solve the kinetic equations using a Fourier
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transform approach (Elsőn and Magde 197*0.
Relatively general expressions for G(t) and AF(t) have been 
published (Icenogle and Elsőn 1983a, Elsőn 1985). For our present purpose, 
however, It is more illustrative to confine our attention to the simplest 
excitation beam shape and to single component systems. In the simplest and 
most frequently used "spot" approach a single circularly symmetric region
of the system is illuminated by a beam with a Gaussian intensity profile: 
P PI(r) = Iq exp(-2r /w ) where w is the exp(-2) radius of the intensity 
distribution and Iq is the (maximum) intensity at the center of the 
monitoring beam. Moreover I'(r) = BI(r) as indicated above. Then the 
characteristic time courses for correlation decay and fluorescence recovery 
for a single component are as follows:
G(t) a [1 + T/tp]"1 (7a)
and
AF(t) « In [(-K)n/n!][1 + n(1 + 2t/TD)]_1 (7b)
for diffusion where Tp = w2/4D;
G(t) a exp[-(t/TV)2] (7c)
and
AF(t) a In [(-K)n/(n + 1)! ]exp{[-2n/(n + DHt/iy)2} (7d)
for uniform flow or drift where Ty = w/V;
G(t) a exp[-(t/tv)2/(1 + T/ip)]/[1 + i/id) (7e)
and
AF(t) oc Zn (-K)nexp}-2(t/iv)2/[1 
{n! [ 1 + n( 1 + 2t/tD)]r1
+ 2t/TD)]}
(7f)
for simultaneous drift and flow.
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It is sometimes advantageous to bleach patterns more complicated than 
a circular spot onto the sample (Smith and McConnell 1978, Lanni and Ware 
1982, Davoust et al. 1982, Koppel and Sheetz 1983). Using periodic 
patterns simplifies the data analysis by yielding directly the Fourier 
components of the detected fluorescence recovery or decay processes (Koppel 
1981). Periodic patterns are also useful for detecting anisotropic 
transport. (Smith et al. 1979).
NEW APPLICATIONS
During the past few years FPR has been used to characterize the 
mechanism of polymerization of purified actin (Lanni et al. 1981, Tait and 
Frieden 1982a,b, Lanni and Ware 1984, Mozo-Villarias and Ware 1984) and the 
interactions of other protein molecules with actin microfilaments (Doi and 
Frieden 1984, Arakawa and Frieden 1984). When an actin monomer is
incorporated into a microfilament, its diffusion coefficient is strongly 
reduced. Hence measurements of the diffusion coefficients of fluorescence 
labeled actin could be used as an assay of the extent polymerization. It 
is possible to gain additional information about polymerization processes 
using FCS. This is due to the fact that FCS and FPR report different
moments of the distribution of aggregate or polymer sizes. This is readily 
illustrated by considering the initial values G(0) and AF(0) for a
distribution of aggregates or polymers, {AjJ. We shall suppose that the 
number of fluorophores on an A^  molecule is equal or proportional to i. 
Assuming a circular Gaussian intensity profile as above, G(0) = (P /nw )
0 _li Qi c^ . We shall also make the reasonable assumptions that the
fluorescence quantum yield is independent of i while the absorption
probability is proportional to i. Then, Qj = iQ-|. Hence G(0) =
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(P2Ql2/nw2) íj i2Ci. To facilitate comparison with this FCS
result we shall suppose that the correpsonding FPR measurements are
performed in the limit of low extents of bleaching. Then from Eq. (6)
Aci(r,0) = I'(r)T Ij pi,j^ j where T is the duration of the
photobleachlng pulse and we have assumed that the system components were 
present at their equilibrium values prior to photobleaching. Let L^  = 
Pt)jcj. Then the initial concentration distributions can be
represented as Ac£(r,0) = I'(r)TLi. Hence AF(0) = (p2BT/nw2)
QjLi- In this limit the mechanism which seems most plausible would
account for the first order disappearance of cj due to bleaching itself
and the first order appearance of c^  due to bleaching Ci+-|: dcj/dt =
I' (r )[--ViCi + Yi+1ci+1 ] • The probability of a photobleaching
event should be proportional to the number of fluorophores, yj = ÍY1-
Hence Li ; -YiCi + Yi+lci+1 = Yit-iCi + (i+1)ci+i]. This
yields Af(0) = (-P^ Ql Y1BT/7tw2) *i icj. Hence the amplitude G(0)
is proportional to the second and the amplitude AF(0) to the first moment 
of the distribution of aggregate concentrations.
This instance provides a simple example of how the result of an FPR 
experiment can depend on the mechanism of the photobleaching process. If, 
all the fluorophores were to be eliminated simultaneously in a single 
photochemical event rather than one at a time as proposed above, then it 
can be shown that AF(0) would also be proportional to the second moment of 
the distribution of aggregate sizes and therefore would be proportional to 
G(0). This sort of highly coupled bleaching process seems unlikely in the 
absence of an extraordinary extent of electronic coupling among the 
fluorophores. The dependence of FPR measurements on the mechanism of 
bleaching has been discussed in greater detail elsewhere (Icenogle and
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Elsőn 1983a,b, Elsőn 1985).
The dependence of G(t) on the second moment of the fluorophore 
aggregate distribution renders it potentially useful for characterizing 
multiple binding and polymerization equilibria. This potential is enhanced 
by methods for circumventing some of the technical difficulties that 
restrict the application of FCS experiments. One of these difficulties 
stems from the need for observing many fluctuations to obtain a 
sufficiently accurate G(x) and the consequent need for long periods of 
data acquisition. The period of data acquisition depends on the average 
duration of the fluctuations. If the principle mode of fluctuation 
relaxation is via diffusion, then the integration time for the experiment, 
E [the time required to measure enough fluctuations to yield a 
sufficiently accurate G(i), cf Eq. (1)], will be proportional to Td - 
w /4D. Hence E may be diminished by reducing w. The extent to which 
this may be done is, however, limited by the resolution limit set by the 
excitation wavelength. Another approach was used in one of the first 
fluorescence fluctuation experiments, a measurement of the molecular weight 
of DNA labeled with ethidium bromide (Weissman et al. 1976). The 
DNA-ethidium sample in a cylindrical cell was rotated through a laser beam 
which served as an excitation source. Hence, rather than measuring 
fluctuations in fluorophore concentration over time in a single region of 
the solution, this approach measures concentration fluctuations over space. 
In a homogeneous system in a steady state the two approaches should give 
equivalent results. The rate of rotation was sufficiently fast that each 
sampled region of the solution was traversed by the laser beam several 
times before there was substantial diffusional redistribution of the DNA 
molecules in the region. This provided a two-fold advantage. First, the
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time scale of the measured fluctuation was set by the rotation rate rather 
than the rate of diffusion of the DNA molecules. Hence G(i) could be 
acquired in a much shorter period of time. Second, the repetitive sampling 
of the regions gave rise to a periodic component to G(t) which could then 
be more readily separated from other fluorescence noise sources which were 
aperiodic (Weissman et al. 1976). Rotating the sample is not so readily 
accomplished with microscopic samples such as cells. Nevertheless the same 
concept can be applied either by scanning the laser beam over the cell 
(Koppel 1979) or by uniformly translating the cell through the laser beam 
(Petersen 1985). Suppose that the cell is translated at a constant 
velocity, V, which is sufficiently fast that no significant redistribution 
of fluorescent components in each sampled region occurs during the time 
required for the beam to traverse the region. Then G(x) - 
G(0)«xp[ (-T/Tv)2] [cf Eq. (7c)] and G(0) = (P2/nw2) Qi2e*i
as shown above. Hence a very useful aspect of this approach is that the 
measured G(t) should have a predictable time behavior, determined by V, 
which can be set as desired. This approach, called scanning FCS (s-FCS), 
has been developed by Petersen and applied to measure the extent of 
aggregation of fluorophores on the surfaces of cells (Petersen 1984, 1985). 
The fact that the scanning rate can be set as desired is useful both to 
increase the rate of acquisition of G(x) and to permit fitting the 
measured G(t) to a known functional form. Furthermore as shown above the 
FCS signal increases as the square of the number of fluorophores per 
aggregate and so becomes more readily measurable in systems of large 
aggregates such as polymers. Hence s-FCS circumvents some of the 
difficulties that impede the application of FCS to cells, and appears to be 
potentially quite useful for characterizing aggregate distributions both on 
the surface and in the cytoplasm of cells and in cell-free systems.
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Another recent development is the coupling of spot photobleaching with 
digital analysis of video images acquired using very low excitation 
intensities from fluorescence labeled cells. This approach has been used 
in an investigation of anisotropic diffusion of a lipid probe in lecithin 
bilayers above and below the lipid phase transiton (Kapitza et al. 1985). 
This work also demonstrated the applicability of the method to observing 
the growth of ligand-receptor clusters on cell surfaces. The approach has 
also been used to investigate the motions of actin microfilaments in the 
extending and retracting lamellipodia of migrating fibroblasts (Felder 
1984). In this work rhodamine-labeled actin was microinjected into 
fibroblasts in culture and allowed to integrate into the microfilament 
system (Kreis et al. 1982). Then, in an active cell a spot was bleached 
into the labeled actin a few microns behind the edge of an active 
lamellipodium. The labelled actin in microfilaments does not diffuse 
significantly on the time scale of the experiment. Hence, the bleached 
spot can be observed over a period of time. The motion of the spot was 
compared to that of the edge of the extending and retracting lamellipodium. 
It was observed that the spot did not experience detectable translation as 
the edge was advancing. In contrast, when the edge retracted the spot also 
retracted although at a slower velocity. This led to the conclusion that 
extension of the lamellipodium does not result from protrusion of formed 
microfiiaments driven by forces generated within the cell body. Rather it 
appears that the extension results from polymerization of actin at the cell 
edge.
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CONCLUSIONS
Although FCS and FPR are closely related methods which can be used for 
measuring reaction kinetics and lateral mobility, they have different 
domains of applicability. FPR is more suitable for studies on living cells 
and has been used extensively to characterize lateral diffusion on the 
surfaces and in the cytoplasm of living cells. Due to its dependence on 
the acquisition of an extended data record, FCS is less useful for studying 
dynamic processes on living cells but does seem likely to find applications 
in characterizing aggregation and multiple binding equilibria both in cells 
in cell-free systems.
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DISCUSSION
ZIDOVETZKI:
The diffusion process you described seems to be three- 
dimensional. Why, then, you treated it as a two-dimensional 
diffusion?
ELSŐN:
There is no need to take diffusion parallel to the optic 
axis of the microscope into account in the application of 
FPR to measure the lateral mobility of actin in lamellar 
regions of fibroblasts. This is because the thickness of 
the lamellar regions are comparable to or less than the 
depth of focus of the objective which was used. Hence 
motion parallel to the optic axis does not produce a 
change in fluorescence intensity and therefore does not 
contribute to the fluorescence recovery.
TRÓN:
Thinking only about the application of FRAP and FCS to 
determine protein lateral diffusion coefficients, the sen­
sitivity of the former is definitely superior to that of 
the FCS. However, using data averaging the signal/noise 
ratio can be increased remarkably in the case of FCS.
I wonder whether the significant difference in the fre­
quency of application of FRAP and FCS is entirely due to 
these different sensitivities or are there any other 
reasons?
ELSŐN:
The principal reason that FCS has found few applications 
is that it can be applied only to very stable systems and 
requires long periods of data acquisition to yield suf­
ficiently accurate correlation functions. FRAP is much 
less restricted by either of these considerations, since 
it requires the measurement only of a single fluorescence 
recovery transient. Signal averaging can be applied to 
FRAP measurements to improve precision in favourable
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instances in which 100 % fluorescence recovery is obtained 
(e.g. R.D. Icenagle and E.L. Elsőn, Biopolymers, 2_2 , 1 9 49— 
1966, 1983.). This however, is merely a matter of improving 
the signal to noise ratio. In contrast, in FCS statistical 
analysis of many microscopic fluctuation transients is 
required in principle to obtain accurate estimations of 
phenomenological parameters, (c.f. D.E. Koppel, Phys. Rev. 
A. _1_0, 1 938-1944 , 1974 .) .
CHERRY:
Did I understand correctly that the theory of coupled pho- 
tobleaching permits an experimental distinction to be 
made between monomeric and oligomeric proteins in mem­
branes?
ELSŐN:
In principle, FCS can be used to measure the degree of 
aggregation of proteins in membranes and in solution.
This results from the fact that FCS reports the second 
moment of the distribution of aggregate sizes, (c.f. D. 
Magde, W.W. Webb, E.L. Elsőn, Biopolymers, 17, 361-376, 
1978.) This approach is now being developed by N.O. Peter­
sen (Can. J. Biochem. Cell. Biol. 6_2 , 1 1 58-1 1 66, 1984).
The theory of coupled photobleaching explains why FPR, in 
contrast, reports the first moment of the size distribu­
tion (under typical conditions of low levels of photo- 
bleaching) and is, therefore, not as useful for character­
izing aggregate sizes.
GOLLOP:
What is the evidence that the laser beam doesn't cause 
changes in the cell other than photobleaching?
ELSŐN:
A variety of studies have shown that although the laser 
beam may cause adventitious photochemical reactions in 
the cell, those do not have a detectable effect on the 
diffusion coefficient measurements, (c.f.: K. Jacobson,
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Y. Hou, I. Wojcieszyn, Exp. Cell. Res., 116, 179-189, 1978; 
D.E. Wolf, M. Edidin, P.R. Dragsten, Proc. Natl. Acad. Sei. 
USA, 11, 2043-2045, 1980; C.-L. Wey, R. Cone, M. Edidin, 
Biophys. J. 33, 225-232, 1981; D.E. Koppel, M.P. Sheetz, 
Nature, 293, 159-161. 1981.)
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INTRODUCTION
The means by which cells swallow substances in their environment can be 
classified into two general categories. One includes a set of non specific 
processes such as fluid phase endocytosis in which villous surface 
structures bend back on themselves, trap fluid as they fuse with the 
membrane, and then pinch off as vesicles at the cytoplasmic surface. The 
other process avoids ingestion of large quantities of fluid and is mediated 
by ligand specific receptors. This review will focus on the latter, ligand 
specific mechanism.
Endocytosed receptors and ligand are often degraded, suggesting that at 
least one role for ligand specific endocytosis is the regulation of blood 
levels of signaling molecules. Another role is the regulation of 
intracellular concentrations of various substances such as low density 
lipoproteins which are needed for membrane synthesis. A considerable 
amount of dynamic and steady state data has appeared in recent years, 
describing various aspects of endocytosis such as binding,internalization, 
degradation and recycling in various receptor ligand systems. Mathematical 
models of some of these processes have been developed. In this paper we 
outline and briefly review the implications of a mathematical model which 
integrates the various features of endocytic processing including the 
relation between sorting pathways, and the modification of pathways when 
more than one ligand is present.
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THE MODEL
The cell surface is considered to be a two dimensional fluid in which 
receptors are more or less free to move, typically with diffusion 
coefficients of order 10 1(^ cm2/sec(Schlesinger et al, 1978). Most 
receptors that are unbound by ligand move freely in and out of coated pits, 
specialized surface structures that under normal conditions continually 
close on themselves to form vesicles at the cytoplasmic side of the 
membrane, and subsequently return to the surface. There are some 
exceptions to free mobility— the receptor for low density lipoprotein being 
a prominent example— in which the receptors appear to be a permanent part 
of the pit. The description of the dynamics of such exceptions will 
clearly be a special case of the more general description in which 
receptors are mobile.
Metabolically active cells at physiological temperatures are continuously 
endocytosing coated pits along with whatever receptors happen to be 
associated with them at the time of ingestion. When ligand is present, 
receptor ingestion is enhanced. The fate of the internalized ligand and 
receptor is variable and depends on the particular system (Gex Fabry and 
DeLisi, 1985). Thus, in the LDL and a macroglobulin systems, the receptor 
is recycled and the ligand degraded, while in the epidermal growth factor 
(EGF) system both receptor and ligand are degraded, with perhaps some 
recycling of the ligand. The insulin system behaves symmetrically to the 
EGF system: the molecule is degraded while its receptor appears to undergo 
degradation with some recycling. For the transferrin system both ligand 
and receptor are recycled.
These observations can be thought of in terms of a general system in which 
the ligand and receptor to varying degrees sort separately; the degree 
depending on local environment, which in turn could be a function of cell 
type or could to some extent be controlled by signals provided by the 
particular receptor-ligand system. The mechanistic basis for these 
differences is not essential to the model presented below, which 
incorporates sorting phenomenologically and can therefore be applied to any 
of the systems. That is to say, we are not attempting to explain why some
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receptors recycle and others are degraded, but we are instead presenting a 
model that accounts for the dynamics of these processes in any given 
system. To the extent that changes in parameter values of such a model 
allow us to interpret the dynamics of a number of different systems, we 
will at least have a simple quantitative characterization of these 
differences. In the present paper our goal is more modest. We will review 
the model and assess the extent to which it is able to simulate and predict 
the dynamics of just one system— epidermal growth factor and its 
receptor— and discuss some of the biological implications of the analysis.
The mathematical model, its justification, and its relation to models of 
endocytosis presented by others have been reviewed previously(Gex Fabry and 
DeLisi, 1984a and ref cited therein; See also Wofsy and Goldstein, 1984). 
The basic idea is simple and not new: when a ligand binds a receptor, the 
receptor undergoes a conformational change which enables it to interact 
with a (hypothesized) coated pit molecule, perhaps a glycoprotein. The 
specificity for ligand is in the receptor only, with all receptor ligand 
complexes interacting with the same, or at most relatively few, coated pit 
proteins. Such two step binding with specificity in the first step only, 
is one mechanism by which ligand specific receptor internalization is 
increased over background and, as outlined below, it accounts 
quantitatively for a wide range of dynamic data on binding, endocytosis, 
recycling and degradation. The minimal mathematical expression of this 
idea requires seven variables: free ligand, free surface receptors, 
receptor-ligand complexes on the surface, free molecules in coated pits to 
which the ligand-receptor complex binds; receptor-ligand-coated pit protein 
complexes, free internalized ligand and free internalized receptor. 
Receptor-ligand complexes inside surface coated pits are assumed to be in 
equilibrium with receptor-ligand complexes outside coated pits (Fig 1). 
Depending on the data being analyzed, the model also readily incorporates 
intracellular ligand— receptor complexes which exist prior to independent 
sorting of the ligand and receptor.
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Fig 1. Receptor ligand complexes formed on the cell surface are 
internalized with coated pits and may then sort independently along one of 
several paths, some directed toward lysosomal degradation with rate 
proportional to k^ and others toward the surface with rate porportional to 
k . L is free ligand; R is free surface receptor; RL is the ligand 
receptor complex; P is the coated pit protein concentration; RLP is the 
ligand-receptor coated pit protein complex; and R. are the internalized 
ligand and receptor.
RESULTS AND DISCUSSION
We will be focusing almost entirely on the kinetic implications of the 
model, the steady state characteristics having been reviewed in detail 
elsewhere (Gex Fabry and DeLisi, 1984a,b). Briefly, however, we note that 
the steady state has a number of features with widespread implications 
including the following. (a) Variations in the number of coated pit 
proteins from one cell system to another can lead to substantial variations 
in the slope and intercept of linear Scatchard plots even when the number 
of ligand specific receptors is invariant. This variability may therefore 
contribute to the large variability seen in the affinities of EGF for its 
receptor, as well as to variations in receptor number determined for a 
variety of systems by Scatchard analysis, (b) As the number of coated pit
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proteins decreases, the Scatchard plot can change from linear to non 
linear, even though only a single class of receptors is present, (c) 
Preincubation of cells with phorbol esters can change a non-linear plot to 
a linear plot. The first two effects are consequences of the two step 
binding mechanism (ligand to its receptor followed by interaction of the 
ligand-receptor complex to the coated pit protein); the last from a 
postulated competition between the EGF-receptor complex and the phorbol 
ester-receptor complex for the same coated pit protein. We now outline 
some dynamic consequences of the model.
A
roI
O
EQ.O
oLU
TDC=3O
ŰŰ
385
B
_w
"55oCDo
0 3
0 3
Cü
Q.
D
OLU
Fig 2. The amount of EGF on the surface of 3T3 cells peaks within the first 
5 minutes and then falls due to internalization(A). On a longer time 
scale, internalization (and thus the total cell associated EGF) continues 
to increase, peaking at about 100 minutes, when the effects of degradation 
become prominent (B). Although data sets A and B were taken in different 
laboratories under slightly different conditions, the model fits both 
(lines through data points) with approximately the same set of parameter 
values. Data from Haigler et al (A) and Brown et al (B).
1. The kinetics of cell association, Internalization and degradation of EGF
Simultaneous determinations of the kinetics of EGF bound to the surface of 
3T3 cells and internalized by those cells display, over the first hour, a 
classic precursor-product relation. The surface bound concentration 
increases for about 5 minutes and then starts decreasing as the 
concentration of internalized EGF builds (Fig 2A) (Haigler et al, 1980). 
Longer time measurements performed by Brown et al (1979) (Fig 2B), also on 
the EGF-3T3 cell system, show degradation beginning at about 40 minutes, 
with the total cell associated EGF starting to drop shortly afterwards. We 
call attention to two aspects of the analysis. First, the model accounts 
quantitatively for these data sets with pretty nearly the same set of 
parameters, the small variations of generally less than a factor of two
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arising in part because the experiments were performed in different 
laboratories under slightly different conditions including different 
temperatures. The parameter values, obtained by fitting the model to the 
data, have been presented elsewhere (Gex Fabry and DeLisi, 1984b). 
Briefly, the forward and reverse rate constants for EGF interacting with 
its receptor on 3T3 cells are about 10a (M-min)-1 and .59min-1 
respectively. The average internalization time is somewhat over a minute; 
the average degradation time is about 50 minutes, and the average recycling 
time is about 20 minutes.
A second feature of the analysis is the distinction between two possible 
mechanisms for ligand induced receptor internalization. One possibility is 
that receptor internalization is enhanced solely as a consequence of an 
increased concentration of receptors in coated pits due to the affinity of 
ligand-receptor complexes for coated pit proteins. Another possibility, 
which is not exclusive of the first, is that the coated pit internalization 
rate depends on the presence of ligand. In fact the analysis indicates an 
eight-fold increase in the endocytic rate during the first 10 minutes 
subsequent to exposing the cells to ligand. It is the increased rate, and 
not coated pit clustering of ligand receptor complexes in itself, that 
makes the major quantitative contribution to the loss of receptors from the 
surface. This finding suggests that clustering is tightly linked to some 
relatively early biochemical event (e.g. activation of a nodal enzyme), 
leading to an increased rate of coated pit endocytosis. Since coated pits 
carry with them any receptors which happen to be present, the enhanced rate 
of endocytosis is not receptor specific, an observation that provides a 
basis lor explaining both homologous and heterologous down regulation; i.e. 
the decreased ability of cells to bind some ligand shortly after 
preincubation with the same or a different ligand.
2. Regulatory Effects of Interacting Populations
Although in vitro experiments are easily performed under conditions in 
which cells are exposed to only a single well defined ligand, numerous 
populations, often highly interactive, are present in vivo, and it is 
important to begin to consider how they might effect one another. A system
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which has been extensively studied is the mutual modulation of EGF and 
phorbol esters, the latter being potent tumor promoters which activate a Ca 
and phospholipid dependent protein kinase. The effect of incubating 
embryonal carcinoma cells with 12-0-tetradecanoyl phorbol-13-acetate (TPA) 
at 37° for 30 minutes prior to adding EGF, is to reduce the binding of EGF 
at 4° (not shown) and 37° (Fig. 3)-
Fig 3. Embryonal Carcinoma (EC) Cells were greincubated in the presence (7) 
and absence (A) of TPA £or 30 minutes at 37°. Cells were then incubated 
with 1 ng/ml EGF at 37°. The curves were obtained by a best least squares 
fit of the data from Salomon (1981)
Such heterologous down regulation is in keeping with the observation made 
in the preceding paragraph on ligand enhanced endocytosis of coated pits, 
and hence of any receptors they might contain. Of note is that 
heterologous down regulation of unoccupied transferrin receptors by phorbol 
esters has recently been observed by Klausner (1984) and May (1984). It is 
worth emphasizing here that specificity in the first step, and its absence
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in the second, suggests that receptor sequences consist of a portion or 
portions which vary from receptor to receptor and which therefore serve to 
recognize a particular ligand, and another portion which is evolutionarily 
conserved and acts as the link to the coated pit protein. Since a certain 
degree of conservation must be dictated by the apolar environment of the 
membrane, the cost of maintaining a relatively invariant portion of a 
receptor sequence would be minimized if the segment were membrane embedded.
The effects of the sequential or simultaneous presence of multiple ligands 
on cells is more complex than heterologous down regulation. Cells 
preincubated for three hours with EGF bind less phorbol 12,13 
dibutyrate(PDB) than cells which had not been preincubated with EGF, but at 
later times, the former cell population shows enhanced binding (Fig 11).
Fig 4. EC cells were preincubated for 3 hrs at 37° in absence (A) or 
presence (a) of 1ug/rol EGF. They were then incubated with 30nM PDB at 37 . 
The curves are best least square fits of the data, which were taken from 
Salomon (1981).
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The early time decrease can be again explained by heterologous down 
regulation. Some insight into the subsequent increase might be provided by 
the fact that the simplest parameter adjustment required to fit the data is 
a delay in the delivery of the second ligand to lysosomes. Such a delay 
could lead to accumulation of ligand receptor complexes in prelysosomal 
organelles, shifting the equilibrium for their separation, and therefore, 
possibly the amount of material that sorts to a given pathway. The net 
result is the retardation and possible partial sparing of ligand 
degradation by the lysosomal machinery.
As a final illustration of the concerted action of several ligands on cell 
activity, possibly resulting in shifts in sorting pathways, we note that 
the ratio of surface to total cell associated EGF is somehwat larger in the 
presence of TPA than in its absence (Salomon, 1981). Analysis of the data 
(Gex Fabry and DeLisi, 1985) indicates that the difference is most likely 
the result of increased release of intact ligand from the intracellular 
volume when TPA is present. The effect might be relevant to the 
observations of Lee and Weinstein (1980) who found that the addition of 
phorbol esters at various times after mixing with EGF was associated with 
decreases in cell bound EGF and increases in the amount of intact EGF in 
the medium. Although the result can be simply explained by assuming that 
TPA induces dissociation of EGF from the surface, our results suggest that 
TPA affects intracellular sorting of EGF, producing a bias toward release 
of intact ligand rather than degradation.
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A major histocompatibility complex (MHC), a group of linked genes 
whose products play important roles in immune recognition and function, 
has been defined in all mammals examined and such complexes exist in 
birds, and likely in all vertebrates (Goetze, 1977). The similarities of 
function of linked MHC genes in mice and humans, the two species whose 
MHC has been carefully studied, is striking and suggests that the complex 
is a functional unit whose genes remain associated due to pressure of 
natural selection. The wide distribution of MHCs and the evidence that 
the component genes have been linked for over 3 0  million years ( that is 
from before the time that rodent and primate stocks separated from the 
main mammalian stem) are striking. They suggest that the complex has 
evolved, probably by gene duplication, from a primitive MHC with other 
functions than the regulation of immune responses and the interactions of 
immunocytes with other cells.
The most commonly held view is that the products of the MHC evolved 
from primitive general systems for recognition at the cell surface (see, 
for example, Burnet, 1971, Bodmer, 1972, Ohno, 1977, Dausset and Contu, 
1980 and Scofield et. al., 1982). Indeed, present structural evidence 
suggests that MHC antigens, imunoglobulins and some other surface 
glycoproteins are all derived from a small, ancestral, membrane protein 
(Hood et.al., 1985). We might expect then to detect ancestral functions 
of the MHC even in the existing MHC's and their products. Indeed, though 
the immune functions of the MHC have always been foremost, there has 
always been a background of ideas and experiments about other, non-immune 
functions of the complex (reviewed by Ivanyi, 1978). While some
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associations of MHC and non-immune function are due to products of genes 
linked to the traditional MHC genes, most of the data on MHC/functional 
associations cannot be associated with unknown genes, and, rather must be 
explained in terms of unknown functions of known MHC gene products.
The products of the MHC have been classified as class I, class II and 
class III. Class III products are complement components and enzymes which 
are not readily related to the primary immune functions of the MHC. We 
will not discuss them further. Class II products are polymorphic surface 
glycoproteins, principally involved in recognition of antigen by helper T 
cells. They are limited in their distribution to a few cell types, 
principally macrophages, endothelial cells and B cells. These antigens 
will receive only passing mention in our discussion. Finally, there are 
class I antigens, plasma membrane glycoproteins consisting of a 44,000 
heavy chain, non-covalently associated with a 11-12,000 light chain.
These antigens are the most polymorphic molecules known, with literally 
hundred of alleles of each of two class I loci. The antigens are present 
on almost every cell of the body (muscle and brain may be exceptions), 
including: liver, kidney and intestinal epithelia, lymphocytes, 
fibroblasts and even erythrocytes. They are present in moderate to high 
numbers, ranging from around lOVcell in mouse erythrocytes to around 
105/cell on lymphocytes. (Kimball and Coligan, 1983)
The class I antigens function immunologically as contexts for 
recognition of foreign, especially viral, antigens by effector T cells. 
That is, they are receptors for effector T cells, and they are highly 
specific receptors. T cells active against a viral antigen presented 
with a particular MHC class I allele will not lyse cells bearing the 
viral antigen together with a different allele of the same MHC antigen. 
(Zinkernagel and Doherty, 1979).
If these antigens retain some of their primitve recognition/ receptor 
function, then we expect them to influence the binding of non-immunologic 
ligands to cell surfaces. For a number of years my laboratory has 
explored this possiblity, studying peptide hormone binding to specific 
receptors as a system, outside of the immune system, in which MHC class I 
antigens might be expected to influence recognition.
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We have worked on both the, H-2K and H-2D class I antigens of mouse 
and on the HLA-A,B,C antigens of humans. At this point we have considera­
ble, though indirect, evidence that class I antigens do affect the 
binding of peptide hormones by their receptors. The time is rapidly 
approaching when physical techniques, such as resonance energy transfer, 
and measurement of rotational and lateral diffusion in membranes, may be 
used to detect and characterise interactions between MHC antigens and 
other cell surface receptors.
The general approach to testing MHC dependence of cell recognition 
phenomena has been through systems in which some aspects of recognition 
can be quantitated. The assumption is made, correctly, that while MHC 
antigens may modify or modulate recognition, they cannot act to abolish a 
recognition system and also cannot, by their presence create a new, 
qualitatively distinct recognition system. Thus all of the work in the 
area of "non-immune recognition" has been on the quantitation of specific 
recognition events such as cell-to-cell adhesion or the binding of 
hormones to specific receptors and subsequent cellular responses.
We began our work with a study of the resultant of peptide hormone 
action in liver, the steady-state level of adenosine 3':5'-cyclic 
monophosphate (cyclic AMP), cAMP. Our strategy was to measure and 
compare cAMP levels in livers of animals of congenic stains, differing 
only for the MHC. The strategy was successful, for we could show that 
the H-2b haplotype was consistently associated with levels of cAMP about 
50Í higher than those in animals of H-2k haplotype, irrespective of the 
strains carrying the H-2 chromosomes (Meruelo and Edidin, 1974) [Figure 
1] The difference in levels segregated in F2 and backcross individuals 
derived from H-2b x H-2k congenic mice, and were later shown to segregate 
with H-2 in fully segregating crosses. Mapping studies with mice bearing 
recombitant MHC's indicated that the gene(s) affecting cAMP levels mapped 
telomerically in the complex, in or to the right of H-2D (Lafuse and 
Edidin, 1978)
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Figure 1. Effects of age and H-2 haplotype on levels of cAMP in liver. 
The top line, A's, gives levels for H-2a animals of various strains. The 
middle line, •, B's, gives levels for H-2^1 animals, and the lower line, 
O. Q's, gives levels for H2 animals. From Meruelo and Edidin, 197^ .
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Steady-state levels of cAMP are a function of hormone binding, 
coupling of receptor to adenylate cyclase via the GTP-binding protein, 
activity of the cyclase itself, and activity of degredative enzymes, 
cyclic nucleotide phosphodiesterases. Careful comparisons of all of 
these systems between congenios led to the clear conclusion that H-2 
affected the glucagon-stimulated adenylate cyclase, but none of the other 
components of the system. This led to further studies in which we showed 
that glucagon, which is the major hormone elevating liver cAMP, binds to 
receptors of different affinity in H-2*3 animals than in H-2k animals. 
Scatchard analysis of the data even indicated that glucagon receptors of 
H-2k animals interacted in a different way than receptors in animals of 
other haplotypes [Figure 2] (Lafuse and Edidin, 1980)
There are a number of other experiments, by us and others which 
similarly indicate that MHC haplotype influences the binding of insulin, 
prostaglandin and cholera toxin to cells. However, none of the experi­
ments discriminates between the effects of products of MHC-linked genes 
and the effects of known MHC antigens. At this point we ought to 
consider the ways in which the MHC might affect peptide hormone 
receptors:
1. MHC antigens are peptide hormone receptors (Svejgaard and Ryder, 
1976).
2. Genes for hormone receptors are linked to the MHC.
3. MHC antigens are obligate parts of functional hormone receptors 
(Simonsen et. al., 1989).
9. MHC antigens interact (weakly) with peptide hormone receptors, 
modifying their affinity and their interactions with one-another 
(Meruelo and Edidin, 1979: Chvatchko et. al, 1983).
5. The products of the MHC or of linked genes enzymatically modify 
hormone receptors.
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Figure 2. Scatchard plots of glucagon binding to liver plasma membranes 
A, from B10.A (H-2a) and B, from B10.Br(H-2k) animals.
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The first two possibilities are the least likely. The structure of 
authentic peptide hormone receptors is quite unlike that of MHC antigens. 
Hence, the antigens are not themselves the receptors. MHC effects have 
been shown for three characterised receptors, for insulin, for glucagon 
and for epidermal growth factor (Czech et al, 1983). Genes for two of 
these receptors, EGF and insulin have been mapped to chromosomes other 
than the MHC chromosome of humans. Given the very great similarity in 
organisation of mouse and human MHC's and linked genes it is likely that 
the receptor genes will not map to the MHC in mice.
The idea that MHC antigens are obligate parts of peptide hormone 
receptors was developed by Simonsen and co-workers (1984), from their 
finding that Daudi cells which do not express MHC antigens also fail to 
bind insulin, and from experiments on the reciprocal effects of peptide 
hormones and of anti-HLA antibodies on each other's binding to HL-60 
cells. In contrast, we found that Daudi cells (from the American Type 
Culture Collection) bear insulin receptors detected both by insulin 
binding and with anti-receptor antibodies. The Daudi insulin receptor 
has a Kd in the nanomolar range and there are a few thousand high 
affinity receptors per cell (K. Hosoi and M. Edidin, unpublished). This 
discordance may relate to clonal variation in Daudi cells, but it seems 
to tell against an obligate role for class I antigens in insulin receptor 
function.
Though we have not been able to use anti-H-2 or anti-HLA antibodies 
to specifically inhibit insulin binding to IM-9 or to liver cell 
membranes (Hosoi, unpublished), we have shown that anti-HLA antibodies 
and EGF reciprocally one another's binding to receptors in A431 cells 
(Schreiber et. al., 1984). Binding of either ligand sets in train a 
complicated series of internalizations and changes in cell metabolism and 
hence the results are not readily interpreted in terms of simple physical 
models of receptor-antigen association.
The possibility that MHC antigens interact weakly with peptide 
hormone receptors was proposed to explain several sets of results, 
including our own on associations of cAMP levels with MHC haplotype.
This interaction is also in line with mainstream immunology's ideas about
399
the function of MHC antigens in the recognition of other surface 
antigens. Direct chemical evidence for such association was obtained by 
Chvatchko and co-workers(1983). They photoaffinity labelled insulin 
receptors in mouse liver membranes and showed that antibodies to class 1 
antigens, but not normal serum or irrelevant anti-I-A antibodies, 
precipitated about 51 of the labelled insulin receptor together with the 
expected MHC heavy chain. The experiments suggest a weak association 
bewteen insulin recpetor and MHC antigens.
The last possibility on my list, enzymatic modification of receptors 
by MHC antigens, is the most speculative. No enzymatic activities have 
been associated with known MHC antigens, though some years ago Parish and 
co-workers (1981) speculated that the antigens might be glycosyltrans- 
ferases, the enzymes which transfer sugars from sugar-nucleotides to 
specific macro-molecular acceptors. Roth (1985) has recently speculated 
that MHC antigens and glycosyltransferases are related by descent 
and has published some preliminary evidence that a galactosyltransferase 
co-purifies with a class II MHC antigen (Furukawa et. al., 1985). If 
other MHC antigens also have transferase properties, then one can readily 
see how some MHC haplotype might modify receptor glycoproteins.
We have now discussed all of my list of the possibilities for MHC 
effects on peptide hormone binding. Though the first two can likely be 
ruled out, we have not resolved the last three of these possibilities. 
While experiments of several sorts suggest themselves, it would be of 
particular interest to make physical measurements of MHC antigen-peptide 
hormone receptor proximity in intact cells.
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DISCUSSION
PECHT:
Is there any evidence for specificity in the interactions 
between MHC components and hormone/growth factor-recep­
tors ?
Have any experiments been done in order to detect such 
interactions (e.g. covalent crosslinking)?
EDIDIN:
Chvatchko and co-workers (FEBS Letters, 163:201) have co­
precipitated a small fraction of affinity-labelled insulin 
receptor with MHC antigens, using anti-MHC antibodies.
I do not know of any other chemical evidence for such 
associations.
SRERE:
Does the quantity of immobile protein change in the mutant 
cells or in the "tailless" construct? Does the distribu­
tion of diffusion coefficients change in these cases?
EDIDIN:
The quantity of immobile label appears higher in cells 
expressing mutant antigens, than in cells expressing 
wild-type antigens. However, the level of mutant antigens 
is lower than that of wild type and part of the immobile 
fraction is probably in fact background, autofluorescence 
or scattered light. We have to re-determine the mobile 
fraction of mutant antigens using a more sensitive photo­
multiplier tube.
CHERRY:
The diffusion coefficient you measured for the antigens 
-9 2-1is close to 10 cm s and hence not as low as often 
observed for plasma membrane proteins. Bearing in mind 
that diffusion is known to decrease with measuring protein 
concentration, it seems to be just possible that you do 
have free diffusion in this case, which would explain
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the similarity in diffusion coefficients of the mutant 
antigens.
EDIDIN:
This may be possible. However, I should note that dif­
fusion of the mutant antigens is completely inhibited 
(0 % mobility) in many cells from dense cultures. This 
effect of culture density on antigen mobility is the same 
as seen for wild-type antigens. That is, diffusion of 
mutant antigens can be reduced to immeasurably low rates 
despite the antigens' lack of cytoplasmic tails.
FÉSŰS:
Have you quantitated the number of mutant proteins on the 
surface in your transfection experiment? If yes, wasn't 
the difference among these numbers too high (because of 
the unpredictability of the transfection experiment) to 
permit comparative experiments regarding the diffusion 
of hormone receptors?
EDIDIN:
We have not measured diffusion of hormone receptors, only 
their affinity. The number of H-2 antigens expressed after 
transfection does vary, but this does not appear to affect 
their lateral diffusion.
ELSŐN:
Is haplotype correlated with susceptibility to diabetes?
Is the efficiency of B-cell activation by antigen or by 
crosslinking surface immunoglobulin (SIg) correlated with 
haplotype? If so, does H-2 antigen cocap with surface 
immunoglobulin?
EDIDIN:
Yes. The main correlation is with a Dr antigen, apparently 
associated with juvenile-onset diabetes (probably involving 
the immune response to a viral infection). However, there
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are also claims of HLA-A and B alleles associated with 
diabetes.
There was one abstract some years ago that claimed haplo- 
type-associated differences in lectin activation of mouse 
lymphocytes. I don't know of any other.
DAMJANOVICH:
There is a contraversy concerning the role of the cyto- 
skeletal elements in controlling the lateral diffusion 
of integral membrane proteins. Would you mind commenting 
this problem?
Do you know any quantitative data on the number of insulin 
receptors per cell surface area when you measure lower 
for insulin binding?
EDIDIN:
Four sets of experiments suggest that cytoskeletal ele­
ments affect lateral diffusion of integral membrane pro­
teins. 1.) Cytochalasin B, which interacts with actin 
filaments, inhibits lateral diffusion. 2.) Lateral diffu­
sion of membrane proteins is increased ten-fold in mem­
branes that have ballooned away from their underlying 
cytoplasm. 3.) Purified membrane proteins in synthetic 
membranes diffuse at least an order of magnitude faster 
than the same proteins in native membranes. 4.) In fibro­
blasts with highly organized cytoskeletons, lateral dif­
fusion is anisotropic, being about 50-fold faster parallel 
to the orientation of the cytoplasmic filaments than per­
pendicular to the filaments.
The number of insulin receptors per cell is highly vari­
able in these lines.
TRÓN:
I think the detailed mechanism of slowing down lateral 
diffusion of proteins in biological membranes is pretty
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far from being wholly understood. There are several pos­
sibilities to do this. You have presented here nice evi­
dence which rules out the decisive role of friction be­
tween the intracellular part of the MHC antigens and the 
cytosole.
Data are presented in the literature on very slow protein 
diffusion in erythrocyte ghosts. However, getting rid of 
the spectrin when preparing ghosts, the rate of diffusion 
is increased practically to the level found with arti­
ficial bilayers. There have been an increasing amount of 
publications during the last years reporting about 
spectrin-like proteins in cells other than erythrocytes.
X wonder if the network of spectrin or spectrin-like pro­
teins on the surface of the cytoplasmic membranes can be 
a general feature of a broad range of cells. Furthermore,
I think, instead of the model with steadily decreased 
diffusional rate or that describing specific interactions 
between membrane proteins and the cytoskeleton one can 
set up another one explaining the slowing down phenomenon 
in the following way. There is a non-inhibited fast dif­
fusion of intramembraneous proteins within each individual 
region of the spectrin-like network and the slow diffusion 
rate in the pm range is simply the consequence of the 
dynamics of eventual opening and closing of gates (pores) 
acrosss the network of the spectrin-like proteins, in the 
case of a great variety of cells. Would you comment that, 
please?
EDIDIN:
There are data indicating that extraction of the erythro­
cyte membrane cytoskeleton increases lateral diffusion of 
band 3 proteins (Golan and Veatch, Proc. Natl. Acad. Sei. 
USA, 77, 2537, 1980). The lateral diffusion of band 3 is 
also increased in erythrocytes which, genetically, lack 
spectrin (Koppel et al., Proc. Natl. Acad. Sei. USA, 78, 
3576, 1981) and the model that you suggest, of a spectrin 
network limiting lateral diffusion without directly in­
teracting with trans-membrane proteins, has been proposed
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by the authors of the latter paper. It remains to be seen 
if similar, spectrin-dependent, constraints exist in nu­
cleated cells.
Dynamics of Biochemical Systems 
S. Dam Janovich, T. Keleti, L. Trón (Eds)
TWO-BINDING-SITE MODEL OF Fc RECEPTORS ON HUMAN K CELLS
JÁNOS GERGELY and GABRIELLA SÁRMAY
Department of Immunology, Eötvös L. University,
H-2131 Göd, Hungary
Fc receptors (FcR) which interact with the C-terminal 
domains of immunoglobulins of various isotypes are expressed on 
a wide range of cells, most of them belonging to the immune 
system. The signals and functions mediated by these receptors 
are manifold and represent partly effector functions (such as 
release of mediators, opsonized phagocytosis, antibody depend­
ent cellular cytotoxicity (ADCC)), and partly regulatory mech­
anisms (e.g. regulation of B cell proliferation, isotype regula­
tion) . Different isotypes of FcR-s are expressed on the same 
T-cells and the prevalent expression of one of the isotypes on 
the account of the others can be induced by a given isotype of 
immunoglobulin.
To understand this functional diversity and flexibility in 
expression one has to consider the structural basis of FcR he­
terogeneity. Similarly to their natural ligands, the immunoglo­
bulin binding receptors on various cells are very heterogenous. 
This fascinating heterogeneity of FcR-s might mean first of all 
differences in the primary structure, and one might suppose 
that immunoglobulins and FcR-s diverge parallelly during phylo­
genesis (1). Besides this obvious form, another type of FcR 
heterogeneity was suggested by us. Studying the structural and 
functional characteristics of IgG-binding FcR-s on human peri­
pheral lymphocytes a phenomenon, called "receptor conversion" 
was described by us, showing that the binding specificity (con­
sequently the function) of different conformational forms of 
the same FcR molecule might be different (2-7).
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In the present paper we summarize our data showing that
- depending on the prevailing stimuli and/or actual level 
of differentiation IgG FcR-s are expressed either in monomeric 
or polymeric (crosslinked) form;
- the monomeric receptor possesses one active binding 
site interacting with the CH3 domain of IgG;
- the crosslinking of the monomeric receptor units results 
in the expression of a second, CH2 domain specific binding site 
(receptor conversion);
- the functions of the two-binding-sites are different.
Monomeric and polymeric forms of IgG FcR-s. The finding 
that human peripheral lymphocytes shed their IgG FcR-s after 
4-37°C temperature shift while another population does not 
shed the FcR-s under identical experimental conditions allowed 
us to distinguish between two forms of IgG binding structures. 
The shed receptors were found to be monomeric, monovalent,
60.000 m.w. molecules possessing only one active binding site 
interacting with the CH3 domain of IgGFc, while two active 
binding sites, one of them CH3, the other CH2 domain specific, 
were found to be expressed on the polymeric (crosslinked, an­
chored) form. In in vitro experiments (6, 7) the crosslinking 
of the isolated monomeric FcR-s either on actomyosin or by 
transglutaminase resulted in "receptor conversion", i.e. in 
the expression of the second binding site for the CH2 domain, 
besides the preexisting CH3 specific one. "Receptor conversion" 
in both directions was observed on the cell membrane as well 
(8, 9). Thus ligand binding Concanavalin A (Con A) or a-IF 
stimulation resulted in the expression of the polymeric, "two 
binding site" form, while anti-ß2-microglobulin antibodies in­
duced shedding and depolymerization of the crosslinked recep­
tors. Moreover, since IgG FcR-s were found to be expressed 
only in polymeric form on K and NK cells (10), one may suppose 
that receptor conversion might not only be the consequence of 
prevailing stimuli but also reflects the actual level of cell 
differentiation.
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The "two-binding-site-model" of IqG FcR-mediated killing 
in ADCC. It is generally accepted that K-cells in ADCC need 
functionally intact IgG FcR-s (11, 12). On the other hand, 
data dealing with the localization of submolecular sites on 
IgGFc reacting with the FcR-s on K-cells are conflicting, and 
the preferential role either of the CH2 or CH3 domains is still 
an unsettled question. The finding that FcR-s are expressed in 
polymeric form on K cells gave us a good opportunity to study
- the two-binding-site character of the FcR-s;
- to localize the groups within the CH2 and CH3 domains 
interacting with the FcR binding sites;
- to identify the function of the individual binding 
sites.
Supposing that the prerequisite of killing in ADCC is the 
simultaneous binding of both IgG Fc domains to both receptor 
binding sites, we studied whether the killing could be abolish­
ed when the bindings of domains to the corresponding sites 
were inhibited separately. To achieve the individual blocking 
of CH2 and CH3 specific binding sites, Clq (interacting with 
CH2) and soluble monomeric FcR (binding to CH3), synthetic po­
lypeptides comprising sequences of human y-1 chains, as well 
as monoclonal antibodies recognizing epitopes expressed within 
CH2 or CH3 domains of IgG1, were used. The results can be sum­
marized as follows:
a. Both Clq and soluble monomeric IgG FcR inhibited ADCC 
dose dependently (10);
b. Three synthetic polypeptides representing CH2 domain 
sequences and a slightly modified CH3 domain sequence showed 
dose dependent inhibitory activity in ADCC (10). A stable spec­
ific interaction between these synthetic peptides and K-cells 
was found, showing that a portion of the synthetic peptides 
adopted the biologically active conformation allowing the high 
affinity binding to the FcR binding sites.
c. Some monoclonal antibodies having specificity for CH2 
or CH3 domain epitopes inhibited ADCC dose dependently and 
significantly, whilst others gave no inhibition. Similar in­
hibition was obtained with antibodies specific for IgG1 sub-
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class, while an other monoclonal antibody having specificity 
for a CH1 domain epitope exerted no inhibitory effect (13).
These data proved that
- IgG FcR possessing two-binding-sites characterize the 
effector lymphocytes of ADCC;
- the simultaneous interaction of the Fc-domains of the 
target-sensitizing antibody with both binding sites is the pre­
requisite of killing;
- the groups reacting with one of the binding sites are 
situated within the CH2 domain in the region of 274/Lys/-
301/Arg/, while the groups interacting with the other binding 
site involve the residues of 408/Ser/-416/Arg/ of the CH3 
domain.
Different functions of the two FcR binding sites. The ob­
servation showing that only simultaneous ligand binding to both 
binding sites is able to induce killing activities does not 
necessarily mean that both sites equally transfer killing sig­
nals. An experimental system described by us allowed to study 
the individual role of each binding site of FcR in ADCC.
We described earlier that Con A stimulated T-cells express 
C3b-acceptor (C3b-A) sites interacting with the metastable 
binding site of nascent C3b molecules. Cell surface proteases 
on Con A activated T cells split C3 which binds to the newly 
expressed C3b-A-s and the cells, armed by the C3b-A-bound C3b 
are ready to form bridges to C3b-receptor (CR) bearing target 
cells. Using C3b-armed Con A-blasts as effectors and CR1-bear­
ing human red blood cells sensitized with anti-D IgG as tar­
gets, an enhanced ADCC was measured (14). Testing the influence 
of CH2 and CH3 domain specific monoclonal antibodies on the 
killing capacity in this system enlighted us on the possible 
function of the CH2 and CH3 specific FcR binding sites (13).
Comparing the effect of F(ab) fragments of the CH2 (A55) 
and CH3 domain specific (x3A8) monoclonal antibodies on EA 
rosette formation as well as on ADCC it was found that the 
CH2 domain specific antibody did not significantly affect the 
EA rosette formation in contrast to the CH3 domain specific
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antibody. On the other hand, the former markedly inhibited ADCC 
activity both of non-stimulated effector cells and Con A stimu­
lated cells in the presence of C3. The inhibitory effect of the 
CH3 specific x3A8 monoclonal antibody was considerably smaller 
and the enhancing effect of C3 on the killing capacity of Con A 
stimulated effectors was not influenced by this antibody.
These results speak for the role of CH3 domain specific 
binding sites in the target-effector binding and emphasize the 
importance of the CH2 specific site in the transfer of killing 
signal.
References
1. Haeffner-Cavallion, N., Klein, M., Dorrington, K.J. (1975) 
Studies on the Fey receptor of the murine macrophage-like 
cell line P388D1. I. The binding of homologous and hetero­
logous immunoglobulin G. J. Immunol. 123, 1905-1913.
2. Sármay, G., István, L., Gergely, J. (1978) Shedding and 
reappearance of Fc, C3 and SRBC receptors on peripheral 
lymphocytes from normal donors and chronic lymphatic 
leukemia patients. Immunology, 3_4, 315-321.
3. Sándor, M., Füst, G., Medgyesi, G.A., Erdei, A., Gergely,
J. (1979) Heterogeneity of Fc receptors on human peri­
pheral mononuclear blood cells. Immunology, 38^ , 553-560 .
4. Sándor, M., Füst, G., Medgyesi, G.A., Gergely, J. (1978) 
Isolation and characterization of Fc receptors shed from 
human peripheral mononuclear cells. Immunology, 3_5, 559-566.
5. Gergely, J., Erdei, A., Sándor, M., Sármay, G., Uher, F.
(1982) The Fc receptor model of membrane cytoplasmic sig­
nalling. Molec. Immunol. J_9 , 1223-1228.
6. Uher, F., Jancsó, A., Sándor, M., Pintér, K., Bíró, E., 
Gergely, J. (1981) Interaction between actomyosin complexes 
and Fc receptors on human peripheral mononuclear blood 
cells. Immun. Letter, 2, 213-217.
7. Fésűs, L., Erdei, A., Sándor, M., Gergely, J. (1982) The 
influence of tissue transglutaminase on the function of Fc 
receptors. Molec. Immunol. J_9 , 39-43.
413
8. Gergely, J., Sándor, M. , Sármay, G., Uher, F. (1984) Fc 
receptors on lymphocytes and K cells. Biochem. Soc. 
Transactions, J_2, 739-743.
9. Sármay, G., Gergely, J. (1983) Activation of lymphocytes 
alters Fc receptor-^^icroblobulin interrelationship on 
the lymphocyte surface. Cell. Immunol. _78, 73-82.
10. Sármay, G., Benczúr, M., Petrányi, Gy., Klein, É., Kahn,
M., Stanworth, D.R., Gergely, J. (1984) Ligand inhibition 
studies on the role of Fc receptors in antigen-dependent 
cell-mediated cytotoxicity. Molec. Immunol. 2_1_, 43-51.
11. Spiegelberg, H.L., Perlmann, H., Perlmann, P. (1976) In­
teraction of K lymphocytes with myeloma proteins of dif­
ferent IgG subclasses. J. Immunol. 117, 1464-1471.
12. Klein, M., Neauport-Sautes, C., Ellerson, J.R., Fridman,
W.H. (1977) Binding site of human IgG subclasses and their 
domains for Fc receptors of activated murine T cells.
J. Immunol. 119, 1077-1088.
13. Sármay, G., Jefferis, R., Klein, E., Benczúr, M., Gergely,
J. (1985) Mapping the functional topography of Fey with 
monoclonal antibodies: localization of epitopes interact­
ing with the binding sites of Fc receptor on human K cells. 
Eur. J. Immunol. 15, 1037-1042.
14. Erdei, A., Benczúr, M., Fábry, Zs., Dietrich, M.P., Gergely, 
J. (1984) C3 cleaved by membrane proteases binds to C3b- 
acceptors expressed on Con A-stimulated human lymphocytes 
and enhances antibody dependent cellular cytotoxicity.
Scand. J. Immunol. 2£, 125-131.
414
DISCUSSION
SEGAL:
Is there a relationship between the Leu-II antigen and 
the type II Fey receptor?
How do you envision that polymerization of the type I 
receptor gives rise to the CH2 binding site on the type II 
receptor?
GERGELY:
It was not investigated.
The consequences of in vitro receptor polymerization were 
studied in rosette inhibition tests. The monomeric recep­
tor inhibits only the EA rosette formation of FcR+ cells 
in contrast to the polymerized soluble FcRI, which inhib­
its the FcRII bearing cells as well.
PECHT:
Did I understand it correctly that those binding sites of 
FcyR interacting with CH2 do not interact with the CH3 
domains and possibly vice versa? This would be in line 
with the report by Baird and Holowka concerning the mode 
of binding of IgE to Fc£R.
GERGELY:
The binding sites of Fc-y-receptors on K cells are domain 
specific, i.e., one of them interacts only with the CH2 
the other with the CH3 domain of IgG. This has been proved 
in inhibition experiments using domain specific monoclonal 
antibodies, synthetic polypeptides represe-ting linear se­
quences of CH2 or CH3 domains, moreover, recently by 
separate inhibition of the binding sites with CH2 or CH3 
domain-deleted myeloma proteins.
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EDIDIN:
Does the anti-ß-2-microglobulin react directly with the 
Fey receptor, to depolymerize it, or is the effect of the 
antibody indirect?
GERGELY:
The binding of anti-ß-2-microglobulin antibodies to lym­
phocyte membrane results in reordering of the membrane in­
cluding the co-shedding of ß-2-microglobulin-antibody 
complexes and Fc receptors. The Fc receptors are present 
in the supernatants of the cells in monomeric form (see 
ref. 9) .
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INTRODUCTION
Protein and lipid elements of the outer cytoplasmic mem­
brane do not form a rigid, static entity despite the role of 
the membrane as border between cell interior and the extracel­
lular space. Every major element of the cell membrane has mo­
bility with different degree of freedom in the plane of the 
membrane as well as perpendicular to it (1, 2). Biophysical 
approach to study these complicated two and three dimensional 
movements of the cell surface elements has been hindered by the 
lack of suitable methodology. The advent of new techniques like 
Fluorescence Recovery After Photobleaching (FRAP), Flow Cyto­
metric Energy Transfer (FCET), measurement of transmembrane 
potential of living cells, determination of rotational parame­
ters of lipid and protein elements of the cell membrane, and 
many other methods brought about new possibilities to study 
dynamic properties of the membrane (1-6, 24, 30, 31, 36).
The general mechanism of transmembrane signalling is not 
independent of the dynamic properties of the cell surface 
lipids and proteins. An accepted scheme of cell activation 
generally starts with an increase of intracellular Ca^+, 
generating Ca +-ATP activating calmodulin and phosphokinase 
systems, ultimately leading to the regulation of DNA replica­
tion (36). The most elementary step in the long line of events 
is the increased permeability of membrane to different ions, 
among them Ca^+. Since any ion transport changes across the 
membrane are connected to opening and closing the ion channels
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is question, the proximity of membrane proteins, their mobility 
(translational or rotational) in the plane of and perpendicular 
to the membrane', as well as the altered membrane potential as a 
consequence of the altered ion transport are of paramount impor­
tance from the view point of information transfer through the 
membrane.
Herewith we present some of our data dealing with the al­
tered properties of lymphocyte membranes when cyclosporin A 
(CsA) a well-known drug, with largely unknown mode of action is 
applied to these cells.
CsA, a cyclic endecapeptide antibiotic, has become essen­
tially indispensable in solid organ transplantation (7-8) for 
suppressing allograft rejection without compromising humoral im­
munity (8). The cellular and molecular mechanism of this selec­
tive effect of CsA on cytotoxic T lymphocytes has not yet been 
explained despite many thorough investigations resulting in data 
on quite a few biochemical interactions of the drug with cellu­
lar metabolism. The dose-response relationship of CsA is gener­
ally studied by observing the suppression of cell mediated cyto­
toxicity in mixed lymphocyte cultures. Thus, in mixed human, 
mouse or guinea pig lymphocyte cultures suppression of prolifer­
ation and generation of cytotoxic T lymphocytes was observed in 
association with inhibition of interleukin-2 (IL-2) production 
(9-11). Subsequently it was shown that IL-2 production was in­
hibited by CsA at the level of mRNA synthesis (12, 13). CsA in­
hibited IL-2 synthesis, but the IL-2 receptor expression remain­
ed intact and the receptors were responsive to IL-2 in mouse 
lymphocyte cultures of Balb/c and C57BL/6J mouse spleen cells 
(14). An inhibition of mitochondrial and lysosomal functions 
was observed after CsA treatment of cultured mouse spleen lym­
phocytes (15). Studies with radio-labeled CsA and thymoma cells 
of mice indicated an association of the drug with a specific in­
tracellular protein fraction (16), and recently it has been 
found that CsA may inhibit the function of calmodulin through 
binding to the protein (17). Efforts were made to investigate the 
preferential uptake of dansyl-labeled CsA by different subsets 
of human peripheral blood lymphocytes. These investigations found 
a "dim" and a "bright" population of cells, classified on the
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basis of their dansyl-CsA content (18, 19). Due to this wide 
variety of effects of CsA at the cellular and molecular levels 
it was suggested by us that an earlier effect of CsA on lympho­
cytes may be the common denominator for the above mentioned and 
far from complete list of different activities of the drug (20, 
21). In order to approach this complex question, efforts were 
made to find the earliest possible effect(s) of the CsA. Since 
the very first theater of any drug-cell encounter is per se the 
cell membrane, characteristic functional and morphological 
changes were sought to monitor the drug-membrane interaction. As 
we reported earlier, CsA and CsG decreased the cytoplasmic mem­
brane potential of splenic and thymus cells of A/J mice without 
differentiating between T and B cells (20, 21).
In our present study on human peripheral blood mononuclear 
cells and mouse spleen and thymus lymphocytes, selected tech­
niques were applied to study the properties of the cytoplasmic 
membrane immediately after CsA treatment; namely (i) flow 
cytometric membrane potential measurements; (ii) combined 
effects of specific ionophores and CsA in a flow cytometric as 
well as in a spectrofluorimetric system; (iii) flow cytometric 
measurements of fluorescence resonance energy transfer on a cell 
by cell basis; (iv) ion flux measurements on CsA treated lym­
phocytes, (v) ESR measurements of lymphocyte membrane in the 
absence and presence of CsA.
The data obtained from the above experiments support the 
view that the addition of the cyclosporin immediately influences 
the properties of the cytoplasmic membrane in such a fashion 
that these effects could subsequently be responsible for the 
later biochemical changes in cell metabolism and ultimately for 
the biological response of lymphocytes to the CsA treatment.
MATERIALS AND METHODS
Cells. Peripheral blood (40-100 ml) from normal human 
volunteers was drawn into EDTA containing tubes. The blood was 
diluted three times with 1.5 mM potassium containing phosphate 
buffered saline (PBS), pH 7.2, and fractionated on Ficoll- 
Hypaque gradients according to the method of Boyum (22) and
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counted in a Coulter counter. HUT-102 cells were a present from 
Dr. Thomas Waldman (NIH). Mouse spleen cells were prepared from 
spleen of A/J mice in the same PBS and were also fractionated 
on Ficoll-Hypaque. Thymus cells of A/J mice were used without 
Ficoll gradient purification. The cell suspensions were kept 
on ice, until they were rewarmed to room temperature for use in 
experiments. The experiments were carried out within 1-3 hours. 
Viability of cells, determined by the fluorescein diacetate 
test in a cell sorter, was higher than 95 % (23)
Determination of the membrane potential in a flow cyto­
meter . For membrane potential measurements the cells were 
labeled with the translocating dye, dihexyloxacarbocyanine 
iodide (DiOC,(3), Molecular Probes Inc., Junction City, OR)O
(24). A stock solution of the dye was prepared in DMSO (spec­
troscopic grade, Zellerbach Inc.) and diluted to 50 yM concen­
tration. This dye solution was added to 1 ml of cell suspension 
containing 1-2x10® cells so that the final concentration was 
125-250 nM. This dye concentration was non-toxic during the 
measurement. Fluorescence intensity of labeled cells was meas­
ured in a Coulter Epics V flow cytometer (25). The laser was 
tuned to 488 nm and the output was usually kept at 400 mW. The 
forward angle light scatter and right angle green fluorescence 
intensities were collected correlatedly for each cell. The 
fluorescence signal was gated with the light scatter so that 
the measured cells were lymphocytes. Since peripheral blood 
lymphocytes and mouse lymphocytes are purported to have no or 
only very few mitochondria, no mitochondrial poison was re­
quired to avoid the interference of mitochondria potential 
with the cytoplasmic one. Changing the extracellular potassium 
concentration from 1.5 to 160 mM was rapidly followed by changes 
in the fluorescence intensity indicating that the measured 
values signaled cytoplasmic potentials. The scaling with potas­
sium made possible to arrange such an instrumental setting 
that the zero potential (non-responding fluorescence) was posi­
tioned at the furthest left of the histograms. Depolarization 
with gramicidin and hyperpolarization with valinomycin also 
signaled a change in cytoplasmic potential and helped to deter­
mine the upper and lower limits. Histograms taken in the flow
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cytometer were evaluated by calculating the peak, mean, CV and 
integral values. Flow cytometers "see" only the cell, including 
the intracellular and the membrane compartments of the three 
compartments (membrane, extra- and intracellular space) into 
which the DiOCg(3) is distributed after staining the cells. 
Thus, the usual equation describing the distribution over the 
compartments will have only two terms on the right side:
r .l with
Vr± = l ai . (t) e 
j J
where r. is any quantitative signal measuring the volume of the 
t hi compartment, t is time, a ^  and b^ . are coefficients and e 
is the base of natural logarithm. However, due to the higher 
solubility of the dye in lipid, the numerical calculation of 
the membrane potential has great difficulties, thus relative 
scaling of the measurable changes in cytoplasmic membrane po­
tential values was achieved as described above. At low extra­
cellular potassium concentration the potential and the fluores­
cence signal were maximal, at high potassium concentration the 
potential was low.
Determination of esterase activity. The activity of non­
specific esterases of the cell membrane was determined essen­
tially as described by Rotman and Papermaster (23). Briefly, 
the amount of the strongly fluorescent fluorescein trapped in­
side the cells was taken as a measure of the enzyme activity. 
Since the fluorescence was measured in a flow cytometer, pos­
sibilities for sensitivities of different subpopulations upon 
different CsA treatment could be investigated. The fluorescein 
diacetate test was performed after incubating the cells for 
5 minutes at 37°C with CsA or DMSO, the solvent for CsA.
Spin labeling of the cell membranes. The spin label, 
5-doxyl-stearic acid, was dissolved in ethanol and the appro­
priate volume was vacuum dried in glass test tubes. The usual
_ o namount of spin label was 8x10 mole for 2x10 spleen lympho­
cytes. The cell suspension was added in about 30 pi PBS to the 
test tubes containing the spin label. To evaluate the effect of
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CsA on lymphocyte membrane 2x10 spleen cells were spin-labeled 
as described above and an ERS spectrum was obtained. The cells 
were recovered from the capillary tube and treated immediately 
with 100 yg CsA dissolved in 1 yl DMSO, after which another ESR 
spectrum was obtained. A similar procedure was followed for 
assessing the effect of 1 yl DMSO on identical spleen cell sus­
pensions. The amount of CsA used for the ESR measurements was 
10 times the highest amount used in the membrane potential ex­
periments. ESR spectra were recorded at x-band with a Varian 
E-9 Century series spectrometer. The temperature of the probe 
was set to 20°C±0.5°C by a Varian variable temperature acces­
sory, using Nj gas flow. The ESR spectra were evaluated using 
the equation for these calculations of Hubbell and McConnell 
(26) as used in experiments similar to ours by Butterfield et 
al. (27).
Measurement of cellular K+ concentration. Cells were pre­
pared either from blood of healthy human volunteers or from the 
spleen of A/J mice by Ficoll gradient as described above. The
cell number was adjusted to 5x10b cells/ml. Samples were in-
4 2cubated in a COj incubator with KC1, 2 yCi/ml (spec. act.
0.19 yCi/mg) in RPMI 1640 medium for 16 hours at 37°C. After 
washing the cells with low potassium PBS, aliquots were taken 
and treated with CsA, ionophores, hormones or combinations 
thereof. At the end of the treatment, cells were layered over 
a 0.5 ml gradient of butylphthalate and oil (10:3 v/v) in 
Eppendorf microcentrifuge tubes. The tubes were centrifuged at 
8000 g for 90 s, frozen in liquid nitrogen and the tip of the 
tube containing the cell pellet was amputated into a counting 
vial and the radioactivity was determined. The method was es­
sentially the same as that described by Segal and Lichtman (28).
Measurement of fluorescence energy transfer on a cell-by- 
cell basis. Flow Cytometric Energy Transfer Measurement (FCET) 
were carried out in a FACS 440 flow cytometer as described earlier 
(29-31). Briefly , the HUT-102 cells were harvested and labeled by 
dansyl-CsA (a present of Dr.Alan Hess, Johns Hopkins Univ.) and 
FITC-conjugated anti-Tac. The anti-Tac monoclonal antibody in as­
cites fluid was a gift from Dr.Thomas Waldman (NIH) . The antibody 
was further purified and labeled with FITC as described earlier
7
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(29). The labeled cells were analysed using a broad band UV ex­
citation of the dansyl. Emission of the dansyl and fluorescein 
dyes was detected correlatedly for each cell, and the energy 
transfer was calculated (30).
Measurement of intracellular calcium content. The intra­
cellular calcium content was measured either with the quin-2 
method (32), or with the indo-lAM dye introduced recently (33). 
Briefly, the changes in the fluorescence intensity of the quin- 
2, were recorded as described earlier (32). The indo dye changes 
its spectral characteristics upon binding the calcium thus in 
this case the changes in fluorescence were observed simulta­
neously at two wavelengths 405 and 480 pm as described earlier 
(33) .
RESULTS
Flow cytometric membrane potential measurements. Human 
peripheral blood lymphocytes were treated with CsA prior to the 
addition of the membrane potential probe DiOC.(3). CsA slowedO
down the uptake kinetics of dye molecules across (or rather 
into) the membrane. The preincubation usually lasted for 5 
minutes with various concentrations of CsA. The upper histo­
grams in Figure 1 show the effect of 10 yg/ml of CsA on the 
uptake of 125 nM DiOCg(3). The lower part of the Figure 1 shows 
the effect of CsA when added to cells which were incubated with 
125 nM DiOCg(3) first, until equilibrium was reached as indi­
cated by two subsequently taken identical histograms. As shown 
in Figure 1, the CsA treatment decreased the amount of the dye 
bound to the cells. Calibration of the histograms according to 
the method of Shapiro (24), demonstrated that the CsA sensitive 
movement of the dye belonged to the membrane potential respon­
sive fraction. Similar depolarizations were observed with
0.5-10 yg/ml of CsA as well as CsG concentrations. The correct­
ed emission and excitation spectra of the dye alone or with 
cells did not show any observable difference (shown in Fig. 2).
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Figure 1.
Upper curves: Human lymphocytes pretreated with 10 Ug/ml CsA 
for 5 minutes were stained with 125 nM DiOC^(3), (left side 
histogram). The right side histogram serves as control with 
pretreatment of 10 yl DMSO. Histograms were taken after 10 
minutes incubation with the membrane potential probe. Lower 
curves: Human lymphocytes were incubated with 125 nM DiOCg(3) 
until equilibrium was reached. The left side histogram shows 
the effect of 10 Ug/ml CsA within 2 minutes, the right side 
one is the DMSO treated control.
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Figure 2.
Corrected fluorescence excitation (solid line) agd emission 
(dashed line) spectra of 100 nM DiOCh(3) with 10 mouse thymus 
cells/ml PBS. The spectra were taken at 25°C. Fluorescence was 
monitored at 508 nm for the excitation spectra and the emission 
spectra were measured with 485 nm excitation. Similar spectra 
taken without cells gave essentially identical curves.
A similar shift of the histograms was followed also with 
thymus and the spleen lymphocytes from A/J mice, showing some­
what higher sensitivity to CsA than human peripheral blood 
cells. Insulin pretreatment prevented the depolarizing effect
of the lower doses of CsA (0.5-1.0 g/ml CsA after 2 units/ml/ 0
/10 cells) on spleen cells (Fig. 3). Insulin was ineffective
when human cells were tested, since resting human lymphocytes
practically have no insulin receptors (28).
4 2Effect of CsA on K loaded lymphocytes. As shown in
Table I mouse spleen and human peripheral lymphocytes released
42potassium upon treatment with CsA. The K loaded cells were 
incubated with 0.2-40 yg/ml CsA for about 5 minutes and the 
intracellular potassium content was determined in control and
CsA treated samples. The insulin pretreatment provided a pro-
4 2tection for the spleen cells against the K releasing effects
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Figure 3.
Effect of hormone pretreatment on the effectiveness of membrane 
depolarization by CsA. The upper histograms show that pretreat­
ment of human lymphocytes with 10^  units/ml of human recombinant 
gamma-interferon abolished the effect of 10 pg/ml CsA. The middle 
histograms show that recombinant IL-2 (10-100 units/ml) enhanced 
the effect of 10 yg/ml CsA. The lower curves show the dose de­
pendent depolarization of mouse lymphocytes with two units/ml of 
insulin. The left side figures are treated only with CsA, while 
the right side ones show the effects of hormones. The x means 
the histogram before, the xx the histogram taken after CsA treat­
ment (with a: none; b: 0.5; c: 1.0 and d: 10 yg/ml CsA). Cell 
number was uniformly 10^ /ml.
of CsA. The ionophores valinomycin, ionomycin and A-23187 
4 2also released K to different extents, as it also shown in 
Table I (10) .
Interaction of hormones and CsA. The hormones IL-2, and 
gamma-interferon which are known to influence the maturation 
of lymphocytes (35), were tested for their effects on the 
cytoplasmic membrane potential. Gamma-interferon had almost 
no effect on the fluorescence of DiOCg(3), thus indicating no 
effect on the membrane potential. However, high doses of gamma- 
interferon protected human lymphocytes against the depolariza­
tion caused by CsA. Interleukin-2 itself decreased the membrane
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Table I.
K+ concentration in lymphocytes before and after
CsA treatment
Treatment K -t concentration
None 129 + 8.6
2 yg/ml CsA 1 10 + 7.5
4 pg/ml CsA 98 + 10.0
20 yg/ml valinomycin 79 + 18.0
2 units/ml insulin 125 + 5
2 units/ml insulin ± 2 yg/ml CsA 123 + 3.6
20 yg/ml gramicidin 20 + 1 .8
2.5 yg/ml ionomycin 80 ± 7.2
1 .0 yg/ml A23187 76 ± 9.3
The data represent the mean ±SD of 5 experiments in mmol/1 
cell water (23). The insulin treatment was carried out with 
mouse spleen cells, all other data were obtained with human 
peripheral blood lymphocytes.
potential of human as well as that of mouse lymphocytes. Depo­
larization due to IL-2 pretreatment was not only additive with 
the depolarization caused by the CsA, but slightly enhanced 
the effect of the latter (Fig. 3).
Combined effect of ionophores and CsA. Combined effects 
of ionophores and CsA were also tested in order to specify the 
nature of the changes in the ion-fluxes upon CsA treatment. 
Since the cytoplasmic membrane potential of resting lymphocytes 
is for all practical purpose a Donnan-potential, generated by 
the uneven distribution of extra- and intracellular potassium, 
the potassium specific ionophore valinomycin was first tested. 
The valinomycin itself can cause hyperpolarization at very low 
concentrations by its potassium specific carrier function. The 
larger concentrations of valinomycin result in a severe loss 
of potassium and a consequent decrease in the cytoplasmic mem­
brane potential (35). Doses of valinomycin which caused a 
slight hyperpolarization of the membrane prevented the depolar-
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Figure 4.
Effect of valinomycin pretreatment on the depolarizing effect of 
CsA. The two upper figures show the changes of histograms upon 
addition of 10 yg/ml CsA before or after (right side picture) 
adding 5 yg/ml valinomycin. The samples were treated with valino­
mycin and CsA after the membrane potential probe reached equilib­
rium with the cells. The two lower pictures show the effect of 
valinomycin preincubation (5 minutes) on the effect of CsA upon 
the DiOCg(3) uptake (DiOCg(3) was added 5 minutes after CsA ad­
dition). The concentration of valinomycin and CsA were as above, 
125 nM DiOCg(3) was applied in all cases. The left side figures 
were taken with samples treated only with CsA and the right side 
ones show the effect of valinomycin pretreatment, x: histograms 
taken before CsA treatment; xx: histograms taken after CsA treat­
ment .
izing effect of CsA (Fig. 4). Higher doses of CsA could par­
tially overcome of this type of protection (data not shown).
The antagonistic effects of valinomycin and CsA were also ob­
served when the kinetics of the uptake of the DiOCg(3) was 
the indicator of the effects. The nonspecific channel forming 
ionophore gramicidin always depolarized the membranes regard­
less of the presence or absence of CsA. Similarly, increased 
extracellular potassium concentration depolarized the membrane 
independently of the effects of CsA. Ionomycin, a calcium 
specific mobile ionophore, caused a small depolarization of the
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cytoplasmic membrane potential (see Table I). When the effect 
of CsA was tested either on the release of the dye from cell 
at equilibrium or on the uptake kinetics, a pretreatment with 
ionomycin showed additivity or enhancement of the effects in 
the case of human lymphocytes. On the contrary after ionomycin 
pretreatment of mouse spleen lymphocytes, a slight but well 
detectable decrease in the effect of CsA was observed (data not 
shown).
The calcium and also magnesium specific ionophore A-23187 
decreased the membrane potential at higher concentration. When 
the addition of A-23178 was combined with CsA, the effects were 
additive, regardless of the sequence of the addition. On the 
other hand, variations in the amount of the extracellular free 
calcium ions obtained by using calcium free buffer or adding 
EDTA to the cell suspension did not influence the membrane de­
polarizing effects of CsA.
Miscellaneous experiments with CsA. Although the uptake 
of the Ca^+ was not a prerequisite for the effect of CsA, the 
release of calcium by the drug could not be excluded without 
experimentation. Flow cytometric measurement with quin-2 did 
not show any calcium release. In another experiment human cells 
were loaded with indo-1 AM dye and the changes in the 405 and 
480 nm fluorescence were followed in a spectrofluorimeter as 
well as in a flow cytometer (33). CsA increased the ratio of 
the 405/480 fluorescence in a dose dependent fashion indicating 
an increase in the intracellular calcium 0.5 yg/ml CsA could in­
crease the 405/480 nm fluorescence ratio by a factor of two.
Monoclonal antibodies available against lymphocyte sub­
class specific antigens were incubated with human as well as 
with mouse cells prior to treatment with CsA. Most of the 
available antibodies, characteristically binding different sub­
sets of T and B lymphocytes did not influence the overall ef­
fect of CsA. Preincubation of human cells with 10 yg/ml of 
OKT4 or OKT8 antibodies before addition of DiOC,(3) and 5-10O
yg/ml of CsA provided a slight protection against the depolar­
izing effect of CsA. When cells were incubated with CsA, and 
fluorescein conjugated antibodies were added to the cells, the 
binding of the antibodies was not influenced by the CsA pre­
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treatment.
Fluorescein diacetate, a non-fluorescent compound, is a 
substrate of membrane bound esterases. The hydrolysis of FDA 
into fluorescein and acetate results in an accumulation of 
fluorescein inside the cells (23). This reaction is also used 
as a viability test because any leakage of the membrane can be 
easily monitored. As is shown in Figure 5, the fluorescence was 
decreased in the presence of CsA.
Figure 5.
Effect of CsA on the fluorescein diacetate hydrolysis test.
The curves starting from above show the kinetics of the de­
velopment of fluorescein fluorescence after pretreating 
mouse spleen lymphocytes with 0 (o), 2 yg/ml (x) and 10 yg/ml 
(o) CsA for 5 minutes. Data were obtained in a flow cytometer.
Experiments were carried out with HUT-102 cells which 
have an abudance of IL-2 receptors at their surface and were 
labeled with fluoresceinated anti-Tac antibody and dansylated 
CsA. The binding of antibody was not influenced by the presence 
of the CsA. If the respective binding sites were close enough
i.e., within 2.0-10 nm, an effective energy transfer should
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occur (29). We could not find energy transfer, thus a close 
proximity of the IL-2 receptors and CsA localization was not 
indicated. The very low energy transfer that was occasionally 
observed could come from energy tunneling between dansyl-CsA 
dissolved in the lipid-phase and the receptor bound FITC con­
jugated monoclonal antibody.
As Table II and Figure 6 demonstrate, the spin probe, 
5-doxyl stearic acid indicated an immediate uptake of the CsA 
into the lipid phase of human peripheral (and also mouse spleen) 
lymphocytes. The increased order parameter also shows a limited 
motional freedom of the spin probe in the presence of CsA.
Figure 6.
ESR curves of 5-doxyl stearic acid probe in human lymphocyte 
membranes before (x) and after (xx) CsA treatment. Further 
experimental details are shown in Table II.
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Table II.
Characteristic ESR parameters of lymphocytes before and after 
CsA treatment
Cell treatment V V I 
7r .. 1 aN S n
Human lymphocytes, 
(control) 2x107 23.90 8.A5 15. A5 13.60 0.635 6
Human lymphocytes, + DMSO (1 yl) 2x107 2A.05 8.60 15.A5 13.65 0.639 2
Human lymphocytes, + 100 yg of CsA in 2x107 1 yl DMSO 2A.62 8.30 16.32 13.72 0.667 3
Standard deviation 
Standard deviation
for Tu ’ = 
for S =
±0.29.
±0.011.
DISCUSSION
A prerequisite to understanding how the CsA acts on partic­
ular T cell subsets is to find the earliest possible functional 
parameter, indicating this particular drug-cell encounter. Bio­
chemical changes in the transmembrane signaling mechanisms un­
doubtedly occur in the presence of CsA as it was shown in a 
number of studies (7-16). However, these studies, by their na­
ture, in most cases follow the changes several hours or days 
after drug treatment. Studies on the possible changes in mem­
brane potential and especially flow cytometric membrane poten­
tial measurements offerred the great advantage of obtaining 
data on a cell by cell basis and gaining information over the 
total or preselected cell population within minutes after ad­
dition of CsA (19-21).
The most important observation of the present paper is 
the dramatic decrease in the membrane potential of both human 
and mouse lymphocytes immediately upon addition of CsA regard­
less of their T or B origin. This membrane depolarizing effect 
of CsA on mouse lymphocytes was prevented or significantly de­
creased in the presence of insulin. On the contrary the human 
lymphocytes responded to the CsA also in the presence of the
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same amount of insulin that protected the mouse lymphocytes, a 
finding in accordance with earlier reports that human lympho­
cytes do not bind insulin (34).
Depolarization of cytoplasmic membrane as indicated by 
translocating dyes like DiOCg(3) can occur by many different 
mechanisms involving several cations and anions. In unstimulated 
lymphocytes, usually having a low amount of mitochondria and a 
cytoplasmic membrane potential that is more than 80 % due to 
the potassium concentration gradient between the extra and 
intracellular spaces as described by the Nernst equation, the 
likeliest ion to be involved in the depolarization is the po­
tassium (36). A decrease in the membrane potential upon addi­
tion of CsA when the cells are already equilibrated with
DiOC,(3) can easily be explained by a potassium release. The
° 4 2release of potassium by CsA was directly demonstrated with K
loaded cells. The CsA may change the transport of potassium 
either directly, by binding proteins belonging to or located 
nearby the potassium channels, or indirectly through influencing 
the structure and function of potassium channel forming proteins 
from the lipid domain of the membrane. Since quinine did not 
influence the effect of CsA (unpublished observation), it was 
unlikely that the voltage gated K+ channels were involved (37). 
The sensitive indo-1 dye revealed an increase of intracellular 
Ca upon addition of CsA. We suggest that this is closely con­
nected with the potassium release, and not an independent phe­
nomenon. The observed decrease in the rate of the uptake of 
the potential probe in the presence of CsA suggests that the 
structure of the lipid domains have been changed, since their 
permeability to the DiOCg(3) significantly decreased in the 
presence of CsA. Again, direct evidence was obtained by the 
ESR measurements wherein the immediate decrease of the motional 
freedom of spin probes incorporated into the cytoplasmic mem­
brane was observed upon addition of CsA. The corrected emission 
and excitation spectra of the DiOCg(3) were very similar or 
rather identical in the presence and absence of cells. This in­
dicates the lack of a strong interaction of the dye and the 
cellular lipids. This, and the substantial changes upon chang­
ing the extracellular potassium concentration, again provided
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additional evidence that the decisive factor determining the 
distribution of the dye is the electrochemical potential 
gradient, and among the conditions applied, the interactions 
of the dye and the lipids play a lesser role. The experiments 
in which combinations of CsA and ionophores, specific for po­
tassium, calcium or calcium and magnesium, were applied showed 
strong interactions with CsA. The valinomycin, ionomycin and 
A-23187 belong to the group of the so-called mobile carriers 
which have hydrophobic characteristics and shuttle their ions 
between the outside and inside borders of the membrane; thus 
these ionophores, influenced by the CsA while dissolved in the 
lipid domains of the membrane, supported the notion that the 
CsA was principally merged into the lipid phase of membrane 
and its effects on ion movements, i.e., the observed depolari­
zation of the cytoplasmic membrane, could be an indirect effect 
upon the potassium channels. It is interesting that the calcium 
and calcium and magnesium specific ionophores can also release 
potassium, most likely by an indirect mechanism. Gramicidin, 
an ionophore, which forms a hydrophilic channel for ions to 
cross the membrane, was not influenced by the presence of CsA. 
Similarly, an increase in the extracellular potassium concen­
tration decreased the membrane potential independent of CsA. 
Since the CsA has a cyclic peptide structure like many of the 
mobile ionophores an ionophore-like effect of CsA cannot be ex­
cluded. Of course, to test such a specific role demands further 
investigations. The CsA inhibits the synthesis of gamma-inter­
feron (38). We investigated the possible direct interaction be­
tween the membrane-receptor binding hormone, the gamma-inter­
feron, and CsA. Human recombinant gamma-interferon showed a 
strong interaction with CsA at the membrane level, by prevent­
ing the depolarizing effect of CsA on human peripheral blood 
mononuclear cells. Alternative possibilities of direct and in­
direct interactions are feasible.
None of the observed effects of CsA at this level could 
be linked to any of the well characterized subpopulations of 
mouse spleen or human peripheral blood leukocytes. A comparison 
of the effects on cells from mouse thymus and spleen respec­
tively did not show a difference. A number of the available
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monoclonal antibodies was incubated with human lymphocytes 
prior to addition of CsA. The membrane potential was not sig­
nificantly changed upon incubation with the antibodies which 
did not modify the depolarizing effect of CsA. The only ex­
ception in which consistent, although a small protection was 
observed in the experiments did occur when cells were prein­
cubated with OKT-4 and OKT-8 antibodies. Since these types of 
monoclonal antibodies are directed against the helper and 
cytotoxic T cell subpopulation and bind 65 % of the peripheral 
T lymphocytes, a strong interaction should have produced a 
readily observable signal. Nonetheless, the helper and cyto­
toxic lymphocytes are those, supposed to be among the targets 
of the immunosuppressive agent CsA (8). Another question con­
cerning the interaction of monoclonal antibodies and CsA, was 
whether the binding of the former was influenced by the latter. 
The labeling of human lymphocytes with FITC conjugated OKT-3,
4 and 8 binding 90, 65 and 35 % of peripheral human lymphocytes, 
respectively, was not influenced even at high CsA concentra­
tions. Interestingly enough, the binding of recombinant IL-2 
to human peripheral blood lymphocytes, (the existence of the 
receptors was verified also with FITC-anti-IL-2 receptor anti­
bodies in parallel samples) enhanced the effect of the CsA on 
the cytoplasmic membrane potential. IL-2 alone did decrease 
somewhat the cytoplasmic membrane potential.
The observed depolarization of the cytoplasmic membrane 
in the presence of CsA is apparently the earliest observable 
effect of the drug on cells. Its indiscriminate action on the 
membrane potential of both T and B lymphocytes is not surpris­
ing since the CsA also influences the B cell activation in a 
dose dependent fashion (39). The changes in ion fluxes are 
known to initiate or abolish cell activation. Blockade of the 
sodium-hydrogen antiport abolished growth factor induced DNA 
synthesis in fibroblasts (40). Likewise a mutation abolishing 
this antiport activity in hamster fibroblasts precluded growth 
at neutral and acidic pH (41). The role of the increase in the 
intracellular calcium in the activation of leukocytes by A-23187 
is well-known, it is noteworthy, however, that CsA prevents 
activation of leukocytes by A-23187 but this blockade can occur
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at different sites as well as at the membrane (42). The possi­
bility that all of the known effects of the CsA on human and 
mouse cells depend upon, or are initiated by, the early depolar­
ization has to be considered. An explanation for the high degree 
of selectivity, of CsA for the cell-mediated cytotoxicity is 
now crucial. The key to this explanation may be found in the 
highly selective response of the different types of cells. As 
in the case of the known major intercellular messengers, the 
hormones, which can also have nonspecific binding to other 
cells as well as their primary targets, CsA may act nonspecifi- 
cally and indiscriminately, yet the answer of certain types of 
cells can be specific and coming only from selected, specifi­
cally sensitive populations.
Evidence provided here support the view that closer in­
vestigation of cell membrane dynamics, even by indirect means 
like membrane potential measurements, can significantly con­
tribute to the understanding of cell-drug and cell-hormone 
interactions.
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DISCUSSION
ZIDOVETZKI:
Did you check, if there is a direct interaction between 
valinomycin and cyclosporin A?
DAMJANOVICH;
Yes, we did. There is no interaction.
PECHT:
Have the ionophoric properties of cyclosporin B been 
examined? How much of its biological activity could be 
explained by such an ionophoric behavior?
DAMJANOVICH:
Several preliminary experiments have been done to get an 
answer to that question. On the basis of these we cannot 
rule out that cyclosporin B may have some ionophoric 
activity. Experiments are in progress in order to clear 
that point.
ZS.-NAGY:
Do you have any data about the effect of CsA on the 
lateral diffusion constant of membrane proteins?
DAMJANOVICH:
No, I haven't. It is an excellent idea to look for that 
question.
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Three lines of evidence were obtained indicating that 
microtubule depolymerization affects the function and the 
physical state of the plasma membrane in Chinese hamster ovary 
(CHO) cells. One line of evidence was obtained with a membrane 
potential sensing dye and flow cytometry. Mictrotubule depoly­
merization with vincristine, colcemid and colchicine resulted 
in membrane depolarization. These effects were due to drug in­
teraction with microtubules because 1.) effects were time 
dependent, 2.) required the entry of the drugs into the cell 
as indicated by the lack of membrane depolarization in a multi­
drug resistant mutant, 3.) a colcemid-resistant tubulin mutant 
did not show membrane potential changes and 4.) taxol, the 
microtubule stabilizing drug, prevented the action of the de- 
polymerizing drugs. Similar conclusions could be drawn from 
ESR studies using maleimid spin probes attached to proteins 
in the membrane. The third line of evidence comes from ESR 
probing of the lipid domain of plasma membranes. These studies 
indicate that the motional freedom of the probes, as expressed 
by the order parameter S, is higher in microtubule depolymer- 
ized cell membrane than in membrane of untreated cells.
Previous studies indicate that microtubules modulate the 
functions of plasma membranes by changing membrane potential 
(1), hormone responsiveness (2, 3), receptor capping (4, 5) and 
exocytosis (6). Connections between microtubules or tubulins 
with cell membrane components have been observed before (7, 8,
9, 10) but the mechanism by which microtubules modulate dif­
ferent membrane functions is not fully understood yet. How­
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ever some studies have demonstrated that the microtubule system 
can directly influence plasma membrane dynamics (11, 12).
In our studies we have shown that depolymerization of mic­
rotubules results in increased motional freedom of fatty acid 
probes inserted into the plasma membrane and of probes attached 
to sulfhydryl groups of proteins embedded in the lipid domain 
of membranes of CHO cells. In addition to this, the plasma mem­
brane potential is changed if microtubules are depolymerized. 
Our results support models based on the anchorage theory in 
which microtubules interact directly or indirectly with the 
cell membrane and influence various membrane functions. Some 
of these studies have been previously reported in the J. Cell 
Biology (12).
MATERIALS AND METHODS
Growth of cells for electron spin resonance (ESR)
Measurements: CHO cells were grown in a-modified minimal 
essential medium (a-MEM) containing 10 % fetal bovine serum 
(M.A. Bioproducts, Walkersville, MD), and the antibiotics 
penicillin (50 U/ml), and streptomycin (50 ug/ml) (Flow Labo­
ratories, Inc., McLean, VA) in monolayer culture as previously 
described (13, 14). The ß-tubulin mutant cell line Cmd-4 was 
selected for growth in colcemid (15) and the multiple drug- 
resistant cell line C5 (gift of V. Ling) was selected for 
growth in colchicine, but has been shown to be resistant to 
different drugs including adriamycin, puromycin and actinomy- 
cin-D (16). 20 h before spin labeling, cells were treated with 
0.25 % trypsin, 2 mM EDTA in Tris-dextrose buffer and suspend­
ed at a density of 2-4x10® cells/ml in 20 ml complete a-MEM 
medium in 120-ml glass bottles. The bottles were sealed after 
gassing, and incubated at 37°C in a gyrorotatory shaker bath 
(New Brunswick Scientific Co., Edison, NJ) at 160 rpm. When 
spin labels were added, cells were at a density of 8x10 /ml 
and were 90 % viable as measured by trypan blue exclusion.
For most studies, cells were grown in suspension in in­
dividual bottles. Prior to spin labeling, they were combined 
and divided into equal portions. Drugs were added as described
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and incubation was continued for an additional 45 min. When 
two drugs were used, as in the case of taxol and colcemid, the 
second drug was added 10 min after the first one. Cells were
then collected by centrifugation and resuspended in phosphate-
£buffered saline (PBS) to a concentration of 10 cells/0.06 ml 
of PBS. With the mutant cells, direct comparison between mutant 
and wild-type cell lines was not possible since we were able to 
show that cells grown to different densities have membranes 
with different fluidities. 10® cells were sufficient to obtain 
good quality ESR spectra.
Spin labeling: To study the membranes of CHO cells, we 
used two spin labels: 5-doxyl stearic acid (SA) and 16-doxyl 
methylstearate (MS), both purchased from Syva Co., Palo Alto, 
CA. and stored in ethanol for several months at -20°C. Appro­
priate volumes of spin label were put into glass centrifuge 
tubes and diluted with 1-2 volumes of ether, prior to evapora-_ Q
tion of the solvents under vacuum. 8x10 mol of spin label was 
used to label 10® cells. The cell suspension in 0.05-0.07 ml 
of PBS was added to the spin label-containing test tubes. To 
get essentially all the spin label into the cellular membrane 
required approximately 30s for the 5-doxyl SA label and 90-120s 
for the 16-doxyl MS, at room temperature. The majority of the 
spin probes are probably located in the plasma membrane as sug­
gested by Bales et al. (17). After preincubation with spin 
labels, the cell suspension was sucked into a 50 pi micropet 
capillary (Clay Adams Div., Parisippany, NJ) and sealed at the 
bottom with Critoseal (Syva Co.). Direct contact of the cell 
suspension with Critoseal was avoided to present leakage of 
Mn^+ ions from the seal into the cell suspension.
Labeling of the membrane proteins: Spin labeling of the 
membrane proteins was done basically as described by Grof and 
Belágyi (18). 20 ml of a solution of maleimide nitroxide 
(1 mg/ml) in ethanol was dried in a conical centrifuge tube.
The spin label was then dissolved in 0.1 ml PBS, and 50 yl of 
a cell suspension of 2-4x10^ cell/ml was added. After 15 min­
utes at room temperature, the suspension was pelleted for 30 
seconds and then washed 3 times by repeated cycles of centri­
fugation-resuspension in the 0.2 ml PBS. The ESR signals of
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the final pellets were measured in 50 yl micropet capillary 
tubes (Clay Adams Co., Parisippany, NJ) sealed with Critoseal 
(Syva Co., Palo Alto, CA).
Evaluation of the ESR spectra: Evaluation for the fatty 
acid type probes was as described earlier by Aszalós et al.
(19) and is based on the equation used by Hűbbel and McConnell
(20) and Butterfield et al. (21). Evaluation of the ESR spectra
obtained with maleimid type spin probe attached to proteins was 
done as described by Gróf and Belágyi (18).
Membrane potential measurements: For membrane potential 
measurements untreated and drug treated aliquots of a CHO cell 
suspension of 3x10® cells/ml were stained with dihexyloxacarbo- 
cyanine iodide (DiOCg(3)), (Molecular Probes Inc.,Junction 
City, OR) dissolved in DMSO, in growth medium. The dye con­
centration was 0.5 yiM, a concentration which was non-toxic to 
cells as determined by a steady fluorescence intensity for 
the duration of the measurements (up to 1 h). The fluorescence 
intensity changes as the cells die and is a very sensitive in­
dicator of cell viability (22). The fluorescence intensity 
being indicative of the membrane potential was shown by the 
addition of agents known to change membrane potential accord­
ing to Waggoner (23). Elevated concentration of extracellular 
K+ (up to 160 mM), 2 yg/ml gramicidin-S and 10 yg/ml cyclosporin 
A decreased while 2 yg/ml valinomycin increased the fluorescence 
intensity as expected for viable cells.
A Coulter EPICS V flow cytometer and its software were 
used for data acquisition and analysis. The laser was tuned to 
488 nm and the output was kept at 400 mW. The flow rate of the3cells was kept low (10 cells/sec.) to provide good resolution. 
The forward angle light scatter and right angle green fluores­
cence signals were collected. To reduce artifacts, the fluores­
cence was usually gated on the scatter signal. For each histo­
gram, the coefficient of variation and the means were calcu-4lated, and 3x10 cells were analyzed.
Immunofluorescence localization of microtubules: Cells 
were grown in 35-mm dishes, were fixed and stained with mouse 
monoclonal antibody to chick a-tubulin (Miles Laboratories 
Elkart, IN), as previously described (12). Microtubules were
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visualized with a Zeiss fluorescence microscope and the degree 
of microtubule depolymerization was estimated by counting the 
fraction of cells with well-formed microtubule systems.
RESULTS
Microtubule-depolymerizing drugs affect motional freedom 
of ESR probes in the membranes: CHO cells treated with various 
anti-microtubule agents were analyzed using spin labels to de­
termine the effect of microtubule depolymerization and stabili­
zation on the motional freedom of the spin probes in the plasma 
membrane. The parameters which we evaluated from the ESR spec­
tra were, 2TU and 2Tj.. These are components of the motionally 
averaged nitrogen hyperfine tensor from which the nitrogen iso­
tropic coupling constant, aN ', and the order parameter, S, can 
be calculated. In a crystal lattice, where there is no motional 
freedom of the probe, the S value would be one, whereas S 
values less than one indicate increasing motion of the spin 
label probe which has been interpreted to imply increased mem­
brane fluidity.
When the 5-doxyl SA was inserted into membrane of CHO 
cells treated with taxol, which stabilizes microtubules, no ef­
fect on ESR spectra was seen, but cells treated with microtu­
bule depolymerizing agents showed significant differences. The 
calculated parameters for untreated cells and CHO cells treat­
ed with 0.5 yg/ml colcemid (1.3 yM), 2.5 yg/ml colchicine (6.3 
yM) , 5 yg/ml podophyllotoxin (12 yM), 2.5 yg/ml vincristine 
3 yM), and 125 yg/ml griseofulvin (350 yM) are shown in Table 
1. These drug treatments were sufficient to cause complete de­
polymerization of microtubules in CHO cells as measured by in­
direct immunofluorescence using anti-tubulin antibodies (data 
not shown).
If the difference between the two values of T|i was less 
than 0.1 gauss, only two measurements were made since the 
standard deviations of S for untreated and colcemid-treated 
cells were found to be 0.004 and 0.005, respectively. Hence, 
the difference between the S values of untreated CHO cells, 
0.680, and of colcemid-treated CHO cells, 0.664, is significant.
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Table I.
ESR parameters of 5-doxyl SA inserted into CHO cellsx
Treatment, lig/ml 1’ ^ J Tl’ T’
fH*“ V S N
no treatment 27.58 (0.15) 9.06 (0.2) 18.41 15.20 0.680+ 9
colcemid, 0.5 27.11 (0.2) 9.20 (0.01) 17.91 15.17 0.665+ 5
colchicine, 2.5 27.10 (0.1) 9.10 (0.1) 18.00 15.16 0.662 2
podophyllotoxin, 5.0 27.15 (0.1) 9.15 (0.1) 18.00 15.16 0.665 2
vincristine, 2.5 26.75 (0.1) 9.40 (0.1) 17.35 15.20 0.638 2
griseofulvin, 125 26.75 (0.1) 9.35 (0.05) 17.40 15.10 0.641 2
taxol, 10 27.66 (0.3) 9.07 (0.2) 18.58 15.20 0.684 4
taxol, 10, followed 
by colcemid 0.5 27.45 (0.1) 9.02 (0.1) 18.42 15.10 0.687 2
beta lumicolchicine, 
2.5 27.35 (0.1) 9.00 (0.1) 18.30 15.12 0.676 2
Experiments performed as described in Materials and Methods, 22°C.
N is the number of data points, S values are calculated as described in 
Materials and Methods. T|| >, Tj_’, and a^’ are in gauss.
Standard deviations 1: 0.004, 2: 0.005.
Table II.
Dose-dependent effect of colcemid on Tg ’ of 5-doxyl SA-treated 
CHO cells correlates with microtubule depolymerization
yg/ml colcemid T» ’ Microtubule depolymerizationX
0 27.70 none
0.1 27.45 few short microtubule segments seen
0.2 27.15 complete
0.5 27.10 complete
Essayed by immunofluorescence.
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Significant differences were also found between untreated 
cells and cells treated with the other microtubule depolymeriz- 
ing agents. We also determined a dose response of CHO cells to 
colcemid. As seen in Table II, the effect of colcemid on T/| ' 
was observed only with amounts of colcemid that detectably de- 
polymerize microtubules. Treatments with taxol and with taxol 
followed by colcemid, which block microtubule depolymerization, 
blocked the observed changes in the motional freedom of the 
probe (Table I). A colchicine analog with no biological activ­
ity, ß-lumicolchicine, resulted in no significant changes in 
membrane fluidity as expressed by the S values (Table I).
Changes in the motional freedom of membrane probes do not 
occur in a colcemid-resistant B-tubulin mutant: The CHO cell 
mutant, Cmd-4, which was selected for resistance to colcemid 
and expresses an altered ß-tubulin (15), was compared to the 
parent cell line for membrane fluidity changes when both cell 
lines were exposed to colcemid. As shown in Table III, the 
parent cell line responded to 0.1 yg/ml colcemid treatment with 
a change in S value from S=0.675 to S=0.659. On the other hand, 
the treated and untreated mutant cell lines showed no signif­
icant difference in the order parameter, i.e., S=0.661 and 
0.659, respectively. The lower S value found for the mutant 
may be due to a somewhat lower density of mutant cells in this 
experiment (see Table III).
Motional freedom of membrane proteins of CHO cells: The 
motional freedom of membrane proteins was determined using ESR 
parameters of a maleimid spin probe which reacts with sulfhyd- 
ryl groups of proteins. Two types of sulfhydryl groups bind 
this spin label: easily accessible, mobile sulfhydryl groups, 
and slow moving sulfhydryl groups seeded deeper in the hydro- 
phobic region of the membrane (19). ESR spectra indicate the 
motional freedom of both types of proteins, from which the slow 
moving proteins can be characterized by the outer hyperfine 
couplings, 2T|j . The two experimental spectra of the two types 
of proteins made it impossible to calculate order parameters, 
however, in this case a larger 2TH could be interpreted as 
either less motional freedom or less polar vicinity of the ESR 
probe (25). Figure 1 shows a typical spectrum obtained
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Table III.
ESR parameters of 5-doxyl SA in colcemid resistant (ß-tubulin 
mutant) and wild-type CHO cellsX
CelIs/treatment V TJ.’ II H 1 H
1 
h- a ’N S
resistant mutant 
no treatment 27.25 9.25 18.00 15.25 0.659
resistant mutant 
0.1 yg/ml colcemid 27.20 9.20 18.00 15.20 0.661
wild-type 
no treatment 27.45 9.10 18.30 15.20 0.675
wild-type
0.1 yg/ml colcemid 27.00 9.15 17.85 15.10 0.659
Experiments performed as described in Materials and Methods, 
22°C.
S values are calculated as described in Materials and Methods. 
T„’ , Tj_’ and a^’ in gauss.
Figure 1
ESR spectra of maleimid type spin probe attached to untreated 
(upper curve) and 2.5 yg/ml vincristine treated (lower curve) 
wild-type CHO cells. Labeling and spectroscopic details are 
described in Materials and Methods.
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with the maleimid probe reacted with sulfhydryl groups of pro­
teins of CHO cells. Results obtained with several different 
microtubule depolymerizing agents and taxol, the depolymeriza­
tion hindering agent, are shown in Table IV.
iaDie iv.
ESR parameter of maleimide spin probe in CHO cells>
Treatment (yg/ml) H=CM S.D.
no treatment 
colchichine (2.5)
58.4 ± 
57.2 ±
0.2 (n=8) 
0.3 (n=8)
vincristine (2.5) 
colcemid (0.2) 
taxol (10)
57.4 ± 0.2 (n=8) 
57.3 ± 0.1 (n=4) 
58.1 ± 0.2 (n=4)
taxol (10) followed by colcemid (0.2) 58.3 ± 0.2 (n=4)
xCells were labeled with the maleimid spin probe as 
described in Materials and Methods. SD = standard 
deviation.
Each applied depolymerizing drug (colchichine, vinblastine 
and colcemid) decreased the value of 2T jj . Taxol, 10 yg/ml had 
no effect alone. Also, no significant change in the 2T|| value 
could be seen when cells were pretreated with taxol (10 yg/ml) 
prior to colcemid (0.2 yg/ml) treatment. Changes in the 2Tn 
values caused by the microtubule depolymerizing drugs are 
statistically significant.
Microtubule depolymerization changes membrane potential: 
The plasma membrane potential of wild-type and mutant CHO cells 
untreated and treated with microtubule depolymerizing agents 
was measured with the fluorescent translocating dye method as 
described in Materials and Methods. Use of a flow cytometric 
technique allowed us to obtain information on a cell by cell
4basis. The fluorescence of 3x10 cells was measured to obtain
one histogram. The fluorescence intensity was a measurement of 
the membrane potential since appropriate fluorescence intensity 
shifts were seen upon addition of known membrane potential
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changing agents as detailed in Materials and Methods. Light 
scatter histograms of treated and untreated CHO cells were 
superimposable, indicating that treated and untreated cells had 
similar shapes. Membrane potential shifts of wild-type CHO cells 
after treatment with 2.5 yg/ml vincristine or 2.5 yg/ml colchi­
cine are shown in Fig. 2. Fluorescence intensity measurement 
of cells within 3 min after addition of 2.5 yg/ml vincristine 
indicated very little fluorescence intensity change as compared 
to that seen after 45 min. This time dependence rules out an 
ionophoric effect of the microtubule depolymerizing agents. The 
dose dependence of the membrane potential shift after addition 
of 0.05, 0.070 and 0.1 yg/ml colcemid was the same as the dose 
dependence of microtubule depolymerization indicating a good 
correlation between these two phenomena (data not shown).
0)
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Figure 2
Histograms of 2.5 yg/ml vin­
cristine (top histogram) and 
2.5 yg/ml colchicine treated 
and untreated CHO cells. In 
both cases treated cells yield­
ed the left histograms. Histo­
grams were obtained as de­
scribed in Materials and Methods 
and were suerimposed electron­
ically.
F lu o re sc e n c e  In tens i ty  (arbitrary units)
Histograms with fluorescence intensities after addition 
of 2.5 yg/ml colcemid, 10 yg/ml taxol and 10 yg/ml taxol fol­
lowed by 2.5 g/ml colcemid to wild-type CHO cells are shown 
in Figure 3. Colcemid alone caused depolarization while taxol
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hyperpolarized CHO cells. Addition of colcemid after taxol 
treatment, however resulted in no significant change in the 
fluorescence intensity as would be expected since taxol blocks 
colcemid-induced microtubule depolymerization.
Figure 3
Histograms of 2.5 yg/ml col­
cemid (top), 10 yg/ml taxol 
(middle) and 10 yg/ml taxol 
followed by 2.5 yg/ml colcemid 
treated CHO cells (bottom). 
Histograms of treated cells 
are marked X in each case. 
Histograms were obtained as 
described in Materials and 
Methods and were superimposed 
electronically.
m
Fluorescence Intensity (arbitrary units)
Two mutant cell lines, a tubulin mutant (Cmd-4) and a 
multidrug resistant mutant which does not accumulate many drugs 
(C5), were tested for membrane potential change after addition 
of 0.1 or 0.075 yg/ml colcemid. The wild-type CHO cells res­
ponded to these treatments, but no fluorescence intensity 
changes were observed with either mutant cells (data not shown). 
These results imply that the colcemid must enter cells and must 
also interact with microtubules to have effects on membrane
potential.
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DISCUSSION
The motion of spin probes in the lipid domain of plasma 
membranes or attached to transmembrane proteins is a sensitive 
and reliable indicator of the physical state of the lipid domain 
of membrane of CHO cells (26) and of membrane bound proteins 
(19) .
This work demonstrates significant increases in the mo­
tional freedom of two ligand probes and one sulfhydryl protein 
probe as a result of depolymerization of microtubules. These 
changes are not the result of a direct effect of the drugs on 
the cell membranes since they are not seem immediately after 
addition of the drugs and are not seen with ß-lumicolchicine, 
a nonfunctional analog of colchicine.
Uptake of the drug by the cells is a prerequisite for the 
observed effects on membrane potential and motional freedom of 
the proteins since the colchicine-resistant drug permeability 
mutant, C5, fails to respond with changes in the motional free­
dom of ESR membrane probes and in the membrane potential (data 
not shown).
We have obtained three kinds of evidence that the anti­
microtubule agents must interact with microtubules to alter the 
motional freedom of the spin label in the membrane or to alter 
plasma membrane potential: (a) the dose response of the effect 
of colcemid is similar to the dose response for depolymeriza­
tion of microtubules for this drug: (b) taxol, a drug known to 
stabilize microtubules in cultured cells (27), blocks the ef­
fect of colcemid on membranes; and (c) a CHO mutant resistant 
to colcemid because of an alteration in ß-tubulin (15) shows 
no effect of colcemid on the motional freedom in the membrane 
or on the plasma membrane potential.
Lai and coworkers, using the same spin label probes to 
study CHO membranes, found that there are differences in the 
motional freedom of the spin probe in the membrane throughout 
the cell cycle with an increase during mitosis and decreases 
in G1 and S (24). We speculate that this increase in the mo­
tional freedom of the probes during mitosis could be the 
result of a reorganization of microtubules as spindles are
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formed. The results of Lai et al. (24) are consistent with our
evidence that depolymerization of microtubules increases mo­
tional freedom of spin labels in unsynchronized cell populations. 
Both studies agree with previous structural observations of 
Porter, who found cell cycle-specific changes in the appearance 
of the cell surface in CHO cells (28). Taken together, these 
results suggest a possible role for microtubules in the media­
tion of some of these morphologic phenomena.
Spin label studies of the motionally restricted protein 
sulfhydryl groups are entirely consistent with results obtain­
ed with ESR probes of the lipid domain (Table IV). The motional 
freedom of the protein bound spin probes increases if the micro­
tubule system is depolymerized and these changes are also hin­
dered by taxol (Table IV). More freely moving protein functions 
seem to parallel the increased motional freedom of the lipid 
domain in cell membranes with depolymerized microtubule systems. 
It is interesting to speculate that some of the labeled sulf­
hydryl groups may belong to ion channels or ion pumps. By this 
argument, ion flux changes across the plasma membrane may mani­
fest changes in membrane potential after microtubule depolimeri- 
zation.
The dye DiOCg(3) which we used for the membrane potential 
measurements can also measure mitochondrial membrane potential 
changes (29). In our studies, we believe that only plasma mem­
brane potential changes were recorded for the following reasons: 
taxol pretreated cells did not respond to colcemid treatment 
and the tubulin mutant cells Cmd-4 did not respond to colcemid 
treatment either. The observed fluorescence intensity changes 
being indicative of membrane potential changes was ascertained 
as described in Materials and Methods
Another way to relate changes in motional freedom of lipid 
and protein probes to altered membrane potential comes from the 
work of Vassilev et al. (1). They have suggested that polymer­
ized microtubules increase ionic conductance through the micro­
tubule lumen. However, both arguments require i.e., microtubule 
lumen vs ion pumps that microtubules directly or indirectly are 
connected to the plasma membrane as has been proposed by others 
based on independent evidence (7).
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DISCUSSION
ZS.-NAGY:
The order parameter you measured is strongly dependent on 
the cell number/volume. How can you assure absolutely 
identical numbers in your test system?
Would you predict how e.g. the passive permeability for 
K+ will change, if the lateral mobility of proteins 
changes in the membrane?
ASZALÓS:
After culturing the cells at well defined conditions and 
measuring the same order parameter, S, many times, you 
can be sure that you have always the same membrane 
"fluidity" of your cells. Also before drug treatment, 
cells were pooled and divided into treated and untreated 
parts.
I have no data to answer your question. I have not seen 
a good discussion on this topic yet either.
CHERRY:
Is it possible that the small changes in order parameters 
are caused by changes in membrane potential, rather than 
vice versa. I ask this because membrane potentials of 
tens of millivolts correspond to high electric field 
strengths across the lipid bilayer which could in turn 
cause compression of the lipid chains.
ASZALÓS:
It is entirely possible what you propose is true. I do 
think that protein conformational change must be first 
followed by membrane potential change. Change in the mo­
tional freedom of lipid molecules may follow these events.
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I. INTRODUCTION
From the liquid crystal two-dimensional nature of membrane 
architecture, molecular motions of membrane constituents are restricted by 
the anisotropic structural factor in addition to the isotropic frictional 
factor. Translational motion of proteins or lipids in membranes is 
structurally restricted in the plane of membrane. Rotational motion of 
membrane proteins across the plane of membrane is practically restricted 
by the amphipathic nature of these molecules. Thus, the major rotational 
diffusion of membrane proteins must be anisotropic rotation around a 
molecular axis perpendicular to the plane of membrane^ >2).
Rotational motion of deuterated lipids and spin labeled lipids in 
membranes has been studied by nuclear magnetic resonance (NMR)F3) or 
electron spin resonance ( E S R ) ^ L  The results are usually analyzed by the 
assumption that the rotational motion of lipid chains around the chain 
axis is much faster than the characteristic time scale of the magnetic 
resonances. Then the spectra give only the "order parameter s ” which 
indicates the angular distribution of chain axis around the membrane 
normal.
Abbreviations: DPH, 1,6 diphenyl-1,3,5-hexatriene; DMPC, dimyristoyl- 
phosphatidylcholine; DPPC, dipalmitoyl-phosphatidylcholine; DOPC, 
dioleoyl phosphatidylcholine; PAPC, 1 -palmitoyl-2-arachidonoyl- 
phosphatidylcholine; PLPC, 1-palmitoyl-2-linoleoyl-phosphatidylcholine; 
TOPC, 1 palnntoyl 2-oleyl-phosphatidylcholine.
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The steady state fluorescence anisotropy of fluorescent dyes embedded 
in membranes have been used as the measure of membrane fluidity. Its value 
is in most cases interpreted in terms of "microviscosity"(5) on the 
assumption of isotropic rotation of probes. Rotational diffusion of a 
small but unspherical molecule embedded in lipid bilayer, however, should 
reveal the anisotropic rotation of lipid hydrocarbon chains in the 
membrane.
In 1977, we studied^®) the molecular motion of a rod like fluorescent 
probe, 1 ,6-diphenyl-l,3,5-hexatriene (DPH), in lipid bilayers with the 
time resolved fluorescence depolarization technique, and proposed the 
wobbling in cone model(^). By this model, we emphasized that the rate and 
range of the rotational motion were important factors to describe the 
dynamic structure of membrane. In this paper we briefly summarize our own 
fluorescence depolarization studies(8,9) on various model and biological 
membranes.
II. TIME RESOLVED FLUORESCENCE DEPOLARIZATION AND WOBBLING IN CONE MODEL
1 ) Fluorescence depolarization
Molecular rotation of fluorescent probes can be followed directly by 
the fluorescence depolarization measurement. Excitation of probes with a 
vertically polarized light pulse produces an ensemble of excited probes of 
whose transition moments are preferentially aligned along the vertical 
direction. Then, the excited probes undergo rotational diffusion and their 
orientations become randomized with time. If one observesthe vertical (Iv ) 
and horizontal (Ih) components of the fluorescence intensity,their time 
courses depend on both the lifetime and the rotational correlation time. 
To separate these dependences, the observed intensities are usually 
analyzed using the fluorescence anisotropy r (t) defined by
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r (t) = (Iv (t) - Ih (t))/IT (1)
where Ifit) = Iv (t) + 2Ijj(t) is the total fluorescence intensity. The 
fundamental anisotropy r0 , the value of r in the absence of rotation, is 
expressed by
rQ = 0.4(3cos2l- 1 )/2 (2)
where Ä is the angle between the absorption and emission transition 
moments. The factor 0.4 is given when the initial distribution of the 
chromophore is isotropic. The anisotropy decay r(t) of a spherical probe 
in isotropic media is expressed by
r(t) = r0exp (—t/<p) (3)
where <p is the rotational correlation time. For a non-spherical probe, a 
single exponential term in equation (3) should be replaced by the sum of 
several exponential terms. The steady state fluorescence anisotropy rs is 
given by
rs = I x(t)r(t)dt / t)r(t)dt (4)
2) Fluorescence anisotropy decays in membrane
Typical results of the fluorescence probe, DPH, embedded in model and 
biological membranes are shown in Fig. 1. The anisotropy decay of DPH 
observed for all membranes so far studied in our laboratory is biphasic 
consisting of an initial rapid decrease and a following stationary phase. 
The process can be expressed by the approximate form:
r (t ) = (r0-r°° )exp(-t/<p) + r=° (5)
The first term indicating the decay from rQ to r°° should be replaced by 
the sum of exponential terms for the strict expression. The second 
stational value r°° indicates the presence of structural restriction on 
the range of rotational motion of probes.
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T i m e  (ns)
Fig.l Typical fluorescence decays of DPH in model and biological 
membranes, a) In pure DMPC vesicles (curves 0) and in vesicles of the 
oxidase-DMPC molar ratio of 4/100 (curves 4). b) Mitochondrial membranes. 
g ( t ) ,  the instrumental response function; Jt (i), the total fluorescence 
intensity (dots, experimental data; dashed and solid lines, calculated 
best-fit curves for single- and double-exponential approximations); r(i), 
fluorescence anisotropy (zigzag lines, experimental; smooth lines, 
calculated best-fit curves for the exponential-plus-constant
approximation).
3) Wobbling in cone model
Wobbling in cone model was proposed to interpret the biphasic decay 
of equation (5), in terms of two essential factors, the rate and range of 
restricted rotational diffusion. In the model, the long axis of the 
fluorescent probe wobbles freely in a cone of semi-angle 0C with a 
wobbling diffusion constant Dw . Although the exact form of anisotropy 
decay r(t) calculated from this model is given by a sum of infinite number 
of exponentials, it can be closely approximated by a simpler forrni);
r(t) = (r0-r°° )exp(-Dwt/os ) + r°° (6)
where os is a constant that depends solely on 0C , or equivalently on 
r°°/rD (see Table I). Then, if an experimental anisotropy decay r(t) is 
approximated by the equation (5), the wobbling diffusion constant Dw can
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be determined by
<p = as/Dw (7)
Futhermore, the residual anisotropy r°° is related to the cone angle 0C 
r°° /r0 = (cos0c (l+cos0c )/2)2 = sß (8)
where s is the "order parameter", which is usually used as a measure of 
the chain orientation in NMR or ESR studies,
In the wobbling in cone model, we assume a box type orientational 
distribution, though the real distribution will be a smooth one. To 
examine the effect of this simplification on the analysis, we
calculated®) the model of gaussian distribution and compared it with the 
original cone model (Table I). The result indicates that, when only two 
parameters are extracted from an experiment, the shape of distribution 
function is not crucial as long as the model contains the two essential 
factors describing the rate and angular rangesof probe rotation
TABLE i
COMPARISON BETWEEN STRICT CONE AND GAUSSIAN 
MODELS
Strict cone model Gaussian model
ado.
8C cr, dt
1.000 0.0 0.0 0.0 0.0
0.989 5.0 0.0022 5.0
0.955 10.0 0.0088 10.0
0.901 15.0 0.0196 15.0
0.831 20.0 0.0342 20.1
0.746 25.0 0.0522 25.2
0.653 30.0 0.0731 30.3
0.555 35.0 0.0962 35.7
0.458 40.0 0.121 41.6 0.101 0.83
0.364 45.0 0.146 48.1 0.119 0.82
0.279 50.0 0.170 55.1 0.132 0.78
0.204 55.0 0.193 61.9 0.143 0.74
0.141 60.0 0.214 67.7 0.152 0.71
0.0904 65.0 0.231 72.3 0.158 0.68
0.0527 70.0 0.245 75.7 0.162 0.66
0.0265 75.0 0.253 78.1 0.165 0.65
0.0104 80.0 0.257 79.9 0.166 0.65
0.0022 85.0 0.255 81.2 0.167 0.65
0.0 90.0 0.250 82.2 0.167 0.67
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III. DYNAMICS OF LIPID HYDROCARBON CHAINS
1) Phase transition
The temperature dependence of the steady state fluorescence 
anisotropy rs of DPH embedded in the lipid bilayers of DMPC DPPC is shown 
in Fig. 2. Sharp changes in rs observed at about 23 °C (DMPC) and 44°C 
(DPPC) indicate the order-disorder phase transition. The corresponding 
changes in wobbling parameters, 0C and Dw , were determined(9) (Fig. 3). 
The orientational distribution of DPH in hydrocarbon regions is highly 
anisotropic in the ordered state.
Fig. 2 (left) and Fig. 3 (right). Temperature dependences of the 
steady-state fluorescence anisotropy (r^) of DPH (left) and of the 
wobbling diffusion constant, Dw , and the cone angle, 0C (left), in 
lecithin membranes. • DPPC multibilayer liposomes; o DPPC sonicated 
vesicles; A  DMPC sonicated vesicles.
2) Viscosity in the cone
In the disordered state at higher temperature than T^, the estimated 
values of 0C are about 70" . These values indicate that the fairly large 
space must be attributed to the cone for the wobbling diffusion. It is
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unnatural to keep such a large void space around DPH molecules. A major 
part of the cone should be occupied by hydrocarbon chains and the probe 
wobbles around due to collision with these chains. The wobbling diffusion 
constant Dw indicates the diffusion rate of probe in such a hydrocarbon 
chain region. The "viscosity in the cone" r]c can be estimated by
Dw = kT/(6i?cVef) (9)
where Ve and f denote the effective volume and the shape factor of the 
probe. The value of Vef of DPH in hydrocarbon chains of lipids can be 
obtained from the observed r(t) of DPH in liquid paraffin because of the 
similar molecular properties of both solvents. The viscosity in the cone 
represents purely the friction against the wobbling motion, and should be 
distinguished from the "microviscosity". The microviscosity is calculated 
from the value of steady state anisotropy on the assumption of isotropic 
rotation of a probe. Then, the structural restriction on the rotation is 
implicitly imposed on the microviscosity. Thus, the estimated values of ??c 
are an order of magnitude smaller than the "microviscosity" values.
3) Effect of double bonds
The effect of double bonds on the dynamic structure of lipid bilayers 
is clearly demonstrated by the changes in 0C and Dw shown in Fig. 400). 
The large increases in the rate and angular ranges are produced by the 
first double bonds introduced into the saturated lecithin molecules 
(DPPC). The values of 0C and Dw of unsaturated lecithins definitely 
indicate the disordered state at a temperature lower than T^ of DPPC. 
The effect of the second and subsequent double bonds is relatively small.
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Fig. A. Temperature dependence of the wobbling diffusion constant, 
Dw, and the cone angle, 0C , for DPH in multilamellar phospholipid 
liposomes. • DPPC; A  POPC, O  PLPC, x  DOPC, A PAPC.
4) Effect of cholesterol
Since cholesterol is a major lipid component of many biological 
membranes, its effect on the dynamic structure of lipid bilayers was 
i n v e s t i g a t e d U ) through the molecular motion of DPH in DMPC-cholesterol 
vesicles. In the disordered state at 35”C , incorporation of cholesterol 
decreases 0C sharply, while Dw remained almost the same value. In the 
ordered state at lCTC , on the other hand, cholesterol increases Dw without 
changing 0C . Similar different effects on the ordered and disordered 
states of lipid bilayers were observed in the reconstituted DMPC-protein 
systems described in the next section.
IV. PROTEIN-LIPID INTERACTION AND DYNAMIC STRUCTURE OF BIOLOGICAL 
MEMBRANES
1) Effect of proteins on lipid dynamics
The effect of protein-lipid interaction on the dynamic structure of
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lipid bilayers was investigated in systems composed of purified cytochrome 
oxidase and synthetic lipids 02) The difference between the effects of 
cytochrome oxidase on the ordered and on the disordered states of DMPC is 
shown in Fig. 5.
Fig. 5. The wobbling diffusion constant, Dw , and the cone angle, 0C , 
for the wobbling motion of DPH in oxidase-DMPC vesicles, o , at 35°C ; • , 
at 1CTC .
At the disordered state above T^, incorporation of the protein 
progressively reduces the range of wobbling motion 0C , while it is not 
affected below T^. On the other hand, the rate of wobbling motion, Dw , is 
little affected by the protein at the disordered state though it is 
increased at the ordered state. At the highest oxidase/lipid ratio of 
4/100, virtually all DPH molecules are at the protein surface and reflect 
the dynamics of hydrocarbon chains in the vicinity of the protein. Here it 
should be noted that the angular range 0C estimated from the fluorescence 
anisotropy decay referes to the motion in the nanosecond time range.
Reduction of the range of motion by the protein was also reported by
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1electron spin resonance (ESR) study(^) using spin-labeled fatty acid or 
phospholipid. ESR spectra show that the exchange between these lipids at 
boundary of protein surface and at bilayer lipids takes at least 50 ns. 
Deuterium nuclear magnetic resonance studies for membranes containing 
cytochrome oxidase indicate that exchange rate between the boundary and 
bilayer lipids exceeds 10^ sec“'^^) These results of fluorescence, ESR 
and NMR studies can be accounted for in a unified manner 0 2 ) t as shown in 
Fig. 6.
Fig. 6. Diagramatic representation of the wobbling motion of DPH in 
membrane. Cone A shows the approximate range of the nanosecond wobbling 
motion of DPH in bilayer part, which, in this figure, is assumed to be in 
the disordered state. A DPH molecule is depicted in this cone. Cones B and 
C show the motion on the surface of the protein.
In the nanosecond time range, lipid hydrocarbon chains in the 
disordered bilayer region exhibit the fast wobbling motion in the cone of 
large 0C (see cone A in Fig. 7). Lipid chains at the protein surface are 
wobbling in the cones with reduced 0C by the restriction of the irregular 
protein surface while their rate is not affected (cones B or C in Fig. 7). 
In the microsecond range, the lipid chains can move around freely among 
these cones and the apparent range of wobbling motion increases.
2) Dynamic structure of biological membranes.
Nanosecond fluorescence depolarization measurements were
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performed(15) at two temperatures 10 and 35°C for typical biological 
membranes. Anisotropy decay r(t) for all these cases was biphasic, and was 
interpreted in terms of the wobbling in cone model. The results are shown
in Fig. 7.
1. 0 0 , -
0 30 60 90
ft (degree)
Fig. 7. Wobbling parameters of DPH in model and biological membranes 
(ref. 15). In two large symbols connected with a dotted line, the open 
symbol with a letter in it denotes Dw and 0C at 35 or 3TC , and the closed 
symbol at IffC . P, purple membrane; E, erythrocyte membrane; M, 
mitochondrial membrane; S, sarcoplasmic reticulum membrane; L, PLPC; 0, 
DOPC; m, DMPC + cytochrome oxidase; o, DOPC + cytochrome oxidase; c, DMPC 
+ cholesterol. The right-hand scale for r/c is an approximate one.
The temperature dependence of Dw and 0C of biological and model 
membranes are quite similar in spite of the large differences in 
compositions of the membranes. Activation energies of 7-8 kcal/mole are 
attributed for the temperature dependence of Dw of all membranes and 
unsaturated lecithin vesicles (see Fig. 4). Thus, the dynamics of lipid 
hydrocarbon chains in membranes is basically that of the disordered state 
of unsaturated lipids.
There is a strong correlation between 0C and the composition of the 
membranes. The correlation may be explained by the effects of protein and 
cholesterol discussed in previous sections. Reduction of 0C in
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sarcoplasmic and mitochondrial membranes compared to 0C in pure 
unsaturated lecithin vesicles is explained by the presence of proteins,
for cholesterol content of these membranes is very low. Relatively small 
0C values of erythrocyte membrane can be attributed to its high 
cholesterol content in addition to protein. In the purple membrane, the
rigid crystalline structure of bacteriorhodopsin molecules (75wt%) 
apprently reduces 0C and Dw .
In summary of our fluorescence s t u d i e s 173, the dynamic structure 
of biological membranes in the lipid hydrocarbon chain region may be
understood by the relative composition of unsaturated phospholipids, 
proteins and cholesterol, and by their interactions.
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CALCIUM CHANNELS LINKING ANTIGEN STIMULATION WITH SECRETION 
FROM MAST CELLS AND BASOPHILS
I. PECHT, B. RIVNAY and A. CORCIA
Departments of Chemical Immunology and Membrane Research, 
The Weizmann Institute of Science, Rehovot 76100, Israel
The role of cytosolic free Ca ions as a messenger coupling extra­
cellular stimuli to an eventual cellular activity is well established (1).
In mast cells and basophils, aggregation of the high affinity Fc receptors 
specific for IgE by antigen initiates a chain of biochemical events which 
culminates in the secretion process (2). Identification of these events 
and their temporal sequence are major research challenges. One of the 
earliest events, identified in mast cells and basophils, as following the 
Fc^R aggregation is the increase in free cytosolic calcium ion concentra­
tion (3). This has been ascribed predominantly to an increase in the plasma 
membrane permeability allowing Ca+^ influx down its steep concentration 
gradient. Several characteristics of the Ca+  ^influx were interpreted as 
reflecting the opening of ion channels in the plasma membrane (4).
An important tool in our effort to resolve the membranal elements in­
volved in forming the Ca+  ^channels has been the anti-allergic drug cromolyn 
(1,3-bis(-2-carboxychromon-5-yloxy)-2-hydroxy propane. This drug can 
inhibit Ca+^ influx into rat peritoneal mast cells or rat basophilic leuke­
mia cells (RBL-2H3 line) and suppress their degranulation process (5,6). 
Employing this drug, a membrane protein has been isolated from the RBL-2H3 
cells by affinity based procedures (7,8). This cromolyn binding protein (CBP) 
was shown to play an essential role in coupling Fc£ aggregation with Ca+  ^
influx into the RBL-2H3 cells (9). Later on .conductance studies on model 
membranes yielded evidence for the ion-channel forming properties of the 
CBP (10). A comparison of conductance behavior of lipid bilayers reconsti­
tuted either with unfractionated plasma membranes of the RBL cells or with 
CBP alone or together with Fc£R,led to the following conclusions: 1) Cation 
fluxes display channel characteristics. 2) This activity is most probably
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contained within the CBP since aggregation with monoclonal anti-CBP anti­
bodies induced channel activity in membranes reconstituted with CBP alone.
3) All the components required for linking IgE mediated aggregation with 
channel opening are found in the unfractionated RBL plasma membrane and can 
be incorporated functionally into planar lipid bilayers. 4) Channel opening 
is specific, as it is induced only by ligands that aggregate the Fc^ . recep­
tor or directly the CBP (10,11).
These results set the stage for a more quantitative examination of the 
channel activity in terms of its amplitude and open time properties. 
Furthermore, a comparison of these parameters as affected by the channel 
activation mode (i.e. antigen or anti-CBP) is essential for identifying the 
active elements and their mechanism of operation. Therefore, we have quan­
titatively examined in model membranes co-reconstituted with the two isola­
ted membrane elements, CBP and the IgE-Fc£R complex, the conductance induced 
upon their aggregation.
RESULTS AND DISCUSSION
Electric currents across bilayers formed at a tip of a micropipette 
were measured. These bilayers were attached to the tip from the lipid mono- 
layer at air interface of vesicles resuspended in buffer (Fig. 1). The 
vesicles were prepared from lipids reconstituted (12,13) with either CBP or 
the IgE-Fc£R complex or with both. Conductance activity was induced either 
by aggregating the Fc^R or the CBP by specific agents. Several precautions 
were taken to ensure that the observed conductance is a specific process 
and not reflecting artifactual behavior (e.g. due to breakdown induced by 
the electrical potential itself). Moreover, it was imperative to examine 
whether the Fc£R by itself does have ion channel properties. This possibil­
ity was raised, for example, by the reports of J.D-E. Young, J. Unkeless and 
Z. Cohn and their associates who observed that the Fc^j, receptor isolated 
from macrophages has intrinsic Na+ channel forming properties (14). Thus, 
experiments in which the pipette-supported membrane contained only the IgE- 
Fc£R complex, were carried out. No channel activity (£■ IpS) could be 
detected in membranes containing only IgE-Fc^R complexes upon aggregation, 
irrespective of whether specific antigen or anti-IgE antibodies were used.
In each of the eight separate experiments of this kind carried out, records 
were monitored for a minimum of twenty minutes and up to 45 after adding 
the aggregating agent,yet no conductance was detected.
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As mentioned above, CBP containing bilayers were shown to allow channel 
activity upon specific aggregation by monoclonal anti CBP antibodies (10).
In order to quantitatively compare the properties of channels activated via 
Fc^R by antigen to those activated directly by monoclonal anti-CBP anti­
bodies, we started of with measurements on membranes containing both pro­
teins. Experiments where anti CBP was the triggering agent resulted in 
channel activity very similar to that induced by specific antigens. Figure 
2a shows several traces from such experiments. Trace 1 (Fig. 2a) contains 
two short lived channels (open times of several ms), the first one with a 
conductance of 4.5 pS and the second 1.5 pS. The channels in this trace 
appear distorted due to the effect of the filtering on such short-lived 
channels. Trace 2 shows a channel of 3.5 pS with longer open time (60msec). 
Like the antigen induced channels (see below), these low conductance and 
short-lived channels induced by anti-CBP appear scattered, with intervals 
up to several hundred milliseconds.
Fig. 1. A schematic illustration of the process of lipid bilayer formation 
at the micropipette tip. In step a the lipid monolayer is formed from the 
vesicles. The pipette is already in the buffer vesicle suspension. Step b 
- removing the pipette, which was kept under positive presence, leads to 
the formation of a monolayer at the tip. Reimmersion in step c leads
to the apposition of lipid chains of the monolayer to that at the water-air 
interface and a bilayer is formed.
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Fí r . 2■ Channel conductances induced in pipette-supported lipid membranes 
containing both the CBP and IgE-Fc£R. The downward deflection in the 
current trace signifies channel opening. The line at the left of each trace 
indicates the closed state level. A: Channels induced by anti-CBP anti­
bodies. Clamp potential was 100 mV in traces 1 and 3 and 40 mV in trace 2. 
Data were low-pass filtered at 100 Hz in traces 1,2 and 3 and digitized at 
3 KHz. B: Channel activity induced by specific antigen (DNP^-BSA). The 
transmembrane potential was clamped at 40 mV (pipette interior negative) 
in traces 1,2 and 4 and at 60 mV in trace 3. Data were low-pass filtered 
at 100 Hz in traces 1 and 4 and 50 Hz in traces 2 and 3 and digitized at a 
sampling frequency of 3 KHz.
Trace 3 presents an example of a small channel with a long open time. 
Several closing and reopening as well as superimposed higher conductance 
levels are also resolved.
In bilayers containing both isolated CBP and Fc^R receptors,channel
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activity was now examined when specific IgE aggregating agents were employed. 
Characteristic conductance is induced by specific antigen (DNP^BSA, 5 nM) 
added to a membrane containing both the IgE-Fc^R complex and the CBP.
Several types of events could be resolved: The most frequently observed 
channels are of low conductance and they remain open for time periods in the 
range of 10-20 msec. Trace 1 of Fig. 2B shows a 2 seconds recording contain­
ing three such channels, detected by our screening program. Due to the 
filtering required to detect these small channels, the precise conductance 
values are difficult to determine, yet the most frequently observed channels 
have a conductance between 1-2 pS. In a few cases, these small channels 
remain open for significantly longer periods, in the range of seconds 
(Fig. 2B, trace 2). Higher conductance levels, as high as 10 pS, sometimes 
appear superimposed on the basic low conductance of the long lived channels 
(Fig. 2B, trace 3). The last type, comprising a small fraction (10%) of 
all the channels observed after addition of specific antigen, are character­
ized by high values of conductance, ranging between 10-30 pS. The higher 
conductance levels appear either isolated or as bursts of activity with 
several different conductance levels as illustrated in Fig. 2B, trace 4.
All the above results clearly suggest that IgE aggregation leads, via 
the Fc£R, to channel opening most probably by co-aggregating the CBP.We did a 
quantitative statistical analysis of the properties of channels induced 
by either of the two different modes of activation. This required the 
accumulation and processing of a large number of events. We have analyzed 
the characteristics of 568 separate single channel events, 397 of which 
were detected in experiments using antigen and the rest with anti-CBP mono­
clonal antibodies.
Histograms of channel conductances were drawn from data obtained either 
by FceR mediated aggregation (Fig. 3A), or by anti-CBP mediated aggregation 
(Fig. 3B). The elementary conductance values were similar in all the exper­
iments, although each of the experiments was carried out at a given poten­
tial in the 40-100 mV range. In this analysis only conductance values 
assignable to the elementary-single channel events are included. Burst 
behavior containing different higher conductance levels as illustrated above 
in Fig. 2 were not included. As figure 3A shows, the majority of the 
detected channels ( 67%) have conductances in the range 1-2 pS. The number 
of events with larger conductance decreases rapidly with rather few events 
having conductances of 7 pS or more.
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Fig. 3. Conductance histograms constructed from single channel events. 
A) induced by antigen (DNP-^-BSA), B) induced by anti-CBP. Total number 
of events analysed is 397 in A and 171 in B.
The majority of channels observed with anti-CBP as agonist also fall 
in the two bins of lower conductance (Fig. 3B) but the fraction of channels 
in the 1-2 pS range is not as large as in panel A. Although this differ­
ence in the histograms may be due to having less data in panel B than in 
panel A, other possibilities (see below) cannot be excluded.
The second parameter examined for both sets of conductance experiments 
was the characteristic time the channel remains open. Histograms were also 
constructed from the observed open-time in the channel records. Figure 4A 
illustrates events triggered by antigen and Figure 4B those induced by anti- 
CBP. Events shorter than 10 milliseconds though detectable, were not 
included in the histograms since the distortion induced by filtration, 
particularly in channels of very short open times, made them less reliable. 
(This limitation imposed by the necessity to filter the data in order to 
resolve channels with small amplitudes, introduces an uncertainty in the 
calculated values of the average open time discussed elsewhere.)
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CONDUCTANCE (pS)
Fig. 4. Open time histograms constructed from single channel events.
A) induced by antigen, B) induced by anti-CBP. Number of events in each 
histogram is the same as in Fig. 3.
Bearing this reservation in mind, the marked similarity of the open time 
histograms shown in the different panels of Fig. A, regardless of the 
channel triggering mode, is still evident. In both cases the majority of 
channels open for short periods, of the order of 10-30 msec and only a small 
fraction of the events have open times of 70 msec or more.
The best fitting of the experimental data to a single exponential 
function is shown in Figure 5. In order to examine the fit of the experi­
mental data to a function of the form y = A.e^  , where y is the number
of events with an open time t, we calculated the best linear regression 
fitting the logarithmic function: In y = In A + (-t/t). The slope of this 
regression line is -1/x, (i.e. the reciprocal value of the average open 
time of the distribution). Fig. 5 shows the linear correlations for each 
set of data. The three groups present good linear correlations with
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Fig. 5. Linear regression analysis of the open time distributions observed 
for single channel events. Each open time distribution was fitted to the 
equation: ln(number of events) = A - t/x (see text). Mean open times (x) 
derived from the slopes of the straight lines were: 11.1 ms for antigen- 
induced channels (o— o), 11.6 ms for anti-CBP induced channels (x— x) and
11.0 ms for the combined data set (•— •).
coefficients of 0.982, 0.972 and 0.982, respectively, justifying the fitting 
to a single exponential function. More significantly, the three regression 
lines are practically parallel, yielding average open times of 11.1, 11.6 
and 11.9 milliseconds, respectively. This is a good indication that the 
channels analysed, irrespective of whether triggered by antigen or by anti- 
CBP, have the same open-time characteristic. Recalling the limitations 
involved in this analysis (see above), the value of 11 ms for the average 
open time of these channels must be considered as an upper limit for this
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parameter.
The conductance measurements described here yield a new insight into 
the initial phase of antigen stimulated secretion from mast cells and baso­
phils. They provide evidence for the direct activation, by the IgE-Fc£R 
membrane complex of another plasma membrane protein component, the CBP, to 
form an open Ca+  ^channel. These observations imply mutual interactions 
between the CBP and Fc^R and raise a number of further interesting ques­
tions, first with respect to the structure and operation mechanism of these 
membrane components, their stoichiometry and control. Another essential 
aspect is how other cellular events couple with this Ca+  ^influx.
Experiments now in progress will hopefully extend the quantitative 
characterization of the ion channel in physico-chemical terms. The marked 
similarity observed for the elementary conductance and open-time values 
observed irrespective of whether triggering is attained via the Fc^R or 
by anti-CBP antibodies has to be further substantiated. Still, it clearly 
suggests the common element which forms the ion channel - the cromolyn 
binding protein.
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DISCUSSION
EDIDIN:
I'm surprised at the long time (more than 1 minute) be­
tween adding agonist to reconstituted membrane prepara­
tions and observing increased conductance. Have you any 
explanation for this?
PECHT:
The kinetics of initiating the conductance may involve 
several factors including the binding and aggregation of 
the membrane-residing IgE antigen. In the absence of 
stirring, this might be the cause for the long delay. 
Still, a detailed examination has to be done in order 
to provide a proper answer.
ELSŐN:
Have you examined the dependence of the rate of initia­
tion of conductance in reconstituted bilayers as a func­
tion of the concentration of protein in the bilayer?
PECHT:
No, not yet. We naturally did look at single channel 
behavior at lower protein concentrations but not at the 
initiation rates.
SEGAL:
In the reconstituted membranes containing both IgE 
receptor and CBP, do you find desensitization after cross 
linking the receptor?
PECHT:
I presume you refer to decay of the conductance, rather 
than to desensitization. (Desensitization is the cell's 
decay in response to addition of Ca2+ ions after antigen 
triggering in its absence and is observed in most cells 
and usually not in the RBL-2H3 cells.) In the lipid bi­
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layers there is a decay of conductance after long periods 
(15-20 min) but we have not pursued that in detail.
ZS.-NAGY:
One of your slides showed the highest conductivity value 
for the artificial membrane when Na+ was present. I wonder 
whether this fact is connected to the observations of a 
group in Chicago (M. Villereal) showing that mitogenic 
Ca2+-effects are realized through the alteration of the 
monovalent (Na+) permeability of the cell membrane.
PECHT:
Indeed, in the absence of Ca2+, conductance of Na+ ions 
seems to take place and with a higher value per single 
channel as shown in the slide you referred to. The rel­
evance of this to mitogenic effects of Ca^+ on Na per­
meability is unclear as we deal with different cells 
(Lymphocytes vs. RBL cells). We do observe interesting 
effects of cytosolic Na+ on secretion from RBL. Yet this 
is a topic of its own.
ASZALÓS:
Could the increase of internal (Ca2+) come from bound 
Ca2 + of your binding protein instead of from Ca2 + influx?
PECHT:
No, the transient rise in cytosolic free Ca2+ is a result
of a net influx from outside the cell. That has been first
45 2 +shown by Foreman and his associates using Ca (for mast
cells) and more recently by M. Beavan and Rivnay for RBL-
45 2 +2H3 cells using the Quin-2 and Ca , respectively.
FÉSŰS:
Is CBP unique to basophils and mast cells? Have you looked 
for it in other types of cells with your monoclonal anti­
body?
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PECHT:
We have looked at cromolyn binding to a limited number 
of different cell types and found that only mast cells 
and basophils bound it. The best tool to check this is 
indeed the monoclonal antibodies but we did not do this 
yet.
ELSŐN:
Can you relate changes in calcium transport via the CBP 
to action of protein kinase C?
PECHT:
We have indeed looked the potential modulation of the 
cytosolic Ca^+ levels by kinase C as effected by phorbol 
esters (cf. R. Sagi-Eisenberg and I. Pecht, Immunol. Lett. 
1984; R. Sagi-Eisenberg, H. Lieman and I. Pecht, Nature, 
1985). Rather interesting synergism (at low concentra­
tions 1-7 nM) and inhibitory (at concentration greater 
than 10 nM) effects on secretion have been components of 
the RBL-2H3 cells by kinase C is being investigated.
ASZALÓS:
Do you know that other cells, also activated by Ca^+ in­
flux would have the same type Ca + influx mechanism?
PECHT:
Ligand activated Ca^+ channels are suggested to operate 
in several other cell types. An interesting possible 
analog to the mast cell case could be the T-cell. There 
are several recent reports suggesting that one of the T-3 
membrane complex in T-lymphocytes is acting as a Ca^+ 
channel.
GOLLOP:
Did you try to check the inhibitory effect of cromolyn 
on the trans-side of the bilayer (the side which has not 
been reconstituted with the different proteins).
485
Yes, we did and as you would have expected the drug does 
not have any effect when added to the trans compartment. 
Neither can you activate it when the agonist is added to 
the wrong side.
SEGAL:
Have you any direct evidence that CBP binds to cross 
linked IgE-receptor, for example by co-precipitation or 
covalent X-linking?
PECHT:
Not yet. We are planning such studies in the very near 
future. There is, however, indication for such interac­
tions from co-patching experiments which naturally do 
not provide direct evidence.
MANNERVIK:
Is it possible that, apart from the effects on the cell 
membrane, the clinical usefulness of cromolyn may be due 
to inhibition of leukotriene biosynthesis? Leukotrienes 
are believed to be orders of magnitude more potent as 
mediators of the effects of asthma.
PECHT:
As I stressed, the detailed mode of cromolyn's pharmaco­
logical action is not settled. Still, as far as I can re­
call it does not interfere with the biosynthesis of leu­
kotrienes. Hence it is not affecting this aspect of al­
lergic disorders.
PECHT:
486
Dynamics of Biochemical Systems 
S. Damjanovich, T. Keleti, L. Trón (Eds)
EFFECT OF MELITTIN AND MEMBRANE POTENTIAL ON THE MOBILITY OF 
BAND 3 PROTEINS IN HUMAN ERYTHROCYTE MEMBRANES
RICHARD J. CHERRY
Department of Chemistry, University of Essex,
Colchester C04 3SQ, UK
INTRODUCTION
In recent years there has been considerable interest in measuring 
rotational and lateral diffusion of membrane proteins. Rotational 
motion has been extensively studied by observing transient dichroism of 
either intrinsic chromophores or triplet probes (Cherry, 1978). In the 
case of triplet probes, increased sensitivity has been obtained by 
methods based on the detection of phosphorescence (Austin et al. 1979) 
or fluorescence depletion (Johnson and Garland, 1981).
Some of the most detailed investigations to date have been performed 
with band 3 proteins, both in erythrocyte membranes (Nigg and Cherry, 
1979a, 1980; Austin et al., 1979) and in reconstituted vesicles 
(Mühlebach and Cherry, 1985). In the erythrocyte membrane, slightly 
more than half of the total band 3 appears to rotate freely, while the 
remainder is restricted by interactions with cytoskeletal proteins (Nigg 
and Cherry, 1980). Long range lateral motion of all of band 3 is 
strongly restricted, probably because even 'free' band 3 is entrapped in 
the interstices of the cytoskeletal network (Koppel et al., 1981).
A particular feature of rotational diffusion measurements is that 
relaxation times are very sensitive to associations between membrane 
proteins. This has been exploited to study, for example, the existence 
of dimers of band 3 in erythrocyte membranes (Nigg and Cherry, 1979b) 
and complex formation between components of electron transport chains in 
mitochondrial and microsomal membranes (Kawato et al. 1981, Gut et al.
1983). The present paper describes further recent applications of this 
approach to erythrocyte membranes. Transient dichroism studies of 
eosin-labeled band 3 demonstrate that the basic polypeptide, melittin, 
promotes the self-aggregation of band 3. Moreover this property appears 
to correlate with its haemolytic activity. In further experiments it is 
shown that a membrane potential can also cause band 3 to aggregate and 
this effect may well be mediated by a potential-dependent conformational 
change of the protein.
METHODS
The transient dichroism technique used to measure rotational
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diffusion of membrane proteins is described in detail elsewhere (Cherry, 
1978). Essentially the sample is excited by a brief linearly polarized 
light pulse from a Nd-YAG laser. Transient absorbance changes are
recorded for light polarized parallel (A„(t)) and perpendicular (AA(t)) 
with respect to the exciflng pulse and the absorption anisotropy r(t), 
at time t after the pulse, calculated from the expression
A„(t)-A1(t)
r (t) = ----------- (1 )
A„ (t)+2A^(t)
The time dependence of the anisotropy depends on rotational diffusion. 
For proteins in membranes, the anisotropy normally decays to a constant 
value r3. If an immobile fraction is present, r3 is increased. The 
parameter r3? is a convenient measure of the immobile fraction, where 
r3? = 100r3/ro and r0 is the anisotropy at t = 0.
Band 3 was labeled in intact human erythrocytes with the triplet 
probe eosin-5-maleimide (Molecular Probes Inc) as described by Nigg and 
Cherry (1979a). All measurements of rotational diffusion were performed 
in ghosts prepared by osmotic lysis. In the case of experiments 
involving melittin, the ghosts were suspended in 5 mM sodium phosphate 
buffer, pH 7.4 and not resealed. For studies of the effect of membrane 
potential, right side out resealed ghosts were prepared as described 
previously (Richards and Eisner, 1982). The ghosts were resealed in a 
phosphate buffer containing 150 mM KC1 to give a high internal K+ 
concentration. The resealed ghosts were resuspended in media containing 
varying concentrations of KC1 with isotonicity maintained by addition of 
the appropriate amount of NaCl. A membrane potential was created by 
adding the ionophore valinomycin in the presence of a K+ gradient. The 
existence of a membrane potential was checked using the fluorescent 
probe 3—3' dipropyl thiodicarbocyanine (diS-C3-(5) as described by 
Waggoner (1979).
Native melittin was purified in the laboratory of Dr. R.C. Hider 
from whole Apis mellifera venom. The product contained no detectable 
phospholipase A2 activity. Succinyl and acetyl melittin derivatives, in 
which the free amino groups are modified, were prepared by methods based 
on those of Habermann and Kowallek (1970). Bacteriorhodopsin was 
obtained from Halobacterium halobiurn and reconstituted into dimyristoyl- 
phosphatidylcholine vesicles as previously described (Cherry et al. 
1978).
EFFECTS OF MELITTIN ON BAND 3 MOBILITY
Melittin is the major constituent of Honey Bee (Apis mellifera) 
venom and is largely responsible for the inflammation and tissue damage 
that follows a sting from this insect. It is a powerful lytic agent and 
haemolysis of erythrocytes is often used to monitor and study its 
activity. Melittin is a polypeptide of relatively simple structure and 
for this reason has attracted much interest as to its mode of action. 
The sequence of 26 amino acids is notable for a cluster of 4 basic 
residues close to the blocked C-terminus and a stretch of mostly apolar 
residues towards the N-terminus (Habermann, 1972).
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In spite of extensive studies of the secondary, tertiary and 
quaternary structures of melittin in a variety of environments, its 
mechanism of action remains elusive. Previous work has tended to 
concentrate on mechanisms involving the lipid component of membranes 
(Dawson et al., 1978; Brown and WUthrich, 1981; Dasseux et al., 1984, 
while the possible role of membrane proteins has been largely neglected. 
The aim of the experiments described here was to test whether melittin 
had any effect on band 3 proteins in erythrocytes which could be 
detected as an altered rotational mobility. If so, a further aim would 
be to discover whether these effects were likely to be important for 
understanding the lytic activity of melittin.
Initial experiments quickly revealed that melittin does indeed have 
a dramatic effect on the rotational mobility of band 3 (Dufton et al.,
1984). Typical results are shown in Fig. 1 where it can be seen that 
increasing melittin concentrations cause increasing retardations in the 
rate of decay of anisotropy. This indicates that melittin causes a loss 
of rotational mobility of band 3. When melittin is present at a 
concentration of 1.1 x 10-7 moles/mg of membrane protein, band 3 is 
almost totally immobilised over the time scale of the measurements.
Analysis of the anisotropy decay curves indicates that the 
immobilising effect is 50% complete at a melittin concentration of 4-5 x 
10-8 moles/mg of membrane protein. By comparison about 2-3 x 10-8 moles 
melittin/mg of membrane protein are required to produce 50% hemolysis of 
intact erythrocytes. The fact that melittin immobilises band 3 at a 
concentration similar to that required for haemolysis provides the first 
indication that membrane proteins may be involved in the lytic 
mechanism.
Time (ms)
Fig. 1 Anisotropy decay curves for erythrocyte membranes at different 
concentrations of native melittin. r(t) was measured at 37°C with 
membranes suspended in 5 mM sodium phosphate buffer, pH 7.4. Concen­
trations of melittin are expressed as moles per milligram of ghost 
protein. (i) Without melittin. (ii) 1.8 x 10-8 mol/mg. (iii) 3.5 x 
10-8 mol/mg. (iv) 4.9 x 10-8 mol/mg. (v) 1.1 x 10-7 mol/mg. Ghost 
protein concentration was 0.6 mg/ml.
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Native melittin contains 6 positive charges (2 Arg, 3 Lys and the 
N-terminus). The free amino groups can be acetylated to leave a net 
charge of 2+ or suceinylated when the net charge becomes 2-. 
Acetylation reduces the haemolytic activity of melittin whilst 
succinylation abolishes it altogether. We have investigated the effects 
of acetyl- and succinyl melittin on band 3 mobility. We find that in 
the case of acetyl-melittin the concentration required to produce 50Í 
immobilisation is about 6 x 10-8 moles/mg of membrane protein whilst 
succinyl melittin produces no effect on band 3 mobility. This good 
correlation between the effects of derivatisation on haemolytic activity 
and immobilising activity strengthens the proposal that membrane 
proteins are involved in the lytic action of melittin.
What is the mechanism whereby melittin immobilises band 3? The 
simplest explanation is that melittin promotes self-association of band 
3 into relatively immobile aggregates. The formation of aggregates has 
previously been invoked to explain the effects of varying cholesterol 
content on band 3 mobility (Mdhlebach and Cherry, 1982). Very recently 
we have collaborated with Dr. S.W. Hui (Roswell Park Memorial Institute, 
Buffalo), who has obtained freeze-fracture electron micrographs of 
erythrocyte membranes treated with melittin or its derivatives. These 
show that native melittin causes aggregation of intramembranous 
particles, acetyl melittin produces the same effect but at higher 
concentrations and succinyl melittin is without effect. The 
concentration of melittin required to aggregate intramembranous 
particles (which principally comprise band 3) is similar to that 
required to immobilise band 3. These results thus provide excellent 
confirmation that immobilisation by melittin is indeed due to band 3 
aggregation in the membrane.
There are a number of ways by which melittin could promote 
aggregation of band 3. Direct interaction between melittin and band 3 
is the most obvious possibility but indirect mechanisms mediated by 
other membrane proteins can also be envisaged. In addition it is 
conceivable that aggregation results from a change in the physical state 
of the lipids induced by melittin.
Experiments are in progress to attempt to distinguish between the 
above possibilities. In addition we have turned to a simpler model 
system to further elucidate the nature of melittin-membrane protein 
interactions. The rotational diffusion of bacteriorhodopsin 
reconstituted into dimyristoylphosphatidylcholine vesicles has been 
previously studied in considerable detail (Cherry and Godfrey, 1982). 
The effects of melittin and its derivatives on bacteriorhodopsin 
mobility in these lipid vesicles have recently been investigated and 
found to be essentially similar to those already observed with band 3 
(Hu et al. 1985). An important advantage of the model system is that it 
is possible to vary the lipid:protein mole ratio (L/P) and hence test 
whether melittin-lipid or melittin-protein interactions are principally 
responsible for the observed effects. Table 1 summarises the results of 
a series of experiments in which the change in r3$ is used as a measure 
of the fraction of bacteriorhodopsin immobilised by melittin.
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Table 1 Immobilization of Bacteriorhodopsin by Native Melittin at 
different Lipid/Protein Ratios
(a) Experiments at constant melittin/protein ratio. (b) Experiments at 
constant melittin/lipid ratio. Note: L/P, Melittin/L and Melittin/P are 
mole ratios. Ar3$ is the change in r3% from the control value. L, 
lipid; P, protein
L/P Melittin/L Melittin/P Ar 3 %
(a) 50 0.063 3.2 23.5
99 0.032 3.2 22.7
161 0.020 3.2 21 .4
(b) 50 0.021 1 .0 8.6
99 0.021 2.0 19.0
161 0.021 3-3 24.2
The results in Table 1 show that the degree of immobilisation is 
determined by the melittin/protein mole ratio and not by the melittin/ 
lipid ratio. This argues strongly for a direct interaction between 
melittin and bacteriorhodopsin and suggest that there may be a similar 
direct interaction with band 3.
A plausible molecular basis for the direct interaction between 
melittin and band 3 or bacteriorhodopsin can be deduced by consideration 
of known structural features. Both band 3 and bacteriorhodopsin possess 
hydrophobic segments which span the lipid bilayer and hydrophilic 
moieties bearing negative charges which reside in the aqueous phase. 
Melittin also possesses hydrophobic and hydrophilic segments but the 
latter is positively charged. Melittin could thus be embedded in the 
lipid bilayer via its hydrophobic segment while its cationic C-terminal 
segment crosslinks the membrane proteins by electrostatic binding to 
anionic residues. Some degree of hydrophobic interaction could also be 
involved in the interaction. The role of electrostatic binding is 
supported by the loss of activity resulting from modification of 
melittin's free amino groups.
The significance of the aggregation effects for the mode of action 
of melittin is twofold. Firstly the results presented above for 
erythrocyte membranes indicate that the mechanism of lysis is likely to 
depend on melittin-intrinsic protein interactions as well as melittin- 
lipid interactions. Secondly, they provide a possible basis for under­
standing the high degree of synergism that exists between melittin and 
phospholipase A2, the second major component of bee venom, in cell lysis 
(Yunes et al., 1977). In cells, uniformly distributed intrinsic 
membrane protein may restrict the access of phospholipase A2 to the 
lipids, especially as many of these proteins have large extracellular 
carbohydrate moieties attached. Aggregation of proteins by melittin 
would clear regions of lipid bilayer which would subsequently be more 
readily susceptible to enzymatic attack.
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EFFECTS OF MEMBRANE POTENTIAL ON BAND 3 MOBILITY
The effects of membrane potential on the mobility of membrane 
proteins has been very little investigated. Edidin and Wei (1977) 
reported that depolarization of cells resulted in an increase in the 
rate of intermixing of surface antigens following fusion of two 
different cell types. It was proposed that the effect is due to 
increased entry of Ca2+ into cells, with a consequent effect on 
restraints to lateral mobility by cytoskeletal elements. Apart from 
this interesting observation, there is virtually no information on 
whether protein mobility is responsive to changes in membrane potential. 
Whilst it is by no means clear that effects are to be expected, the 
topic appears well worth investigating in view of the ubiquity of 
potentials across cell membranes.
Here, preliminary results are presented on the effect of membrane 
potential on band 3 rotational mobility in erythrocyte membranes. These 
experiments were performed on right side out resealed ghosts prepared as 
described under Methods. The membrane potential was detected by the 
fluorescent probe diS-C3-(5). A decrease in the fluorescent intensity 
of the probe was observed upon addition of valinomycin for resealed 
ghosts with the external K+ concentration [K]0 = 0 mM (nominally) 
corresponding to hyperpolarization. An increase in fluorescent 
intensity was observed for [K]0 = 150 mM, whilst a null point was found 
at [K]o = 100 mM.
The effect of membrane potential on band 3 mobility is illustrated 
by the results shown in Figure 2. The anisotropy decay curve was first 
determined for resealed ghosts with [K0] = 0 mM. Then valinomycin was 
added and the anisotropy decay remeasured within 2-3 minutes. It is 
clear that hyperpolarization of the membrane has a dramatic effect. The 
decay in anisotropy is abolished corresponding to immobilization of band 
3 on the millisecond time scale.
Time (ms)
Fig. 2 Anisotropy decay curves for resealed erythrocyte ghosts in the 
presence and absence of valinomycin. r(t) was measured at 37°C with 
ghosts suspended in 0 mM KC1, 150 mM NaCl, 4 mM Hepes buffer, pH 7.5.
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When similar measurements were performed with [K0] = 100 mM, no 
change in the anisotropy decay was detected upon addition of valino- 
mycin. Moreover, valinomycin had no effect on band 3 mobility when 
added to leaky ghosts. Finally, different K+ concentrations in the 
range 0-150 mM had no effect in the absence of valinomycin on either 
resealed or leaky ghosts. These control experiments clearly show that 
the immobilization of band 3 occurs only under conditions where a 
membrane potential is produced across the erythrocyte membrane.
The change in band 3 mobility is accompanied by a further entirely 
unexpected result. In the deoxygenated samples used for rotation 
measurements, the triplet state lifetime of the eosin probe is about 2 
ms. Under the same conditions which produce an immobilization of band 
3, a large drop in triplet lifetime to about 0.5 ms was observed. Again 
no effect was detected unless a membrane potential was produced.
Further experiments were performed in which the membrane was 
depolarized by addition of valinomycin to resealed ghosts with [K0] = 
150 mM. Somewhat surprisingly, the effects were rather similar to those 
obtained with [K0] = 0 mM, namely immobilization of band 3 and decrease 
in the eosin triplet lifetime.
We have not attempted to quantify the membrane potentials produced 
in these experiments, since there is considerable uncertainty in the 
leakiness of resealed ghosts. Probably the potentials are not too far 
from the K+ Nernst potential which implies values in the order of tens 
of millivolts. In considering possible explanations of the effects on 
band 3 mobility, it should be noted that potentials of this magnitude 
applied across a lipid bilayer of thickness 5 nm correspond to an 
electric field in the order of 107 V/m. Conceivably, this high electric 
field could affect band 3 either directly by inducing a change in 
conformation or indirectly via compression of the lipids. The large 
change in triplet lifetime of the eosin probe is a strong indication 
that a conformational change in band 3 occurs. It is known that 
tryptophan is a quencher of the eosin triplet state (Kraljió and 
Lindqvist, 1974) and hence a conformational change which brought the 
probe closer to such a residue could conceivably explain the lifetime 
change. The conformational change could in turn lead to aggregation of 
band 3, which would account for the loss of mobility.
The experiments described here demonstrate that structural changes 
in the erythrocyte membrane result from changes in membrane potential. 
It is interesting to conjecture whether similar effects might occur with 
membrane proteins present in excitable systems. At present we have very 
little understanding at the molecular level of how, for example, an 
electrical signal causes release of neurotransmitters from presynaptic 
terminals or how depolarization of muscle leads to release of Ca2+ 
stored in sarcoplasmic reticulum. A recent electron microscopic 
observation that acetylcholine release from synaptosomes may be 
accompanied by aggregation of intramembranous particles (Israel et al. 
1981) is a hint that aggregation of membrane proteins may be an 
important phenomenon. The experiments described here represent an 
approach by which such phenomena might be further investigated.
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DISCUSSION
DAMJANOVICH:
We observed a phenomenon, namely when we reached equilib­
rium after addition of valinomycin at high K+ concentra­
tion, the fluorescence was further decreased upon addition 
of gramicidin. It was assumed that in the latter case the 
membrane itself was also equilibrated. It would be inter­
esting to check this phenomenon in your system.
CHERRY:
Yes, we should try other ways of influencing the membrane 
potential and it would certainly be worthwhile to perform 
further experiments with gramicidin A.
ZIDOVETZKY:
What was the behavior of the rotational correlation times 
during the band 3 aggregation?
It looked, as though your freeze-fracture results indicate 
the non-randomization rather than aggregation of band 3.
CHERRY:
Because there are probably different sized aggregates 
present it is not possible to extract meaningful correla­
tion times. All one can say is that with increasing melit- 
tin there is an increasing contribution from more slowly 
rotating species.
I agree. It is hard to tell from freeze-fracture whether 
you have true aggregation.
ZIDOVETZKI:
So, the best evidence for aggregation is coming from the 
rotational diffusion measurements rather than from freeze- 
fracture .
497
CHERRY:
Yes, but it is more convincing when the two techniques 
agree.
PECHT:
Could the effect of melittin still be accounted for by 
the interaction with the lipid rather than with band 3 or 
rhodopsin? It seems difficult to reconcile a direct effect 
of the peptide on two such different proteins. Hence in­
teraction with the lipid indirectly modifying the respec­
tive lipid-protein behavior seems to me a still viable 
possibility.
CHERRY:
I think the data I presented for bacteriorhodopsin clearly 
indicate a direct melittin-protein interaction. We do not 
know yet if this conclusion can be applied to band 3. How­
ever, they both possess anionic residues in their hydro­
philic regions which could participate in melittin binding.
SRERE:
Since your proposal and data indicate an ionic interaction 
between melittin and band 3 is there evidence for an ef­
fect of ionic strength on the interaction.
CHERRY:
This is a tricky question to answer because high ionic 
strength (e.g. 1 M NaCl) dissociates ankyrin leading to
an enhancement of band 3 mobility and break up of ghosts 
into smaller vesicles which themselves have significant 
tumbling. The experiments we have performed at high ionic 
strength are therefore difficult to interpret but they 
are consistent with reversibility of the melittin-induced 
band 3 aggregation.
KELETI:
What is the effect of the proteins which are known to be 
bound to band 3 protein?
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CHERRY:
These are experiments we still have to perform. For example, 
it would be interesting to know if removal of cytoskeletal 
proteins influenced the effect of melittin on band 3.
499

Dynamics of Biochemical Systems 
S. Damjanovich, T. Keleti, L. Trón (Eds)
NUCLEAR MAGNETIC RESONANCE STUDY OF THE INTERACTION OF 
PHOSPHOLIPID BILAYERS WITH POLYPEPTIDE ANTIBIOTICS
RAPHAEL ZIDOVETZKI*, UTPAL BANERJEE**, ROBERT R. BIRGE*** 
and SUNNEY I. CHAN*
*Dept. of Biology, University of California, Riverside, USA, 
**Dept. of Chemistry, California Institute of Technology, 
Pasadena, CA, USA,
***Dept. of Chemistry, Carnegie-Mellan University,
Pittsburg, PA, USA
ABSTRACT
In this work we examine the interaction of three cell 
membrane-active polypeptide antibiotics: polymyxin B, gramici­
din S, and valinomvcin with artificial phospholipid bilayers
2 31using a combination of H- and P-nuclear magnetic resonance 
(NMR) spectroscopy. This combination of NMR measurements allow­
ed to distinguish a character of interaction of the antibiotics 
with either single phospholipid bilavers or with bilayers with 
composition similar to the outer cell membrane of gamma-negative 
bacteria. The results showed that only weak surface interaction 
takes place between the antibiotics and the neutral phospholi­
pid membranes. However, each of the antibiotics studied inter­
acts strongly with negatively charged phospholipids, penetrat­
ing into the interior of the membranes.
INTRODUCTION
In recent years, there has been considerable interest in 
the mechanism of action of polypeptide antibiotics. Polymyxin B 
sulfate is a cyclic polypeptide which carries five positively 
charged diamino-butyric acid residues (Storm et al., 1977). 
Lipid-polymyxin B interactions were studied using a variety of 
biophysical methods, including fluorescence polarization, 
electron microscopy (Hartman et al., 1978), electron paramag­
netic resonance spectroscopy (Galla and Trudell, 1982), calori­
metry (Sixl and Galla, 1982), and Raman spectroscopy (Mushaya-
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karara and Levin, 1984). Some data suggest that polymyxin B 
does not bind to zwitterionic lipids (Teuber and Miller, 1 977; 
Hartmann et al., 1978), while in the other works the presence 
of interactions of polymyxin B with such lipids was reported 
(Mushayakarara and Levin, 1984).
Gramicidin S is a cyclodecapeptide antibiotic, isolated by 
Gaux and Brazhnikova (1944). It is effective against the gram­
negative bacteria, and it was suggested that the action of 
gramicidin S on both artificial and natural membranes is mainly 
due to interactions with negatively charged lipids (Ishida and 
Mizushima, 1969; Shezhkova et al., 1975). It was suggested in 
other works, that after initial absorption on the membrane sur­
face via ionic interactions, the hydrophobic residues of gram­
icidin S interact with the lipids' acyl side-chains (Yonezawa 
et al., 1982) .
Valinomycin is a cyclododecadepsipeptide antibiotic pro­
duced by Streptomyces fulvissimus. Valinomycin alters the 
ionic permeability of natural (Moore and Pressman, 1964) and 
artificial (Lev and Buzhinsky, 1967) lipid membranes. Previous 
works using ^H-NMR (Hsu and Chan, 1973) and Raman spectroscopy 
(Susi et al., 1979) suggested that valinomycin penetrates into 
the bilayers of dimyristoyl lecithin (DML), but does not in­
crease the ordering of the lipid chains.
31 2Using a combination of P- and H-NMR, we compared the 
interactions of these three antibiotics with lipid bilayers 
composed of a single lipid, DML and composed of a mixture of 
phospholipids similar to the lipid composition of outer cell 
membrane of gram-negative bacteria. The obtained results 
clarified the character of interactions of the antibiotics 
with the phospholipid bilayers and the possible cause of the 
toxicity of these antibiotics.
MATERIALS AND METHODS
Dimyristoyl phosphatidylcholine (DML) was obtained from 
Sigma Chemicals and was checked for purity by thin layer
chromatography. All other phospholipids listed below, and all 
2H-labelled lipids were purchased from Avanti Polar Lipids,
502
Birmingham, Alabama. The lipids were pure by thin layer chroma­
tography. Unlabelled synthetic lipids: dipalmitoylphosphatidyl- 
ethanolamine (DPPE), and dipalmitoylphosphatidylglycerol (DPPG). 
Unlabelled lipid extracts from coli cell membrane: phospha- 
didylethanolamine (PE) and diphosphatidylglycerol (DPG, cardio-
lipin).
2H-labelled synthetic lipids: diperdeuteromyristoylphos- 
phatidy1-choline (DML-d^^); diperdeuteropalmitoylphosphatidyl- 
ethanolamine (DPPE-dg2) and diperdeuteropalmitoylphosphatidyl- 
glycerol (DPPG-d„).oz
Gramicidin S dihydrochloride (Sigma) was dissolved in t^O- 
dioxane (5:2 v/v), filtered and lyophilized prior to use. Poly­
myxin B sulfate was purchased from Sigma. Valinomycin was pur­
chased from Calbiochem.
Multilamellar dispersions used in this study were made as 
follows: first, the lipids, or the lipid-antibiotic mixture, 
were dissolved in methanol or CDCl^ in an NMR tube. The solvent 
was then evaporated off with dry nitrogen and the tube was kept 
under vacuum for at least eight hours. The thin film thus 
formed was hydrated with a 25 mM Tris buffer solution (pD 7.4) 
in D20 by repeated vortexing on a mixer and gentle warming with 
a heat gun. The vortexing was continued for about five minutes 
until a uniform white suspension was obtained. The samples 
were always fully hydrated and was typically 1:10 w/v in lipid 
to water. When polymyxin B was used, it was added to the dry 
lipids as a solution in the Tris buffer. The multilayers with 
composition similar to the E^ coli membranes (model Jh_ Coli
membrane's) had the following lipids: 59 % PE; 19 % DPPE; 19 %
2DPPG; 3 % DPG. In H-NMR experiments either DPPE or DPPG was 
substituted with DPPE-dg2 or DPPG-dg2, respectively.
21 P- and 2H-NMR-spectra were acquired at 11.74T (500.13 
MHz 1H frequency) on a Bruker WM500 spectrometer as previously 
described Banerjee et al., 1985).
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RESULTS AND DISCUSSION
31The typical P spectra of DML multilayers with and without 
added antibiotics are given in Fig. 1. Fully hydrated DML multi­
layers were used, at temperature above the temperature of gel- 
liquid crystalline phase transition (Tc> . The P spectrum of 
control DML sample is characteristic to the bilayer conforma­
tion of the lipids molecules (Seelig, 1978). The rapid intra­
molecular isomerization of the head group and the rotational 
diffusion of the lipid molecules about the axis, perpendicular 
to the plain of the bilayer (director) cause the axial averag­
ing and only two components of chemical shift tensor (a) can be 
obtained, which correspond to the orientations parallel (a ),
or perpendicular (a ) to the director. The chemical shift ani-
31sotropy, arising from the dependence of the P chemical shift 
of a lipid molecule on its orientation relative to the magnetic 
field, is defined in such a case as Aa=0 -a . From the spectra 
in Figure 1 Aa can be determined from the splitting between the 
edges of the spectrum of the half height of the low-frequency 
"foot". The chemical shift anisotropy Aa depends on molecular 
motions and orientation of the phospholipid headgroups. As the 
motional state of the lipids depends on temperature, and under­
goes a sharp change of the phase transition temperature, Aa is 
a sensitive measure of the gel-liquid crystalline phase transi­
tion temperature. We used the measurements of Aa to compare 
the motional state of DML in the absence and presence of the 
antibiotics, and the effect of an antibiotic on the phase tran­
sition temperature. The lineshapes of all four spectra in Fig.
1 are characteristic of the phospholipids in multi-lamellar 
phase. That implies that at the molar ratio of DML to anti­
biotic of 5.7:1 the bilayer phase is still maintained for all 
three antibiotics studied. Further increase of antibiotic con­
centration led to disruption of bilayer structure only in case 
of gramicidin S (see below). The comparison of spectra with 
and without antibiotics shows that the effects of the presence 
of antibiotics on Aa are different in each case. Figures 2-4 
summarize the temperature dependence of Aa for DML in the 
presence and absence of different concentrations of antibiotics.
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Figure 1.
31P-NMR spectra of lipid headgroups in fully hydrated DML- 
antibiotic mixtures. The spectra were recorded at 202.49 MHz 
frequency at 25.3°C. The samples with antibiotics had 5.7:1 
DML:antibiotic mole ratio. (A) DML; (B) DML plus gramicidin 
S; (C) DML plus valinomycin; (D) DML plus polymyxin B.
The temperature dependence of Ao in the presence and absence 
of different concentrations of polymyxin B is given in Fig. 2. 
The results show that the Aa is largely unaffected by the 
presence of polymyxin B up to a molar ratio of polymyxin B: 
Lipid of 1:5.7. Only at even higher concentration (1:3) there 
is a small (4°) change in the phase transition temperature of 
DML, but even at that high concentration, the presence of 
polymyxin B does not change the values of Aa either above or 
below the phase transition temperature. These results are con­
sistent with the studies showing that polymyxin B does not in­
teract with neutral lipids (Teuber and Miller, 1972). The ef­
fect of valinomycin on Aa in shown in Fig. 3. The results show 
that Aa is decreased above Tc in the presence of valinomycin.
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Figure 2.
Plot of Ag  versus temperature for polymyxin B containing DML 
multilayers (x-x) no polymyxin B mole ratio; (V-V) 16:1 DML:po- 
lymyxin B mole ratio (+-+) 3:1 DML:polymyxin B mole ratio.
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Figure 3.
Plot of Aa versus temperature for valinomycin containing 
DML multilayers, (x-x) no valinomycin, (+-+) 16:1 DML:va- 
linomycin mole ratio; (o-o) 5.5:1 DML:valinomycin mole 
ratio.
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Figure 4.
Plot of Aa versus temperature for gramicidin S containing DML 
multilayers, (x-x) no gramicidin S added; (+-+) 33:1 DML:gram- 
icidin S mole ratio; (o-o) 16:1 DML:gramicidin S mole ratio;
(V-V) 5.5:1 DML:gramicidin S mole ratio.
The phase transition temperature is decreased by 5°. These 
results indicate that valinomycin, unlike polymyxin B does 
react with phospholipid bilayers. The effect of gramicidin S 
on Aa is quite different from those of the other antibiotics 
studied (Figure 4). The strongest effect of molar concentra­
tions of up to 17 % is observed in the vicinity of the phase 
transition temperature. Little effect is observed of gramicidin 
S concentration of 3 mol % (Fig. 1). Increase of gramicidin S 
concentration to 6 mol % changes Tß by 3°, but does not change 
significantly at the temperatures higher than 4° above the T , 
or immediately below T . However, Aa starts to decrease mono­
tonously at T^ + 3°, then increases to the values of the con­
trol DML immediately below T , forming sharp singularity in Aa 
curve at Tc (Fig. 4). This behavior is even more pronounced at 
gramicidin S molar concentration of 12 %, when decrease in Aa
starts at T +10°, and Aa reaches the lowest value observed c
by us: 36 ppm (Fig. 4). Even at that concentration of gramici­
din S, Ao is less affected by the presence of the antibiotic
40
“8°
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: 0 
I 
I
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below Tc> Interesting effect is observed in the P spectra 
lineshape at 17 mole % of gramicidin S in the vicinity of Tc 
The spectra obtained are consistent with both gel and liquid 
crystalline phases present simultaneously (Figure 5, right).
31
DML: GrS 
I6: l(M/M)
Figure 5.
31 2P- (right) and H-NMR (left) spectra of DML with added gram- 
icidin S at different temperatures. The mole ratio DML:gramici­
din S was 16:1.
Such a behavior was not observed by us for the other anti­
biotics studied in the present or previous (Banerjee et al.,
1985) work. Further increase in gramicidin S concentration to
3137 mol % led to the change in P-NMR lineshape to produce a
single peak at a position characteristic of isotropic motions
of the phospholipid molecules. Even in that case, however,
decrease in temperature resulted in the formation of a bilayer
31lineshape and finally most of the P intensity was in the bi­
layer lineshape (data not shown). In our previous work on in­
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teraction of another polypeptide antibiotic, alamethicin, with
31DML, we performed extensive simulations of the P-NMR spectra 
lineshape in order to determine what parameters can account 
for the observed change of A ct (Banerjee et al., 1985). Applying 
the results of these simulations to the present case, we can 
attribute a decrease of Act in both valinomycin, and gramicidin 
S case, to the change of the tilt angles 0 and $ of the phos­
pholipid headgroups relative to the director. In case of vali­
nomycin, this change in tilt angles is temperature independent 
above Tq , as illustrated by horizontal line for Act (Fig. 3).
In case of gramicidin S, however, the changes in tilt angles
are temperature dependent above T , with maximal deviation im-
c 31mediately above the phase transition temperature. The P-NMR 
results show that valinomycin and gramicidin S interact with 
phospholipid bilayers at temperatures above T . The previous 
simulations showed that the spectral shape, though not Act, is 
affected by change in T2 . Especially affected is the low field 
"foot" of a spectrum (Banerjee et al., 1985). We observed such 
a change in the present case upon addition of gramicidin S, 
indicating that gramicidin S decreases of the phospholipid 
headgroups.
Further information on interaction of the antibiotics with 
2DML was attained H-NMR of chain perdeuterated DML in the pres-
2ence and absence of antibiotics. The H-NMR spectra of DML-d^ 
at a temperature slightly above the phase transition are shown 
in Figure 6. Each of these spectra represents the superposition 
of axially averaged power patterns arising from the different 
deuterons for each CD2 segment along the chains. The CD bond 
order parameter for the i1"*1 segment, SCD can be derived from 
the quadrupolar splitting observed at the perpendicular orien­
tation, where
K  = (!) (e2(iQ/h) s±cd
2
and e is the CD deuteron quadrupolar coupling constant.
It has been shown by specific deuteration of lipids that the 
order parameter profile along the chains of a phospholipid mo­
lecule in a multilayer shows a plateau for the methylene seg-
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ments near the glycerol backbone (Seelig, 1977). The corres­
ponding quadrupolar patterns due to these segments are nearly 
coincident with one another and the signals at the perpendicu­
lar orientations overlap near the edge of the spectrum. Since 
the lower parts of the chains are more disordered, the quadru­
polar patterns from these methylene segments show well-resolved 
peaks at the perpendicular orientation. The quadrupol split­
tings are also sensitive to temperature, even above Tc- The
resolution allows to distinguish up to thirteen splittings
2above Tß (Banerjee et al., 1985). We performed the H-NMR
measurements with each antibiotic as a function of temperature
and antibiotic concentration parallel with the 31P-NMR measure- 
2ments. The H-NMR spectra of DML-d^ in the presence and ab­
sence of each of the antibiotics studied are given in Fig. 6.
A comparison of the spectra in the presence and absence of po­
lymyxin B (Figure 6 A,D) shows that this antibiotic has no
3 ”effect on the hydrocarbon chains of the bilayer. The 'P spectra 
(Figures 1, 2) showed that polymyxin B does not change either 
orientation of the phospholipid headgroups or the phase transi­
tion temperature of DML. We therefore conclude that polymyxin
B does not interact with DML. Different picture emerges when
2one considers valinomycin. The H-spectra of DML-d,- ^ in the 
presence of valinomycin shows that the effect of this antibiotic 
on the hydrocarbon chains is minimal. Small change is observed 
for the outermost peak which arises from the methylene segments 
near the glycerol backbone, with all other peaks remaining un­
changed. The spectrum with valinomycin also does not show 
broadening observed upon incorporation of proteins into bi­
layers (Seelig and Seelig, 1978; Rice et al., 1979). The ef-
31 2feet of valinomycin on P- and H-NMR spectra of DML is con­
sistent with the antibiotic molecule interacting with the sur­
face of the bilayers.
2The H-NMR spectrum of DML-d,-^ in the presence of grami­
cidin S is given in Figure 6C. The presence of gramicidin S
led both to the broadening of the spectrum and to the change
31of the spectral shape. These results, together with the P- 
NMR measurements indicate that gramicidin S does penetrate into 
the bilayer above the phase transition temperature. In the
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32 °C
DML :X = 5.7:1 (M/M) D
Figure 6.
2 . . .H-NMR spectra of DML-d  ^multilayers with added antibiotics
at 32°C. The samples had 5.7:1 DML-d -antibiotic molar ratio:
(A) no antibiotic added; (B) with valinomycin; (C) with gram­
icidin S; (D) with polymyxin B.
vicinity of the phase transition temperature the combination
31 2of P- and H-NMR shows the presence of the bilayers at two 
phases, corresponding to liquid crystalline and gel phases. 
Further increase in gramicidin S concentration causes complete 
disruption of the bilayer. However, even in this case, cooling 
of the sample leads to the formation of bilayers.
We used a mixture of Eb_ coli lipid extracts and synthetic 
lipids (see Methods) to construct bilayers with a composition 
similar to the composition of the outer cell membrane of E .coli 
We then proceeded to study the interaction of such bilayers 
with the antibiotics using  ^P- and ^H-NMR. The ^P spectra of 
the multilayers in the presence and absence of the antibiotics
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LIPID X = 16 I (M/M)
Figure 7.
31
P -N M R  spectra of lipid headgroups of model E. coli  membranes 
(see text) with added antibiotics at 25.3°C. The samples with 
antibiotic had 16:1 lipid:antibiotic mole ratio: (A) no anti­
biotics added; ( B )  with valinomycin; (C) with polymyxin B;
( D )  w i t h  g r a m i c i d i n  S .
31are given in Figure 7. The P spectrum of the fully hydrated 
lipids indicates that the lipids are in bilayer conformation 
(Figure 1 A).
The "^P-spectra of the lipids with each of the antibiotics 
studied show a peak at 0 ppm, corresponding to a fully averaged 
by fast isotropic motion NMR spectrum of phospholipids. That 
indicates that the presence of antibiotics induces, in various 
degrees, the formation of lipid micelles already at a concen­
tration of 6 mol %. This effect is the smallest one in the case 
of polymyxin B, with only a minor portion of the intensity of 
the signal being in the isotropic peak (Figure 7C). The iso-
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Figure 8.
2 . 2 H-NMR spectra of model E. coli membranes with added H-la-
belled lipids. (A) with DPPE-d, • (B) with DPPG-d .oz bz
tropic peak becomes more prominent in the case of added vali- 
nomycin (Figure 7B), and becomes dominant in the presence of 
gramicidin S (Figure 7D). In order to further characterize the 
interaction of the antibiotics with model Eh_ coli membranes, 
we substituted part of the lipids with the synthetic lipids 
with perdeuterated side chains. In one type of samples we sub­
stituted DPPG with DPPG-dg2i and in another we substituted 25 % 
of EL_ coli PE extract with synthetic-DPPE-d^ • Figure 8A is 
identical to the spectrum of DPPG-d^ (Figure 8B) in chemically 
identical model EL_ coli membrane. This means that the distribu­
tion of order parameters along the side chain is the same for
both PE and PG and indicates the uniform distribution of these
2lipids in the bilayers. The H-spectra of both PE and PG are 
significantly altered upon the addition of 6 mol % ofpolymyxin 
B (Figure 9). The shapes of both spectra are still characteris-
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Figure 9.
2H-spectra of model E. coll membrane with added polymycin B 
of 32°C. Mole ratio lipid:polymyxin B was 5.7:1 (A) with 2H- 
labelled PE; (B) with 2H-labelled PG.
tic of the bilayer conformation, with only small portion of
intensity being in the isotropic peak in the center, which is
consistent with the ^P-spectrum of the lipids with polymyxin
B (Figure 7C). The spectra, however, exhibit line broadening,
making the fine structure observed for pure lipids (Figure 8)
unresolvable. Both the broadening effect and the intensity of
the isotropic peak are somewhat more pronounced in the spectrum
of DPPE-d,_ (Figure 9B), probably indicating that polymyxin B,
while perturbing the structures of both PE and PG, interacts
stronger with the former. The preferential interaction of an
antibiotic with the PE component of the membrane is more pro-
2nounced in the case of gramicidin S (Figure 10). The H-spec-
trum of DPPG-d,„ in the presence of 6 mol % of gramicidin S o Z
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Figure 10.
H-spectra of model E_. coli membranes with added gramicidin S at 32°C.
(dsz-PE)
+  Val
2 x 1 0 4 0  - 2 x 1 0 4
Hz
Figure 11.
2H-NMR spectrum of model E. coli membranes with added valino- 
mycin at 32°C. Mole ratio lipid-valinomycin was 5.7:1. In this 
experiment the 2H-labelled lipid was PE.
515
still has most of the intensity in the bilayer shape (Figure 
10B). It does exhibit line broadening similar to the one ob­
served in the case of polymyxin B. The bilayer structure is
maintained, however, only by a small percentage of the PE com-
2ponent, most of this lipid giving the isotropic H-NMR peak
(Figure 10A). The PE composes 78 % of model bilayers, and the
31PG only 19 %. Thus, the isotropic peak of the P-spectrum of 
the lipids with gramicidin S can be probably attributed to PE,
while the bilayer part of the spectrum to both the PG and the
2part of the PE. The H-spectrum of DPPE-d^ in the model E. 
coli membrane in the presence of valinomycin is given in 
Figure 11. As in the case of gramicidin S, valinomycin also 
disrupts the bilayer structure significantly.
CONCLUSIONS
31The combined use of P-NMR of the lipid headgroups and
2H-NMR of the acyl side chains showed the extent of the inter­
action of each of the antibiotics studied with the lipid mem­
branes .
No perturbation of the lipid bilayer structure is observed 
31 2by P- or H-NMR of DML in the presence of polymyxin B, and 
only small change in Tc when concentration of polymyxin B is 
raised to 37 mol %. We thus conclude that polymyxin B does not 
interact with DML.
Relatively small perturbation of DML bilayer structure was
observed upon addition of up to 6 mol % of either valinomycin
or gramicidin S. The perturbation was reflected mostly in the
31change of Aa in the P spectrum, and minor change in the outer 2peaks of H-spectrum. This is consistent with valinomycin in­
teracting with the surface of the bilayers only.
Unlike the other two antibiotics, gramicidin S perturbs 
the structure of both phospholipid headgroups and the acyl 
side chains, which indicates that this antibiotic does pene­
trate into the DML bilayer. The interaction takes place, how­
ever, only above the phase transition temperature of the lipids. 
Only a very high concentration of gramicidin S (37 mol %) was 
sufficient to disrupt the bilayer structure.
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The effect of the antibiotics on model E. coli membranes
was very different from that on DML. A completely different 
picture emerged from the data where the model E_^  coli bilayers 
were used. Polymyxin B molecule is probably inserted into the 
membrane, which stays largely in the bilayer comformation. Both 
valinomycin and gramicidin S have a strong destructive effect 
on the model coli membranes. Gramicidin S primarily perturbs 
the structure of the PE component of the model membranes.
The interaction of valinomycin with the PE is also very 
strong. The interaction of each of these antibiotics with PE 
is probably one of the sources of their toxicity, as PE is one 
of the major components of the mammalian cell membranes.
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DISCUSSION
PECHT:
Could you elaborate on the correlation between the struc­
ture of the different antibiotics and their interactions 
with the lipid bilayers?
ZIDOVETZKI:
Each antibiotic studied is an amphipathic molecule, and 
has surfaces which can interact with both polar and 
hydrophobic regions of a bilayer. There is a lot of in­
formation in literature on conformational structures of 
those molecules, and their state of aggregation, which 
is critical for establishing the mode of interaction with 
the membranes. For example, polymyxin B has positively 
charged tail, which probably binds to negatively charged 
phospholipid head groups, and hydrophobic ring, which 
penetrates into the bilayer.
ELSŐN:
Do you have any information about the influence of a po­
tential difference across the membrane on the interactions 
between alamethicin and membrane lipids?
ZIDOVETZKI:
It is technically very difficult to introduce an electric 
potential difference in a sample inside the bore of 11.7 
Tesla magnet. Besides that we need milligram amount of 
lipids in experiments, orders of magnitude more than is 
used in channel recording experiments. So, I don't think 
it will be done by NMR in the near future.
DAMJANOVICH:
I was looking for some biphasic effect of valinomycin, 
depending on concentration, as it is known that valino­
mycin can either hyper- or hypopolarize membranes.
Would you mind commenting on this question?
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ZIDOVETZKI:
It is too early to say now, but, interestingly, we did
31observe that the effect of valinomycin on P-NMR spectrum 
of DML at some point does decrease with the increased con­
centration of the antibiotic.
ASZALÓS:
Have you thought about trying amphotericin B in your sys­
tem, since the intercalation of this antibiotic into lipid 
domains is known.
ZIDOVETZKI:
Indeed, that probably would be interesting.
CHERRY: 2Were the H-NMR experiments with valinomycin performed in 
the presence or absence of K+?
ZIDOVETZKI:
Yes, we already started it, at one concentration of K+.
We were surprised not to see any difference. We plan to 
increase the concentration of K+.
CHERRY:
Can you put an upper limit on the proportion of valino­
mycin which is in the interior of the bilayer.
ZIDOVETZKI:
In the measurements I referred to, probably not more 
than 10 %.
KRETSCHMER:
Did you look for changes in the spectra of antibiotics 
(1^C, 1H, 1^N) interacting with bilayers?
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ZIDOVETZKI:
A spectrum of an antibiotic bound to a membrane becomes
too broad to be observed under normal conditions. We used 1H-NMR to make sure that all of the antibiotic in a sample 
is bound to membranes, which is indicated by the absence 
of a well-resolved spectrum.
520
Dynamics of Biochemical Systems 
S. Damjanovich, T. Keleti, L. Trón (Eds)
KINETICS AS A TOOL FOR THE STUDY OF TRANSMEMBRANE EXCHANGES 
EXEMPLIFIED BY THE STUDY OF THE OXOGLUTARATE TRANSLOCATOR
CLAUDINE M. SLUSE-GOFFART and F.E. SLUSE
Faculté des Sciences, Département de Chimie Générale et de 
Chimie Physique, et Faculté de Médecine, Laboratoire de 
Biochimie et de Physiologie Générales, Institut de Chimie 
(B-6), Sart-Tilman, B-4000 Liege, Belgium
INTRODUCTION
In heart, the malate/aspartate shuttle is the main transferring device 
of reducing equivalents (NADH formed during glycolysis) from the cytosol to 
the mitochondrial respiratory chain. In this shuttle, cytosolic malate en­
ters into the mitochondria while matricial oxoglutarate goes out. These two 
fluxes of anions through the inner mitochondrial memhrane are coupled by the 
oxoglutarate translocator, which performs a one-to-one exchange.
To know the way of action of the oxoglutarate translocator, the first 
thing to do is to determine its kinetic mechanism in situ. Fortunately, 
isolated rat-heart mitochondria can be treated to contain only one kind of 
exchangeable anion, the concentration of which can be varied to some extent. 
Moreover, by working at 2 °C, we have achieved good conditions to measure 
initial rates. When possible, initial-rate analysis is in fact the best me­
thod to determine a kinetic mechanism because no assumption has to be made 
a priori.
THE KINETIC MECHANISM [1]
The double reciprocal plots of the exchange between external labelled 
malonate and internal malonate catalysed by the oxoglutarate translocator, 
exhibit straight lines with a common point situated on the abscissa. This 
kinetic behaviour has been observed for twelve exchanges, homologous or 
heterologous, with malate, oxoglutarate, malonate or succinate as substrates. 
The position of the common point is characteristic of the substrate for 
which the concentration is varied, it does not depend on the nature of the 
partner anion. These observations indicate a rapid-equilibrium random mecha­
nism with independent binding of the two substrates. The oxoglutarate trans­
locator spans the membrane and has two independent sites : one site acces-
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sitié to the external substrate and one site accessible to the internal 
substrate.
DETAILED STUDY OF THE CYTOSOLIC FACE OF THE TRANSLOCATOR [2,3]
Of course, we have initially explored rather limited ranges of sub­
strate concentrations and we have found that all the substrates apparently 
behaved according to Michaelian kinetics. But, if the range of external oxo- 
glutarate concentration is widely extended, things become much more compli­
cated : the kinetic and binding saturation curves of external oxoglutarate 
(from 0.05 to 300 pM) are not hyperbolic but have four jumps (Fig.1) which 
are more pronounced in the binding curve. The well-defined intermediary pla­
teau in Fig.1B corresponds to half saturation.
The fact that similar structures have been observed in both curves sug-
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Fig.1. Satur a t i o n  curves by external o x o g l u t a v a t e . Lower curve : equilibrium 
binding. Upper curve : initial uptake rate against i+ mM-internal malate.I1*]
gests that these structures are not accidental and must have some signifi­
cance. They are indeed reproducible [U], However, reproducible artefacts 
could be introduced by the method used to obtain the data. In that case we 
would expect the same type of artefacts for other substrates. This is not 
the case : the double reciprocal plot of malate uptake is linear over a wide 
concentration range (from 0.05 to 8U0 pM) .
If malate and oxoglutarate have the same binding sites, their very dif­
ferent behaviour could simply be due to the fact that the oxoglutarate trans­
locator is an oligomer made of identical subunits in which malate binding 
does not induce any conformational change while oxoglutarate binding does. 
In order to be sure that malate has the same binding sites as oxoglutarate 
we have studied the effect of external malate on the initial rate of oxoglu­
tarate uptake : the rate of oxoglutarate uptake in the presence of malate is 
equal to the rate in the absence of malate on condition that oxoglutarate 
concentration is divided by one plus the ratio between the external malate 
concentration and its Michaelis constant. This equality implies that malate 
and oxoglutarate are competitive and that malate does not modify the affinity 
of the unloaded sites for external oxoglutarate (and reciprocally). This 
strongly suggests that malate binding does not induce a conformational change 
while the conformational change induced by oxoglutarate is localized to the
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oxoglutarate loaded subunit without modification of the neighbouring sub­
units. It must be emphasized that the conformational change induced by the 
external oxoglutarate is localized on the external face of the translocator. 
It cannot be perceived by the internal substrate because we know that inter­
nal and external binding are independent.
We can now consider the possible meanings of the four jumps in the ex- 
ternal-oxoglutarate binding curve. The first point is that these jumps and 
their intermediary plateaus can be described as changeovers of negative and 
positive cooperativities. The mean affinity of an unloaded site for external 
oxoglutarate (Fig.2), first decreases, indicating negative cooperativity. 
It is followed by an increase of affinity, thus, positive cooperativity. 
This changeover repeats three times because the binding curve has three 
intermediary plateaux. This macroscopic behaviour may either reflect actual 
changeovers of cooperativities at the microscopic level or not. We will suc­
cessively consider these two possibilities.
Fig.2. Mean affinity (Ka) of an unloaded site for external oxoglutarate as 
a function of bound oxoglutarate (b). The curve has been obtained by smooth­
ing of the experimental points. Ka = b/((B-b)[OG]) where [OG] is the free 
external-oxoglutarate concentration and B is the maximal binding.
We will first assume that we deal with a single type of oligomer. In 
that case, the oxoglutarate binding must obey to an Adair's equation whose
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degree, n, is equal to the number of subunits. Of course, we would like to 
know how many subunits are necessary to observe four jumps. This will be 
done through the number of necessary inflexion points : six in this case. 
The abscissae of the inflexion points are the roots of a polynomial that is 
obtained when we do the second derivative of the Adair's function. The degree 
of this polynomial is 3n-3, so that it cannot have more than 3n-3 positive 
roots. This leads to a minimum of 3 subunits. However, it is impossible to 
obtain four jumps with an Adair's equation of degree three and even four : 
only two jumps are possible. It can be demonstrated that the polynomial of 
degree 3n-3 cannot have more than n-1 positive roots (to be published). In 
our case this means that at least seven subunits are associated to form an 
oxoglutarate translocator if it is assumed that a single type of oligomer is 
responsible for the four jumps. Actually, the number of binding subunits 
would probably be higher than seven according to the following estimation : 
if the first jump of the binding curve is taken as the saturation of one 
site per translocator, three sites are loaded after the second jump, nine 
after the third and eighteen after the last jump.
Let us see the other possible interpretation : could the four jumps of 
the binding curve be due to four independent contributions ? It is possible 
if these contributions are not Michaelian. Indeed the sum of hyperbola cannot 
give a curve with inflexion points. The different contributions, except per­
haps that of the first jump,have to be sigmoidal. We will thus suppose now 
that four oligomeric species of isozymic translocators, exhibiting posi­
tive cooperativity, coexist in our mitochondrial preparation. To make this 
hypothesis compatible with the fact that malate uptake is Michaelian we 
have to assume that the isotranslocators are made with the same subunits 
which may be associated in various ways to form various types of oligomers 
or that it is the membranous environment which may differ. Contrary to oxo­
glutarate, malate which binds without conformational change of the translo­
cator, will not perceive such differences which concern only the interac­
tions of the subunits between themselves or with the environment. However, 
this interpretation is not so simple as it seems at first sight. The reason 
is the internal/external independence observed in the kinetics. The general 
form of the initial-rate equation for an exchange between A and B is the 
product of the maximal rate which depends of the studied exchange, a func­
tion f of the concentration of the external substrate A, function which is 
specific to this substrate, and a function g specific to the internal subs-
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träte B :
ÜA/B Vk/B * fA ^ A ^  X gB([B]) '
If the measured rate is the sum of different contributions which have dif­
ferent f functions for the external substrate, they must have the same g 
function for the internal substrate so that the f functions can be gathered 
in one factor :
VA/B A/B A/B
y ----- f 2 + • • • )  X g ^ ([B ] )
V A / B  2 B
Since the resulting f function cannot depend on B, the ratios of the indi­
vidual maximal rates to the total one must have fixed values whatever B : 
the influence that B has on the individual maximal rates is the same for 
each contribution. These two constraints indicate that the oxoglutarate
isotranslocators must be equivalent for the internal substrate. They would 
differ only on their cytosolic face. It is difficult to say if such a situ­
ation is more plausible than our first hypothesis of a single oligomer with 
a great number of interacting subunits.
THE CATALYTIC STEP [3]
Is the catalytic step (the rate limiting step) accompanied by a confor­
mational change ?
When alone in the external medium, malate has a Michaelian kinetics. It 
is clear that, during the catalytic step, a conformational change of a sub­
unit to reach the activated state cannot be detected because the resulting 
changes in the subunit interactions are independent on the degree of satu­
ration of the translocator by external malate. But, external oxoglutarate, 
by modifying the conformation of the subunit to which it binds, will influ­
ence the catalytic rate constant of malate uptake.
If, on the contrary, the conformation of the subunit which translocates 
malate does not change, the catalytic rate constant of a malate-loaded sub­
unit will be the same whatever conformation of the neighbouring subunits show. 
In that case, the only effect of oxoglutarate will be to competitively in­
hibit the binding of malate. It is easy to deduce that the initial rate of 
malate uptake inhibited by oxoglutarate, v', will be equal to its value in 
absence of oxoglutarate, v, multiplied by the proportion of sites unoccupied 
by oxoglutarate. This relation can easily be tested by plotting the ratio 
v '  /v as a function of the bound oxoglutarate : it varies linearly between 1 
in the absence of oxoglutarate and zero when oxoglutarate is saturating. A 
non-linear variation between these two points indicates that the activation
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is accompanied "by a conformational change (Fig.3). Most of the experimental
Fig.3. Effect of external oxoglutavate on malate uptake. y^ax/B is "the 
initial rate of malate uptake in the presence of hound oxoglutarate (b^g). 
^Mal/B the initial rate of malate uptake in the absence of external oxo­
glutarate. Redrawn from [3]
points are above the straight line indicating that oxoglutarate can activate 
the uptake of bound malate. Oxoglutarate thus has a mixed effect : it inhib­
its malate binding competitively but can activate the catalytic step of ma­
late uptake. The net effect, when the translocator is poorly saturated with 
external oxoglutarate, is an increase of the initial rate of malate uptake. 
At higher saturations by oxoglutarate the net effect is an inhibition of the 
malate uptake. An important conclusion of this experiment is that the cata­
lytic step of malate uptake is accompanied by a conformational change. We 
have proposed the following interpretation :
A conformational change of the external surface part of the translocator is 
likely to occur when malate leaves its surface site to penetrate deeper in the 
translocator. Malate is probably transferred into a channel in which it can 
migrate to the other side in exchange with the internal substrate. It is 
also likely that in this new conformation, the surface site is no longer ac­
cessible to the bulk solution so that only one malate can bind to one sub­
unit and penetrate into the channel. The transfer step of malate has a very
channel„ -1 A c t i v a t e d -----►s ta t e
Binding Transfer
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small equilibrium constant : if it was not the case, A species would not 
be in negligible concentration and malate uptake would not be Michaelian. 
Because of its small equilibrium constant, the transfer step is seen as the 
first step of the catalytic event and not as part of binding.
Let us imagine now that external malate is exchanged with internal oxo- 
glutarate. Oxoglutarate will arrive in front of the triangular conformation 
and will be transferred to the surface site with a conformational change of 
the external part of the translocator. It means that the conformation reached 
by the external part of the translocator after the transfer step of an ex­
ternal substrate is the same whatever the substrate is. The surface site 
cannot remember the substrate which has passed through it.
Binding Transfer Exchange
When a step is accompanied by a conformational change, the kinetic parame­
ters, in this case equilibrium constants, will depend on the changes in the 
interactions of the subunit with the neighbouring subunits and with the 
membrane. In brief, it will depend on the environment of the subunit. The 
asterisk indicates the value that this equilibrium constant would have if 
its interactions with the environment were kept constant. These values with 
an asterisk, are the intrinsic values of the equilibrium constants. As we 
suspect that all the subunits are identical,we will suppose that they all 
have the same set of intrinsic values.
Considering the case where malate and oxoglutarate are both present in 
the external medium, the ratio of their uptake rates in exchange with the 
internal substrate B is :
^M ql/B
OG/B
(K )I Id,-[Mai] KMq[ K*. . k.
Mal (K ) Mal /B  ' ' i n t  o'i
I [Ol.[0G] k\.* l^ int pl; 
0 G < * in ,O > /
l^ int a [
t O G (  K ) OG/B 
v n intO '/
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To obtain the initial rate of malate uptake (numerator) we have done the 
sum for every possible environment i of the subunit, following the 
scheme above from the left to the right. For the first step, we have to 
multiply the concentration of unloaded subunit by the concentration of ma­
late and by the affinity of the subunit for malate in order to obtain the 
bound-malate concentration. Among these three factors, only the first one 
depends on the environment. For the transfer step, the intrinsic equilibrium 
constant has to be multiplied by a factor which accounts for the change of 
interactions with the environment due to the conformational change. Finally, 
we have the rate constant of the exchange step. In the denominator, the same 
process has been followed with oxoglutarate instead of malate. We have a 
simplification here, because the square conformation which has been formed 
during the oxoglutarate binding disappears during the transfer step. We can 
now take out those factors that do not depend on the environment and we see 
then that the sum over i is the same in the numerator and in the denominator. 
We thus obtain a simple law (for a more rigorous presentation see [3]), 
which tells us that when two substrates are present together in a compart­
ment, the ratio of their initial rates of exchange with a substrate of the 
other compartment, is proportional to the ratio of their concentrations :
^Mal/B
ü Óg/b
feMal/B ^Mal Kt Mai
feOG/B K0G Kt OG
[Mai]
[OG]
This linear relationship verified experimentally is important because it 
strongly supports the view that all the subunits are identical even if we 
have a mixture of isotranslocators. In these experiments the internal sub­
strate is malate so that the slope of the line indicates that each subunit 
is about 9 times more efficient in exchanging oxoglutarate with malate than 
in exchanging malate with malate.
We still have to provide an experimental evidence for the existence of 
a conformational change during the oxoglutarate transfer step. This can be 
done by showing that the catalytic rate constant of oxoglutarate uptake 
varies with the degree of saturation of the translocator by oxoglutarate. 
The mean catalytic rate constant of an external site loaded with oxogluta­
rate is simply the ratio between the initial rate and the binding. It fluc­
tuates with the binding value (Fig.lt). The catalytic cooperativity is ini­
tially positive in contrast to the binding cooperativity which was first 
negative. There are three changeovers from positive to negative cooperati-
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vity. The cooperative effects on the catalytic rate constant show that a 
conformational change takes place during the catalytic step of oxoglutarate 
exchange.
Fig.!*. Mean apparent catalytic rate constant of an oxoglutarate-loaded ex­
ternal site as a function of bound oxoglutajrate. The internal substrate is 
h mM malate. The curve has been obtained by smoothing the experimental 
points.
THE POSSIBLE REGULATORY ROLE OF THE OXOGLUTARATE TRANSLOCATOR [U,5]
Despite the fact that the complex effects induced by external oxogluta­
rate are not yet fully understood, it is clear that the translocator is 
oligomeric and undergoes conformational changes leading to cooperative phe­
nomena. The oxoglutarate translocator is thus comparable to oligomeric en­
zymes known to play a regulatory role in vivo by controlling metabolite 
fluxes. However, it could be objected that the comparison is not valid be­
cause our observations have been made at 2 °C and not at physiological tem­
perature. The observed complexity could result from an aggregation of a 
monomeric translocator during the lowering of temperature and leading,at 
2 0C,to a mixture of monomers, dimers, trimers and so on. To this, it car. 
be answered that it is not sure that the inner membrane of heart mitochon­
dria is fluid enough to allow such aggregation. The protein content is high 
and some works suggest the existence of a rigid protein network. Further-
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more we have a strong argument to exclude the possibility of a mixture of 
oligomers of various sizes. Indeed, in such a mixture, the proportions of 
the various oligomers will differ if the total concentration of subunit in 
the membrane is modified. For example, if the concentration of monomer at 
physiological temperature is increased the ratio of dimer to monomer at 2 °C 
will normally increase. Consequently, the shape of the external oxoglutarate 
binding curve will change. Of course, we are not able to vary the translo­
cator concentration in the membrane but fortunately, nature has done it for 
us. We have observed an increase in the oxoglutarate binding by a factor 1.6 
not depending on the oxoglutarate concentration and thus without modifica­
tion of the shape of the binding curve. This binding increase can only be 
due to an increase in the translocator concentration and shows that all the 
translocators have the same number of subunits, even if several isozymes are 
present. An aggregation process during the lowering of temperature appears 
improbable and it is likely that the behaviour of the translocator at phy­
siological temperature is similar to that at 2 °C. We maintain our sugges­
tion that the oxoglutarate translocator could play a regulatory role in vivo.
Very interesting is the fact that the increase in concentration of the 
translocator that we have fortuitously observed seems to be a response of 
the organism to a mutation which has decreased the efficiency of the trans­
locator. This may be considered as further indication that it plays a 
regulatory role. In accordance with this view, the oxoglutarate translocator 
has natural effectors. We have observed an inhibition by external free ADP 
and an activation by internal aspartate.
CONCLUSIONS
The kinetic and binding studies of the oxoglutarate translocator in situ 
have been fruitful despite their great complexity. The kinetic mechanism has 
been determined, and we now have a more precise idea of the structure of the 
translocator and of the conformational changes it undergoes during its activ­
ity cycle.
In summary (Fig.5) a functional subunit of the translocator seems to 
have three domains which could be either specialized subunits or parts of a 
single polypeptide . Two binding parts are situated near the two membrane 
surfaces, and are separated by a central catalytic part that we have called 
channel. Here is represented the exchange between an external oxoglutarate 
anion and an internal malate anion. Binding of external oxoglutarate to the 
external binding part induces a conformational change of this part. We have
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Fig.5. Schematio representation of a functional subunit of the oxoglutarate 
translocator exchanging external oxoglutarate with internal malate. Steps 
involved in the initial rate. Redrawn from [^ ]
supposed that internal malate behaves in the same way as external malate and 
does not induce a conformational change during its binding. The central cata­
lytic part is not modified by the substrate binding so that in any case the 
two substrates bind independently. The binding steps leading to the ternary 
complex, are in rapid equilibrium. The phenomenological catalytic step be­
gins with a near-equilibrium transfer of the two substrates into the channel 
accompaniedby a conformational change of the two surface parts. It is likely 
that, in this new conformation, the binding sites are no longer accessible 
to substrates in the aqueous solution. The next step, the exchange of the 
two substrates within the channel, is rate limiting. We have represented the 
steps that are implied in the initial-rate equation. Of course, complete 
reaction involves the transfer of the products to the surface parts and their 
release into the aqueous solutions. The translocator could be made by asso­
ciation of several such functional subunits. It is also possible that the 
two ends of a single channel are surrounded by several binding subunits.
Thorough kinetic studies of the other anion translocators of mitochon­
dria are still lacking. It is regrettable that the so widely accepted single 
site carrier model (ping-pong mechanism) be not yet supported by clear kine­
tic evidence . On the contrary it is excluded for the oxoglutarate translo­
cator and is made questionable for the adenine-nucleotide translocator [6] 
and for the glutamate-asparate translocator [7].
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DISCUSSION
RICARD:
I quite agree with the idea that a conformation change 
has to occur during catalysis, but I believe, that during 
the conversion of a ground state to a transition state, 
the energy required to reach the top of a barrier has to 
come from the protein. Therefore, the protein has to be 
strained in the ground state and unstrained in the cor­
responding transition state.
SLUSE-GOFFART
I don't disagree with that. Actually, our catalytic step 
is not a single step. The conformational change occurs 
during the first sub-step, not during the activation: the 
state reached after the transfer step is a ground state.
KELETI:
I wonder whether you have any independent physico-chemic­
al evidence of the steric change of the translocator or 
is the theory based only on kinetic data?
SLUSE-GOFFART:
The theory is based only on kinetic data.
BARDSLEY:
Did you try statistical tests on the data or have you 
relied upon counting inflexions? The maximum number of 
critical points is an invariant for a given order but 
these are more subtle invariant features, such as the 
curvature as a function of the distance along the curve.
If statistical tests require a fairly low order Adair 
equation but for close fit to your data as judged by 
your hand-drawn curves you need a very high order Adair 
equation, it suggests that the Adair model is the wrong 
one.
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SLUSE-GOFFART:
No statistical tests have been tried. Our conviction 
regarding the number of inflexion points is supported 
by the reproducibility, by the fact that they are present 
in both the binding curve and the kinetic curve (the two 
methods are somewhat different) and by the fact that an 
analogous substrate (which has been proved to have the 
same binding sites) does not exhibit any deviation from 
a Michaelis-Menten behavior (and this excludes the occur­
rence of systematic error).
The equilibrium binding curve must obey either to an 
Adair's equation or to a sum of Adair's equations. In any 
case the whole order must be high to account for the struc­
tures in the curve. Rejection (or support) of this by 
means of statistical tests would require the use of well 
adapted tests taking local structures and not only the 
whole curve into account.
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According to the conventional carrier model, transport 
depends on a substrate site that is alternately exposed on op­
posite sides of the membrane. When the idea was first proposed, 
a sort of ferryboat was envisaged, which forms a revers­
ible complex with the substrate and diffuses across the mem­
brane (1). This has turned out to be true of certain small 
ion translocators, or ionophores, such as valinomycin and non- 
actin (2). However, a mechanism of this kind is extremely un­
likely in the case of the transporters that normally function 
in the cell membrane, which in all systems investigated have 
been shown to be protein molecules that span the membrane and 
are relatively fixed in position. Nevertheless, in terms of 
the kinetics of transport, these systems have often been shown 
to behave like a ferryboat, with a substrate binding site 
first exposed on one side of the membrane and then on the other. 
The explanation may well be that the substrate site is located 
in a closed channel, which is first open at one end, connect­
ing the site with the solution on that side of the membrane, 
and then closed here and opened at the other end, thus con­
necting the site with the solution on the opposite side (3). 
Hence, transport would depend on the occurrence of conforma­
tional changes, the opening and closing of channels connecting 
the substrate site with either side of the membrane giving 
rise alternately to two different carrier forms: an inward­
facing form in which the substrate site is accessible via an 
open channel to the cell interior, and an outward-facing form,
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in which it is accessible to the medium outside (Fig. 1).
Figure 1. Diagrammatic representation of a transport 
protein (carrier) with a gated channel mechanism. The 
carrier spans the membrane, and alternates between out- 
ward-facing and inward-facing conformations, in which the 
substrate site is accessible, via a channel that opens 
and closes, to the outer or inner solution, respective­
ly. The hatched areas lining the channels represent com­
plementary protein structures that alternately adhere 
closely, blocking the channel, or separate, opening it.
The existence of highly specific substrate binding sites 
in carriers was established long ago, and evidence has accu­
mulated in several different transport systems for the involve­
ment of carrier conformational changes in transport, and for 
the existence of distinct inward-facing and outward-facing 
carrier forms. The channels that would open and close in con­
cert on opposite sides of the membrane remain hypothetical, 
however, and it is the purpose of this paper to consider evi­
dence that could bear on their involvement in transport. The 
approach is indirect, and depends on the investigation of 
sites that affect the rate of transport but are partly or 
wholly outside the substrate site: the question posed will be 
whether the sites are accessible on only one side of the mem­
brane, and further, whether they become accessible on the same 
side of the membrane as the exposed substrate site. It may be 
inferred that such sites, if exposed or masked in unison with 
the appearance and disappearance of the substrate site, are 
likely to be located within the hypothetical channels.
To investigate this problem, evidence will be reviewed on
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the action of inhibitors on two facilitated transport systems 
in erythrocyte membranes, those for choline and glucose. The 
object is to determine the sidedness of the action of an inhi­
bitor with reference to both (a) the orientation of the sub­
strate site in the carrier (inward-facing or outward-facing), 
and (b) the inner and outer surfaces of the membrane.
OBSERVATIONS 
A . Glucose transport
This system equilibrates glucose across the red cell mem­
brane. The carrier has been isolated, and is an integral mem­
brane protein with an apparent molecular weight of 46,000 
(4). Controversy continues about the details of the mechan­
ism, despite a long history of experimental investigation, but 
at present the conventional carrier model appears to provide 
the most satisfactory explanation of the results (4-6). The 
experiments to be reviewed have to do with the inhibition of 
the system by three different substances: two reversible in­
hibitors, cytochalasin B and phloretin, and an irreversible 
inhibitor, sodium tetrathionate.
1) Cytochalasin B
The first questions to be answered are whether the inhib­
ition is asymmetric, and if so, to which carrier form, inward- 
-facing or outward-facing, the inhibitor is bound. As cyto­
chalasin B, when added to a suspension of red cells, rapidly 
crosses the membrane by simple diffusion, it could conceivably 
add to the carrier on both sides and inhibit symmetrically. 
In fact, it inhibits asymmetrically, the inhibition of exit 
being competitive, and the inhibition of entry noncompetitive 
(7,8). The carrier model predicts exactly this behavior when 
a competitive inhibitor is restricted to the cell interior 
(9). The reason is as follows: in an exit experiment, the
substrate and inhibitor are present in the same compartment 
and can compete with one another, but in an entry experiment, 
they are in different compartments and therefore cannot com­
pete (though the inhibitor, by tying up the carrier on the in­
side, would still reduce the rate of transport). We may con-
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elude that cytochalasin B adds exclusively to the inward­
facing form of the carrier, and hence, that a cytochalasin B 
binding site is present in the inward-facing but not the out­
ward facing form.
The second question is whether cytochalsin B attacks the 
carrier at the same surface of the membrane as the exposed 
substrate site, that is, the inner surface. Since carriers 
span the membrane and are simultaneously exposed on both 
sides, it is possible, in theory, for the substrate site to be 
exposed on one surface of the membrane while an inhibitor site 
is exposed on the other surface.
The location of the cytochalasin B site with respect to 
the inner and outer surfaces of the membrane was established 
by showing that the site is susceptible to digestion by prote­
olytic enzymes introduced into the cell interior, but resis­
tant to attack by enzymes in the suspending medium (10). Fur­
ther, the site was shown to be near the N-terminal end of the 
glucose transporter protein (11,12), which is exposed on the 
cytoplasmic surface of the cell membrane.
The third question is whether the cytochalasin binding 
site is separate from the substrate site. It has been sug­
gested that this inhibitor may form an attachment within the 
substrate site (13,14), but the following evidence indicates 
that its main attachment is elsewhere. (1) Cytochalasin B 
gives strong protection, probably steric in nature, against 
the irreversible inhibitor 2,4-fluorodinitrobenzene (15,16), 
while equilibrated substrates increase the rate of reaction of 
fluorodinitrobenzene with the system (17). (2) Substrates and
substrate an alogs give protection, again probably steric, 
against the irreversible inhibitor butanedione, while cyto­
chalasin B accelerates the reaction of the inhibitor (16,18). 
(3) Cytochalasin B is a much larger molecule than glucose and 
is non-polar, in contrast to the highly polar glucose; never­
theless, it is bound about 100,000 times more strongly than 
the substrate (15,19). It is still possible that the cyto­
chalasin site partly overlaps the substrate site, which would 
explain its competitive mechanism.
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In answer, then, to the above questions, it may be said 
that cytochalasin B binds to the inward-facing carrier, that 
it adds on the inner surface of the membrane, and that its 
site of attachment is largely outside the substrate site.
2. Phloretin
The action of phloretin is also asymmetric, but the pat­
tern of inhibition is opposite to that seen with cytochalasin 
B: the inhibition of entry is competitive, and the inhibition
of exit non-competitive. It follows that phloretin is bound 
to the outward-facing form of the carrier but not to the 
inward-facing form, even though it readily enters the cell
(20,21).
The following evidence suggests that phloretin binds to 
the carrier on the same surface of the membrane as the exposed 
substrate site, that is, on the outer surface. Phlorizin, the 
glucoside of phloretin, also inhibits glucose entry competi­
tively and glucose exit noncompetitively, showing that it too 
adds to the outward-facing carrier form (6). Since phlorizin 
fails to penetrate the cell membrane (22), its binding site 
must lie on the outer surface, and it would be reasonable to 
assume that phloretin also exerts its effect from the outside, 
by binding at the same site. It could, however, be argued 
that owing to its glucose residue, phlorizin binds at a site 
to which phloretin does not bind, but for the following rea­
sons this does not seem likely: first, the glucose residue 
has been shown to play no role in phlorizin binding (23); sec­
ond, the affinity of phlorizin is 100 times greater than that 
of glucose (19,20); and third, the binding site appears to be 
in a hydrophobic region of the carrier (23). The evidence 
suggests that phloretin and phlorizin could well bind at the 
same site, on the outer surface of the membrane.
Though the binding of phloretin and glucose is mutually 
exclusive, as if both added at the substrate site, the follow­
ing evidence argues for separate binding sites. First, the 
structure of phloretin, and its nonpolar character, contrasts 
with the structure of the highly polar glucose molecule; on 
this account, phloretin should bind less strongly than glucose
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at the substrate site, but in fact it binds to the carrier
10,000 times more strongly than glucose (19,20). Second, 
transported substrates, as well as maltose, a non-transported 
glucose analog, protect the carrier against reaction with bu- 
tanedione,but phloretin fails to do so, indicating that the 
chemical reacts in the substrate site, in a region outside the 
phloretin site (16,18). Phloretin's competitive mechanism 
could be explained by assuming that the inhibitor site partly 
overlaps the substrate site; but it is possible that wholly 
separate allosteric sites are involved.
3. Sodium tetrathionate
Tetrathionate reacts with thiol groups in proteins, and 
on reaction with the glucose carrier it produces a partial in­
hibition of transport, which persists after removal of the un­
reacted inhibitor (24). The inhibition develops gradually, as 
expected where a covalent bond is formed. The rate of the re­
action, i.e. the rate at which the transport system is inacti­
vated, is not significantly altered by equilibrated glucose 
(24), showing that the reaction takes place outside the sub­
strate site. Reversible competitive inhibitors bound exclu­
sively to the outward-facing carrier (maltose and phloretin) 
sharply increase the rate of inactivation; whereas reversible 
competitive inhibitors bound exclusively to the inward-facing 
carrier (cytochalasin B and androstenedione) almost completely 
protect the system against tetrathionate (6). It follows that 
tetrathionate reacts with the outward-facing but not the 
inward-facing carrier, as the following line of reasoning 
shows. In the absence of substrates or inhibitors, the ccar­
rier should be an equilibrium mixture of the inner and outer 
conformations, with only the outer form reacting with tetra­
thionate; and in the presence of equilibrated glucose, the 
equilibrium of inner and outer forms is not greatly disturbed, 
i.e. the proportion of the outer form is much the same as in 
the absence of glucose, and the rate of inactivation is there­
fore about the same. In the presence of an inhibitor bound 
exclusively to the outer conformation, all the carriers are 
drawn into the form of the outward-facing complex, and the
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rate of inactivation therefore increases greatly. In the pres­
ence of an inhibitor bound exclusively to the inner conforma­
tion, on the other hand, all the carriersiarerdrawn into the 
form of the inward-facing complex, which is unreactive with 
tetrathionate, and the inactivation rate is therefore reduced 
to near zero.
The question remains whether tetrathionate reacts with 
the carrier on the outer surface of the membrane, the inner 
surface, or both. Tetrathionate, being a large anion, would 
not be able to penetrate the cell membrane by passive diffu­
sion. However, it does slowly enter the red cell, as a sub­
strate of the anion-exchange carrier (25). When this system 
was inhibited, blocking the entry of tetrathionate, the rate 
of inactivation of glucose transport was unchanged (6). It 
may therefore be concluded that tetrathionate reacts only on 
the external surface of the red cell membrane.
B Choline transport
This carrier allows choline to equilibrate across the red 
cell membrane. It has a high degree of steric specificity for 
the substrate, and forms an exceptionally strong electrostatic 
bond with it. Distinct inward-facing and outward-facing car­
rier conformations function in transport, and the conventional 
carrier model has been found to provide a simple, unified ex­
planation of diverse observations on the system.
1. N-Ethylmaleimide (NEM)
NEM, a small, lipid-soluble molecule that rapidly enters 
the cell by passive diffusion across the cell membrane, pro­
gressively inhibits transport by reacting with a thiol group 
in the carrier (26). The reaction must be outside the sub­
strate site, as equilibrated choline gives the carrier no pro­
tection. The effects of substrate analogs located on either 
side of the membrane show that the thiol group with which NEM 
reacts is exposed in the inner carrier form and masked in the 
outer (26,27). The evidence may be summarized as follows. 
Non-transported substrate analogs bound exclusively or almost 
exclusively to the inward-facing carrier form (dipropylamino-
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ethanol and dibutylaminoethanol) sharply increase the rate of 
inactivation. By contrast, non-transported analogs bound ex­
clusively to the outward-facing carrier, such as N, N, Il­
dimé thy 1-n-pentyl (2-hydroxyethyl) ammonium ion, give almost 
complete protection. This evidence is similar to that for the 
case of tetrathionate inhibition of glucose transport, though 
in the reverse sense. Further evidence was obtained with a 
series of choline analogs transported at intermediate rates 
(27): the effect of an analog present in the external solution 
was found to be quantitatively related to its ability to alter 
the carrier partition between its inward-facing and outward­
facing forms in the steady state. A well transported analog, 
the carrier complex of which moves much faster than the free 
carrier, shifts the partition inward and accelerates the in­
activation. Analogs in the series with progressively lower 
transport rates are progressively less able to alter the par­
tition and to increase the rate of inactivation. Thus, an 
analog whose complex moves at the same rate as the free car­
rier would disturb neither the carrier partition nor the inac­
tivation rate. A slowly transported analog, whose complex is 
less mobile than the free carrier, shifts the partition out­
ward and, to a corresponding degree, reduces the rate of in­
activation .
The question of whether NEM reacts with the carrier on 
the inner or outer surface of the membrane may be approached 
as follows: since inactivation increases sharply as the pH is 
raised, the sidedness of the reaction may be determined by 
comparing the effects of internal and external pH. In the red 
cell, pH equilibration depends on the operation of the anion 
exchanger, and when this system is blocked by a specific inhi­
bitor, the pH inside and outside the cell may be controlled 
independently. The reaction with NEM is found to be indepen­
dent of the external pH, but sensitive to the internal pH (R. 
Deves and R. M. Krupka, to be published), and it may be con­
cluded that the reactive thiol group is only exposed on the 
cytoplasmic surface of the cell membrane.
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HYPOTHESIS
In each of the cases discussed, we find that an inhibi­
tory site is located partly or wholly outside the substrate 
site. The inhibitory site is accessible on only one side of 
the membrane, though not continuously so: rather, it is ex­
posed when the substrate site is exposed on that side of the 
membrane, and masked when the substrate site moves to the 
other side. A further point is that inhibitory sites —  dif­
ferent inhibitory sites —  are associated with both surfaces of 
the membrane.
An essential difference is apparent between the behavior 
of the substrate site and that of an inhibitory site, which 
could possibly provide a clue as to the function of the lat­
ter: the substrate site, in effect, moves right across the
membrane, allowing a bound substrate molecule to do the same, 
while the region of the carrier containing an inhibitory site 
could at best move part way across the membrane. On the other 
hand, the coincident exposure and closure of the two sites 
suggest that their functions could be interrelated. This co­
incidence, as well as the confinement of an inhibitory site to 
one side of the membrane, may be explained by assuming that 
the site lies within a channel on one side of the membrane, 
through which the substrate gains access to the substrate 
site; and more particularly, that it lies within the region of 
the channel postulated to open and close alternately, whose 
function, central to the operation of a transport protein, is 
to expose the substrate site on one side of the membrane in 
one carrier conformation, and then to seal it off in the other 
conformation (see Fig. 1).
It would follow that the investigation of these inhibi­
tory sites might provide evidence on the nature of the comple­
mentary protein surfaces that may reasonably be postulated to 
form the channel walls: these structures would appear to ad­
here closely to one another in one state, so as to prevent the 
diffusion of even small molecules or ions into the closed 
channel, and yet to separate from one another rather freely, 
coming into contact with the aqueous solution in the other
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state. The rates of separation and apposition must be rela­
tively high, since the rate of carrier reorientation, which 
limits the rate of transport, is dependent on this process. 
Possibly, therefore, the forces of association between the 
complementary surfaces would not be too strong, and would be 
balanced by the energy released when they are surrounded by 
water. It may be proposed that the two surfaces are formed by 
different domains in the carrier polypeptide chain.
If such surfaces form the sites of attachment for phlore- 
tin and cytochalasin B, then they are likely to be partly non­
polar, corresponding to the nonpolar character of the inhib­
itors. They may also contain the relatively nonpolar thiol 
group, which is involved in both the choline and glucose car­
rier. Other evidence (Deves, R. and Krupka, R.M., to be pub­
lished) suggests that in the choline carrier an ionizing group 
of pKa 6.8 may be present in the same area. Possibly these 
regions of the polypeptide chain comprise a mosaic of polar 
and nonpolar amino acid side chains, allowing them either to 
associate closely with one another, or to separate and inter­
act with the aqueous solution.
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DISCUSSION
RICARD:
I have two questions:
Is there any evidence for a role played by electrostatic 
attraction effects in choline transport? Is the transport 
process altered by a change of ionic strength?
Are there any inhibitors bound to the two sides of the 
gate? If so, they should behave as non-competitive for 
the entry and exit processes. Is that so?
KRUPKA:
We have not studied the effect of ionic strength on 
choline binding, partly because at low salt concentra­
tions the cells tend to become unstable; there is also 
the problem that with whole cells, which are used in our 
experiments, changes in the chloride concentration in 
the external solution produce large changes in membrane 
potential, and one would have to sort out the two effects. 
We do know, however, that the positive charge in the sub­
strate choline makes an unusually large contribution to 
the strength of binding, which is several orders of 
magnitude larger than in the case of acetylcholinesterase: 
a very strong electrostatic bond between the substrate and 
the carrier site must therefore be formed.
In answer to the second question, there are indeed inhib­
itors bound on both sides, for example certain steroids 
in the case of the glucose carrier. Here the inhibition 
of both entry and exit should be noncompetitive. However, 
such inhibitors do not have the properties we are looking 
for, and for this reason we have not considered them here.
CORNISH-BOWDEN:
You seem to be assuming in your models that your sub­
strate and inhibitor are always competitive in the me­
chanistic sense, i.e. that one or other may be bound but
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not both simultaneously. However, given that the two are 
quite different in structure, it seems likely that the in­
hibitor might bind after the substrate but might prevent 
the translocation (catalytic) step. It is not clear to me 
that any of your data exclude this possibility.
Second, you discussed whether phloretin and phlorizin 
might act in different ways at different sites. Although 
I agree with you that plausibility arguments make this 
unlikely, I suspect that experiments with both inhibitors 
present simultaneously would resolve this unambiguously.
KRUPKA:
Generally speaking, if the inhibitor is noncompetitive in 
the mechanistic sense, then the inhibition kinetics would 
be noncompetitive in all experiments, including entry and 
exit. The observed competitive inhibitors are therefore 
evidence for a competitive mechanism. The kinetic anal­
ysis of inhibition shows that equilibrium exchange 
provides the best test, and experiments in the literature, 
by Widdas and others, have also shown that the inhibition 
by phloretin and cytochalasin B is competitive in mecha­
nism .
In answer to the second question, I am afraid that even 
this test would not absolutely prove that both inhibitors 
bind at the same site, since one could postulate, rather 
implausibly it is true, that they bind at separate but 
interacting sites. Nevertheless, the demonstration of com­
petition between the inhibitors would add to the likeli­
hood that they bind at a single site, and this would prob­
ably be an experiment worth doing.
ASZALÓS:
Do you have any experience with quinine the voltage gated 
K+ channel inhibitor?
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KRUPKA:
No, we do not, though I think it would be interesting to 
examine the effect of quinine on the choline transporter.
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m atio n  o f  enzym e system s — 
tw o b ind ing  s ite s  m odel o f 
IgG  R c recep to r — in te ra c tio n  
o f  M HC an tig en s  a n d  recep to rs  
fo r p ep tid e  h o rm ones — m em ­
b ran e  d ynam ics an d  in fo rm a ­
tio n  tra n s fe r  — m o b ility  o f  
m em brane p ro te in s .
T he re ad e r m a y  e x p e c t to  
o b ta in  a  b road  u p d a te  on  c u r­
re n t issues in d y n am ic  fe a tu re s  
o f  m olecu lar a n d  ce llu la r sy s ­
tem s.
F ield  of in terest: th is  vo lum e 
will be o f  g re a t  va lue  an d  
in te re s t to  enzym olog ists , b io ­
chem ists, t r a n s p o r t  p h y sio lo ­
g ists, b iophysic ists , im m u n o lo ­
g ists, cell b io log ists, an d  o th e rs  
s tu d y in g  dy n am ic  p ro p e r tie s  o f 
b iochem ical sy s tem s  and  w ish ­
ing to  keep  a b re a s t o f  adv an ces 
in th is  rap id ly  ex p an d in g  field .
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